JP5313881B2 - テトラヒドロイソキノリン化合物 - Google Patents
テトラヒドロイソキノリン化合物 Download PDFInfo
- Publication number
- JP5313881B2 JP5313881B2 JP2009509297A JP2009509297A JP5313881B2 JP 5313881 B2 JP5313881 B2 JP 5313881B2 JP 2009509297 A JP2009509297 A JP 2009509297A JP 2009509297 A JP2009509297 A JP 2009509297A JP 5313881 B2 JP5313881 B2 JP 5313881B2
- Authority
- JP
- Japan
- Prior art keywords
- dihydroisoquinolin
- reaction
- preparation
- alkyl
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 title description 4
- -1 tetrahydroisoquinoline compound Chemical class 0.000 claims abstract description 246
- UWYZHKAOTLEWKK-UHFFFAOYSA-N tetrahydro-isoquinoline Natural products C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 claims abstract description 133
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 7
- 239000005557 antagonist Substances 0.000 claims abstract description 6
- 102000009410 Chemokine receptor Human genes 0.000 claims abstract description 5
- 108050000299 Chemokine receptor Proteins 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 89
- 150000003839 salts Chemical class 0.000 claims description 46
- 239000012453 solvate Substances 0.000 claims description 40
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims description 32
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000000623 heterocyclic group Chemical group 0.000 claims description 23
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 229910052736 halogen Inorganic materials 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 14
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 13
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- 208000006673 asthma Diseases 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 5
- SBBFSIQOOZQKKP-UHFFFAOYSA-N 4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-n-propan-2-ylaniline Chemical compound C1=CC(NC(C)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 SBBFSIQOOZQKKP-UHFFFAOYSA-N 0.000 claims description 5
- DGPANUZXNUTJOW-UHFFFAOYSA-N 4-[[2-[7-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-n-propan-2-ylaniline Chemical compound C1=CC(NC(C)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=C(F)C=C2C1 DGPANUZXNUTJOW-UHFFFAOYSA-N 0.000 claims description 5
- 208000031886 HIV Infections Diseases 0.000 claims description 5
- 208000037357 HIV infectious disease Diseases 0.000 claims description 5
- URORDZYAMABDCQ-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound N1=CC=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C URORDZYAMABDCQ-UHFFFAOYSA-N 0.000 claims description 5
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims description 5
- IOLIRYWWTZUZRD-UHFFFAOYSA-N n-[3-[[2-[3-[(4-chlorophenyl)methyl]-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(Cl)=CC=2)=C1 IOLIRYWWTZUZRD-UHFFFAOYSA-N 0.000 claims description 5
- DJOCPVYIQSSAJH-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-5-(methanesulfonamido)phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC(NS(=O)(=O)C)=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 DJOCPVYIQSSAJH-UHFFFAOYSA-N 0.000 claims description 5
- RTZPNLVBMMVRTR-UHFFFAOYSA-N n-ethyl-4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound C1=CC(NCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 RTZPNLVBMMVRTR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052727 yttrium Inorganic materials 0.000 claims description 5
- BZCZDYJXTHBPAS-UHFFFAOYSA-N 1-[3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 BZCZDYJXTHBPAS-UHFFFAOYSA-N 0.000 claims description 4
- PSXNYCCAUSONPM-UHFFFAOYSA-N 1-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 PSXNYCCAUSONPM-UHFFFAOYSA-N 0.000 claims description 4
- KKFHJKMDBMTQHZ-UHFFFAOYSA-N 2-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]propan-2-ol Chemical compound C1=CC(C(C)(O)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 KKFHJKMDBMTQHZ-UHFFFAOYSA-N 0.000 claims description 4
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 4
- 201000010105 allergic rhinitis Diseases 0.000 claims description 4
- 125000002541 furyl group Chemical group 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 4
- 125000001041 indolyl group Chemical group 0.000 claims description 4
- OTCUBZWQWCYTQD-UHFFFAOYSA-N n,n-diethyl-3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 OTCUBZWQWCYTQD-UHFFFAOYSA-N 0.000 claims description 4
- PJSDNTXPQILKLI-UHFFFAOYSA-N n,n-diethyl-3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 PJSDNTXPQILKLI-UHFFFAOYSA-N 0.000 claims description 4
- VMTNOBGPSZXCHM-UHFFFAOYSA-N n-[(4-tert-butylphenyl)methyl]-2-[3-[(4-chlorophenyl)methyl]-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(C(C)(C)C)=CC=C1CNCCN1C(CC=2C=CC(Cl)=CC=2)CC2=CC(F)=CC=C2C1 VMTNOBGPSZXCHM-UHFFFAOYSA-N 0.000 claims description 4
- XHZGAMVJANPMBO-UHFFFAOYSA-N n-[(4-tert-butylphenyl)methyl]-2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(C(C)(C)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 XHZGAMVJANPMBO-UHFFFAOYSA-N 0.000 claims description 4
- USPSOTKRUJXQMU-UHFFFAOYSA-N n-[(4-tert-butylphenyl)methyl]-2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(C(C)(C)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 USPSOTKRUJXQMU-UHFFFAOYSA-N 0.000 claims description 4
- WDUANCPTTZQWSY-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 WDUANCPTTZQWSY-UHFFFAOYSA-N 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 4
- 125000005493 quinolyl group Chemical group 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- LGLSWIYCJZCHHJ-UHFFFAOYSA-N 4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-n-(2-methoxyethyl)aniline Chemical compound C1=CC(NCCOC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 LGLSWIYCJZCHHJ-UHFFFAOYSA-N 0.000 claims description 3
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 3
- 208000011231 Crohn disease Diseases 0.000 claims description 3
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 3
- 201000008937 atopic dermatitis Diseases 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 201000009890 sinusitis Diseases 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 521
- 238000002360 preparation method Methods 0.000 description 486
- 150000001875 compounds Chemical class 0.000 description 475
- 238000005160 1H NMR spectroscopy Methods 0.000 description 434
- 239000003921 oil Substances 0.000 description 414
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 264
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 230
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 165
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 160
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 112
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 111
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 102
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 102
- 239000000203 mixture Substances 0.000 description 99
- 239000012044 organic layer Substances 0.000 description 97
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 92
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 91
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 91
- 230000002829 reductive effect Effects 0.000 description 88
- 239000002904 solvent Substances 0.000 description 87
- 239000000243 solution Substances 0.000 description 86
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 85
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 78
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 78
- 238000004519 manufacturing process Methods 0.000 description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 69
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 61
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 60
- 239000011541 reaction mixture Substances 0.000 description 59
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 58
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 51
- 235000017557 sodium bicarbonate Nutrition 0.000 description 51
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 46
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 39
- 235000002639 sodium chloride Nutrition 0.000 description 36
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 34
- 238000001816 cooling Methods 0.000 description 34
- 238000000034 method Methods 0.000 description 34
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 33
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 33
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 30
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 30
- 229920006395 saturated elastomer Polymers 0.000 description 30
- 239000002585 base Substances 0.000 description 29
- 238000010898 silica gel chromatography Methods 0.000 description 29
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 27
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- 239000002253 acid Substances 0.000 description 25
- 239000003153 chemical reaction reagent Substances 0.000 description 25
- 229910000027 potassium carbonate Inorganic materials 0.000 description 23
- 125000006239 protecting group Chemical group 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 21
- 235000011054 acetic acid Nutrition 0.000 description 19
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 18
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- 239000012267 brine Substances 0.000 description 18
- 239000012043 crude product Substances 0.000 description 18
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 18
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 17
- 239000012279 sodium borohydride Substances 0.000 description 17
- 229910000033 sodium borohydride Inorganic materials 0.000 description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 15
- 239000001257 hydrogen Substances 0.000 description 15
- 229910000029 sodium carbonate Inorganic materials 0.000 description 15
- 239000010410 layer Substances 0.000 description 14
- 239000012300 argon atmosphere Substances 0.000 description 13
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 13
- 150000002576 ketones Chemical class 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 12
- PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000012230 colorless oil Substances 0.000 description 12
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 12
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 12
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 11
- 239000012280 lithium aluminium hydride Substances 0.000 description 11
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 239000012298 atmosphere Substances 0.000 description 10
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 9
- 210000003979 eosinophil Anatomy 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 9
- TVEATUXLUJMMIF-UHFFFAOYSA-N 3-[(4-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(F)=CC=C1CC1NCC2=CC=CC=C2C1 TVEATUXLUJMMIF-UHFFFAOYSA-N 0.000 description 8
- DYULYGZNVYGVAN-UHFFFAOYSA-N 3-benzyl-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1CC1=CC=CC=C1 DYULYGZNVYGVAN-UHFFFAOYSA-N 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000002194 synthesizing effect Effects 0.000 description 8
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 description 7
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- 239000003638 chemical reducing agent Substances 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 238000010511 deprotection reaction Methods 0.000 description 7
- 150000002537 isoquinolines Chemical class 0.000 description 7
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 7
- DUZMTCNYUWRPRZ-UHFFFAOYSA-N 2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound NCCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 DUZMTCNYUWRPRZ-UHFFFAOYSA-N 0.000 description 6
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 6
- GDXXYJRQFQZYNL-UHFFFAOYSA-N 9h-fluoren-1-ylmethyl carbamate Chemical compound C1C2=CC=CC=C2C2=C1C(COC(=O)N)=CC=C2 GDXXYJRQFQZYNL-UHFFFAOYSA-N 0.000 description 6
- 239000012448 Lithium borohydride Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000008595 infiltration Effects 0.000 description 6
- 238000001764 infiltration Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000002808 molecular sieve Substances 0.000 description 6
- BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 6
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 6
- IOEPOEDBBPRAEI-UHFFFAOYSA-N 1,2-dihydroisoquinoline Chemical compound C1=CC=C2CNC=CC2=C1 IOEPOEDBBPRAEI-UHFFFAOYSA-N 0.000 description 5
- HXGHMCLCSPQMOR-UHFFFAOYSA-N 3-chloro-2-methylbenzoic acid Chemical compound CC1=C(Cl)C=CC=C1C(O)=O HXGHMCLCSPQMOR-UHFFFAOYSA-N 0.000 description 5
- LCXWXBGRPSHICV-UHFFFAOYSA-N 6-fluoro-3-[(4-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(F)=CC=C1CC1NCC2=CC=C(F)C=C2C1 LCXWXBGRPSHICV-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 238000010531 catalytic reduction reaction Methods 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 5
- 150000002367 halogens Chemical class 0.000 description 5
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 5
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 5
- XMMYDIUCQUKLEC-UHFFFAOYSA-N isoquinoline;1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1.C1=NC=CC2=CC=CC=C21 XMMYDIUCQUKLEC-UHFFFAOYSA-N 0.000 description 5
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 5
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 229910003446 platinum oxide Inorganic materials 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 4
- GEKRISJWBAIIAA-UHFFFAOYSA-N 5-methylhexanal Chemical compound CC(C)CCCC=O GEKRISJWBAIIAA-UHFFFAOYSA-N 0.000 description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KGIRCIQLZWQLNY-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=CC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C KGIRCIQLZWQLNY-UHFFFAOYSA-N 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- LKXYJYDRLBPHRS-UHFFFAOYSA-N bromocyclopropane Chemical compound BrC1CC1 LKXYJYDRLBPHRS-UHFFFAOYSA-N 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- 229910052757 nitrogen Chemical group 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- FJANNOJSTOGZHK-UHFFFAOYSA-N 1-adamantyl carbamate Chemical compound C1C(C2)CC3CC2CC1(OC(=O)N)C3 FJANNOJSTOGZHK-UHFFFAOYSA-N 0.000 description 3
- QBELEDRHMPMKHP-UHFFFAOYSA-N 1-bromo-2-chlorobenzene Chemical compound ClC1=CC=CC=C1Br QBELEDRHMPMKHP-UHFFFAOYSA-N 0.000 description 3
- QPLJYAKLSCXZSF-UHFFFAOYSA-N 2,2,2-trichloroethyl carbamate Chemical compound NC(=O)OCC(Cl)(Cl)Cl QPLJYAKLSCXZSF-UHFFFAOYSA-N 0.000 description 3
- HVCORBMTSJAUPJ-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound NCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 HVCORBMTSJAUPJ-UHFFFAOYSA-N 0.000 description 3
- MPQGOGFABYJFJP-UHFFFAOYSA-N 2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-5-amine Chemical compound CC(C)CC1CC2=C(N)C=CC=C2CN1CCNCC1=CC=CC=C1 MPQGOGFABYJFJP-UHFFFAOYSA-N 0.000 description 3
- UAKIKRZYVPPKIQ-UHFFFAOYSA-N 2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-amine Chemical compound CC(C)CC1CC2=CC=C(N)C=C2CN1CCNCC1=CC=CC=C1 UAKIKRZYVPPKIQ-UHFFFAOYSA-N 0.000 description 3
- CEAXWPDVLUCACQ-UHFFFAOYSA-N 2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-8-amine Chemical compound CC(C)CC1CC2=CC=CC(N)=C2CN1CCNCC1=CC=CC=C1 CEAXWPDVLUCACQ-UHFFFAOYSA-N 0.000 description 3
- FVMWOYIAYZAQSD-UHFFFAOYSA-N 2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-nitrophenyl)methyl]ethanamine Chemical compound [O-][N+](=O)C1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 FVMWOYIAYZAQSD-UHFFFAOYSA-N 0.000 description 3
- JEMYMMFITNUMJP-UHFFFAOYSA-N 2-benzyl-6-fluoro-3,4-dihydro-1h-isoquinoline-3-carboxylic acid Chemical compound OC(=O)C1CC2=CC(F)=CC=C2CN1CC1=CC=CC=C1 JEMYMMFITNUMJP-UHFFFAOYSA-N 0.000 description 3
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- GCGBPPCSOJNFDC-UHFFFAOYSA-N 2-oxoethyl carbamate Chemical compound NC(=O)OCC=O GCGBPPCSOJNFDC-UHFFFAOYSA-N 0.000 description 3
- QWYTUBPAXJYCTH-UHFFFAOYSA-N 2-trimethylsilylethyl carbamate Chemical compound C[Si](C)(C)CCOC(N)=O QWYTUBPAXJYCTH-UHFFFAOYSA-N 0.000 description 3
- NKSZCPBUWGZONP-UHFFFAOYSA-N 3,4-dihydroisoquinoline Chemical compound C1=CC=C2C=NCCC2=C1 NKSZCPBUWGZONP-UHFFFAOYSA-N 0.000 description 3
- AMJQHOGLKIZODY-UHFFFAOYSA-N 3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNC(CC(C)C)CC2=C1 AMJQHOGLKIZODY-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- FZTAXMPYFVERJO-UHFFFAOYSA-N 4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound C1=CC(N)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 FZTAXMPYFVERJO-UHFFFAOYSA-N 0.000 description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 3
- OTXINXDGSUFPNU-UHFFFAOYSA-N 4-tert-butylbenzaldehyde Chemical compound CC(C)(C)C1=CC=C(C=O)C=C1 OTXINXDGSUFPNU-UHFFFAOYSA-N 0.000 description 3
- LSVRTMXEBSTIEF-UHFFFAOYSA-N 7-fluoro-3-[(4-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(F)=CC=C1CC1NCC2=CC(F)=CC=C2C1 LSVRTMXEBSTIEF-UHFFFAOYSA-N 0.000 description 3
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 3
- ZZOKVYOCRSMTSS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl carbamate Chemical compound C1=CC=C2C(COC(=O)N)C3=CC=CC=C3C2=C1 ZZOKVYOCRSMTSS-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 3
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 101150003085 Pdcl gene Proteins 0.000 description 3
- 235000002597 Solanum melongena Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 208000002205 allergic conjunctivitis Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 208000024998 atopic conjunctivitis Diseases 0.000 description 3
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 3
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 3
- LVKCSZQWLOVUGB-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].C[CH-]C LVKCSZQWLOVUGB-UHFFFAOYSA-M 0.000 description 3
- AYLPUAIRASFOJG-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 AYLPUAIRASFOJG-UHFFFAOYSA-N 0.000 description 3
- BWOWOLLMMZBHAQ-UHFFFAOYSA-N n-methoxy-n-methylisoquinoline-3-carboxamide Chemical compound C1=CC=C2C=NC(C(=O)N(C)OC)=CC2=C1 BWOWOLLMMZBHAQ-UHFFFAOYSA-N 0.000 description 3
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 3
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 3
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical class O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 3
- 150000002993 phenylalanine derivatives Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- DUOOWHFGXZMCRC-UHFFFAOYSA-N tert-butyl n-[(3-aminophenyl)methyl]-n-[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]carbamate Chemical compound C=1C=CC(N)=CC=1CN(C(=O)OC(C)(C)C)CCN1CC2=CC=CC=C2CC1CC1=CC=C(F)C=C1 DUOOWHFGXZMCRC-UHFFFAOYSA-N 0.000 description 3
- XVSGJKVILBFMPB-UHFFFAOYSA-N tert-butyl n-[(3-chloro-2-methylphenyl)methyl]carbamate Chemical compound CC1=C(Cl)C=CC=C1CNC(=O)OC(C)(C)C XVSGJKVILBFMPB-UHFFFAOYSA-N 0.000 description 3
- RXJOEKWQWAKFSV-UHFFFAOYSA-N tert-butyl n-benzyl-n-(2-oxoethyl)carbamate Chemical compound CC(C)(C)OC(=O)N(CC=O)CC1=CC=CC=C1 RXJOEKWQWAKFSV-UHFFFAOYSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- LVLANIHJQRZTPY-UHFFFAOYSA-N vinyl carbamate Chemical compound NC(=O)OC=C LVLANIHJQRZTPY-UHFFFAOYSA-N 0.000 description 3
- BIRYISZHZQLKBV-UHFFFAOYSA-N (2-benzyl-6-fluoro-3,4-dihydro-1h-isoquinolin-3-yl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1CC2=CC(F)=CC=C2CN1CC1=CC=CC=C1 BIRYISZHZQLKBV-UHFFFAOYSA-N 0.000 description 2
- KMRUOPWMFMXHMI-UHFFFAOYSA-N (2-ethylpyridin-4-yl)methanol Chemical compound CCC1=CC(CO)=CC=N1 KMRUOPWMFMXHMI-UHFFFAOYSA-N 0.000 description 2
- QTGFEUBWVORKPJ-UHFFFAOYSA-N (2-ethylpyridin-4-yl)methyl methanesulfonate Chemical compound CCC1=CC(COS(C)(=O)=O)=CC=N1 QTGFEUBWVORKPJ-UHFFFAOYSA-N 0.000 description 2
- LESUPVCBJDWKJH-UHFFFAOYSA-N (3-chloro-2-methylphenyl)methanamine Chemical compound CC1=C(Cl)C=CC=C1CN LESUPVCBJDWKJH-UHFFFAOYSA-N 0.000 description 2
- AHZGUZWGHGQNDN-UHFFFAOYSA-N (3-chloro-2-methylphenyl)methanol Chemical compound CC1=C(Cl)C=CC=C1CO AHZGUZWGHGQNDN-UHFFFAOYSA-N 0.000 description 2
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 2
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- VQGDDCYJQRWDJY-UHFFFAOYSA-N 1,1,1-trifluoro-n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=C(NS(=O)(=O)C(F)(F)F)C=CC=2)CC2=CC=C(F)C=C2C1 VQGDDCYJQRWDJY-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RZYPBXIFDQKVDT-UHFFFAOYSA-N 1-(3-fluorophenyl)-4-methylpentan-2-ol Chemical compound CC(C)CC(O)CC1=CC=CC(F)=C1 RZYPBXIFDQKVDT-UHFFFAOYSA-N 0.000 description 2
- NDZYPHLNJZSQJY-QNWVGRARSA-N 1-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-3-[(1r,2s)-2-[[(3s)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]methyl]cyclohexyl]urea Chemical compound CC1=C(C(=O)C)SC(NC(=O)N[C@H]2[C@@H](CCCC2)CN2C[C@H](CC=3C=CC(F)=CC=3)CCC2)=N1 NDZYPHLNJZSQJY-QNWVGRARSA-N 0.000 description 2
- ONBRNYXILJPWQW-UHFFFAOYSA-N 1-[2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-yl]ethanone Chemical compound CC(C)CC1CC2=CC=C(C(C)=O)C=C2CN1CCNCC1=CC=CC=C1 ONBRNYXILJPWQW-UHFFFAOYSA-N 0.000 description 2
- CWCVODASTCJVBQ-UHFFFAOYSA-N 1-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 CWCVODASTCJVBQ-UHFFFAOYSA-N 0.000 description 2
- DAZMGVRGYCCIFY-UHFFFAOYSA-N 1-[4-[[2-[2-(benzylamino)ethyl]-3,4-dihydro-1h-isoquinolin-3-yl]methyl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 DAZMGVRGYCCIFY-UHFFFAOYSA-N 0.000 description 2
- NIXYHFWGICUSLK-UHFFFAOYSA-N 1-[7-acetyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]-2,2,2-trifluoroethanone Chemical compound C1=C(C(C)=O)C=C2CN(C(=O)C(F)(F)F)C(CC(C)C)CC2=C1 NIXYHFWGICUSLK-UHFFFAOYSA-N 0.000 description 2
- HXTMQWIYPHKZSY-UHFFFAOYSA-N 1-chloro-3-(chloromethyl)-2-methylbenzene Chemical compound CC1=C(Cl)C=CC=C1CCl HXTMQWIYPHKZSY-UHFFFAOYSA-N 0.000 description 2
- ADZUEEUKBYCSEY-UHFFFAOYSA-N 1h-indole-5-carbaldehyde Chemical compound O=CC1=CC=C2NC=CC2=C1 ADZUEEUKBYCSEY-UHFFFAOYSA-N 0.000 description 2
- JTHPYPYGISRPQY-UHFFFAOYSA-N 2,2,2-trifluoro-1-[3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanone Chemical compound C1=CC=C2CN(C(=O)C(F)(F)F)C(CC(C)C)CC2=C1 JTHPYPYGISRPQY-UHFFFAOYSA-N 0.000 description 2
- HIKRJHFHGKZKRI-UHFFFAOYSA-N 2,4,6-trimethylbenzaldehyde Chemical compound CC1=CC(C)=C(C=O)C(C)=C1 HIKRJHFHGKZKRI-UHFFFAOYSA-N 0.000 description 2
- AJOGMCIATUBFAT-UHFFFAOYSA-N 2-(1-adamantyl)propan-2-ylcarbamic acid Chemical compound C1C(C2)CC3CC2CC1(C(C)(NC(O)=O)C)C3 AJOGMCIATUBFAT-UHFFFAOYSA-N 0.000 description 2
- VPVFQDMANSFAHW-UHFFFAOYSA-N 2-(3,5-ditert-butylphenyl)propan-2-ylcarbamic acid Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C(C)(C)NC(O)=O)=C1 VPVFQDMANSFAHW-UHFFFAOYSA-N 0.000 description 2
- CNDFVCQBHBRZOS-UHFFFAOYSA-N 2-(3-bromophenyl)-2-propan-2-yl-1,3-dioxolane Chemical compound C=1C=CC(Br)=CC=1C1(C(C)C)OCCO1 CNDFVCQBHBRZOS-UHFFFAOYSA-N 0.000 description 2
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 2
- WSDYWTLQDFKKPC-UHFFFAOYSA-N 2-[(3-chloro-2-methylphenyl)methyl]isoindole-1,3-dione Chemical compound CC1=C(Cl)C=CC=C1CN1C(=O)C2=CC=CC=C2C1=O WSDYWTLQDFKKPC-UHFFFAOYSA-N 0.000 description 2
- OGOJCOWNOXOGRY-UHFFFAOYSA-N 2-[(3-nitrophenyl)methylamino]ethanol Chemical compound OCCNCC1=CC=CC([N+]([O-])=O)=C1 OGOJCOWNOXOGRY-UHFFFAOYSA-N 0.000 description 2
- WAGIKNJEOPPAJN-UHFFFAOYSA-N 2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-6-amine Chemical compound CC(C)CC1CC2=CC(N)=CC=C2CN1CCNCC1=CC=CC=C1 WAGIKNJEOPPAJN-UHFFFAOYSA-N 0.000 description 2
- ZZBLRMUCAGCIGZ-UHFFFAOYSA-N 2-[3-[(4-chlorophenyl)methyl]-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound NCCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(Cl)C=C1 ZZBLRMUCAGCIGZ-UHFFFAOYSA-N 0.000 description 2
- HHRPNYFPQPGLQJ-UHFFFAOYSA-N 2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methyl-3-nitrophenyl)methyl]ethanamine Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 HHRPNYFPQPGLQJ-UHFFFAOYSA-N 0.000 description 2
- HAKAEAOJYMRHNF-UHFFFAOYSA-N 2-anilino-1-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanone Chemical compound C1C2=CC=CC=C2CC(CC=2C=CC=CC=2)N1C(=O)CNC1=CC=CC=C1 HAKAEAOJYMRHNF-UHFFFAOYSA-N 0.000 description 2
- XIJHPNPXBNSFBC-UHFFFAOYSA-N 2-benzyl-6-fluoro-3,4-dihydro-1H-isoquinoline Chemical compound C1CC2=CC(F)=CC=C2CN1CC1=CC=CC=C1 XIJHPNPXBNSFBC-UHFFFAOYSA-N 0.000 description 2
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- NTWBHJYRDKBGBR-UHFFFAOYSA-N 2-ethylbenzaldehyde Chemical compound CCC1=CC=CC=C1C=O NTWBHJYRDKBGBR-UHFFFAOYSA-N 0.000 description 2
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- DXHGIBOFIAYSDE-UHFFFAOYSA-N 2-methyl-n-(5-methylhexylidene)propane-1-sulfinamide Chemical compound CC(C)CCCC=NS(=O)CC(C)C DXHGIBOFIAYSDE-UHFFFAOYSA-N 0.000 description 2
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 2
- LPTJGJKNRQDZLV-UHFFFAOYSA-N 2-phenylethyl n-ethylcarbamate Chemical compound CCNC(=O)OCCC1=CC=CC=C1 LPTJGJKNRQDZLV-UHFFFAOYSA-N 0.000 description 2
- QJEVTQXYAOHBEY-UHFFFAOYSA-N 3-(2-propan-2-yl-1,3-dioxolan-2-yl)benzaldehyde Chemical compound C=1C=CC(C=O)=CC=1C1(C(C)C)OCCO1 QJEVTQXYAOHBEY-UHFFFAOYSA-N 0.000 description 2
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 2
- BPGULSVLAPCRPI-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC(F)=CC=C2CNC1CC1=CC=C(Cl)C=C1 BPGULSVLAPCRPI-UHFFFAOYSA-N 0.000 description 2
- IPXOVSAHFWXYFG-UHFFFAOYSA-N 3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 IPXOVSAHFWXYFG-UHFFFAOYSA-N 0.000 description 2
- ZNYGUJDHUSZDJO-UHFFFAOYSA-N 3-benzyl-6-fluoro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC(F)=CC=C2CNC1CC1=CC=CC=C1 ZNYGUJDHUSZDJO-UHFFFAOYSA-N 0.000 description 2
- NWWAXNAOOUDEBG-UHFFFAOYSA-N 3-benzylisoquinoline Chemical compound C=1C2=CC=CC=C2C=NC=1CC1=CC=CC=C1 NWWAXNAOOUDEBG-UHFFFAOYSA-N 0.000 description 2
- ATSBTGDYKIKNDI-UHFFFAOYSA-N 3-ethenyl-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]-5-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC(C=C)=CC(C(=O)NCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 ATSBTGDYKIKNDI-UHFFFAOYSA-N 0.000 description 2
- HGZJJKZPPMFIBU-UHFFFAOYSA-N 3-formylbenzonitrile Chemical compound O=CC1=CC=CC(C#N)=C1 HGZJJKZPPMFIBU-UHFFFAOYSA-N 0.000 description 2
- RBIGKSZIQCTIJF-UHFFFAOYSA-N 3-formylthiophene Chemical compound O=CC=1C=CSC=1 RBIGKSZIQCTIJF-UHFFFAOYSA-N 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- QCBSHOMDNLCSSL-UHFFFAOYSA-N 4-(2-methyl-1,3-dioxolan-2-yl)benzaldehyde Chemical compound C=1C=C(C=O)C=CC=1C1(C)OCCO1 QCBSHOMDNLCSSL-UHFFFAOYSA-N 0.000 description 2
- UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- WRQVNFXBYPQFMR-UHFFFAOYSA-N 4-methyl-1-(2-methylphenyl)pentan-2-amine Chemical compound CC(C)CC(N)CC1=CC=CC=C1C WRQVNFXBYPQFMR-UHFFFAOYSA-N 0.000 description 2
- FOAQOAXQMISINY-UHFFFAOYSA-N 4-morpholin-4-ylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1N1CCOCC1 FOAQOAXQMISINY-UHFFFAOYSA-N 0.000 description 2
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 2
- ISDBWOPVZKNQDW-UHFFFAOYSA-N 4-phenylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC=CC=C1 ISDBWOPVZKNQDW-UHFFFAOYSA-N 0.000 description 2
- LADWQVSXGNCVNF-UHFFFAOYSA-N 6-methyl-3-(2-methylpropyl)-3,4-dihydroisoquinoline Chemical compound CC1=CC=C2C=NC(CC(C)C)CC2=C1 LADWQVSXGNCVNF-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PYFCNOHAJLOZTC-UHFFFAOYSA-N C(C)C=1C=NC=CC1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound C(C)C=1C=NC=CC1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C PYFCNOHAJLOZTC-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- CDEMHJCJMMOFMB-UHFFFAOYSA-M ClC1=CC=C([Mg]Br)C=C1 Chemical compound ClC1=CC=C([Mg]Br)C=C1 CDEMHJCJMMOFMB-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102100023688 Eotaxin Human genes 0.000 description 2
- 101710139422 Eotaxin Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- XFYAWPAZTYPJEZ-UHFFFAOYSA-N N-[2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1H-isoquinolin-6-yl]acetamide Chemical compound CC(C)CC1CC2=CC(NC(C)=O)=CC=C2CN1CCNCC1=CC=CC=C1 XFYAWPAZTYPJEZ-UHFFFAOYSA-N 0.000 description 2
- VVIGODUJDYZFJW-UHFFFAOYSA-N N-[2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1H-isoquinolin-7-yl]acetamide Chemical compound CC(C)CC1CC2=CC=C(NC(C)=O)C=C2CN1CCNCC1=CC=CC=C1 VVIGODUJDYZFJW-UHFFFAOYSA-N 0.000 description 2
- KFEUUDPTIWTUCH-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CCN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound N1=CC=C(C=C1)NC(CCN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C KFEUUDPTIWTUCH-UHFFFAOYSA-N 0.000 description 2
- KVTKGPKOERVARC-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CN1CC2=CC(=CC=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=CC=C(C=C1)NC(CN1CC2=CC(=CC=C2CC1CC1=CC=C(C=C1)F)F)C KVTKGPKOERVARC-UHFFFAOYSA-N 0.000 description 2
- YSJWBZOLJLXTLT-UHFFFAOYSA-N N1C=NC2=C1C=CC(=C2)NC(CN2CC1=CC=C(C=C1CC2CC2=CC=C(C=C2)F)F)C Chemical compound N1C=NC2=C1C=CC(=C2)NC(CN2CC1=CC=C(C=C1CC2CC2=CC=C(C=C2)F)F)C YSJWBZOLJLXTLT-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 2
- NEWDWVCIZOCAHK-UHFFFAOYSA-N [2-(4-methoxyphenyl)-2-oxoethyl]carbamic acid Chemical compound COC1=CC=C(C(=O)CNC(O)=O)C=C1 NEWDWVCIZOCAHK-UHFFFAOYSA-N 0.000 description 2
- CCOALSBHGYNLLS-UHFFFAOYSA-M [Br-].FC1=CC=CC=C1[Mg+] Chemical compound [Br-].FC1=CC=CC=C1[Mg+] CCOALSBHGYNLLS-UHFFFAOYSA-M 0.000 description 2
- RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- YMHOWYPCFBSSAA-UHFFFAOYSA-N isoquinolin-3-yl(phenyl)methanone Chemical compound C=1C2=CC=CC=C2C=NC=1C(=O)C1=CC=CC=C1 YMHOWYPCFBSSAA-UHFFFAOYSA-N 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 2
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- DQDWATOXYCARFV-UHFFFAOYSA-M magnesium;2-methanidylpropane;bromide Chemical compound [Mg+2].[Br-].CC(C)[CH2-] DQDWATOXYCARFV-UHFFFAOYSA-M 0.000 description 2
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 description 2
- SBVAHKLCEFVYTE-UHFFFAOYSA-N methyl 3-[(3-benzyl-8-fluoro-1h-isoquinolin-2-yl)sulfonyl]propanoate Chemical compound COC(=O)CCS(=O)(=O)N1CC2=C(F)C=CC=C2C=C1CC1=CC=CC=C1 SBVAHKLCEFVYTE-UHFFFAOYSA-N 0.000 description 2
- OXABODPWZZTKFE-UHFFFAOYSA-N methyl 3-[(3-benzyl-8-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)sulfonyl]propanoate Chemical compound COC(=O)CCS(=O)(=O)N1CC2=C(F)C=CC=C2CC1CC1=CC=CC=C1 OXABODPWZZTKFE-UHFFFAOYSA-N 0.000 description 2
- NVRBFAAAYVABRB-UHFFFAOYSA-N methyl 3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzoate Chemical compound COC(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 NVRBFAAAYVABRB-UHFFFAOYSA-N 0.000 description 2
- FYMPGRLIJXTJHI-UHFFFAOYSA-N methyl 3-[[2-fluoro-6-(3-phenylprop-2-enyl)phenyl]methylsulfamoyl]propanoate Chemical compound COC(=O)CCS(=O)(=O)NCC1=C(F)C=CC=C1CC=CC1=CC=CC=C1 FYMPGRLIJXTJHI-UHFFFAOYSA-N 0.000 description 2
- YNMNJPSYJOLCAZ-UHFFFAOYSA-N methyl 3-benzoyl-7-fluoro-3,4-dihydro-1h-isoquinoline-2-carboxylate Chemical compound COC(=O)N1CC2=CC(F)=CC=C2CC1C(=O)C1=CC=CC=C1 YNMNJPSYJOLCAZ-UHFFFAOYSA-N 0.000 description 2
- MDKIMAVCFBYLJS-UHFFFAOYSA-N methyl 4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 MDKIMAVCFBYLJS-UHFFFAOYSA-N 0.000 description 2
- ADWFVXIVJJLXSB-UHFFFAOYSA-N methyl 5-methyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinoline-2-carboxylate Chemical compound C1=CC(C)=C2CC(CC(C)C)N(C(=O)OC)CC2=C1 ADWFVXIVJJLXSB-UHFFFAOYSA-N 0.000 description 2
- UXDXURSGQKKSJW-UHFFFAOYSA-N methyl 6-fluoro-1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical compound FC1=CC=C2CNC(C(=O)OC)CC2=C1 UXDXURSGQKKSJW-UHFFFAOYSA-N 0.000 description 2
- YVOUNAIHOXXDQS-UHFFFAOYSA-N methyl 7-fluoro-3,4-dihydro-1H-isoquinoline-2-carboxylate Chemical compound C1=C(F)C=C2CN(C(=O)OC)CCC2=C1 YVOUNAIHOXXDQS-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- XFXNRWXAMSOJPY-UHFFFAOYSA-N methyl n-[4-methyl-1-(2-methylphenyl)pentan-2-yl]carbamate Chemical compound COC(=O)NC(CC(C)C)CC1=CC=CC=C1C XFXNRWXAMSOJPY-UHFFFAOYSA-N 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- HMYIYZWYYMNGCY-UHFFFAOYSA-N n,n-diethyl-3-formylbenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C=O)=C1 HMYIYZWYYMNGCY-UHFFFAOYSA-N 0.000 description 2
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 2
- GETGAZVYEDZLAS-UHFFFAOYSA-N n-[(2-ethylpyridin-4-yl)methyl]-2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=NC(CC)=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 GETGAZVYEDZLAS-UHFFFAOYSA-N 0.000 description 2
- PAPLAUMNTWAXBK-UHFFFAOYSA-N n-[(4-ethylphenyl)methyl]-2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(CC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 PAPLAUMNTWAXBK-UHFFFAOYSA-N 0.000 description 2
- VORJPJUOIOYYFT-UHFFFAOYSA-N n-[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]aniline Chemical compound C=1C=CC=CC=1NCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 VORJPJUOIOYYFT-UHFFFAOYSA-N 0.000 description 2
- OVKOKIVKNCDYQL-UHFFFAOYSA-N n-[2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-5-yl]acetamide Chemical compound CC(C)CC1CC(C(=CC=C2)NC(C)=O)=C2CN1CCNCC1=CC=CC=C1 OVKOKIVKNCDYQL-UHFFFAOYSA-N 0.000 description 2
- MUZBIWOJNZPGDQ-UHFFFAOYSA-N n-[2-[2-(benzylamino)ethyl]-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-8-yl]acetamide Chemical compound CC(C)CC1CC2=CC=CC(NC(C)=O)=C2CN1CCNCC1=CC=CC=C1 MUZBIWOJNZPGDQ-UHFFFAOYSA-N 0.000 description 2
- SHBWGSPOAQJCLM-UHFFFAOYSA-N n-[3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 SHBWGSPOAQJCLM-UHFFFAOYSA-N 0.000 description 2
- XMEIPIIJKZMAQU-UHFFFAOYSA-N n-[3-[[2-[6-chloro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(Cl)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 XMEIPIIJKZMAQU-UHFFFAOYSA-N 0.000 description 2
- JAHZCLBGUQQLBQ-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CC(C)CC1CC2=CC(F)=CC=C2CN1CCNCC1=CC=CC(NS(C)(=O)=O)=C1 JAHZCLBGUQQLBQ-UHFFFAOYSA-N 0.000 description 2
- JUIFIHVYZFUVQU-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(2-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C(=CC=CC=2)F)=C1 JUIFIHVYZFUVQU-UHFFFAOYSA-N 0.000 description 2
- YSJXQPJNIDWCGR-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 YSJXQPJNIDWCGR-UHFFFAOYSA-N 0.000 description 2
- OTWXLNCICZINIQ-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]ethanesulfonamide Chemical compound CCS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 OTWXLNCICZINIQ-UHFFFAOYSA-N 0.000 description 2
- PPHINCBZTWKZNZ-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]propane-1-sulfonamide Chemical compound CCCS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 PPHINCBZTWKZNZ-UHFFFAOYSA-N 0.000 description 2
- RYQRJBHCZOJTFZ-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]propane-2-sulfonamide Chemical compound CC(C)S(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 RYQRJBHCZOJTFZ-UHFFFAOYSA-N 0.000 description 2
- ISVMIJSINAXQNZ-UHFFFAOYSA-N n-[3-[[2-[7-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(CNCCN2C(CC3=CC=C(F)C=C3C2)CC=2C=CC(F)=CC=2)=C1 ISVMIJSINAXQNZ-UHFFFAOYSA-N 0.000 description 2
- BOOOEGYUEOILMG-UHFFFAOYSA-N n-[3-ethyl-5-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC(CC)=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 BOOOEGYUEOILMG-UHFFFAOYSA-N 0.000 description 2
- RTXGOPAORXYQTP-UHFFFAOYSA-N n-[4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 RTXGOPAORXYQTP-UHFFFAOYSA-N 0.000 description 2
- UQVLDVBDYSSYKO-UHFFFAOYSA-N n-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]-2-methoxyacetamide Chemical compound C1=CC(NC(=O)COC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 UQVLDVBDYSSYKO-UHFFFAOYSA-N 0.000 description 2
- YCBODLGSKLAPHS-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-5-chloro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CC1CC=2C(Cl)=CC=CC=2CN1CCNCC1=CC=CC=C1 YCBODLGSKLAPHS-UHFFFAOYSA-N 0.000 description 2
- VZBBURDYQRFHAA-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-5-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CC1CC=2C(F)=CC=CC=2CN1CCNCC1=CC=CC=C1 VZBBURDYQRFHAA-UHFFFAOYSA-N 0.000 description 2
- QQSXIWGENDUBGU-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-6-chloro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CC1CC2=CC(Cl)=CC=C2CN1CCNCC1=CC=CC=C1 QQSXIWGENDUBGU-UHFFFAOYSA-N 0.000 description 2
- FVXXDUAHEUMXRT-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CC1CC2=CC(F)=CC=C2CN1CCNCC1=CC=CC=C1 FVXXDUAHEUMXRT-UHFFFAOYSA-N 0.000 description 2
- SNTRRVFMYRMRIV-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CC1CC2=CC(OC)=CC=C2CN1CCNCC1=CC=CC=C1 SNTRRVFMYRMRIV-UHFFFAOYSA-N 0.000 description 2
- KQULKJZWUVQREH-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-7-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC(F)=CC=C2CC1CC1=CC=CC=C1 KQULKJZWUVQREH-UHFFFAOYSA-N 0.000 description 2
- MMWXZVAJVMKILF-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-8-chloro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC=2C(Cl)=CC=CC=2CC1CC1=CC=CC=C1 MMWXZVAJVMKILF-UHFFFAOYSA-N 0.000 description 2
- RETWFQWVTZRWSF-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-8-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC=2C(F)=CC=CC=2CC1CC1=CC=CC=C1 RETWFQWVTZRWSF-UHFFFAOYSA-N 0.000 description 2
- ZLGMNZFKFJUVEJ-UHFFFAOYSA-N n-benzyl-2-(3-methyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound CC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 ZLGMNZFKFJUVEJ-UHFFFAOYSA-N 0.000 description 2
- PKVBNTQHNQHXSI-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 PKVBNTQHNQHXSI-UHFFFAOYSA-N 0.000 description 2
- XJMVIDRDUNCNNK-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylpropyl)-5-nitro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC(C(=CC=C2)[N+]([O-])=O)=C2CN1CCNCC1=CC=CC=C1 XJMVIDRDUNCNNK-UHFFFAOYSA-N 0.000 description 2
- PEDCOPADGVFZAC-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylpropyl)-6-nitro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC([N+]([O-])=O)=CC=C2CN1CCNCC1=CC=CC=C1 PEDCOPADGVFZAC-UHFFFAOYSA-N 0.000 description 2
- FMEUWGZJLPCNPA-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylpropyl)-7-nitro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC=C([N+]([O-])=O)C=C2CN1CCNCC1=CC=CC=C1 FMEUWGZJLPCNPA-UHFFFAOYSA-N 0.000 description 2
- ZLKINYPOJPOYBI-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylpropyl)-8-nitro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC=CC([N+]([O-])=O)=C2CN1CCNCC1=CC=CC=C1 ZLKINYPOJPOYBI-UHFFFAOYSA-N 0.000 description 2
- IVZVSJLGEGKZKZ-UHFFFAOYSA-N n-benzyl-2-[3-(2-phenylethyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC=CC=C2CC1CCC1=CC=CC=C1 IVZVSJLGEGKZKZ-UHFFFAOYSA-N 0.000 description 2
- WCMXAJZVHRMYNB-UHFFFAOYSA-N n-benzyl-2-[3-(3-phenylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=CC=CC=1CCCC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 WCMXAJZVHRMYNB-UHFFFAOYSA-N 0.000 description 2
- BIIORXUIUHEJDR-UHFFFAOYSA-N n-benzyl-2-[3-(4-methylpentyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CCCC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 BIIORXUIUHEJDR-UHFFFAOYSA-N 0.000 description 2
- QOFHUXSYVASIOY-UHFFFAOYSA-N n-benzyl-2-[3-(cyclohexylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC=CC=C2CC1CC1CCCCC1 QOFHUXSYVASIOY-UHFFFAOYSA-N 0.000 description 2
- OKHBFWYGLLOEKB-UHFFFAOYSA-N n-benzyl-2-[3-(cyclopentylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC=CC=C2CC1CC1CCCC1 OKHBFWYGLLOEKB-UHFFFAOYSA-N 0.000 description 2
- SMTSXKOPMDBGOG-UHFFFAOYSA-N n-benzyl-2-[3-[(2,4-difluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound FC1=CC(F)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 SMTSXKOPMDBGOG-UHFFFAOYSA-N 0.000 description 2
- QMGHYUYVSGVURV-UHFFFAOYSA-N n-benzyl-2-[3-[(2-chlorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound ClC1=CC=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 QMGHYUYVSGVURV-UHFFFAOYSA-N 0.000 description 2
- SRPSUFOCQDEYGR-UHFFFAOYSA-N n-benzyl-2-[3-[(2-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound FC1=CC=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 SRPSUFOCQDEYGR-UHFFFAOYSA-N 0.000 description 2
- SRGFIPCDCHJHAI-UHFFFAOYSA-N n-benzyl-2-[3-[(2-methylphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC1=CC=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 SRGFIPCDCHJHAI-UHFFFAOYSA-N 0.000 description 2
- VPXLBACZMSQULA-UHFFFAOYSA-N n-benzyl-2-[3-[(3,4-dichlorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 VPXLBACZMSQULA-UHFFFAOYSA-N 0.000 description 2
- IMYZDURSLPPUSO-UHFFFAOYSA-N n-benzyl-2-[3-[(3-chlorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound ClC1=CC=CC(CC2N(CC3=CC=CC=C3C2)CCNCC=2C=CC=CC=2)=C1 IMYZDURSLPPUSO-UHFFFAOYSA-N 0.000 description 2
- PUBBIINMWVGKSM-UHFFFAOYSA-N n-benzyl-2-[3-[(3-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound FC1=CC=CC(CC2N(CC3=CC=CC=C3C2)CCNCC=2C=CC=CC=2)=C1 PUBBIINMWVGKSM-UHFFFAOYSA-N 0.000 description 2
- JAMWNTCVKCUUHE-UHFFFAOYSA-N n-benzyl-2-[3-[(3-methylphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC1=CC=CC(CC2N(CC3=CC=CC=C3C2)CCNCC=2C=CC=CC=2)=C1 JAMWNTCVKCUUHE-UHFFFAOYSA-N 0.000 description 2
- NDZKIDIJHSEHPP-UHFFFAOYSA-N n-benzyl-2-[3-[(4-chlorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(Cl)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 NDZKIDIJHSEHPP-UHFFFAOYSA-N 0.000 description 2
- SDBCSRZRBXZCLO-UHFFFAOYSA-N n-benzyl-2-[3-[(4-chlorophenyl)methyl]-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=C(Cl)C=CC=1CC1CC2=CC(F)=CC=C2CN1CCNCC1=CC=CC=C1 SDBCSRZRBXZCLO-UHFFFAOYSA-N 0.000 description 2
- YLINHQYYLITFGW-UHFFFAOYSA-N n-benzyl-2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 YLINHQYYLITFGW-UHFFFAOYSA-N 0.000 description 2
- CFXAOWATQOHUOE-UHFFFAOYSA-N n-benzyl-2-[3-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(OC)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 CFXAOWATQOHUOE-UHFFFAOYSA-N 0.000 description 2
- ZAVGQCVBLFXXDA-UHFFFAOYSA-N n-benzyl-2-[3-[(4-methylphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(C)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=CC=C2C1 ZAVGQCVBLFXXDA-UHFFFAOYSA-N 0.000 description 2
- KKUMDHIXTQCUKC-UHFFFAOYSA-N n-benzyl-2-[5-methyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=C(C)C=CC=C2CN1CCNCC1=CC=CC=C1 KKUMDHIXTQCUKC-UHFFFAOYSA-N 0.000 description 2
- YWAGERQMNAEPTE-UHFFFAOYSA-N n-benzyl-2-[6-chloro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=C(Cl)C=C2C1 YWAGERQMNAEPTE-UHFFFAOYSA-N 0.000 description 2
- GXXCUYHYAFDDGO-UHFFFAOYSA-N n-benzyl-2-[6-fluoro-3-[(2-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C=1C=CC=C(F)C=1CC1CC2=CC(F)=CC=C2CN1CCNCC1=CC=CC=C1 GXXCUYHYAFDDGO-UHFFFAOYSA-N 0.000 description 2
- KMMQQGNLIQCPKW-UHFFFAOYSA-N n-benzyl-2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC=C(F)C=C2C1 KMMQQGNLIQCPKW-UHFFFAOYSA-N 0.000 description 2
- CHNBJBJLJJMIHY-UHFFFAOYSA-N n-benzyl-2-[6-methyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC(C)=CC=C2CN1CCNCC1=CC=CC=C1 CHNBJBJLJJMIHY-UHFFFAOYSA-N 0.000 description 2
- NMEBVXULBPGDII-UHFFFAOYSA-N n-benzyl-2-[7-chloro-3-[(4-chlorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(Cl)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC(Cl)=CC=C2C1 NMEBVXULBPGDII-UHFFFAOYSA-N 0.000 description 2
- SHRGGQXRSLIKKS-UHFFFAOYSA-N n-benzyl-2-[7-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC=CC=2)CC2=CC(F)=CC=C2C1 SHRGGQXRSLIKKS-UHFFFAOYSA-N 0.000 description 2
- BGJYWWIWZNRNHE-UHFFFAOYSA-N n-benzyl-2-[7-methyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC=C(C)C=C2CN1CCNCC1=CC=CC=C1 BGJYWWIWZNRNHE-UHFFFAOYSA-N 0.000 description 2
- GHYHAUOIVCLELZ-UHFFFAOYSA-N n-benzyl-2-[8-methyl-3-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CC1CC2=CC=CC(C)=C2CN1CCNCC1=CC=CC=C1 GHYHAUOIVCLELZ-UHFFFAOYSA-N 0.000 description 2
- UOJPPFBNVWWCFR-UHFFFAOYSA-N n-benzyl-3-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)propan-1-amine Chemical compound C1C2=CC=CC=C2CC(CC=2C=CC=CC=2)N1CCCNCC1=CC=CC=C1 UOJPPFBNVWWCFR-UHFFFAOYSA-N 0.000 description 2
- ZXLVSBIOKUMOJT-UHFFFAOYSA-N n-ethyl-3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound CCNC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 ZXLVSBIOKUMOJT-UHFFFAOYSA-N 0.000 description 2
- BKSVZFZBEIKODN-UHFFFAOYSA-N n-ethyl-3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound CCNC(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 BKSVZFZBEIKODN-UHFFFAOYSA-N 0.000 description 2
- GBHGLMXAGURXGE-UHFFFAOYSA-N n-ethyl-4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound C1=CC(NCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 GBHGLMXAGURXGE-UHFFFAOYSA-N 0.000 description 2
- WWQNCBUJPXNORM-UHFFFAOYSA-N n-ethyl-4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound C1=CC(C(=O)NCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 WWQNCBUJPXNORM-UHFFFAOYSA-N 0.000 description 2
- XRMRJHNLKBFKFF-UHFFFAOYSA-N n-methoxy-n,3-dimethylbutanamide Chemical compound CON(C)C(=O)CC(C)C XRMRJHNLKBFKFF-UHFFFAOYSA-N 0.000 description 2
- IIKFNBQKESFHPI-UHFFFAOYSA-N n-methoxy-n-methyl-2-(2-methylphenyl)acetamide Chemical compound CON(C)C(=O)CC1=CC=CC=C1C IIKFNBQKESFHPI-UHFFFAOYSA-N 0.000 description 2
- 239000007923 nasal drop Substances 0.000 description 2
- 229940100662 nasal drops Drugs 0.000 description 2
- LAIZPRYFQUWUBN-UHFFFAOYSA-L nickel chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2] LAIZPRYFQUWUBN-UHFFFAOYSA-L 0.000 description 2
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 2
- MGCGJBXTNWUHQE-UHFFFAOYSA-N quinoline-4-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CC=NC2=C1 MGCGJBXTNWUHQE-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- CESUXLKAADQNTB-UHFFFAOYSA-N tert-butanesulfinamide Chemical compound CC(C)(C)S(N)=O CESUXLKAADQNTB-UHFFFAOYSA-N 0.000 description 2
- ACNRTYKOPZDRCO-UHFFFAOYSA-N tert-butyl n-(2-oxoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC=O ACNRTYKOPZDRCO-UHFFFAOYSA-N 0.000 description 2
- SDGAEEOZLQGQKY-UHFFFAOYSA-N tert-butyl n-[(2-fluoro-6-iodophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=C(F)C=CC=C1I SDGAEEOZLQGQKY-UHFFFAOYSA-N 0.000 description 2
- FFQDZADGYIVGOD-UHFFFAOYSA-N tert-butyl n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]-n-[(3-nitrophenyl)methyl]carbamate Chemical compound C=1C=CC([N+]([O-])=O)=CC=1CN(C(=O)OC(C)(C)C)CCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 FFQDZADGYIVGOD-UHFFFAOYSA-N 0.000 description 2
- IMNXMUORQVNBSY-UHFFFAOYSA-N tert-butyl n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-5-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(NC(=O)OC(C)(C)C)=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 IMNXMUORQVNBSY-UHFFFAOYSA-N 0.000 description 2
- JAQGDABYAFVZCH-UHFFFAOYSA-N tert-butyl n-[[2-fluoro-6-(3-phenylprop-2-enyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=C(F)C=CC=C1CC=CC1=CC=CC=C1 JAQGDABYAFVZCH-UHFFFAOYSA-N 0.000 description 2
- HQZPQMYDLOAKBC-UHFFFAOYSA-N tert-butyl n-[[3-chloro-2-(2-oxo-3-phenylpropyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(Cl)=C1CC(=O)CC1=CC=CC=C1 HQZPQMYDLOAKBC-UHFFFAOYSA-N 0.000 description 2
- PMZGPTFFKMLZIM-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-(3-benzyl-6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]carbamate Chemical compound C=1C=CC=CC=1CN(C(=O)OC(C)(C)C)CCN1CC2=CC=C(F)C=C2CC1CC1=CC=CC=C1 PMZGPTFFKMLZIM-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- AXTXAVIVKGDCLE-UHFFFAOYSA-N (1,1-dibromo-2-methylpropan-2-yl) carbamate Chemical compound BrC(Br)C(C)(C)OC(N)=O AXTXAVIVKGDCLE-UHFFFAOYSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- JTSATFMUQDFMSV-UHFFFAOYSA-N (2,4-difluorophenyl)-isoquinolin-3-ylmethanone Chemical compound FC1=CC(F)=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 JTSATFMUQDFMSV-UHFFFAOYSA-N 0.000 description 1
- JGAWOCLKWDZZOC-UHFFFAOYSA-N (2-chlorophenyl)-isoquinolin-3-ylmethanone Chemical compound ClC1=CC=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 JGAWOCLKWDZZOC-UHFFFAOYSA-N 0.000 description 1
- FYXZRUMWEIPHKL-UHFFFAOYSA-N (2-fluoro-6-iodophenyl)methanamine Chemical compound NCC1=C(F)C=CC=C1I FYXZRUMWEIPHKL-UHFFFAOYSA-N 0.000 description 1
- ZOZPYLCOLVGGRP-UHFFFAOYSA-N (2-fluorophenyl)-isoquinolin-3-ylmethanone Chemical compound FC1=CC=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 ZOZPYLCOLVGGRP-UHFFFAOYSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- PJGNZKSPRGYRLK-UHFFFAOYSA-N (3,4-dichlorophenyl)-isoquinolin-3-ylmethanone Chemical compound C1=C(Cl)C(Cl)=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 PJGNZKSPRGYRLK-UHFFFAOYSA-N 0.000 description 1
- KRGIBFCGEGKHLR-UHFFFAOYSA-N (3-ethylpyridin-4-yl)methanol Chemical compound CCC1=CN=CC=C1CO KRGIBFCGEGKHLR-UHFFFAOYSA-N 0.000 description 1
- ADQDZCZAZFQMHF-UHFFFAOYSA-N (3-ethylpyridin-4-yl)methyl methanesulfonate Chemical compound CCC1=CN=CC=C1COS(C)(=O)=O ADQDZCZAZFQMHF-UHFFFAOYSA-N 0.000 description 1
- ITQMQLUKMFEJDB-UHFFFAOYSA-N (3-fluoro-2-methylphenyl)methanamine Chemical compound CC1=C(F)C=CC=C1CN ITQMQLUKMFEJDB-UHFFFAOYSA-N 0.000 description 1
- GZMJGSWNFDZTNZ-UHFFFAOYSA-N (3-fluoro-2-methylphenyl)methanol Chemical compound CC1=C(F)C=CC=C1CO GZMJGSWNFDZTNZ-UHFFFAOYSA-N 0.000 description 1
- IVPHCQXBGAFXNB-UHFFFAOYSA-N (3-fluorophenyl)-isoquinolin-3-ylmethanone Chemical compound FC1=CC=CC(C(=O)C=2N=CC3=CC=CC=C3C=2)=C1 IVPHCQXBGAFXNB-UHFFFAOYSA-N 0.000 description 1
- KEUPLGRNURQXAR-UHFFFAOYSA-N (4-chlorophenyl) acetate Chemical compound CC(=O)OC1=CC=C(Cl)C=C1 KEUPLGRNURQXAR-UHFFFAOYSA-N 0.000 description 1
- ZNOREXRHKZXVPC-UHFFFAOYSA-N (4-fluorophenyl) acetate Chemical compound CC(=O)OC1=CC=C(F)C=C1 ZNOREXRHKZXVPC-UHFFFAOYSA-N 0.000 description 1
- ZPAUYYCBIFOCHF-UHFFFAOYSA-N (4-fluorophenyl)-isoquinolin-3-ylmethanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 ZPAUYYCBIFOCHF-UHFFFAOYSA-N 0.000 description 1
- RYTPCWXDKCCDBI-UHFFFAOYSA-N (4-methoxy-2-methylphenyl)methanamine Chemical compound COC1=CC=C(CN)C(C)=C1 RYTPCWXDKCCDBI-UHFFFAOYSA-N 0.000 description 1
- HIGOQWJOANGLIL-UHFFFAOYSA-N (4-methoxy-2-methylphenyl)methanol Chemical compound COC1=CC=C(CO)C(C)=C1 HIGOQWJOANGLIL-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- BPARIXKHXBXFHU-UHFFFAOYSA-N 1,3-bis(4-fluorophenyl)propan-2-one Chemical compound C1=CC(F)=CC=C1CC(=O)CC1=CC=C(F)C=C1 BPARIXKHXBXFHU-UHFFFAOYSA-N 0.000 description 1
- ZGTFNNUASMWGTM-UHFFFAOYSA-N 1,3-thiazole-2-carbaldehyde Chemical compound O=CC1=NC=CS1 ZGTFNNUASMWGTM-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- NHXAYTCRAVHZQZ-UHFFFAOYSA-N 1-(3-bromophenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=CC(Br)=C1 NHXAYTCRAVHZQZ-UHFFFAOYSA-N 0.000 description 1
- MNFOAJNHYAMHMO-UHFFFAOYSA-N 1-(3-fluorophenyl)-4-methylpentan-2-amine Chemical compound CC(C)CC(N)CC1=CC=CC(F)=C1 MNFOAJNHYAMHMO-UHFFFAOYSA-N 0.000 description 1
- VFOQQVXUYFHUSG-UHFFFAOYSA-N 1-(3-fluorophenyl)-4-methylpentan-2-one Chemical compound CC(C)CC(=O)CC1=CC=CC(F)=C1 VFOQQVXUYFHUSG-UHFFFAOYSA-N 0.000 description 1
- AQMNBXSAFVAZNH-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxy-2-methylbenzene Chemical compound COC1=CC=C(CCl)C(C)=C1 AQMNBXSAFVAZNH-UHFFFAOYSA-N 0.000 description 1
- OUKQTRFCDKSEPL-UHFFFAOYSA-N 1-Methyl-2-pyrrolecarboxaldehyde Chemical compound CN1C=CC=C1C=O OUKQTRFCDKSEPL-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- CHGWVMQMJSCXAQ-UHFFFAOYSA-N 1-[3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]ethanone Chemical compound C1=C(C(C)=O)C=C2CNC(CC(C)C)CC2=C1 CHGWVMQMJSCXAQ-UHFFFAOYSA-N 0.000 description 1
- MFAIFDMEAOXQFU-UHFFFAOYSA-N 1-[3-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 MFAIFDMEAOXQFU-UHFFFAOYSA-N 0.000 description 1
- DEMIKXVKYRGORY-UHFFFAOYSA-N 1-[4-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 DEMIKXVKYRGORY-UHFFFAOYSA-N 0.000 description 1
- ODQYQATTXIDFHG-UHFFFAOYSA-N 1-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]propan-2-amine Chemical compound CC(N)CN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 ODQYQATTXIDFHG-UHFFFAOYSA-N 0.000 description 1
- MGHBDQZXPCTTIH-UHFFFAOYSA-N 1-bromo-2,4-difluorobenzene Chemical compound FC1=CC=C(Br)C(F)=C1 MGHBDQZXPCTTIH-UHFFFAOYSA-N 0.000 description 1
- DMRXISNUOWIOKV-UHFFFAOYSA-N 1-bromobutan-2-ol Chemical compound CCC(O)CBr DMRXISNUOWIOKV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- UEBFLTZXUXZPJO-UHFFFAOYSA-N 1-methylimidazole-2-carbaldehyde Chemical compound CN1C=CN=C1C=O UEBFLTZXUXZPJO-UHFFFAOYSA-N 0.000 description 1
- OXADKJPOZQYWIG-UHFFFAOYSA-N 1-methylpyrrole-3-carbaldehyde Chemical compound CN1C=CC(C=O)=C1 OXADKJPOZQYWIG-UHFFFAOYSA-N 0.000 description 1
- ZAZQKVZJRMHPQP-UHFFFAOYSA-N 1-oxidopyridin-1-ium-4-carbaldehyde Chemical compound [O-][N+]1=CC=C(C=O)C=C1 ZAZQKVZJRMHPQP-UHFFFAOYSA-N 0.000 description 1
- WMQUKDQWMMOHSA-UHFFFAOYSA-N 1-pyridin-4-ylethanone Chemical compound CC(=O)C1=CC=NC=C1 WMQUKDQWMMOHSA-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- ZQEXIXXJFSQPNA-UHFFFAOYSA-N 1h-imidazole-5-carbaldehyde Chemical compound O=CC1=CNC=N1 ZQEXIXXJFSQPNA-UHFFFAOYSA-N 0.000 description 1
- WXSGQHKHUYTJNB-UHFFFAOYSA-N 2,6-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(OC)=C1C=O WXSGQHKHUYTJNB-UHFFFAOYSA-N 0.000 description 1
- QOJQBWSZHCKOLL-UHFFFAOYSA-N 2,6-dimethylbenzaldehyde Chemical compound CC1=CC=CC(C)=C1C=O QOJQBWSZHCKOLL-UHFFFAOYSA-N 0.000 description 1
- DWKLSWPFGOTZII-UHFFFAOYSA-N 2-(1-adamantyl)propan-2-yl carbamate Chemical compound C1C(C2)CC3CC2CC1(C(C)(OC(N)=O)C)C3 DWKLSWPFGOTZII-UHFFFAOYSA-N 0.000 description 1
- RZWGTXHSYZGXKF-UHFFFAOYSA-N 2-(2-methylphenyl)acetic acid Chemical compound CC1=CC=CC=C1CC(O)=O RZWGTXHSYZGXKF-UHFFFAOYSA-N 0.000 description 1
- KPJXVLVCTUUFBA-UHFFFAOYSA-N 2-(3,5-ditert-butylphenyl)propan-2-yl carbamate Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C(C)(C)OC(N)=O)=C1 KPJXVLVCTUUFBA-UHFFFAOYSA-N 0.000 description 1
- CTGZPOIWVAVMDS-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n,n-bis[(4-chlorophenyl)methyl]ethanamine Chemical compound C1=CC(Cl)=CC=C1CN(CC=1C=CC(Cl)=CC=1)CCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 CTGZPOIWVAVMDS-UHFFFAOYSA-N 0.000 description 1
- RMSMTIMJOOZJRG-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2,6-dimethoxyphenyl)methyl]ethanamine Chemical compound COC1=CC=CC(OC)=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 RMSMTIMJOOZJRG-UHFFFAOYSA-N 0.000 description 1
- XCEOWCCWWWJGGL-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-chlorophenyl)methyl]ethanamine Chemical compound ClC1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 XCEOWCCWWWJGGL-UHFFFAOYSA-N 0.000 description 1
- SVZZCNIFSNWECQ-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-ethylphenyl)methyl]ethanamine Chemical compound CCC1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 SVZZCNIFSNWECQ-UHFFFAOYSA-N 0.000 description 1
- SFNVYRCPUFRXTP-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-fluorophenyl)methyl]ethanamine Chemical compound FC1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 SFNVYRCPUFRXTP-UHFFFAOYSA-N 0.000 description 1
- ORVYPJQALOBRLU-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-methoxyphenyl)methyl]ethanamine Chemical compound COC1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 ORVYPJQALOBRLU-UHFFFAOYSA-N 0.000 description 1
- AHXRJOSJBKDVPU-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-methylphenyl)methyl]ethanamine Chemical compound CC1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 AHXRJOSJBKDVPU-UHFFFAOYSA-N 0.000 description 1
- OLPWRMVZEVPWOJ-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-nitrophenyl)methyl]ethanamine Chemical compound [O-][N+](=O)C1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 OLPWRMVZEVPWOJ-UHFFFAOYSA-N 0.000 description 1
- TXEOJKLNVQMPJL-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3,4-dichlorophenyl)methyl]ethanamine Chemical compound C1=C(Cl)C(Cl)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 TXEOJKLNVQMPJL-UHFFFAOYSA-N 0.000 description 1
- OANBCXBSEOOBAK-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-chlorophenyl)methyl]ethanamine Chemical compound ClC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 OANBCXBSEOOBAK-UHFFFAOYSA-N 0.000 description 1
- DLRMWDAUDVHVAY-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-ethylphenyl)methyl]ethanamine Chemical compound CCC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 DLRMWDAUDVHVAY-UHFFFAOYSA-N 0.000 description 1
- GMHHNWCVQQOFSU-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-fluorophenyl)methyl]ethanamine Chemical compound FC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 GMHHNWCVQQOFSU-UHFFFAOYSA-N 0.000 description 1
- FETJBBQDQLZFNY-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-methoxyphenyl)methyl]ethanamine Chemical compound COC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 FETJBBQDQLZFNY-UHFFFAOYSA-N 0.000 description 1
- MJNCZTZMESTJSD-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-methylphenyl)methyl]ethanamine Chemical compound CC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 MJNCZTZMESTJSD-UHFFFAOYSA-N 0.000 description 1
- FZSGRXISKRNTFM-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(3-nitrophenyl)methyl]ethanamine Chemical compound [O-][N+](=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 FZSGRXISKRNTFM-UHFFFAOYSA-N 0.000 description 1
- KBNPNTJZJZOAAD-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-chlorophenyl)methyl]ethanamine Chemical compound C1=CC(Cl)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 KBNPNTJZJZOAAD-UHFFFAOYSA-N 0.000 description 1
- MWROKFOJCWMGTP-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-ethylphenyl)methyl]ethanamine Chemical compound C1=CC(CC)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 MWROKFOJCWMGTP-UHFFFAOYSA-N 0.000 description 1
- HUXMRDNRKNZFCU-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-fluorophenyl)methyl]ethanamine Chemical compound C1=CC(F)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 HUXMRDNRKNZFCU-UHFFFAOYSA-N 0.000 description 1
- UPQRPGHLHARWJG-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-methoxyphenyl)methyl]ethanamine Chemical compound C1=CC(OC)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 UPQRPGHLHARWJG-UHFFFAOYSA-N 0.000 description 1
- OJLGMVDQXXUACL-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-methylphenyl)methyl]ethanamine Chemical compound C1=CC(C)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 OJLGMVDQXXUACL-UHFFFAOYSA-N 0.000 description 1
- LLHGWOQLIJMQQE-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-nitrophenyl)methyl]ethanamine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 LLHGWOQLIJMQQE-UHFFFAOYSA-N 0.000 description 1
- QODOCQDLQLJURI-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-phenylphenyl)methyl]ethanamine Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 QODOCQDLQLJURI-UHFFFAOYSA-N 0.000 description 1
- ISZUHKJDBQTYQN-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-tert-butylphenyl)methyl]ethanamine Chemical compound C1=CC(C(C)(C)C)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 ISZUHKJDBQTYQN-UHFFFAOYSA-N 0.000 description 1
- WOAPBMZAGJNISY-UHFFFAOYSA-N 2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[[4-(trifluoromethyl)phenyl]methyl]ethanamine Chemical compound C1=CC(C(F)(F)F)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 WOAPBMZAGJNISY-UHFFFAOYSA-N 0.000 description 1
- KWRVVGCOELJXPN-UHFFFAOYSA-N 2-(3-fluorophenyl)acetaldehyde Chemical compound FC1=CC=CC(CC=O)=C1 KWRVVGCOELJXPN-UHFFFAOYSA-N 0.000 description 1
- CQXGKEUCRVMOMW-UHFFFAOYSA-N 2-(3-methyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C1=CC=C2CN(CCN)C(C)CC2=C1 CQXGKEUCRVMOMW-UHFFFAOYSA-N 0.000 description 1
- GFOGBVQXIQGBKG-UHFFFAOYSA-N 2-(4-bromophenyl)-2-methyl-1,3-dioxolane Chemical compound C=1C=C(Br)C=CC=1C1(C)OCCO1 GFOGBVQXIQGBKG-UHFFFAOYSA-N 0.000 description 1
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- SJFINNZSPGTLTE-UHFFFAOYSA-N 2-[(3-fluoro-2-methylphenyl)methyl]isoindole-1,3-dione Chemical compound CC1=C(F)C=CC=C1CN1C(=O)C2=CC=CC=C2C1=O SJFINNZSPGTLTE-UHFFFAOYSA-N 0.000 description 1
- SDRYVUAIFUMFJX-UHFFFAOYSA-N 2-[(4-methoxy-2-methylphenyl)methyl]isoindole-1,3-dione Chemical compound CC1=CC(OC)=CC=C1CN1C(=O)C2=CC=CC=C2C1=O SDRYVUAIFUMFJX-UHFFFAOYSA-N 0.000 description 1
- OXRGWCYTZJGQTP-UHFFFAOYSA-N 2-[(4-nitrophenyl)methylamino]ethanol Chemical compound OCCNCC1=CC=C([N+]([O-])=O)C=C1 OXRGWCYTZJGQTP-UHFFFAOYSA-N 0.000 description 1
- NYHWBRVPAOVIRW-UHFFFAOYSA-N 2-[3-(cyclohexylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound NCCN1CC2=CC=CC=C2CC1CC1CCCCC1 NYHWBRVPAOVIRW-UHFFFAOYSA-N 0.000 description 1
- FMPSUVHPNGOKFX-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2,4,6-trimethylphenyl)methyl]ethanamine Chemical compound CC1=CC(C)=CC(C)=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 FMPSUVHPNGOKFX-UHFFFAOYSA-N 0.000 description 1
- GFFRYYVGMPOLDJ-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-nitrophenyl)methyl]ethanamine Chemical compound [O-][N+](=O)C1=CC=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 GFFRYYVGMPOLDJ-UHFFFAOYSA-N 0.000 description 1
- ZPWZILIRVDCDSU-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-methylphenyl)methyl]ethanamine Chemical compound CC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 ZPWZILIRVDCDSU-UHFFFAOYSA-N 0.000 description 1
- QVLZLAMDHKPQOD-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-nitrophenyl)methyl]ethanamine Chemical compound [O-][N+](=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 QVLZLAMDHKPQOD-UHFFFAOYSA-N 0.000 description 1
- IRVQKCKPOPZQHN-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-morpholin-4-ylphenyl)methyl]ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC(=CC=2)N2CCOCC2)CC2=CC=CC=C2C1 IRVQKCKPOPZQHN-UHFFFAOYSA-N 0.000 description 1
- LTIQXVOCSLJVHA-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound NCCN1CC2=CC=CC=C2CC1CC1=CC=C(F)C=C1 LTIQXVOCSLJVHA-UHFFFAOYSA-N 0.000 description 1
- QNDWNUYEUDAVNV-UHFFFAOYSA-N 2-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]anilino]acetic acid Chemical compound C1=CC(NCC(=O)O)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 QNDWNUYEUDAVNV-UHFFFAOYSA-N 0.000 description 1
- QSIVJAGNBSUXQJ-UHFFFAOYSA-N 2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n,n-bis(pyridin-4-ylmethyl)ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCN(CC=2C=CN=CC=2)CC=2C=CN=CC=2)CC2=CC=C(F)C=C2C1 QSIVJAGNBSUXQJ-UHFFFAOYSA-N 0.000 description 1
- GZFAYYUSFPQPAJ-UHFFFAOYSA-N 2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n,n-bis(thiophen-3-ylmethyl)ethanamine Chemical compound C1=CC(F)=CC=C1CC1N(CCN(CC2=CSC=C2)CC2=CSC=C2)CC2=CC=C(F)C=C2C1 GZFAYYUSFPQPAJ-UHFFFAOYSA-N 0.000 description 1
- HKARZMTYFJMNCV-UHFFFAOYSA-N 2-[7-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound NCCN1CC2=CC(F)=CC=C2CC1CC1=CC=C(F)C=C1 HKARZMTYFJMNCV-UHFFFAOYSA-N 0.000 description 1
- QOYDUSIIOQHJMI-UHFFFAOYSA-N 2-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 QOYDUSIIOQHJMI-UHFFFAOYSA-N 0.000 description 1
- PQMDXYXYOQAVFO-UHFFFAOYSA-N 2-benzyl-3-[(4-methylphenyl)methyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1=CC(C)=CC=C1CC1N(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 PQMDXYXYOQAVFO-UHFFFAOYSA-N 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- 125000006280 2-bromobenzyl group Chemical group [H]C1=C([H])C(Br)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CEFMMQYDPGCYMG-UHFFFAOYSA-N 2-chloro-6-methylbenzoic acid Chemical compound CC1=CC=CC(Cl)=C1C(O)=O CEFMMQYDPGCYMG-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 description 1
- CEUXIAUEIGSQSZ-UHFFFAOYSA-N 2-cyclopentylacetaldehyde Chemical compound O=CCC1CCCC1 CEUXIAUEIGSQSZ-UHFFFAOYSA-N 0.000 description 1
- IIMANNDVEYWYJO-UHFFFAOYSA-N 2-ethoxy-4-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl-[(3-nitrophenyl)methyl]amino]butanoic acid Chemical compound C=1C=CC([N+]([O-])=O)=CC=1CN(CCC(OCC)C(O)=O)CCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 IIMANNDVEYWYJO-UHFFFAOYSA-N 0.000 description 1
- FAACTMVXBNSPJA-UHFFFAOYSA-N 2-fluoro-6-iodobenzonitrile Chemical compound FC1=CC=CC(I)=C1C#N FAACTMVXBNSPJA-UHFFFAOYSA-N 0.000 description 1
- ZWDVQMVZZYIAHO-UHFFFAOYSA-N 2-fluorobenzaldehyde Chemical compound FC1=CC=CC=C1C=O ZWDVQMVZZYIAHO-UHFFFAOYSA-N 0.000 description 1
- OFBVGDCXXGXDKU-UHFFFAOYSA-N 2-fluoropyridine-3-carbaldehyde Chemical compound FC1=NC=CC=C1C=O OFBVGDCXXGXDKU-UHFFFAOYSA-N 0.000 description 1
- WOLIMEQXFWSBTE-UHFFFAOYSA-N 2-fluoropyridine-4-carbaldehyde Chemical compound FC1=CC(C=O)=CC=N1 WOLIMEQXFWSBTE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 1
- VOCKNCWQVHJMAE-UHFFFAOYSA-N 2-methoxypyridine-4-carbaldehyde Chemical compound COC1=CC(C=O)=CC=N1 VOCKNCWQVHJMAE-UHFFFAOYSA-N 0.000 description 1
- XAIPYJOARQNIHN-UHFFFAOYSA-N 2-methyl-5-(4-methylphenyl)pentan-2-amine Chemical compound CC1=CC=C(CCCC(C)(C)N)C=C1 XAIPYJOARQNIHN-UHFFFAOYSA-N 0.000 description 1
- SWIFJGQWFHLUTO-UHFFFAOYSA-N 2-methyl-n-(4-methylpentylidene)propane-1-sulfinamide Chemical compound CC(C)CCC=NS(=O)CC(C)C SWIFJGQWFHLUTO-UHFFFAOYSA-N 0.000 description 1
- ZLAOMUYYTVPTAA-UHFFFAOYSA-N 2-methyl-n-(4-phenylbutylidene)propane-1-sulfinamide Chemical compound CC(C)CS(=O)N=CCCCC1=CC=CC=C1 ZLAOMUYYTVPTAA-UHFFFAOYSA-N 0.000 description 1
- KKOPYUKQPCQGEM-UHFFFAOYSA-N 2-morpholin-4-ylacetaldehyde Chemical compound O=CCN1CCOCC1 KKOPYUKQPCQGEM-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 description 1
- 125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 description 1
- 125000006288 3,5-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(C([H])=C1F)C([H])([H])* 0.000 description 1
- NSMDBQYWQPQJBI-UHFFFAOYSA-N 3-(2-methyl-1,3-dioxolan-2-yl)benzaldehyde Chemical compound C=1C=CC(C=O)=CC=1C1(C)OCCO1 NSMDBQYWQPQJBI-UHFFFAOYSA-N 0.000 description 1
- RLIQRGCPHOIIEH-UHFFFAOYSA-N 3-(2-methylpropyl)-7-nitro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C([N+]([O-])=O)C=C2CNC(CC(C)C)CC2=C1 RLIQRGCPHOIIEH-UHFFFAOYSA-N 0.000 description 1
- XQKXJABPTCIISQ-UHFFFAOYSA-N 3-(2-methylpropyl)-8-nitro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC([N+]([O-])=O)=C2CNC(CC(C)C)CC2=C1 XQKXJABPTCIISQ-UHFFFAOYSA-N 0.000 description 1
- VQGJKAHUTMOEPH-UHFFFAOYSA-N 3-(2-methylpropyl)isoquinoline Chemical compound C1=CC=C2C=NC(CC(C)C)=CC2=C1 VQGJKAHUTMOEPH-UHFFFAOYSA-N 0.000 description 1
- YFULSPUFXDLEEX-UHFFFAOYSA-N 3-(2-phenylethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1CCC1=CC=CC=C1 YFULSPUFXDLEEX-UHFFFAOYSA-N 0.000 description 1
- SOGSIRMTVIOLCT-UHFFFAOYSA-N 3-(2-phenylethyl)isoquinoline Chemical compound C=1C2=CC=CC=C2C=NC=1CCC1=CC=CC=C1 SOGSIRMTVIOLCT-UHFFFAOYSA-N 0.000 description 1
- QYPSXORKGISICY-UHFFFAOYSA-N 3-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)propan-1-amine Chemical compound NCCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 QYPSXORKGISICY-UHFFFAOYSA-N 0.000 description 1
- YDJHQBLVUPCJJJ-UHFFFAOYSA-N 3-(3-methylbutyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNC(CCC(C)C)CC2=C1 YDJHQBLVUPCJJJ-UHFFFAOYSA-N 0.000 description 1
- FRVGAWZBQVMHCP-UHFFFAOYSA-N 3-(3-methylbutyl)-3,4-dihydroisoquinoline Chemical compound C1=CC=C2C=NC(CCC(C)C)CC2=C1 FRVGAWZBQVMHCP-UHFFFAOYSA-N 0.000 description 1
- PDBNNJZYHKDOKA-UHFFFAOYSA-N 3-(3-phenylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1CCCC1=CC=CC=C1 PDBNNJZYHKDOKA-UHFFFAOYSA-N 0.000 description 1
- TUXJGMYLRQDGMP-UHFFFAOYSA-N 3-(3-phenylpropyl)-3,4-dihydroisoquinoline Chemical compound C1C2=CC=CC=C2C=NC1CCCC1=CC=CC=C1 TUXJGMYLRQDGMP-UHFFFAOYSA-N 0.000 description 1
- IYXYNMPERQYEON-UHFFFAOYSA-N 3-(4-methylpentyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNC(CCCC(C)C)CC2=C1 IYXYNMPERQYEON-UHFFFAOYSA-N 0.000 description 1
- GTWNUGFGWAFVIG-UHFFFAOYSA-N 3-(4-methylpentyl)-3,4-dihydroisoquinoline Chemical compound C1=CC=C2C=NC(CCCC(C)C)CC2=C1 GTWNUGFGWAFVIG-UHFFFAOYSA-N 0.000 description 1
- CVKOOKPNCVYHNY-UHFFFAOYSA-N 3-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC(C#N)=C1 CVKOOKPNCVYHNY-UHFFFAOYSA-N 0.000 description 1
- RQXXJEZYJLKHQI-UHFFFAOYSA-N 3-(cyclohexylmethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1CC1CCCCC1 RQXXJEZYJLKHQI-UHFFFAOYSA-N 0.000 description 1
- WMSASGWDCHPRCU-UHFFFAOYSA-N 3-(cyclohexylmethyl)isoquinoline Chemical compound C=1C2=CC=CC=C2C=NC=1CC1CCCCC1 WMSASGWDCHPRCU-UHFFFAOYSA-N 0.000 description 1
- DEKPUCNYYBDDHY-UHFFFAOYSA-N 3-(cyclopentylmethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1CC1CCCC1 DEKPUCNYYBDDHY-UHFFFAOYSA-N 0.000 description 1
- WUJQTKBVPNTQLU-UHFFFAOYSA-N 3-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC(C=O)=C1 WUJQTKBVPNTQLU-UHFFFAOYSA-N 0.000 description 1
- BYVZCCQZKXUIHZ-UHFFFAOYSA-N 3-[(2,4-difluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound FC1=CC(F)=CC=C1CC1NCC2=CC=CC=C2C1 BYVZCCQZKXUIHZ-UHFFFAOYSA-N 0.000 description 1
- ZUWZKXSBDCBHAY-UHFFFAOYSA-N 3-[(2,4-difluorophenyl)methyl]isoquinoline Chemical compound FC1=CC(F)=CC=C1CC1=CC2=CC=CC=C2C=N1 ZUWZKXSBDCBHAY-UHFFFAOYSA-N 0.000 description 1
- YVTGVZNSROLPOW-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound ClC1=CC=CC=C1CC1NCC2=CC=CC=C2C1 YVTGVZNSROLPOW-UHFFFAOYSA-N 0.000 description 1
- VRUYUATVGDAPSS-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl]isoquinoline Chemical compound ClC1=CC=CC=C1CC1=CC2=CC=CC=C2C=N1 VRUYUATVGDAPSS-UHFFFAOYSA-N 0.000 description 1
- MJVPBHPJUJRHPL-UHFFFAOYSA-N 3-[(2-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound FC1=CC=CC=C1CC1NCC2=CC=CC=C2C1 MJVPBHPJUJRHPL-UHFFFAOYSA-N 0.000 description 1
- LOEHBJLPZYKASX-UHFFFAOYSA-N 3-[(2-fluorophenyl)methyl]isoquinoline Chemical compound FC1=CC=CC=C1CC1=CC2=CC=CC=C2C=N1 LOEHBJLPZYKASX-UHFFFAOYSA-N 0.000 description 1
- RJATVZVSFXLBTP-UHFFFAOYSA-N 3-[(2-methylphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1=CC=CC=C1CC1NCC2=CC=CC=C2C1 RJATVZVSFXLBTP-UHFFFAOYSA-N 0.000 description 1
- RYOFJTOVDDOFEU-UHFFFAOYSA-N 3-[(2-methylphenyl)methyl]isoquinoline Chemical compound CC1=CC=CC=C1CC1=CC2=CC=CC=C2C=N1 RYOFJTOVDDOFEU-UHFFFAOYSA-N 0.000 description 1
- IPCRNTQZIDVJBE-UHFFFAOYSA-N 3-[(3,4-dichlorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1NCC2=CC=CC=C2C1 IPCRNTQZIDVJBE-UHFFFAOYSA-N 0.000 description 1
- RARBIBBXNFXIHI-UHFFFAOYSA-N 3-[(3,4-dichlorophenyl)methyl]isoquinoline Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1=CC2=CC=CC=C2C=N1 RARBIBBXNFXIHI-UHFFFAOYSA-N 0.000 description 1
- SGCSLQQWSLRGSM-UHFFFAOYSA-N 3-[(3-chlorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound ClC1=CC=CC(CC2NCC3=CC=CC=C3C2)=C1 SGCSLQQWSLRGSM-UHFFFAOYSA-N 0.000 description 1
- XLQOZFDCGVRGOT-UHFFFAOYSA-N 3-[(3-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound FC1=CC=CC(CC2NCC3=CC=CC=C3C2)=C1 XLQOZFDCGVRGOT-UHFFFAOYSA-N 0.000 description 1
- COHUETXGFKWVBN-UHFFFAOYSA-N 3-[(3-fluorophenyl)methyl]isoquinoline Chemical compound FC1=CC=CC(CC=2N=CC3=CC=CC=C3C=2)=C1 COHUETXGFKWVBN-UHFFFAOYSA-N 0.000 description 1
- QRMJSOYZKFAHQC-UHFFFAOYSA-N 3-[(3-methylphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1=CC=CC(CC2NCC3=CC=CC=C3C2)=C1 QRMJSOYZKFAHQC-UHFFFAOYSA-N 0.000 description 1
- BQLCSMZBCYRDFF-UHFFFAOYSA-N 3-[(3-methylphenyl)methyl]isoquinoline Chemical compound CC1=CC=CC(CC=2N=CC3=CC=CC=C3C=2)=C1 BQLCSMZBCYRDFF-UHFFFAOYSA-N 0.000 description 1
- PVSNWLRFRGEESH-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(Cl)=CC=C1CC1NCC2=CC=CC=C2C1 PVSNWLRFRGEESH-UHFFFAOYSA-N 0.000 description 1
- QSESQYROVYRYTD-UHFFFAOYSA-N 3-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(OC)=CC=C1CC1NCC2=CC=CC=C2C1 QSESQYROVYRYTD-UHFFFAOYSA-N 0.000 description 1
- FUJLUYHARBVVGG-UHFFFAOYSA-N 3-[(4-methoxyphenyl)methyl]isoquinoline Chemical compound C1=CC(OC)=CC=C1CC1=CC2=CC=CC=C2C=N1 FUJLUYHARBVVGG-UHFFFAOYSA-N 0.000 description 1
- LMWOFQQNXSDVNB-UHFFFAOYSA-N 3-[(4-methylphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(C)=CC=C1CC1NCC2=CC=CC=C2C1 LMWOFQQNXSDVNB-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- CYDQJDAMJMUXBI-UHFFFAOYSA-N 3-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n,n-bis(pyridin-4-ylmethyl)propan-1-amine Chemical compound C1=CC(F)=CC=C1CC1N(CCCN(CC=2C=CN=CC=2)CC=2C=CN=CC=2)CC2=CC=CC=C2C1 CYDQJDAMJMUXBI-UHFFFAOYSA-N 0.000 description 1
- LLLHWSDKKCTRJV-UHFFFAOYSA-N 3-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]propan-1-amine Chemical compound NCCCN1CC2=CC=CC=C2CC1CC1=CC=C(F)C=C1 LLLHWSDKKCTRJV-UHFFFAOYSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- VOBIGYALHVGKRW-UHFFFAOYSA-N 3-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 VOBIGYALHVGKRW-UHFFFAOYSA-N 0.000 description 1
- KATHOWLMCPYKEN-UHFFFAOYSA-N 3-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]benzonitrile Chemical compound N#CC1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC=CC=2)=C1 KATHOWLMCPYKEN-UHFFFAOYSA-N 0.000 description 1
- PGWFISRHNFIVSP-UHFFFAOYSA-N 3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(CNCCN2C(CC3=CC=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 PGWFISRHNFIVSP-UHFFFAOYSA-N 0.000 description 1
- TUAOGGROXWRQLB-UHFFFAOYSA-N 3-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=C(C=CC=2)C#N)CC2=CC=CC=C2C1 TUAOGGROXWRQLB-UHFFFAOYSA-N 0.000 description 1
- LAILWHKKNFSVIT-UHFFFAOYSA-N 3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=C(C=CC=2)C#N)CC2=CC=C(F)C=C2C1 LAILWHKKNFSVIT-UHFFFAOYSA-N 0.000 description 1
- FXRUFEDTDXWPFL-UHFFFAOYSA-N 3-[[4-(2-methyl-1,3-dioxolan-2-yl)phenyl]methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C=1C=C(CC2NCC3=CC=CC=C3C2)C=CC=1C1(C)OCCO1 FXRUFEDTDXWPFL-UHFFFAOYSA-N 0.000 description 1
- AUEWBDOSIRGRTR-UHFFFAOYSA-N 3-[[4-(2-methyl-1,3-dioxolan-2-yl)phenyl]methyl]isoquinoline Chemical compound C=1C=C(CC=2N=CC3=CC=CC=C3C=2)C=CC=1C1(C)OCCO1 AUEWBDOSIRGRTR-UHFFFAOYSA-N 0.000 description 1
- MUMZCPYOPCRZPK-UHFFFAOYSA-N 3-amino-5-ethyl-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]benzamide Chemical compound CCC1=CC(N)=CC(C(=O)NCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 MUMZCPYOPCRZPK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- XJZLLWJEFMKSNV-UHFFFAOYSA-N 3-benzyl-5-chloro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C=2C(Cl)=CC=CC=2CNC1CC1=CC=CC=C1 XJZLLWJEFMKSNV-UHFFFAOYSA-N 0.000 description 1
- HKURKIZMXOLQCC-UHFFFAOYSA-N 3-benzyl-5-fluoro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C=2C(F)=CC=CC=2CNC1CC1=CC=CC=C1 HKURKIZMXOLQCC-UHFFFAOYSA-N 0.000 description 1
- YMCNRMCRKLEPFP-UHFFFAOYSA-N 3-benzyl-6-chloro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC(Cl)=CC=C2CNC1CC1=CC=CC=C1 YMCNRMCRKLEPFP-UHFFFAOYSA-N 0.000 description 1
- OVNKRYQGZCBENR-UHFFFAOYSA-N 3-benzyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC(OC)=CC=C2CNC1CC1=CC=CC=C1 OVNKRYQGZCBENR-UHFFFAOYSA-N 0.000 description 1
- JRKVLFPZGYTNRW-UHFFFAOYSA-N 3-benzyl-8-chloro-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CC=2C(Cl)=CC=CC=2CC1CC1=CC=CC=C1 JRKVLFPZGYTNRW-UHFFFAOYSA-N 0.000 description 1
- CLXFQXOCAABOII-UHFFFAOYSA-N 3-benzyl-8-fluoro-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CC=2C(F)=CC=CC=2CC1CC1=CC=CC=C1 CLXFQXOCAABOII-UHFFFAOYSA-N 0.000 description 1
- 125000006279 3-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Br)=C1[H])C([H])([H])* 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- AQJGUTQMEVWECA-UHFFFAOYSA-N 3-ethenyl-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC(C=C)=CC([N+]([O-])=O)=C1 AQJGUTQMEVWECA-UHFFFAOYSA-N 0.000 description 1
- DFTQWDXVTOCMSV-UHFFFAOYSA-N 3-ethyl-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]-5-(methanesulfonamido)benzamide Chemical compound CCC1=CC(NS(C)(=O)=O)=CC(C(=O)NCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 DFTQWDXVTOCMSV-UHFFFAOYSA-N 0.000 description 1
- LLYXUFQXCNIGDG-UHFFFAOYSA-N 3-ethylbenzaldehyde Chemical compound CCC1=CC=CC(C=O)=C1 LLYXUFQXCNIGDG-UHFFFAOYSA-N 0.000 description 1
- XMKZAIHFVHJGPV-UHFFFAOYSA-N 3-fluoro-2-methylbenzoic acid Chemical compound CC1=C(F)C=CC=C1C(O)=O XMKZAIHFVHJGPV-UHFFFAOYSA-N 0.000 description 1
- PIKNVEVCWAAOMJ-UHFFFAOYSA-N 3-fluorobenzaldehyde Chemical compound FC1=CC=CC(C=O)=C1 PIKNVEVCWAAOMJ-UHFFFAOYSA-N 0.000 description 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 1
- KLKQXQXSZCNWLZ-UHFFFAOYSA-N 3-fluoropyridine-4-carbaldehyde Chemical compound FC1=CN=CC=C1C=O KLKQXQXSZCNWLZ-UHFFFAOYSA-N 0.000 description 1
- AYYCJLDODRZCOB-UHFFFAOYSA-N 3-formylbenzamide Chemical compound NC(=O)C1=CC=CC(C=O)=C1 AYYCJLDODRZCOB-UHFFFAOYSA-N 0.000 description 1
- UHDNUPHSDMOGCR-UHFFFAOYSA-M 3-formylbenzoate Chemical compound [O-]C(=O)C1=CC=CC(C=O)=C1 UHDNUPHSDMOGCR-UHFFFAOYSA-M 0.000 description 1
- AZVSIHIBYRHSLB-UHFFFAOYSA-N 3-furaldehyde Chemical compound O=CC=1C=COC=1 AZVSIHIBYRHSLB-UHFFFAOYSA-N 0.000 description 1
- UEKQPSAKUNXFHL-UHFFFAOYSA-N 3-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNC(C)CC2=C1 UEKQPSAKUNXFHL-UHFFFAOYSA-N 0.000 description 1
- BNYKZFOZWZMEJD-UHFFFAOYSA-N 3-methylimidazole-4-carbaldehyde Chemical compound CN1C=NC=C1C=O BNYKZFOZWZMEJD-UHFFFAOYSA-N 0.000 description 1
- RFLDHZLAQOBNRW-UHFFFAOYSA-N 3-phenyl-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC=CC=C2CNC1C1=CC=CC=C1 RFLDHZLAQOBNRW-UHFFFAOYSA-N 0.000 description 1
- RCUMJJBGXUQSOF-UHFFFAOYSA-N 4-(2-hydroxypropan-2-yl)benzaldehyde Chemical compound CC(C)(O)C1=CC=C(C=O)C=C1 RCUMJJBGXUQSOF-UHFFFAOYSA-N 0.000 description 1
- MNFZZNNFORDXSV-UHFFFAOYSA-N 4-(diethylamino)benzaldehyde Chemical compound CCN(CC)C1=CC=C(C=O)C=C1 MNFZZNNFORDXSV-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- QXNNNGWWYVAIDI-UHFFFAOYSA-N 4-[(3-aminophenyl)methyl-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]amino]-2-ethoxybutanoic acid Chemical compound C=1C=CC(N)=CC=1CN(CCC(OCC)C(O)=O)CCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 QXNNNGWWYVAIDI-UHFFFAOYSA-N 0.000 description 1
- QFFKCAIVWXHZOQ-UHFFFAOYSA-N 4-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl-[[3-(methanesulfonamido)phenyl]methyl]amino]butanoic acid Chemical compound CS(=O)(=O)NC1=CC=CC(CN(CCCC(O)=O)CCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 QFFKCAIVWXHZOQ-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- ZTGMKIAOHUNKEW-UHFFFAOYSA-N 4-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 ZTGMKIAOHUNKEW-UHFFFAOYSA-N 0.000 description 1
- NDPSTVFJABKZQF-UHFFFAOYSA-N 4-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 NDPSTVFJABKZQF-UHFFFAOYSA-N 0.000 description 1
- UCFMFEYCIFRHEN-UHFFFAOYSA-N 4-[[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethylamino]methyl]phenol Chemical compound C1=CC(O)=CC=C1CNCCN1C(CC=2C=CC=CC=2)CC2=CC=CC=C2C1 UCFMFEYCIFRHEN-UHFFFAOYSA-N 0.000 description 1
- LPYUYJXXNBEMJU-UHFFFAOYSA-N 4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 LPYUYJXXNBEMJU-UHFFFAOYSA-N 0.000 description 1
- MNNLEJKMAXYWJL-UHFFFAOYSA-N 4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 MNNLEJKMAXYWJL-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 1
- XXFKOBGFMUIWDH-UHFFFAOYSA-N 4-chloro-2-methylbenzoic acid Chemical compound CC1=CC(Cl)=CC=C1C(O)=O XXFKOBGFMUIWDH-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- QWDCXCRLPNMJIH-UHFFFAOYSA-N 4-formylbenzamide Chemical compound NC(=O)C1=CC=C(C=O)C=C1 QWDCXCRLPNMJIH-UHFFFAOYSA-N 0.000 description 1
- GOUHYARYYWKXHS-UHFFFAOYSA-M 4-formylbenzoate Chemical compound [O-]C(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-M 0.000 description 1
- MSVRGYOYISBGTH-UHFFFAOYSA-N 4-methoxy-2-methylbenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(C)=C1 MSVRGYOYISBGTH-UHFFFAOYSA-N 0.000 description 1
- FYGUIFQXSZCBSZ-UHFFFAOYSA-N 4-methyl-1-(3-methylphenyl)pentan-2-amine Chemical compound CC(C)CC(N)CC1=CC=CC(C)=C1 FYGUIFQXSZCBSZ-UHFFFAOYSA-N 0.000 description 1
- RKFMRIOWPNGTDS-UHFFFAOYSA-N 4-methyl-1-(3-methylphenyl)pentan-2-one Chemical compound CC(C)CC(=O)CC1=CC=CC(C)=C1 RKFMRIOWPNGTDS-UHFFFAOYSA-N 0.000 description 1
- XWXRUKSDOMRNFR-UHFFFAOYSA-N 4-methyl-1-(4-methylphenyl)pentan-2-amine Chemical compound CC(C)CC(N)CC1=CC=C(C)C=C1 XWXRUKSDOMRNFR-UHFFFAOYSA-N 0.000 description 1
- BWQBRHDVGPMNOG-UHFFFAOYSA-N 4-methyl-1-(4-methylphenyl)pentan-2-one Chemical compound CC(C)CC(=O)CC1=CC=C(C)C=C1 BWQBRHDVGPMNOG-UHFFFAOYSA-N 0.000 description 1
- KHWGAWBXQOKXIJ-UHFFFAOYSA-N 4-methyl-3-nitrobenzaldehyde Chemical compound CC1=CC=C(C=O)C=C1[N+]([O-])=O KHWGAWBXQOKXIJ-UHFFFAOYSA-N 0.000 description 1
- JGEGJYXHCFUMJF-UHFFFAOYSA-N 4-methylpentanal Chemical compound CC(C)CCC=O JGEGJYXHCFUMJF-UHFFFAOYSA-N 0.000 description 1
- NHFRGTVSKOPUBK-UHFFFAOYSA-N 4-phenylbutanal Chemical compound O=CCCCC1=CC=CC=C1 NHFRGTVSKOPUBK-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- PYXLUTFXCKNNJK-UHFFFAOYSA-N 5-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-2-methylaniline Chemical compound C1=C(N)C(C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 PYXLUTFXCKNNJK-UHFFFAOYSA-N 0.000 description 1
- WOEQKTIKGKIFAE-UHFFFAOYSA-N 5-methyl-1-phenylhexan-2-amine Chemical compound CC(C)CCC(N)CC1=CC=CC=C1 WOEQKTIKGKIFAE-UHFFFAOYSA-N 0.000 description 1
- KGVUPHWSIMRIPI-UHFFFAOYSA-N 5-methyl-3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNC(CC(C)C)CC2=C1C KGVUPHWSIMRIPI-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- YPZPKXYJVVLLLD-UHFFFAOYSA-N 6-chloro-3-[(4-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(F)=CC=C1CC1NCC2=CC=C(Cl)C=C2C1 YPZPKXYJVVLLLD-UHFFFAOYSA-N 0.000 description 1
- BFKCGEMZNZGAFG-UHFFFAOYSA-N 6-fluoro-3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound FC1=CC=C2CNC(CC(C)C)CC2=C1 BFKCGEMZNZGAFG-UHFFFAOYSA-N 0.000 description 1
- AORJYYWTGHXYKV-UHFFFAOYSA-N 6-fluoro-3-[(2-fluorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1C2=CC(F)=CC=C2CNC1CC1=CC=CC=C1F AORJYYWTGHXYKV-UHFFFAOYSA-N 0.000 description 1
- PZPNGWWKCSJKOS-UHFFFAOYSA-N 6-fluoropyridine-3-carbaldehyde Chemical compound FC1=CC=C(C=O)C=N1 PZPNGWWKCSJKOS-UHFFFAOYSA-N 0.000 description 1
- QIVKZLAEVBESAY-UHFFFAOYSA-N 6-methyl-1-phenylheptan-2-amine Chemical compound CC(C)CCCC(N)CC1=CC=CC=C1 QIVKZLAEVBESAY-UHFFFAOYSA-N 0.000 description 1
- KQRNWBAEMBTPLY-UHFFFAOYSA-N 6-methyl-3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1=CC=C2CNC(CC(C)C)CC2=C1 KQRNWBAEMBTPLY-UHFFFAOYSA-N 0.000 description 1
- FHBUXTAMSWKEIK-UHFFFAOYSA-N 7-chloro-3-[(4-chlorophenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(Cl)=CC=C1CC1NCC2=CC(Cl)=CC=C2C1 FHBUXTAMSWKEIK-UHFFFAOYSA-N 0.000 description 1
- LEAYQHZXCGYWGV-UHFFFAOYSA-N 7-methyl-3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(C)C=C2CNC(CC(C)C)CC2=C1 LEAYQHZXCGYWGV-UHFFFAOYSA-N 0.000 description 1
- ITOIJHSAHQYNHP-UHFFFAOYSA-N 7-methyl-3-(2-methylpropyl)-3,4-dihydroisoquinoline Chemical compound C1=C(C)C=C2C=NC(CC(C)C)CC2=C1 ITOIJHSAHQYNHP-UHFFFAOYSA-N 0.000 description 1
- ZXRZRPHRJDELJY-UHFFFAOYSA-N 8-methyl-3-(2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(C)=C2CNC(CC(C)C)CC2=C1 ZXRZRPHRJDELJY-UHFFFAOYSA-N 0.000 description 1
- BGWDSSODYCCAOC-UHFFFAOYSA-N 8-methyl-3-(2-methylpropyl)-3,4-dihydroisoquinoline Chemical compound C1=CC(C)=C2C=NC(CC(C)C)CC2=C1 BGWDSSODYCCAOC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DZCGETOOQHWIPO-UHFFFAOYSA-N C(C(C)C)N1CC2=CC=CC=C2CC1C Chemical compound C(C(C)C)N1CC2=CC=CC=C2CC1C DZCGETOOQHWIPO-UHFFFAOYSA-N 0.000 description 1
- VFWPRBPPTYNUDJ-UHFFFAOYSA-N C(C)(C)(C)OC(=O)N1C=NC2=C1C=CC(=C2)NC(CN2CC1=CC=C(C=C1CC2CC2=CC=C(C=C2)F)F)C Chemical compound C(C)(C)(C)OC(=O)N1C=NC2=C1C=CC(=C2)NC(CN2CC1=CC=C(C=C1CC2CC2=CC=C(C=C2)F)F)C VFWPRBPPTYNUDJ-UHFFFAOYSA-N 0.000 description 1
- DNKPCWVLSIBXPJ-UHFFFAOYSA-N CN1C(=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound CN1C(=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C DNKPCWVLSIBXPJ-UHFFFAOYSA-N 0.000 description 1
- FGPITMWFOPLBEL-UHFFFAOYSA-N CN1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound CN1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C FGPITMWFOPLBEL-UHFFFAOYSA-N 0.000 description 1
- QGQOXSAVTOZCJG-UHFFFAOYSA-N CN1C(=NC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound CN1C(=NC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C QGQOXSAVTOZCJG-UHFFFAOYSA-N 0.000 description 1
- AANZCAVMEHVBQY-UHFFFAOYSA-N CN1C=NC=C1NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound CN1C=NC=C1NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C AANZCAVMEHVBQY-UHFFFAOYSA-N 0.000 description 1
- UKQAZCPZPBIFMY-UHFFFAOYSA-N COC1=NC=CC(=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound COC1=NC=CC(=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C UKQAZCPZPBIFMY-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- NXVLKDQVCYYECT-UHFFFAOYSA-N FC1=NC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound FC1=NC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C NXVLKDQVCYYECT-UHFFFAOYSA-N 0.000 description 1
- ARCUSAQJTPKNKN-UHFFFAOYSA-N FC1=NC=CC(=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound FC1=NC=CC(=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C ARCUSAQJTPKNKN-UHFFFAOYSA-N 0.000 description 1
- SVPSYZAAFMEUBS-UHFFFAOYSA-N FC1=NC=CC=C1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound FC1=NC=CC=C1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C SVPSYZAAFMEUBS-UHFFFAOYSA-N 0.000 description 1
- QEZHTBZYLJYAHA-UHFFFAOYSA-N FC=1C=C2CC(N(CC2=CC1)CCNCN(C1=CC=CC=C1)CCCC(=O)OCC)CC1=CC=C(C=C1)F Chemical compound FC=1C=C2CC(N(CC2=CC1)CCNCN(C1=CC=CC=C1)CCCC(=O)OCC)CC1=CC=C(C=C1)F QEZHTBZYLJYAHA-UHFFFAOYSA-N 0.000 description 1
- VKFPTBRTTDPGRJ-UHFFFAOYSA-N FC=1C=NC=CC1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound FC=1C=NC=CC1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C VKFPTBRTTDPGRJ-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- HXWLJXWBJMWNEB-UHFFFAOYSA-N N-[2-methyl-5-(4-methylphenyl)pentan-2-yl]formamide Chemical compound CC1=CC=C(CCCC(C)(C)NC=O)C=C1 HXWLJXWBJMWNEB-UHFFFAOYSA-N 0.000 description 1
- UKERDACREYXSIV-UHFFFAOYSA-N N-methoxy-N-methylbenzamide Chemical compound CON(C)C(=O)C1=CC=CC=C1 UKERDACREYXSIV-UHFFFAOYSA-N 0.000 description 1
- LAGNBBAGHJTXPC-UHFFFAOYSA-N N1=C(C=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=C(C=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C LAGNBBAGHJTXPC-UHFFFAOYSA-N 0.000 description 1
- HWBKVGNMAGKSIH-UHFFFAOYSA-N N1=C(C=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound N1=C(C=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C HWBKVGNMAGKSIH-UHFFFAOYSA-N 0.000 description 1
- MIYDGRHSPUZWPB-UHFFFAOYSA-N N1=CC(=CC2=CC=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=CC(=CC2=CC=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C MIYDGRHSPUZWPB-UHFFFAOYSA-N 0.000 description 1
- RFNICKTUPZJBQE-UHFFFAOYSA-N N1=CC(=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=CC(=CC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C RFNICKTUPZJBQE-UHFFFAOYSA-N 0.000 description 1
- ZUJLXHKSAOTENB-UHFFFAOYSA-N N1=CC(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound N1=CC(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C ZUJLXHKSAOTENB-UHFFFAOYSA-N 0.000 description 1
- SWHFRJYUYSWEAS-UHFFFAOYSA-N N1=CC=C(C2=CC=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1=CC=C(C2=CC=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C SWHFRJYUYSWEAS-UHFFFAOYSA-N 0.000 description 1
- WKOJSBKYKWVMSJ-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)Cl)F)C Chemical compound N1=CC=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)Cl)F)C WKOJSBKYKWVMSJ-UHFFFAOYSA-N 0.000 description 1
- KNLRWYSELLMFOE-UHFFFAOYSA-N N1=CC=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound N1=CC=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C KNLRWYSELLMFOE-UHFFFAOYSA-N 0.000 description 1
- RSPCNBJPRQFCKW-UHFFFAOYSA-N N1=CN=CC(=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C Chemical compound N1=CN=CC(=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=C(C=C1)F)C RSPCNBJPRQFCKW-UHFFFAOYSA-N 0.000 description 1
- SJNVBQJBOXCHFM-UHFFFAOYSA-N N1C(=NC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1C(=NC=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C SJNVBQJBOXCHFM-UHFFFAOYSA-N 0.000 description 1
- IABDEADDJJHQRW-UHFFFAOYSA-N N1C=CC2=CC(=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1C=CC2=CC(=CC=C12)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C IABDEADDJJHQRW-UHFFFAOYSA-N 0.000 description 1
- VIOSZCFSOUNYHW-UHFFFAOYSA-N N1C=NC=C1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound N1C=NC=C1NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C VIOSZCFSOUNYHW-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- XJJNLADWOISIEQ-UHFFFAOYSA-N O1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound O1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C XJJNLADWOISIEQ-UHFFFAOYSA-N 0.000 description 1
- ZNYHXWNTBQOCMC-UHFFFAOYSA-N O1C=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound O1C=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C ZNYHXWNTBQOCMC-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 101100272976 Panax ginseng CYP716A53v2 gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- COWKVMDXCXVGLZ-UHFFFAOYSA-N S1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound S1C(=CC=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C COWKVMDXCXVGLZ-UHFFFAOYSA-N 0.000 description 1
- BJYSWFFPMBZHBN-UHFFFAOYSA-N S1C(=NCC1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound S1C(=NCC1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C BJYSWFFPMBZHBN-UHFFFAOYSA-N 0.000 description 1
- LLLPQAGKZIZGNV-UHFFFAOYSA-N S1C=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C Chemical compound S1C=C(C=C1)NC(CN1CC2=CC=C(C=C2CC1CC1=CC=C(C=C1)F)F)C LLLPQAGKZIZGNV-UHFFFAOYSA-N 0.000 description 1
- YJHDZGVJMDQUIA-UHFFFAOYSA-N S1C=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C Chemical compound S1C=C(C=C1)NC(CN1CC2=CC=CC=C2CC1CC1=CC=CC=C1)C YJHDZGVJMDQUIA-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- OJUHIDQVEFLXSE-UHFFFAOYSA-N [2-(4-methoxyphenyl)-2-oxoethyl] carbamate Chemical compound COC1=CC=C(C(=O)COC(N)=O)C=C1 OJUHIDQVEFLXSE-UHFFFAOYSA-N 0.000 description 1
- NFSMTXPGEBBLLV-UHFFFAOYSA-M [Br-].CC1=CC=CC([Mg+])=C1 Chemical compound [Br-].CC1=CC=CC([Mg+])=C1 NFSMTXPGEBBLLV-UHFFFAOYSA-M 0.000 description 1
- WMJMABVHDMRMJA-UHFFFAOYSA-M [Cl-].[Mg+]C1CCCCC1 Chemical compound [Cl-].[Mg+]C1CCCCC1 WMJMABVHDMRMJA-UHFFFAOYSA-M 0.000 description 1
- PIHADXVWBDVYGY-UHFFFAOYSA-N [methoxy(methyl)amino] 2-ethoxy-2-methoxy-2-propoxyacetate Chemical compound COC(C(=O)ON(OC)C)(OCCC)OCC PIHADXVWBDVYGY-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical class N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 150000001539 azetidines Chemical class 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- WQNUUUQZWTYKEB-UHFFFAOYSA-N benzyl n-[(3,5-diaminophenyl)methyl]-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]carbamate Chemical compound NC1=CC(N)=CC(CN(CCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)C(=O)OCC=2C=CC=CC=2)=C1 WQNUUUQZWTYKEB-UHFFFAOYSA-N 0.000 description 1
- PZJBFDHOIGBIHN-UHFFFAOYSA-N benzyl n-[[3,5-bis(methanesulfonamido)phenyl]methyl]-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]carbamate Chemical compound CS(=O)(=O)NC1=CC(NS(=O)(=O)C)=CC(CN(CCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)C(=O)OCC=2C=CC=CC=2)=C1 PZJBFDHOIGBIHN-UHFFFAOYSA-N 0.000 description 1
- VPOQFZQUXQEZJN-UHFFFAOYSA-N benzyl n-[[3,5-bis[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]methyl]-n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(NC(=O)OC(C)(C)C)=CC(CN(CCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)C(=O)OCC=2C=CC=CC=2)=C1 VPOQFZQUXQEZJN-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000034196 cell chemotaxis Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- VRMCUSOYAGQGBH-UHFFFAOYSA-N ditert-butyl 4-amino-5-formylbenzene-1,3-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1=CC(C=O)=C(N)C(C(=O)OC(C)(C)C)=C1 VRMCUSOYAGQGBH-UHFFFAOYSA-N 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- VMWJHHAOVXQCLE-UHFFFAOYSA-N ethyl 2-(4-fluorophenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(F)C=C1 VMWJHHAOVXQCLE-UHFFFAOYSA-N 0.000 description 1
- GKBBFFSHPKMSPN-UHFFFAOYSA-N ethyl 2-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl-[(3-nitrophenyl)methyl]amino]acetate Chemical compound C=1C=CC([N+]([O-])=O)=CC=1CN(CC(=O)OCC)CCN1CC2=CC=C(F)C=C2CC1CC1=CC=C(F)C=C1 GKBBFFSHPKMSPN-UHFFFAOYSA-N 0.000 description 1
- UVDAOCWUIAQDKJ-UHFFFAOYSA-N ethyl 2-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]anilino]acetate Chemical compound C1=CC(NCC(=O)OCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 UVDAOCWUIAQDKJ-UHFFFAOYSA-N 0.000 description 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
- XIMFCGSNSKXPBO-UHFFFAOYSA-N ethyl 2-bromobutanoate Chemical compound CCOC(=O)C(Br)CC XIMFCGSNSKXPBO-UHFFFAOYSA-N 0.000 description 1
- UGKNTHJOKZCTJK-UHFFFAOYSA-N ethyl 4-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]anilino]butanoate Chemical compound C1=CC(NCCCC(=O)OCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 UGKNTHJOKZCTJK-UHFFFAOYSA-N 0.000 description 1
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- PLXYGLOXTJGYAS-UHFFFAOYSA-N ethyl n-[4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 PLXYGLOXTJGYAS-UHFFFAOYSA-N 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- BLHLJVCOVBYQQS-UHFFFAOYSA-N ethyllithium Chemical compound [Li]CC BLHLJVCOVBYQQS-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- UTJJAXBCOUNNMH-UHFFFAOYSA-N isoquinolin-3-yl-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 UTJJAXBCOUNNMH-UHFFFAOYSA-N 0.000 description 1
- ZQAKFNOWFUZMGZ-UHFFFAOYSA-N isoquinolin-3-yl-(3-methylphenyl)methanone Chemical compound CC1=CC=CC(C(=O)C=2N=CC3=CC=CC=C3C=2)=C1 ZQAKFNOWFUZMGZ-UHFFFAOYSA-N 0.000 description 1
- IPCXLHDYSNBFNK-UHFFFAOYSA-N isoquinolin-3-yl-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC2=CC=CC=C2C=N1 IPCXLHDYSNBFNK-UHFFFAOYSA-N 0.000 description 1
- HCTDNIXGRCTOOQ-UHFFFAOYSA-N isoquinolin-3-yl-[4-(2-methyl-1,3-dioxolan-2-yl)phenyl]methanone Chemical compound C=1C=C(C(=O)C=2N=CC3=CC=CC=C3C=2)C=CC=1C1(C)OCCO1 HCTDNIXGRCTOOQ-UHFFFAOYSA-N 0.000 description 1
- KVMMIDQDXZOPAB-UHFFFAOYSA-N isoquinoline-3-carboxylic acid Chemical compound C1=CC=C2C=NC(C(=O)O)=CC2=C1 KVMMIDQDXZOPAB-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- RMXGWLUCCKWPGK-UHFFFAOYSA-M magnesium;1,2-dichlorobenzene-5-ide;bromide Chemical compound [Mg+2].[Br-].ClC1=CC=[C-]C=C1Cl RMXGWLUCCKWPGK-UHFFFAOYSA-M 0.000 description 1
- MPIXEEVXDGICED-UHFFFAOYSA-M magnesium;1-methanidyl-3-methylbenzene;chloride Chemical compound [Mg+2].[Cl-].CC1=CC=CC([CH2-])=C1 MPIXEEVXDGICED-UHFFFAOYSA-M 0.000 description 1
- NMQPDYTXGLHYDX-UHFFFAOYSA-M magnesium;1-methanidyl-4-methylbenzene;chloride Chemical compound [Mg+2].[Cl-].CC1=CC=C([CH2-])C=C1 NMQPDYTXGLHYDX-UHFFFAOYSA-M 0.000 description 1
- UKZCGMDMXDLAGZ-UHFFFAOYSA-M magnesium;2-methylpropane;bromide Chemical compound [Mg+2].[Br-].C[C-](C)C UKZCGMDMXDLAGZ-UHFFFAOYSA-M 0.000 description 1
- IWCVDCOJSPWGRW-UHFFFAOYSA-M magnesium;benzene;chloride Chemical compound [Mg+2].[Cl-].C1=CC=[C-]C=C1 IWCVDCOJSPWGRW-UHFFFAOYSA-M 0.000 description 1
- ZMPYQGQHGLLBQI-UHFFFAOYSA-M magnesium;chlorobenzene;bromide Chemical compound [Mg+2].[Br-].ClC1=CC=C[C-]=C1 ZMPYQGQHGLLBQI-UHFFFAOYSA-M 0.000 description 1
- DTKMKZYEOXZPQZ-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=C[C-]=C1 DTKMKZYEOXZPQZ-UHFFFAOYSA-M 0.000 description 1
- QGEFGPVWRJCFQP-UHFFFAOYSA-M magnesium;methanidylbenzene;bromide Chemical compound [Mg+2].[Br-].[CH2-]C1=CC=CC=C1 QGEFGPVWRJCFQP-UHFFFAOYSA-M 0.000 description 1
- RBWRWAUAVRMBAC-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=[C-]C=C1 RBWRWAUAVRMBAC-UHFFFAOYSA-M 0.000 description 1
- YAMQOOCGNXAQGW-UHFFFAOYSA-M magnesium;methylbenzene;bromide Chemical compound [Mg+2].[Br-].CC1=CC=CC=[C-]1 YAMQOOCGNXAQGW-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- YQXQWFASZYSARF-UHFFFAOYSA-N methanol;titanium Chemical compound [Ti].OC YQXQWFASZYSARF-UHFFFAOYSA-N 0.000 description 1
- YTNGWXICCHJHKA-UHFFFAOYSA-N methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical group C1=CC=C2CNC(C(=O)OC)CC2=C1 YTNGWXICCHJHKA-UHFFFAOYSA-N 0.000 description 1
- KCXLDHCJHIQVGH-UHFFFAOYSA-N methyl 2-benzyl-6-fluoro-3,4-dihydro-1h-isoquinoline-3-carboxylate Chemical compound COC(=O)C1CC2=CC(F)=CC=C2CN1CC1=CC=CC=C1 KCXLDHCJHIQVGH-UHFFFAOYSA-N 0.000 description 1
- LWJZGJNMJBUUMC-UHFFFAOYSA-N methyl 3-chlorosulfonylpropanoate Chemical compound COC(=O)CCS(Cl)(=O)=O LWJZGJNMJBUUMC-UHFFFAOYSA-N 0.000 description 1
- UVSBCUAQEZINCQ-UHFFFAOYSA-N methyl 3-formylbenzoate Chemical compound COC(=O)C1=CC=CC(C=O)=C1 UVSBCUAQEZINCQ-UHFFFAOYSA-N 0.000 description 1
- FEIOASZZURHTHB-UHFFFAOYSA-N methyl 4-formylbenzoate Chemical compound COC(=O)C1=CC=C(C=O)C=C1 FEIOASZZURHTHB-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- YARXNRIJEQZFCG-UHFFFAOYSA-N n,n-diethyl-4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound C1=CC(N(CC)CC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 YARXNRIJEQZFCG-UHFFFAOYSA-N 0.000 description 1
- BHMZXPICTYGDDU-UHFFFAOYSA-N n,n-diethyl-4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N(CC)CC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 BHMZXPICTYGDDU-UHFFFAOYSA-N 0.000 description 1
- HKHXOSGMUKPHOS-UHFFFAOYSA-N n-(2-cyclopentylethylidene)-2-methylpropane-1-sulfinamide Chemical compound CC(C)CS(=O)N=CCC1CCCC1 HKHXOSGMUKPHOS-UHFFFAOYSA-N 0.000 description 1
- XDYRUDMBCQCLHF-UHFFFAOYSA-N n-(6-methyl-1-phenylheptan-2-yl)formamide Chemical compound CC(C)CCCC(NC=O)CC1=CC=CC=C1 XDYRUDMBCQCLHF-UHFFFAOYSA-N 0.000 description 1
- WLPDZGUVGOJCJA-UHFFFAOYSA-N n-[(2,6-dimethylphenyl)methyl]-2-(3-methyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound CC1CC2=CC=CC=C2CN1CCNCC1=C(C)C=CC=C1C WLPDZGUVGOJCJA-UHFFFAOYSA-N 0.000 description 1
- SXTSGLULOHODBX-UHFFFAOYSA-N n-[(2-ethylphenyl)methyl]-2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CCC1=CC=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 SXTSGLULOHODBX-UHFFFAOYSA-N 0.000 description 1
- XWXIBANCNVWZMH-UHFFFAOYSA-N n-[(4-ethylphenyl)methyl]-2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound C1=CC(CC)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 XWXIBANCNVWZMH-UHFFFAOYSA-N 0.000 description 1
- OWCVZYAGOWXQNN-UHFFFAOYSA-N n-[2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]-2-phenylethanamine Chemical compound C=1C=CC=CC=1CCNCCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 OWCVZYAGOWXQNN-UHFFFAOYSA-N 0.000 description 1
- ZVLMKXKSECXXEZ-UHFFFAOYSA-N n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]pyridin-2-amine Chemical compound C1=CC(F)=CC=C1CC1N(CCNC=2N=CC=CC=2)CC2=CC=C(F)C=C2C1 ZVLMKXKSECXXEZ-UHFFFAOYSA-N 0.000 description 1
- WZOPEFOPLXCIMG-UHFFFAOYSA-N n-[3-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]-n-methylpropane-2-sulfonamide Chemical compound CC(C)S(=O)(=O)N(C)C1=CC=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 WZOPEFOPLXCIMG-UHFFFAOYSA-N 0.000 description 1
- RACHYDFLFCLFOL-UHFFFAOYSA-N n-[4-[[2-[3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC=CC=C2C1 RACHYDFLFCLFOL-UHFFFAOYSA-N 0.000 description 1
- VJJUIBLDTPFFMU-UHFFFAOYSA-N n-[4-methyl-1-(3-methylphenyl)pentan-2-yl]formamide Chemical compound CC(C)CC(NC=O)CC1=CC=CC(C)=C1 VJJUIBLDTPFFMU-UHFFFAOYSA-N 0.000 description 1
- AOAPHPSUBHVOCP-UHFFFAOYSA-N n-[4-methyl-1-(4-methylphenyl)pentan-2-yl]formamide Chemical compound CC(C)CC(NC=O)CC1=CC=C(C)C=C1 AOAPHPSUBHVOCP-UHFFFAOYSA-N 0.000 description 1
- HFYPGUQUPANAHU-UHFFFAOYSA-N n-[5-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-2-methylphenyl]acetamide Chemical compound C1=C(C)C(NC(=O)C)=CC(CNCCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)=C1 HFYPGUQUPANAHU-UHFFFAOYSA-N 0.000 description 1
- WGKPANLCBVDAAP-UHFFFAOYSA-N n-[5-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]-2-methylphenyl]methanesulfonamide Chemical compound C1=C(NS(C)(=O)=O)C(C)=CC=C1CNCCN1C(CC=2C=CC(F)=CC=2)CC2=CC(F)=CC=C2C1 WGKPANLCBVDAAP-UHFFFAOYSA-N 0.000 description 1
- GOYMDOJCPIJHAN-UHFFFAOYSA-N n-benzyl-2-(3-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-methylethanamine Chemical compound C=1C=CC=CC=1CN(C)CCN1CC2=CC=CC=C2CC1CC1=CC=CC=C1 GOYMDOJCPIJHAN-UHFFFAOYSA-N 0.000 description 1
- YMKJXQJRESACAU-UHFFFAOYSA-N n-benzyl-2-(3-phenyl-3,4-dihydro-1h-isoquinolin-2-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCN1CC2=CC=CC=C2CC1C1=CC=CC=C1 YMKJXQJRESACAU-UHFFFAOYSA-N 0.000 description 1
- QGRLLBWXFXNZPC-UHFFFAOYSA-N n-benzyl-2-[3-(2-methylbutyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CCC(C)CC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 QGRLLBWXFXNZPC-UHFFFAOYSA-N 0.000 description 1
- OIVDRVHBEBHNDQ-UHFFFAOYSA-N n-benzyl-2-[3-(3-methylbutyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanamine Chemical compound CC(C)CCC1CC2=CC=CC=C2CN1CCNCC1=CC=CC=C1 OIVDRVHBEBHNDQ-UHFFFAOYSA-N 0.000 description 1
- RVJFXBCWUZCHPO-UHFFFAOYSA-N n-benzyl-3-phenylprop-2-en-1-amine Chemical compound C=1C=CC=CC=1C=CCNCC1=CC=CC=C1 RVJFXBCWUZCHPO-UHFFFAOYSA-N 0.000 description 1
- TUOHQDZMLRWNSH-UHFFFAOYSA-N n-cyclopropyl-4-[[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethylamino]methyl]aniline Chemical compound C1=CC(F)=CC=C1CC1N(CCNCC=2C=CC(NC3CC3)=CC=2)CC2=CC=C(F)C=C2C1 TUOHQDZMLRWNSH-UHFFFAOYSA-N 0.000 description 1
- 125000004998 naphthylethyl group Chemical group C1(=CC=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-O nitrosooxidanium Chemical compound [OH2+]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-O 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- SEVSMVUOKAMPDO-UHFFFAOYSA-N para-Acetoxybenzaldehyde Natural products CC(=O)OC1=CC=C(C=O)C=C1 SEVSMVUOKAMPDO-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical compound NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- KPBSJEBFALFJTO-UHFFFAOYSA-N propane-1-sulfonyl chloride Chemical compound CCCS(Cl)(=O)=O KPBSJEBFALFJTO-UHFFFAOYSA-N 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- FREJAOSUHFGDBW-UHFFFAOYSA-N pyrimidine-5-carbaldehyde Chemical compound O=CC1=CN=CN=C1 FREJAOSUHFGDBW-UHFFFAOYSA-N 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- RYGIHSLRMNXWCN-UHFFFAOYSA-N quinoline-3-carbaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CN=C21 RYGIHSLRMNXWCN-UHFFFAOYSA-N 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 125000001010 sulfinic acid amide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 1
- UGXIXTVPUPDIDL-UHFFFAOYSA-N tert-butyl 5-formylbenzimidazole-1-carboxylate Chemical compound O=CC1=CC=C2N(C(=O)OC(C)(C)C)C=NC2=C1 UGXIXTVPUPDIDL-UHFFFAOYSA-N 0.000 description 1
- QZWULXHMKCIONL-UHFFFAOYSA-N tert-butyl n-(2-hydroxyethyl)-n-[(3-nitrophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)N(CCO)CC1=CC=CC([N+]([O-])=O)=C1 QZWULXHMKCIONL-UHFFFAOYSA-N 0.000 description 1
- MLDSDVASYUUDLT-UHFFFAOYSA-N tert-butyl n-(3-oxopropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCC=O MLDSDVASYUUDLT-UHFFFAOYSA-N 0.000 description 1
- VRSMDNKCLOEKHI-UHFFFAOYSA-N tert-butyl n-[(4-methyl-3-nitrophenyl)methyl]-n-(2-oxoethyl)carbamate Chemical compound CC1=CC=C(CN(CC=O)C(=O)OC(C)(C)C)C=C1[N+]([O-])=O VRSMDNKCLOEKHI-UHFFFAOYSA-N 0.000 description 1
- AUZUJSLFYNZGAW-UHFFFAOYSA-N tert-butyl n-[(4-nitrophenyl)methyl]-n-(2-oxoethyl)carbamate Chemical compound CC(C)(C)OC(=O)N(CC=O)CC1=CC=C([N+]([O-])=O)C=C1 AUZUJSLFYNZGAW-UHFFFAOYSA-N 0.000 description 1
- DQFAQVJDIDGLCI-UHFFFAOYSA-N tert-butyl n-[2-[6-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]-n-[[3-(propan-2-ylsulfonylamino)phenyl]methyl]carbamate Chemical compound CC(C)S(=O)(=O)NC1=CC=CC(CN(CCN2C(CC3=CC(F)=CC=C3C2)CC=2C=CC(F)=CC=2)C(=O)OC(C)(C)C)=C1 DQFAQVJDIDGLCI-UHFFFAOYSA-N 0.000 description 1
- FUHMQBUAETXMOD-UHFFFAOYSA-N tert-butyl n-[2-[7-fluoro-3-[(4-fluorophenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]ethyl]-n-[(4-nitrophenyl)methyl]carbamate Chemical compound C=1C=C([N+]([O-])=O)C=CC=1CN(C(=O)OC(C)(C)C)CCN1CC2=CC(F)=CC=C2CC1CC1=CC=C(F)C=C1 FUHMQBUAETXMOD-UHFFFAOYSA-N 0.000 description 1
- NMTOVOOJQCRDJZ-UHFFFAOYSA-N tert-butyl n-[[3-fluoro-2-(2-oxo-3-phenylpropyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(F)=C1CC(=O)CC1=CC=CC=C1 NMTOVOOJQCRDJZ-UHFFFAOYSA-N 0.000 description 1
- HKOWRZMOVBLMOD-UHFFFAOYSA-N tert-butyl n-[[4-methoxy-2-(2-oxo-3-phenylpropyl)phenyl]methyl]carbamate Chemical compound COC1=CC=C(CNC(=O)OC(C)(C)C)C(CC(=O)CC=2C=CC=CC=2)=C1 HKOWRZMOVBLMOD-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Description
CCR3のリガンドであるエオタキシンは細胞走化性を有するサイトカインという意味で名づけられたケモカインの1種で、CCR3に特異的に結合し、細胞内カルシウム濃度の上昇、細胞骨格の変化をもたらし、結果として細胞運動機能の亢進を引き起こす(非特許文献2)。また、好酸球においてCCR3が活性化されると、好酸球表面上の接着分子の発現亢進を引き起こすことにより、組織への好酸球の浸潤を促進することが示唆され(非特許文献3)、さらに細胞内の顆粒に存在するMBP(Major Basic Protein)、ECP(Eosinophil Cationic Protein)といった細胞傷害性を有する塩基性蛋白の顆粒からの分泌を引き起こし、結果として組織傷害性に作用する(非特許文献4)。
CCR3の発現レベルを健常者と比較した検討において、喘息患者の気道生検で、mRNAレベル、蛋白レベルともに有意に発現が亢進していること、また、CCR3を遺伝子工学的に欠失させたノックアウトマウスを用いた検討、CCR3蛋白の中和抗体を投与した検討、抗原感作、誘発による病態モデル等において、気管支肺胞洗浄液中の好酸球数の減少とともに、気道過敏性の亢進を改善させることなどが報告されている(非特許文献5〜7)。
以上の知見から、CCR3は、病変局所に好酸球の浸潤が見られることを特徴とした喘息、アレルギー性鼻炎、アレルギー性結膜炎、アトピー性皮膚炎などの疾患の発生、進展に深く関与しており、CCR3拮抗薬はこれらの疾患の予防または治療に有効であることが期待される(非特許文献8〜14)。
これまでにCCR3拮抗薬としては、直鎖アルキルアミン誘導体(特許文献1)、ピペリジン誘導体(特許文献2〜4、非特許文献11、15〜21)、モルホリン誘導体(特許文献5〜7)、ピロリジン誘導体(特許文献8、9)、ピペラジン誘導体(特許文献10、11)、ビシクロピペリジン誘導体(非特許文献22)、アゼチジン誘導体(特許文献12)などが報告されている。
また、テトラヒドロイソキノリン骨格を有するCCR3拮抗薬(特許文献13、14)の報告もあるが、本発明化合物はこれらの文献に開示されている化合物とは構造も活性の強度も異なる。
ちなみに、その他のテトラヒドロイソキノリン化合物としては、一般式(i)で示される化合物(特許文献15)や、一般式(ii)で示される化合物(特許文献16)等も知られているが、これらの文献にはCCR3拮抗活性については開示も示唆もなく、また、本発明の式(1)で示される特定のテトラヒドロイソキノリン化合物についても全く開示されていない。
すなわち、本発明は、一般式(1)で示されるテトラヒドロイソキノリン化合物又はその製薬学的に許容される塩を含む。さらに、本発明は、以下の態様を含む。
1. 下記式(1):
R1、R2、R3、R4は、同一または異なって、−H、−ハロゲン、置換されていてもよいC1−6アルキル、−OH、−O−C1−6アルキル、−SH、−S−C1−6アルキル、−COOH、−CO−C1−6アルキル、−CO−O−C1−6アルキル、−CO−NH−C1−6アルキル、−NO2、−NH2、−NH−C1−6アルキル、−N(C1−6アルキル)2、または−NH−CO−C1−6アルキル、を示し、
R5は、置換されていてもよいC1−6アルキル(但し、アミノメチルを除く)、置換されていてもよいC3−10シクロアルキル、置換されていてもよいC6−14アリール、−C1−6アルキレン−置換されていてもよいC3−10シクロアルキル、または−C1−6アルキレン−置換されていてもよいC6−14アリールを示し、
R6は、−H、置換されていてもよい−C1−6アルキル、または−Y’−A’を示し、
XはC1−6アルキレンを示し、
Y及びY’は、同一または異なって、単結合又はC1−6アルキレンを示し、
A及びA’は、同一または異なって、置換されていてもよいC6−14アリールまたは置換されていてもよい3〜15員のヘテロ環基を示し、
nは0または1を示す。)
で示されるテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
3. Xがエチレン、Yがメチレン、R6が-Hである上記2.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
4. R1、R4が-Hで、R2、R3が、同一又は異なって、-Hまたは-ハロゲンである上記3.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
5. R5が、置換されていてもよいベンジルである上記4.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
6. R5が、ハロゲノベンジルである上記5.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
7. nが0で、R5が、-C1-6アルキレン-置換されていてもよいC6-14アリールで、A及びA’が、同一または異なって、置換されていてもよい3〜15員のヘテロ環基、またはナフチルである上記1.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
8. A及びA’が、同一または異なって、ピリジル、ピリジル N-オキシド、ピリミジニル、イミダゾリル、ピロリル、チエニル、フリル、チアゾリル、キノリル、インドリル、及びベンゾイミダゾリルから選ばれる置換されていてもよいヘテロ環基、またはナフチルである上記7.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
9. R1、R2、R3、及びR4が、同一または異なって、-Hまたは-ハロゲン、Xがエチレン、Yがメチレン、R6が-Hである上記8.記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
10. N−(4−tert−ブチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−アセチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
3−[[2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド、
N−(4−tert−ブチル ベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−アセチルベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−[3−(メタンスルホニルアミノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3,5−ジメタンスルホニルアミノベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−エチルアニリン、
N−[4−(4−モルホリノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−(2−メトキシエチル)アニリン、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド、
N−[4−(1−ヒドロキシ−1−メチルエチル)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]ベンズアミド、
N−(4−tert−ブチル ベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−メタンスルホニルアミノベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[7−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン、
N−(ピリジン−4−イル)メチル−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、及び
N−(ピリジン−4−イル)メチル−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン
から選択されるテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
11. 上記1.〜10.のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物と、製薬学的に許容される担体とからなる医薬組成物。
12. 上記1.〜10.のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物を有効成分とするケモカインレセプタータイプ3(CCR3)拮抗剤。
13. 上記1.〜10.のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物を有効成分とする喘息、アレルギー性鼻炎、副鼻腔炎、アレルギー性結膜炎、アトピー性皮膚炎、潰瘍性大腸炎、クローン病、関節リウマチ、自己免疫疾患、HIV感染、またはHIV感染に伴う疾患の予防及び/または治療剤。
本明細書中、「置換されていてもよい」とは、無置換、あるいは、「同一または異なる置換基を1から置換可能な最大数有していること」を示す。
また、「-C1-6アルキレン-C3-10シクロアルキル」とは、前記C1-6アルキレンの結合手の一つと前記C3-10シクロアルキルとが結合した基である。具体的には、シクロプロピルメチル、シクロプロピルエチル、シクロプロピルプロピル、シクロペンチルメチル、シクロペンチルエチル、シクロペンチルプロピル、シクロヘキシルメチル、シクロヘキシルエチル、シクロヘキシルプロピル等が挙げられる。
また、「-C1-6アルキレン-C6-14アリール」とは、前記C1-6アルキレンの結合手の一つと前記C6-14アリールとが結合した基である。具体的には、ベンジル、フェネチル、フェニルプロピル、フェニルブチル、フェニルペンチル、フェニルヘキシル、ナフチルメチル、ナフチルエチル、ナフチルプロピル、ナフチルブチル、ナフチルペンチル、ナフチルヘキシル、インデニルメチル、インデニルエチル、インデニルプロピル、アズレニルメチル、アズレニルエチル、アズレニルプロピル、アントリルメチル、アントリルエチル、アントリルプロピル、フェナントリルメチル、フェナントリルエチル、フェナントリルプロピル、フルオレニルメチル、フルオレニルメチル、フルオレニルプロピル等が挙げられる。
また、「-C1-6アルキレン-3〜15員のヘテロ環基」とは、前記C1-6アルキレンの結合手の一つと前記3〜15員のヘテロ環基とが結合した基である。具体的には、ピリジルメチル、ピリジルエチル、ピリジルプロピル、テトラヒドロピラニルメチル、テトラヒドロピラニルエチル、テトラヒドロピラニルプロピル、モルホリニルメチル、モルホリニルエチル、モルホリニルプロピル等が挙げられる。
また、「ハロゲノベンジル」とは、ベンゼン環上の1個以上の任意の水素原子が、同一または異なった前記「ハロゲン」で置換されたベンジル基を意味する。具体的には2−フルオロベンジル、3−フルオロベンジル、4−フルオロベンジル、2−ブロモベンジル、3−ブロモベンジル、4−ブロモベンジル、2−クロロベンジル、3−クロロベンジル、4−クロロベンジル、3,4−ジフルオロベンジル、3,5−ジフルオロベンジル、3,4−ジブロモベンジル、3,5−ジブロモベンジル、3,4−ジクロロベンジル、3,5−ジクロロベンジル等が挙げられ、好ましくは2−フルオロベンジル、4−フルオロベンジル、2−クロロベンジル、4−クロロベンジルである。
「置換されていてもよいC1-6アルキル」、「置換されていてもよいC3-10シクロアルキル」、「置換されていてもよいC6-14アリール」、「置換されていてもよい3〜15員のヘテロ環基」、「-C1-6アルキレン-置換されていてもよいC3-10シクロアルキル」、および、「-C1-6アルキレン-置換されていてもよいアリール」は、無置換であるか、あるいは、上記置換基を1から3個(最も好ましくは1個)有することが好ましい。
(A) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、nが0で、Aが以下の式で示される基である化合物、その製薬学的に許容される塩、またはそれらの溶媒和物
(B) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、Xがエチレン、Yがメチレン、R6が-Hである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(C) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、R1、R4が-Hで、R2、R3が、同一又は異なって、-Hまたは-ハロゲンである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(D) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、R5が、置換されていてもよいベンジルである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(E) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、R5が、ハロゲノベンジルである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(F) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、nが0で、R5が、-C1-6アルキレン-置換されていてもよいC6-14アリール(さらに好ましくは置換されてもよいベンジル)で、A及びA’が、同一または異なって、置換されていてもよい3〜15員のヘテロ環基、またはナフチルである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(G) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、A及びA’が、同一または異なって、ピリジル、ピリジル N-オキシド、ピリミジニル、イミダゾリル、ピロリル、チエニル、フリル、チアゾリル、キノリル、インドリル、及びベンゾイミダゾリルから選ばれる置換されていてもよいヘテロ環基、またはナフチルである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
(H) 一般式(1)で示されるテトラヒドロイソキノリン化合物において、R1、R2、R3、及びR4が、同一または異なって、-Hまたは-ハロゲン、Xがエチレン、Yがメチレン、R6が-Hである化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
N−(4−tert−ブチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例96)、
N−(3−アセチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例106)、
3−[[2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド(実施例115)、
N−(4−tert−ブチルベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例121)、
N−(3−アセチルベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例122)、
N−[3−(メタンスルホニルアミノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例126)、
N−(3,5−ジメタンスルホニルアミノベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例133)、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン(実施例138)、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−エチルアニリン(実施例139)、
N−[4−(4−モルホリノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例140)、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−(2−メトキシエチル)アニリン(実施例150)、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド(実施例151)、
N−[4−(1−ヒドロキシ−1−メチルエチル)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例154)、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]ベンズアミド(実施例155)、
N−(4−tert−ブチルベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例156)、
N−(3−メタンスルホニルアミノベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例157)、
4−[[2−[7−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン(実施例161)、
N−(ピリジン−4−イル)メチル−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例171)、及び
N−(ピリジン−4−イル)メチル−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン(実施例180)
本発明化合物の、代表的な製造方法を以下に示す。
本発明化合物(1)は一般式(2)で示される1,2,3,4−テトラヒドロイソキノリン誘導体から製造することができる。
一般式(2)で示される1,2,3,4−テトラヒドロイソキノリン誘導体は、例えば次の製造法に従い製造することができる。
あるいは塩基の存在下又は非存在下、等量あるいは過剰量のN,O−ジメチルヒドロキシルアミン、メタノール、エタノール、又は無水酢酸と溶媒中で反応させることにより目的物(W=N,O−ジメチルヒドロキシルアミン、メトキシ、エトキシ、又はアセトキシ)が得られる。
この時、反応試薬として、DCC、WSC、オキザリルクロライド、チオニルクロライド等を使用することができる。
溶媒としては、例えばジクロロメタン、クロロホルム、テトラヒドロフラン、トルエン、ジオキサン、メタノール、エタノール、酢酸エチル、アセトニトリル、プロピオニトリル、水等を単独又は組み合わせて使用することができる。
塩基としては例えばピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化リチウム等が挙げられる。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは15分〜3日間である。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム等を単独又は組み合わせて使用することができるが、この限りではない。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは15分〜3日間である。
溶媒としては、例えばメタノール、エタノール、プロパノール、エチレングリコール、プロパンジオール、テトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム、水等を単独又は組み合わせて使用することができる。
塩基としてはピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化リチウム等が挙げられる。
接触還元反応における水素圧は、通常、常圧〜50気圧、好ましくは常圧〜10気圧である。
反応条件は、80〜380℃、好ましくは100〜200℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばメタノール、エタノール、プロパノール、酢酸エチル、水等を単独又は組み合わせて使用することができる。
接触還元反応における水素圧は、通常、常圧〜50気圧、好ましくは常圧〜10気圧である。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム等を単独又は組み合わせて使用することができる。
酸としては例えば塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。
塩基としてはピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム等が挙げられる。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばメタノール、エタノール、プロパノール、酢酸エチル、水等を単独又は組み合わせて使用することができる。
接触還元反応における水素圧は、通常、常圧〜50気圧、好ましくは常圧〜10気圧である。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム等を単独又は組み合わせて使用することができる。
酸としては塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。
反応条件は、0〜250℃、好ましくは30〜200℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばメタノール、エタノール、プロパノール、テトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル等を単独又は組み合わせて使用することができる。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは1時間〜3日間である。
この時、反応試薬として無水酢酸、DCC、WSC、オキザリルクロライド等を使用することができる。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、メタノール、エタノール、酢酸エチル、アセトニトリル、プロピオニトリル、水等を単独又は組み合わせて使用することができる。
酸としては例えば塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。
塩基としてはピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化リチウム等が挙げられる。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは15分〜3日間反応である。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム等を単独又は組み合わせて使用することができる。
反応条件は、0〜300℃、好ましくは50〜250℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばメタノール、エタノール、プロパノール、エチレングリコール、プロパンジオール、テトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム、水等を単独又は組み合わせて使用することができる。
酸としては例えば塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。
接触還元反応における水素圧は、通常、常圧〜50気圧、好ましくは常圧〜10気圧である。
反応条件は、−100〜200℃、好ましくは−50〜150℃にて1分〜5日間、好ましくは1時間〜3日間である。
この時、反応試薬として硫酸マグネシウム。硫酸銅、PPTS、チタニウム(IV)メトキシド、チタニウム(IV)エトキシド等を使用することができる。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム、ジクロロメタン等を単独又は組み合わせて使用することができる。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは15分〜3日間である。
溶媒としては、例えばテトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム、ジクロロメタン等を単独又は組み合わせて使用することができる。
反応条件は、−100〜180℃、好ましくは−80〜130℃にて1分〜5日間、好ましくは15分〜3日間である。
酸としては例えば塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。溶媒としては例えばメタノール、エタノール、プロパノール、エチレングリコール、プロパンジオール、テトラヒドロフラン、トルエン、ジオキサン、ジエチルエーテル、クロロホルム、水等を単独又は組み合わせて使用することができる。反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは15分〜3日間である。
この時、反応試薬としてn-ブチルリチウム、tert-ブチルリチウム、sec-ブチルリチウム、メチルリチウム、エチルリチウム等を単独又は組み合わせて使用することができる。
溶媒としては、例えばテトラヒドロフラン、ジエチルエーテル、トルエン、ジオキサン、酢酸エチル、等を単独又は組み合わせて使用することができる。
反応条件は、−100〜50℃、好ましくは−80〜30℃にて1分〜5日間、好ましくは15分〜3日間である。
酸としては塩酸、硫酸、臭素酸、酢酸、トリフルオロ酢酸等を単独又は組み合わせて使用することができる。溶媒としては、例えばテトラヒドロフラン、ジエチルエーテル、トルエン、ジオキサン、酢酸エチル、クロロホルム、ジクロロメタン、水等を単独又は組み合わせて使用することができる。反応条件は、−80〜180℃、好ましくは−50〜150℃にて1分〜5日間、好ましくは1時間〜3日間反応させることによって目的物が得られる。
溶媒としては、例えばメタノール、エタノール、プロパノール、酢酸エチル、水等を単独又は組み合わせて使用することができる。
接触還元反応における水素圧は、通常、常圧〜50気圧、好ましくは常圧〜10気圧である。
反応条件は、−80〜180℃、好ましくは−30〜130℃にて1分〜5日間、好ましくは1時間〜3日間である。
溶媒としては、例えばクロロホルム、ジクロロメタン、テトラヒドロフラン、トルエン、ジオキサン、酢酸エチル、アセトニトリル等を単独又は組み合わせて使用することができる。
塩基としてはピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化リチウム等が挙げられる。
反応条件は、−80〜150℃、好ましくは0〜150℃にて1分〜5日間、好ましくは15分〜3日間である。
溶媒としては、例えばクロロホルム、ジクロロメタン、テトラヒドロフラン、トルエン、ジオキサン、酢酸エチル、アセトニトリル等を単独又は組み合わせて使用することができる。
塩基としてはピリジン、トリエチルアミン、ジイソプロピルエチルアミン、炭酸カリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化リチウム等が挙げられる。
反応試薬としてはCDI、トリホスゲン等が挙げられる。
反応条件は、−80〜180℃、好ましくは0〜150℃にて1分〜5日間、好ましくは15分〜3日間である。
式(1)で示されるテトラヒドロイソキノリン化合物やその製薬学的に許容される塩の溶媒和物としては、各種の水和物や溶媒和物(例えば、エタノールなどのアルコールとの溶媒和物)が挙げられる。
各種の異性体は異性体間の物理化学的性質の差を利用し、常法により単離できる。たとえばラセミ混合物は、例えば酒石酸等の一般的な光学活性酸とのジアステレオマー塩に導き光学分割する方法等の一般的ラセミ分割法により、光学的に純粋な異性体に導くことができる。また、ジアステレオマー混合物は、例えば分別結晶化または各種クロマトグラフィー等により分割できる。また、光学活性な化合物は適当な光学活性な原料を用いることにより製造することもできる。
医薬組成物の投与ルートは、特に限定されず、治療目的に応じて適宜選択できる。例えば、経口剤、注射剤、坐剤、軟膏剤、吸入剤、点眼剤、点鼻剤、貼付剤等のいずれでもよい。これらの投与形態に適した医薬組成物は、公知の製剤方法を利用することによって製造できる。
a) N−メトキシ−N−メチルイソキノリン−3−カルボキシアミドの製造
1H-NMR (CDCl3)δ:3.47 (3H, s), 3.80 (3H, s), 7.69 (1H, ddd, J = 1.2, 8.0, 8.0 Hz), 7.76 (1H, ddd, J = 1.2, 8.0, 8.0 Hz), 7.92 (1H, d, J = 8.0 Hz), 8.02 (1H, d, J = 8.0 Hz), 8.14 (1H, s), 9.25 (1H, s).
1H-NMR (CDCl3)δ:7.51 (2H, dd, J= 7.5, 7.5 Hz), 7.61 (1H, dd, J = 1.2, 7.5 Hz), 7.76 (1H, ddd, J= 1.2, 7.8, 7.8 Hz), 7.80 (1H, ddd, J = 1.2, 7.8, 7.8 Hz), 8.01 (1H, d, J= 7.8 Hz), 8.05-8.12 (3H, m), 8.47 (1H, s), 9.34 (1H, s).
1H-NMR (CDCl3)δ:4.32 (2H, s), 7.20-7.27 (5H, m), 7.43 (1H, s), 7.54 (1H, m), 7.61-7.67 (1H, m), 7.72 (1H, d, J= 8.3 Hz), 7.94 (1H, d, J = 8.1 Hz), 9.22 (1H, s).
1H-NMR (CDCl3)δ:2.66 (1H, dd, J = 10.5, 16.1 Hz), 2.74-2.92 (3H, m), 3.13-3.23 (1H, m), 4.03 (2H, s), 6.98-7.15 (4H, m), 7.25-7.36 (5H, m).
1H-NMR (CDCl3)δ:1.44 (9H, s), 2.51 (1H, dd, J= 9.8, 13.2 Hz), 2.58 (1H, dd, J = 2.4, 16.6 Hz), 2.68-2.95 (4H, m), 3.18-3.37 (3H, m), 3.84 (2H, s), 5.00 (1H, brs), 7.02-7.32 (9H, m).
1H-NMR (CDCl3)δ:2.34 (2H, brs), 2.53 (1H, dd, J= 9.9, 13.3 Hz), 2.59 (1H, dd, J = 4.4, 16.9 Hz), 2.68-2.90 (5H, m), 2.93 (1H, dd, J = 5.0, 13.3 Hz), 3.23-3.31 (1H, m), 3.85 (2H, s), 7.04-7.09 (2H, m), 7.12-7.18 (3H, m), 7.20 (1H, dd, J = 7.3, 7.3 Hz), 7.25-7.36 (3H, m).
1H-NMR (CDCl3)δ:2.49 (1H, dd, J = 9.8, 13.2 Hz), 2.56 (1H, dd, J = 3.8, 16.5 Hz), 2.45-2.66 (1H, br), 2.75-2.96 (6H, m), 3.20-3.28 (1H, m), 3.78 (2H, s), 3.81 (2H, s), 7.01-7.08 (2H, m), 7.09-7.21 (5H, m), 7.22-7.34 (7H, m).
1H-NMR (CDCl3)δ:2.29 (3H, s), 2.44 (1H, dd, J= 10.5, 12.8 Hz), 2.57 (1H, dd, J = 4.4, 16.6 Hz), 2.61-2.73 (2H, m), 2.75-2.87 (2H, m), 2.88-2.95 (1H, m), 2.97 (1H, dd, J = 3.2, 12.8 Hz), 3.18-3.30 (1H, m), 3.57 (2H, s), 3.83 (1H, d, J = 15.7 Hz), 3.90 (1H, d, J = 15.7 Hz), 7.01-7.05 (2H, m), 7.06-7.10 (2H, m), 7.11-7.16 (2H, m), 7.16-7.22 (1H, m), 7.23-7.30 (3H, m), 7.31-7.36 (4H, m).
a) N−3−[[3−ベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル]プロピル]フタルイミドの製造
1H-NMR (CDCl3)δ:1.96 (2H, tt, J = 6.9, 6.9 Hz), 2.40 (1H, dd, J = 10.4, 12.8 Hz), 2.51 (1H, dd, J = 3.4, 16.1 Hz), 2.68-2.83 (3H, m), 2.90 (1H, dd, J = 2.9, 16.1 Hz), 3.18-3.27 (1H, m), 3.76 (1H, d, J = 14.8 Hz), 3.80 (2H, t, J = 6.8 Hz), 3.83 (1H, d, J = 14.8 Hz), 6.96-7.05 (2H, m), 7.07-7.12 (4H, m), 7.17 (1H, dd, J = 7.3, 7.3 Hz), 7.23-7.29 (2H, m), 7.65 (2H, dd, J= 2.9, 5.4 Hz), 7.79 (2H, dd, J = 2.9, 5.4 Hz).
1H-NMR (CDCl3)δ:1.74 (2H, tt, J = 7.0, 7.0 Hz), 2.45 (1H, dd, J = 10.2, 13.0 Hz), 2.59 (1H, dd, J = 4.0, 16.5 Hz), 2.68-2.85 (5H, m), 2.97 (1H, dd, J = 3.9, 13.0 Hz), 3.22-3.30 (1H, m), 3.82 (1H, d, J = 15.9 Hz), 3.89 (1H, d, J = 15.9 Hz), 7.03-7.08 (2H, m), 7.11-7.16 (4H, m), 7.20 (1H, dd, J = 7.4, 7.4 Hz), 7.25-7.31 (2H, m).
1H-NMR (CDCl3)δ:1.85 (2H, tt, J = 7.0, 7.0 Hz), 2.46 (1H, dd, J = 10.2, 13.0 Hz), 2.58 (1H, dd, J = 4.0, 16.5 Hz), 2.66-2.88 (5H, m), 2.93 (1H, dd, J = 3.9, 13.0 Hz), 3.22-3.33 (1H, m), 3.76 (2H, s), 3.86 (1H, s), 3.87 (1H, s), 7.00-7.34 (14H, m).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 10.5, 12.9 Hz), 2.58 (1H, dd, J = 4.3, 16.5 Hz), 2.77-2.86 (8H, m), 2.95 (1H, d, J = 3.2 Hz), 2.98 (1H, d, J = 3.2 Hz), 3.21-3.26 (1H, m), 3.83 (1H, d, J = 16.0 Hz), 3.91 (1H, d, J = 16.0 Hz)、7.03-7.06 (2H, m), 7.11-7.29 (12H, m).
a) 2−(2−アニリノアセチル)−3−ベンジル−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ: 2.54 (0.5H, dd, J = 9.8, 13.2 Hz), 2.68-2.94 (3H, m), 3.09 (0.5H, dd, J = 3.9, 15.9 Hz), 3.44 (0.5H, d, J = 15.6 Hz), 3.85 (0.5H, d, J = 15.6 Hz), 3.90 (0.5H, d, J = 15.9), 3.97 (0.5H, d, J = 15.9), 4.27-4.32 (0.5H, m), 4.46 (0.5H, d, J = 18.0 Hz), 4.53 (0.5H, d, J = 15.9 Hz), 4.64 (0.5H, d, J = 15.9 Hz), 4.77 (0.5H, br), 4.94 (0.5H, br), 5.17-5.23 (0.5H, m), 5.27 (0.5H, d, J = 18.0 Hz), 6.53 (1H, d, J= 8.5 Hz), 6.65 (1H, d, J = 8.5 Hz), 6.70 (0.5H, d, J = 7.4 Hz), 6.73 (0.5H, d, J = 7.4 Hz), 7.10-7.33 (11H, m).
b) N−フェニル−2−[3−ベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 2.66 (1H, dd, J = 10.6, 16.5 Hz), 2.79 (1H, dd, J = 3.6, 16.2 Hz), 2.80-2.92 (2H, m), 3.14-3.19 (1H, m), 3.32 (2H, t, J = 5.2 Hz), 3.84 (2H, t, J = 5.2 Hz), 4.03 (2H, s), 6.67 (2H, d, J = 7.3 Hz), 6.74 (1H, dd, J= 7.3, 7.3 Hz), 7.00-7.07 (2H, m), 7.10-7.13 (1H, m), 7.18 (1H, d, J = 7.3 Hz), 7.20 (1H, d, J = 7.3 Hz), 7.25-7.29 (4H, m), 7.33 (2H, d, J = 6.8 Hz).
a) 3−(4−クロロベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ: 2.51-2.61 (1H, m), 2.70-2.87 (3H, m), 3.07-3.13 (1H, m), 3.99 (2H, s), 6.98-7.03 (2H, m), 7.08-7.10 (2H, m), 7.15 (2H, d, J = 7.8 Hz), 7.27 (2H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ: 1.44 (9H, s), 2.47 (1H, dd, J = 9.4, 13.3 Hz), 2.54 (1H, dd, J = 4.0, 16.5 Hz), 2.68-2.73 (1H, m), 2.78-2.88 (3H, m), 3.20-3.34 (3H, m), 3.80 (1H, d, J = 17.0 Hz), 3.84 (1H, d, J= 17.0 Hz), 7.05-7.07 (4H, m), 7.15-7.18 (1H, m), 7.24-7.27 (2H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 9.8, 13.2 Hz), 2.52 (1H, dd, J = 3.6, 16.5 Hz), 2.75-2.79 (3H, m), 2.81-2.89 (3H, m), 3.16-3.22 (1H, m), 3.77 (2H, s), 3.79 (2H, s), 6.96-7.06 (3H, m), 7.10-7.19 (3H, m), 7.24-7.31 (5H, m), 7.35-7.37 (2H, m).
a) 3−(3−クロロベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ: 2.53-2.65 (1H, m), 2.73-2.87 (3H, m), 3.11-3.19 (1H, m), 4.03 (2H, s), 6.99-7.02 (1H, m), 7.04-7.07 (1H, m), 7.10-7.15 (3H, m), 7.22-7.28 (3H, m).
1H-NMR (CDCl3)δ: 1.44 (9H, s), 2.48 (1H, dd, , J = 9.5, 13.2 Hz), 2.55 (1H, dd, J = 3.8, 16.5 Hz), 2.68-2,73 (1H, m), 2.77-2.89 (3H, m), 3.19-3.34 (3H, m), 3.80 (1H, d, J = 16.2 Hz), 3.85 (1H, d, J= 16.2 Hz), 7.00 (1H, d, J = 7.1 Hz), 7.04-7.08 (2H, m), 7.12-7.21 (5H, m).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 9.8, 13.4 Hz), 2.51 (1H, dd, J = 3.6, 16.6 Hz), 2.74-2.78 (3H, m), 2.81-2.88 (3H, m), 3.16-3.22 (1H, m), 3.77 (2H, s), 3.80 (2H, s), 7.01-7.06 (2H, m), 7.11-7.19 (2H, m), 7.20 (1H, d, J= 8.8 Hz), 7.22 (1H, d, J = 8.8 Hz), 7.26-7.32 (5H, m), 7.36-7.38 (2H, m).
a) 3−(2−クロロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ:7.40-7.48 (3H, m), 7.55 (1H, m), 7.75-7.83 (2H, m), 8.01-8.07 (2H, m), 8.54 (1H, s), 9.29 (1H, m).
1H-NMR (CDCl3)δ:4.45 (2H, s), 7.18-7.42 (5H, m), 7.54 (1H, m), 7.64 (1H, m), 7.71 (1H, m), 7.94 (1H, m), 9.23 (1H, s).
1H-NMR (CDCl3)δ:2.64-2.81 (2H, m), 2.90-3.05 (2H, m), 3.28 (1H, m), 4.05 (2H, s), 7.00-7.40 (8H, m).
1H-NMR (CDCl3)δ:2.50-2.61 (2H, m), 2.75-2.90 (4H, m), 2.96-3.11 (2H, m), 3.37 (1H, m), 3.79 (2H, s), 3.82 (2H, s), 7.02-7.34 (13H, m).
a) 3−(3,4−ジクロロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 7.59 (1H, d, J = 12.7 Hz), 7.77-7.85 (2H, m), 7.97-8.13 (3H, m), 8.27 (1H, d, J = 2.8 Hz), 8.55 (1H, s), 9.33 (1H, s).
1H-NMR (CDCl3)δ: 4.25 (2H, s), 7.16 (1H, dd, J = 1.9, 8.3 Hz), 7.37 (1H, d, J = 8.3 Hz), 7.40 (1H, d, J = 1.9 Hz), 7.45 (1H, s), 7.57 (1H, ddd, J = 1.2, 7.5, 7.5 Hz), 7.67 (1H, ddd, J = 1.2, 7.5, 7.5 Hz ), 7.75 (1H, brd, J = 8.3 Hz), 7.95 (1H, brd, J = 8.3 Hz), 9.21 (1H, s).
1H-NMR (CDCl3)δ: 2.56-2.87 (4H, m), 3.09-3.19 (1H, m), 4.02 (2H, s), 7.00-7.12 (5H, m), 7.24-7.38 (2H, m).
1H-NMR (CDCl3)δ: 1.42 (9H, s), 2.46 (1H, dd, J = 9.5, 13.3 Hz), 2.51 (1H, dd, J = 4.1, 16.2 Hz), 2.68-2.87 (4H, m), 3.20-3.29 (3H, m), 3.77 (1H, d, J = 16.1 Hz), 3.83 (1H, d, J = 16.1 Hz), 7.03-7.05 (2H, m), 7.11-7.16 (2H, m), 7.21-7.27 (3H, m).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 9.6, 13.4 Hz), 2.49 (1H, dd, J = 3.9, 16.4 Hz), 2.72-2.80 (3H, m), 2.81-2.88 (3H, m), 3.16-3.24 (1H, m), 3.76 (2H, s), 3.81 (2H, s), 7.00-7.05 (3H, m), 7.14-7.17 (3H, m), 7.25-7.31 (6H, m).
a) 3−(4−フルオロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ:7.19 (2H, dd, J = 8.7, 8.7 Hz), 7.76-7.84 (2H, m), 8.03 (1H, d, J = 8.0 Hz), 8.10 (1H, d, J = 8.0 Hz), 8.16-8.22 (2H, m), 8.51 (1H, s), 9.31 (1H, s).
1H-NMR (CDCl3)δ:2.60 (1H, dd, J = 10.5, 16.1 Hz), 2.70-2.86 (3H, m), 3.05-3.15 (1H, m), 4.01 (2H, s), 6.96-7.06 (4H, m), 6.98-7.11 (2H, m), 7.18-7.22 (2H, m).
1H-NMR (CDCl3)δ:1.44 (9H, s), 2.46-2.60 (2H, m), 2.69-2.76 (1H, m), 2.80-2.95 (3H, m), 3.20-3.38 (3H, m), 3.88 (2H, s), 5.10 (1H, brs), 6.98 (2H, dd, J = 8.6, 8.6 Hz), 7.04-7.12 (4H, m), 7.14-7.19 (2H, m).
1H-NMR (CD3OD)δ:2.46 (1H, dd, J = 9.8, 13.4 Hz), 2.53 (1H, dd, J = 4.0, 16.5 Hz), 2.75-2.95 (6H, m), 3.14-3.22 (1H, m), 3.80 (2H, d, J = 4.6 Hz), 3.85 (2H, s), 6.96 (2H, dd, J = 8.8, 8.8 Hz), 7.01-7.06 (2H, m), 7.07-7.16 (4H, m), 7.27-7.37 (5H, m).
a) 3−(3−フルオロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ:7.31 (1H, m), 7.49 (1H, m), 7.75-7.92 (4H, m), 8.00-8.10 (2H, m), 8.51 (1H, s), 9.34 (1H, s).
1H-NMR (CDCl3)δ:4.30 (2H, s), 6.93 (1H, m), 7.01 (1H, m), 7.10 (1H, m), 7.28 (1H, m), 7.45 (1H, s), 7.56 (1H, m), 7.66 (1H, m), 7.74 (1H, d, J = 8.5 Hz), 7.94 (1H, d, J = 8.5 Hz), 9.22 (1H, s).
1H-NMR (CDCl3)δ:2.58-2.90 (4H, m), 3.16 (1H, m), 4.03 (2H, s), 6.90-7.32 (8H, m).
1H-NMR (CDCl3)δ:2.44-2.56 (2H, m), 2.72-2.94 (6H, m), 3.21 (1H, m), 3.79 (4H, s), 6.80-7.33 (13H, m).
a) 3−(2−フルオロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 7.21-7.55 (3H, m), 7.70 (1H, m), 7.80-7.90 (2H, m), 8.11-8.20 (2H, m), 8.47 (1H, s), 9.28 (1H, s).
1H-NMR (CDCl3)δ: 4.46 (2H, s), 7.09 (1H, m), 7.25-7.33 (2H, m), 7.38 (1H, s), 7.50-7.75 (4H, m), 7.94 (1H, m), 9.23 (1H, s).
1H-NMR (CDCl3)δ: 2.60-2.95 (4H, m), 3.15 (1H, m), 4.02 (2H, s), 6.98-7.14 (4H, m), 7.22-7.36 (4H, m).
1H-NMR (CDCl3)δ: 2.44-2.60 (2H, m), 2.70-2.95 (6H, m), 3.22 (1H, m), 3.79 (4H, s), 7.04-7.31 (13H, m).
a) 3−(2,4−ジフルオロベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 6.90 (1H, m), 7.03 (1H, m), 7.75-7.84 (5H, m), 9.63 (1H, s), 9.28 (1H, s).
1H-NMR (CDCl3)δ: 4.28 (2H, s), 7.11 (1H, m), 7.14-7.28 (2H, m), 7.38 (1H, s), 7.47 (1H, m), 7.57 (1H, m), 7.66 (1H, m), 7.87 (1H, m), 9.15 (1H, s).
1H-NMR (CDCl3)δ: 2.56-2.94 (4H, m), 3.18 (1H, m), 4.05 (2H, s), 6.83 (1H, m), 6.98-7.14 (4H, m), 7.20-7.30 (2H, m).
1H-NMR (CDCl3)δ: 2.45-2.60 (2H, m), 2.70-3.00 (6H, m), 3.25 (1H, m), 3.75-3.82 (4H, m), 6.75 (1H, m), 6.96-7.34 (11H, m).
a) 2−ベンジル−3−(4−メチルベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ: 2.41 (3H, s), 3.04 (1H, dd, J = 5.6, 17.0 Hz), 3.31 (1H, dd, J = 7.6, 17.0 Hz), 3.60 (1H, d, J = 15.0 Hz), 3.79-3.83 (2H, m), 3.97 (1H, d, J = 15.0 Hz), 4.48 (1H, dd, J = 5.6, 7.6 Hz), 6.96 (1H, d, J = 7.3 Hz), 7.11-7.27 (10H, m), 8.04 (2H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ: 2.34 (3H, s), 2.64-2.84 (4H, m), 3.10-3.17 (1H, m), 4.02 (2H, s), 6.99-7.15 (8H, m).
1H-NMR (CDCl3)δ: 2.29 (3H, s), 2.56-2.64 (2H, m), 2.87-2.99 (5H, m), 3.10-3.18 (1H, m), 3.37-3.44 (1H, m), 3.58 (1H, d, J = 15.8 Hz), 3.78 (1H, d, J = 15.8 Hz), 4.02 (2H, s), 6.93 (1H, d, J = 6.8 Hz), 7.05-7.36 (12H, m).
a) 3−(3−メチルベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 2.44 (3H, s), 7.36-7.43 (2H, m), 7.74-7.86 (4H, m), 8.00-8.09 (2H, m), 8.45 (1H, s), 9.34 (1H, s).
1H-NMR (CDCl3)δ: 2.32 (3H, s), 4.28 (2H, s), 7.03-7.23 (4H, m), 7.43 (1H, m), 7.53 (1H, m), 7.64 (1H, m), 7.72 (1H, m), 7.92 (1H, m), 9.21 (1H, s).
1H-NMR (CDCl3)δ: 2.35 (3H, s), 2.60-2.90 (4H, m), 3.15 (1H, m), 4.02 (2H, s), 6.99-7.14 (7H, m), 7.22 (1H, m).
1H-NMR (CDCl3)δ: 2.31 (3H, s), 2.43 (1H, m), 2.56 (1H, m), 2.75-2.95 (6H, m), 3.22 (1H, m), 3.80 (4H, s), 6.88-7.33 (13H, m).
a) 3−(2−メチルベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 2.39 (3H, s), 7.26-7.33 (2H, m), 7.41-7.48 (2H, m), 7.74-7.82 (2H, m), 7.99-8.07 (2H, m), 8.46 (1H, s), 9.32 (1H, s).
1H-NMR (CDCl3)δ: 2.29 (3H, s), 4.34 (2H, s), 7.18-7.30 (5H, m), 7.53 (1H, m), 7.60-7.67 (2H, m), 7.93 (1H, m), 9.22 (1H, s).
1H-NMR (CDCl3)δ: 2.36 (3H, s), 2.65-2.92 (4H, m), 3.16 (1H, m), 4.03 (2H, s), 7.00-7.24 (8H, m).
1H-NMR (CDCl3)δ: 2.22 (3H, s), 2.48-2.60 (2H, m), 2.70-2.98 (6H, m), 3.22 (1H, m), 3.80 (2H, s), 3.82 (2H, s), 7.00-7.32 (13H, m).
a) 3−(4−メトキシベンゾイル)イソキノリンの製造
1H-NMR (CDCl3)δ: 3.90 (3H, s), 6.99 (2H, d, J = 6.8 Hz), 7.33-7.82 (2H, m), 8.00 (1H, m), 8.07 (1H, m), 8.15 (2H, d, J = 6.8Hz), 8.44 (1H, s), 9.33 (1H, s).
1H-NMR (CDCl3)δ: 3.80 (3H, s), 4.26 (2H, s), 6.86 (2H, d, J = 6.6 Hz), 7.24 (2H, d, J = 6.6 Hz), 7.40 (1H, s), 7.53 (1H, m), 7.63 (1H, m), 7.71 (1H, m), 7.92 (1H, m), 9.21 (1H, s).
1H-NMR (CDCl3)δ: 2.58-2.86 (4H, m), 3.10 (1H, m), 3.81 (3H, s), 4.02 (2H, s), 6.87 (2H, d, J = 8.8 Hz), 6.98-7.12 (4H, m), 7.17 (2H, d, J = 8.8 Hz).
1H-NMR (CDCl3)δ: 2.42 (1H, m), 2.55 (1H, m), 2.70-2.92 (6H, m), 3.17 (1H, m), 3.78 (3H, s), 3.79 (2H, s), 6.80 (2H, d, J = 8.8 Hz), 6.98-7.08 (4H, m), 7.12-7.18 (2H, m), 7.22-7.34 (5H, m).
a) 3−[4−(2−メチル−1,3−ジオキソラン−2−イル)ベンゾイル]イソキノリンの製造
1H-NMR (CDCl3)δ: 1.69 (3H, s), 3.76-3.85 (2H, m), 4.00-4.12 (2H, m), 7.63 (2H, d, J = 8.1 Hz), 7.76-7.83 (2H, m), 8.02-8.10 (4H, m), 8.50 (1H, s), 9.34 (1H, s).
1H-NMR (CDCl3)δ: 1.64 (3H, s), 3.74-3.82 (2H, m), 3.98-4.06 (2H, m), 4.30 (2H, s), 7.29 (2H, d, J = 8.1 Hz), 7.42 (2H, d, J = 8.1 Hz), 7.47 (1H, s), 7.54 (1H, m), 7.65 (1H, m), 7.74 (1H, m), 7.93 (1H, m), 9.22 (1H, s).
1H-NMR (CDCl3)δ: 1.67 (3H, s), 2.60-2.90 (4H, m), 3.14 (1H, m), 3.80-3.85 (2H, m), 4.00-4.08 (4H, m), 6.98-7.14 (4H, m), 7.23 (2H, d, J = 8.1 Hz), 7.44 (2H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ: 2.57 (3H, s), 2.50-2.56 (2H, m), 2.74-2.98 (6H, m), 3.23 (1H, m), 3.79 (2H, s), 3.76-3.84 (2H, m), 7.00-7.38 (11H, m), 7.85 (2H, d, J = 8.3 Hz).
a) tert−ブチル 2−[3−メチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルカルバメートの製造
1H-NMR (CDCl3)δ:1.07 (3H, d, J = 6.4 Hz), 1.44 (9H, s), 2.54-2.64 (2H, m), 2.69-2.76 (1H, m), 2.96-3.12 (2H, m), 3.22-3.30 (2H, m), 3.66-3.78 (2H, m), 5.08 (1H, brs), 7.00-7.16 (4H, m).
1H-NMR (CDCl3)δ:1.11 (3H, d, J = 6.4 Hz), 2.56-2.84 (4H, m), 2.94-3.10 (2H, m), 3.28-3.33 (1H, m), 3.67-3.84 (2H, m), 7.01-7.14 (4H, m).
1H-NMR (CDCl3)δ:1.06 (3H, d, J = 6.6 Hz), 2.56 (1H, dd, J= 5.6, 16.1 Hz), 2.62-2.72 (1H, m), 2.74-2.82 (3H, m), 2.98 (1H, dd, J = 4.8, 16.1 Hz), 3.02-3.10 (1H, m), 3.65 (1H, d, J = 15.6 Hz), 3.72 (1H, d, J = 15.6 Hz), 3.83 (2H, s), 6.96-7.01 (1H, m), 7.04-7.15 (3H, m), 7.24-7.33 (5H, m).
a) イソプロピル 3−キノリノケトンの製造
1H-NMR (CDCl3)δ: 1.27 (6H, d, J = 6.8 Hz), 4.22 (1H, sept, J = 6.8 Hz), 7.71-7.79 (2H, m), 8.00 (1H, d, J = 7.8 Hz), 8.05 (1H, d, J = 7.8 Hz), 8.49 (1H, s), 9.29 (1H, s).
1H-NMR (CDCl3)δ: 0.95 (3H, d, J = 1.2 Hz), 0.97 (3H, d, J = 1.2 Hz), 2.15-2.27 (1H, m), 2.79 (2H, d, J = 7.3 Hz), 7.43 (1H, s), 7.52 (1H, dd, J = 7.4, 7.4 Hz), 7.64 (1H, dd, J = 7.4, 7.4 Hz), 7.74 (1H, d, J = 8.2 Hz), 7.92 (1H, d, J = 8.2 Hz), 9.20 (1H, s).
1H-NMR (CDCl3)δ: 0.92-0.98 (6H, m), 1.31-1.38 (1H, m), 1.40-1.47 (1H, m), 1.78-1.90 (1H, m), 2.48 (1H, dd, J = 10.8, 16.3 Hz), 2.79 (1H, dd, J = 3.8, 16.1 Hz), 2.91-2.98 (1H, m), 4.03 (1H, d, J = 15.8 Hz), 4.09 (1H, d, J = 15.8 Hz), 7.00-7.02 (1H, m), 7.06-7.14 (3H, m).
1H-NMR (CDCl3)δ: 0.89 (6H, d, J = 6.6 Hz), 1.16-1.22 (1H, m), 1.36-1.43 (1H, m), 1.64-1.71 (1H, m), 2.52-2.66 (2H, m), 2.76 (3H, brs), 2.91-3.03 (2H, m), 3.73 (2H, s), 3.84 (2H, s), 6.96-7.00 (1H, m), 7.06-7.14 (3H, m), 7.25-7.34 (5H, m).
a) N−(4−メチルペンチリデン)−2−メチルプロパンスルフィンアミドの製造
1H-NMR (CDCl3)δ: 0.93 (6H, d, J= 6.6 Hz), 1.19 (9H, s), 1.47-1.67 (3H, m), 2.50-2.55 (2H, m), 8.07 (1H, t, J = 4.6 Hz).
1H-NMR (CDCl3)δ: 0.89 (3H, d, J= 6.6 Hz), 0.90 (3H, d, J = 6.6 Hz), 1.22-1.69 (5H, m), 2.44 (1H, dd, J = 8.8, 13.4 Hz), 2.82 (1H, dd, J = 4.4, 13.4 Hz), 2.92-2.98 (1H, m), 7.18-7.32 (5H, m).
c) 3−(3−メチルブチル)−3,4−ジヒドロイソキノリンの製造
1H-NMR (CDCl3)δ: 0.92 (3H, d, J = 6.6 Hz), 0.93 (3H, d, J = 6.6 Hz), 1.29-1.39 (1H, m), 1.42-1.52 (1H, m), 1.54-1.67 (2H, m), 1.75-1.85 (1H, m), 2.56 (1H, dd, J = 12.8, 15.9 Hz), 2.77 (1H, dd, J = 5.8, 15.9 Hz), 3.44-3.54 (1H, m), 7.15 (1H, d, J = 7.3 Hz), 7.27-7.37 (3H, m), 8.33 (1H, d, J = 2.7 Hz).
1H-NMR (CDCl3)δ: 0.92 (6H, d, J = 6.6 Hz), 1.25-1.40 (2H, m), 1.45-1.61 (3H, m), 2.51 (1H, dd, J = 11.0, 16.6 Hz), 2.78-2.87 (2H, m), 4.04 (1H, d, J = 16.0 Hz), 4.09 (1H, d, J= 16.0 Hz), 7.00-7.03 (1H, m), 7.06-7.13 (3H, m).
1H-NMR (CDCl3)δ: 0.86 (3H, d, J = 6.4 Hz), 0.88 (3H, d, J = 6.4 Hz), 1.19-1.28 (4H, m), 1.43-1.56 (10H, m), 2.46-2.88 (5H, m), 3.22-3.51 (2H, m), 3.74-3.78 (2H, m), 4.47-4.48 (2H, m), 6.98-7.00 (1H, m), 7.03-7.06 (1H, m), 7.09-7.14 (2H, m), 7.22-7.32 (5H, m).
1H-NMR (CDCl3)δ: 0.85 (3H, d, J = 6.6 Hz), 0.86 (3H, d, J = 6.6 Hz), 1.20-1.34 (3H, m), 1.45-1.61 (2H, m), 2.53-2.58 (1H, m), 2.63-2.78 (4H, m), 2.84-2.93 (2H, m), 3.70 (1H, d, J = 16.1 Hz), 3.77 (1H, d, J = 16.1 Hz), 3.83 (2H, s), 6.97-7.00 (1H, m), 7.05-7.07 (1H, m), 7.09-7.15 (2H, m), 7.22-7.32 (5H, m).
a) N−(5−メチルヘキシリデン)−2−メチルプロパンスルフィンアミドの製造
1H-NMR (CDCl3)δ: 0.89 (6H, d, J = 6.6 Hz), 1.20 (9H, s), 1.21-1.27 (1H, m), 1.51-1.67 (4H, m), 2.47-2.53 (2H, m), 8.05-8.08 (1H, m).
得られた油状物のうち208 mgをメタノール2 mLに溶解し、氷冷下、4N 塩酸・酢酸エチル0.5 mLを加えて攪拌した。室温で3.5時間攪拌した。反応終了後、反応液を氷冷下、飽和重曹水、酢酸エチルを加えて、有機層を分離し、水層に再度酢酸エチルを加え抽出し、有機層を合わせて、飽和食塩水で洗浄した。有機層を無水硫酸ナトリウムで乾燥後、減圧濃縮し溶媒を留去、シリカゲルクロマトグラフィーを用いて精製して 目的物を黄色油状物として96.9 mg(収率 53%)得た。
1H-NMR (CDCl3)δ: 0.87 (6H, d, J = 6.6 Hz), 1.17-1.26 (2H, m), 1.31-1.39 (2H, m), 1.41-1.59 (3H, m), 2.50 (1H, dd, J = 8.8, 13.4 Hz), 2.81 (1H, dd, J = 5.1, 13.4 Hz), 2.98-3.05 (1H, m), 7.18-7.38 (5H, m).
1H-NMR (CDCl3)δ: 0.85 (6H, d, J = 6.6 Hz), 1.08-1.61 (7H, m), 2.66 (1H, dd, J = 8.0, 13.9 Hz), 2.76-2.88 (2H, m), 7.12-7.32 (5H, m), 8.13 (1H, s).
1H-NMR (CDCl3)δ: 0.89 (6H, d, J = 6.6 Hz), 1.20-1.27 (2H, m), 1.42-1.63 (4H, m), 1.72-1.82 (1H, m), 2.56 (1H, dd, J = 12.4, 16.1 Hz), 2.77 (1H, dd, J = 5.8, 16.1 Hz), 3.49-3.56 (1H, m), 7.15 (1H, d, J = 7.3 Hz), 7.27-7.36 (3H, m), 8.33 (1H, d, J = 2.7 Hz).
1H-NMR (CDCl3)δ: 0.89 (6H, d, J = 6.8 Hz), 1.19-1.28 (2H, m), 1.39-1.60 (5H, m), 2.52 (1H, dd, J = 10.5, 16.1 Hz), 2.81 (1H, dd, J = 3.9, 16.1 Hz), 2.84-2.90 (1H, m), 4.05 (1H, d, J = 15.8 Hz), 4.10 (1H, d, J= 15.8 Hz), 7.00-7.03 (1H, m), 7.06-7.13 (3H, m).
1H-NMR (CDCl3)δ: 0.86 (6H, d, J = 6.8 Hz), 1.12-1.18 (2H, m), 1.24-1.37 (3H, m), 1.43-1.52 (11H, m), 2.47-2.92 (5H, m), 3.22-3.49 (2H, m), 3.74-3.78 (2H, m), 4.47-4.49 (2H, m), 6.97-7.01 (1H, m), 7.03-7.06 (1H, m), 7.10-7.13 (2H, m), 7.20-7.32 (5H, m).
1H-NMR (CDCl3)δ: 0.85 (6H, d, J = 6.6 Hz), 1.12-1.18 (2H, m), 1.26-1.36 (3H, m), 1.45-1.56 (2H, m), 2.57 (1H, dd, J = 6.6, 17.6 Hz), 2.61-2.75 (4H, m), 2.87-2.92 (2H, m), 3.71 (1H, d, J = 16.1 Hz), 3.76 (1H, d, J = 16.1 Hz), 3.81 (2H, s), 6.97-7.00 (1H, m), 7.05-7.13 (3H, m), 7.21-7.34 (5H, m).
a) 3−シクロヘキシルメチルイソキノリンの製造
1H-NMR (CDCl3)δ:0.98-1.32 (5H, m), 1.60-1.78 (5H, m), 1.82-1.95 (1H, m), 2.80 (2H, d, J = 7.1 Hz), 7.42 (1H, s), 7.51 (1H, dd, J = 7.9, 7.9 Hz), 7.63 (1H, dd, J = 7.9, 7.9 Hz), 7.74 (1H, d, J = 7.9 Hz), 7.92 (1H, d, J = 7.9 Hz), 9.21 (1H, s).
1H-NMR( CDCl3)δ: 0.98-1.02 (2H, m), 1.10-1.58 (6H, m), 1.62-1.80 (5H, m), 2.01 (1H, brs), 2.49 (1H, dd, J= 10.5, 16.4 Hz), 2.79 (1H, dd, J = 3.6, 16.4 Hz), 2.94-3.04 (1H, m), 4.04 (1H, d, J = 16.1 Hz), 4.09 (1H, d, J= 16.1 Hz), 6.98-7.03 (1H, m), 7.04-7.08 (1H, m), 7.08-7.14 (2H, m).
1H-NMR (CDCl3)δ:0.84-0.97 (2H, m), 1.12-1.32 (4H, m), 1.44 (9H, s), 1.42-1.53 (2H, m), 1.60-1.78 (5H, m), 2.55 (1H, dd, J = 5.6, 16.6 Hz), 2.57-2.64 (1H, m), 2.66-2.76 (1H, m), 2.92 (1H, dd, J = 5.2, 16.6 Hz), 3.08-3.36 (3H, m), 3.80 (2H, s), 5.24 (1H, brs), 7.00-7.10 (2H, m), 7.11-7.17 (2H, m).
1H-NMR (CDCl3)δ:0.83-0.96 (2H, m), 1.09-1.46 (6H, m), 1.62-1.79 (5H, m), 2.54 (1H, dd, J = 5.3, 16.7 Hz), 2.58-2.63 (1H, m), 2.64-2.72 (1H, m), 2.86 (2H, t, J = 5.7 Hz), 2.94 (1H, dd, J= 5.3, 16.8 Hz), 3.05-3.12 (1H, m), 3.54 (2H, brs), 3.77 (2H, s), 6.98-7.04 (1H, m), 7.05-7.15 (3H, m).
1H-NMR (CDCl3)δ:0.79-0.94 (2H, m), 1.06-1.26 (4H, m), 1.28-1.46 (2H, m), 1.58-1.74 (5H, m), 2.42-2.56 (1H, br), 2.52 (1H, dd, J= 5.0, 16.5 Hz), 2.60-2.68 (1H, m), 2.71-2.79 (3H, m), 2.91 (1H, dd, J = 5.1, 16.5 Hz), 3.02-3.10 (1H, m), 3.72 (2H, s), 3.84 (2H, s), 6.96-7.00 (1H, m), 7.04-7.15 (3H, m), 7.22-7.34 (5H, m).
a) N−(2−シクロペンチルエチリデン)−2−メチルプロパンスルフィンアミドの製造
1H-NMR (CDCl3)δ: 1.20 (9H, s), 1.51-1.69 (6H, m), 1.79-1.80 (2H, m), 2.15-2.23 (1H, m), 2.53 (2H, dd, J = 5.1, 6.8 Hz), 8.06 (1H, t, J = 5.1 Hz).
1H-NMR (CDCl3)δ: 1.08-1.19 (2H, m), 1.48-1.86 (8H, m), 1.95-2.05 (1H, m), 2.52 (1H, dd, J = 10.5, 16.1 Hz), 2.84 (1H, dd, J = 3.4, 16.1 Hz), 2.89-2.97 (1H, m), 4.05 (1H, d, J = 16.1 Hz), 4.11 (1H, d, J = 16.1 Hz), 7.00-7.03 (1H, m), 7.06-7.09 (1H, m), 7.11-7.14 (2H, m).
1H-NMR (CDCl3)δ: 1.01-1.09 (2H, m), 1.18-1.37 (2H, m), 1.46-1.63 (4H, m), 1.69-1.79 (2H, m), 1.80-1.90 (1H, m), 2.58 (1H, dd, J = 4.6, 16.4 Hz), 2.63-2.78 (4H, m), 2.90-3.01 (2H, m), 3.73 (2H, s), 3.82 (2H, s), 6.97-7.00 (1H, m), 7.05-7.08 (1H, m), 7.11-7.14 (2H, m), 7.22-7.32 (5H, m).
1H-NMR (CDCl3)δ: 2.65-2.85 (4H, m), 3.09 (2H, d, J = 7.6 Hz), 3.58 (1H, d, J = 15.6 Hz), 3.69-3.74 (3H, m), 3.90 (1H, d, J = 15.6 Hz), 7.03 (1H, dd, J = 4.4, 4.4 H), 7.10 (1H, dd, J = 4.4, 4.4 Hz), 7.16-7.18 (2H, m), 7.26-7.31 (10H, m).
a) ベンジル 3−イソキノリノケトンの製造
1H-NMR (CDCl3)δ: 4.66 (2H, s), 7.23-7.26 (1H, m), 7.30 (1H, d, J = 7.4 Hz), 7.32 (1H, d, J = 7.4 Hz), 7.39 (2H, d, J = 6.8 Hz), 7.72-7.77 (2H, m), 7.98-8.00 (1H, m), 8.05-8.07 (1H, m), 8.50 (1H, s), 9.32 (1H, s).
1H-NMR (CDCl3)δ: 3.05-3.09 (2H, m), 3.15-3.19 (2H, m), 7.15-7.22 (5H, m), 7.35 (1H, s), 7.45-7.49 (1H, m), 7.55-7.59 (1H, m), 7.65 (1H, d, J = 8.2 Hz), 7.87 (1H, d, J = 8.2 Hz), 9.16 (1H, s).
1H-NMR (CDCl3)δ: 1.84-1.91 (2H, m), 2.59 (1H, dd, J = 10.4, 16.2 Hz), 2.78-2.95 (4H, m), 4.07 (2H, s), 7.01-7.03 (1H, m), 7.07-7.14 (3H, m), 7.18-7.31 (5H, m).
1H-NMR (CDCl3)δ: 1.43 (9H, s), 1.60-1.69 (1H, m), 1.84-1.92 (1H, m), 2.56-2.77 (5H, m), 2.90-3.00 (2H, m), 3.18-3.25 (2H, m), 3.76 (1H, d, J = 16.3 Hz), 3.81 (1H, d, J = 16.3 Hz), 7.00-7.03 (1H, m), 7.07-7.15 (4H, m), 7.18 (2H, d, J= 7.3 Hz), 7.25-7.29 (2H, m).
1H-NMR (CDCl3)δ: 1.58-1.67 (1H, m), 1.85-1.93 (1H, m), 2.59-2.78 (7H, m), 2.90-3.00 (2H, m), 3.71 (1H, d, J = 16.6 Hz), 3.78 (1H, d, J = 16.6 Hz), 3.81 (2H, s), 6.96-7.01 (1H, m), 7.06-7.08 (1H, m), 7.12-7.18 (5H, m), 7.23-7.27 (3H, m), 7.31 (4H, m).
a) N−(4−フェニルブチリデン)−2−メチルプロパンスルフィンアミドの製造
1H-NMR (CDCl3)δ: 1.20 (9H, s), 1.97 (2H, tt, J = 7.6, 7.6 Hz), 2.55 (2H, dt, J= 4.4, 7.6 Hz), 2.70 (2H, t, J = 7.6 Hz), 7.17-7.31 (5H, m), 8.09 (1H, t, J= 4.4 Hz).
1H-NMR (CDCl3)δ: 1.65-1.97 (4H, m), 2.55 (1H, dd, J = 13.4, 16.1 Hz), 2.69 (2H, t, J = 7.6 Hz), 2.75 (1H, dd, J = 5.9, 16.1 Hz), 3.49-3.59 (1H, m), 7.12-7.36 (9H, m), 8.32 (1H, d, J = 2.7 Hz).
1H-NMR (CDCl3)δ: 1.54-1.65 (2H, m), 1.73-1.84 (2H, m), 2.51 (1H, dd, J = 10.2, 16.4 Hz), 2.67 (2H, t, J = 7.7 Hz), 2.81 (1H, dd, J = 3.7, 16.4 Hz), 2.86-2.93 (1H, m), 4.03 (1H, d, J = 16.1 Hz), 4.08 (1H, d, J = 16.1 Hz), 7.00-7.02 (1H, m), 7.05-7.07 (1H, m), 7.10-7.13 (2H, m), 7.16-7.21 (3H, m), 7.25-7.30 (2H, m).
1H-NMR (CDCl3)δ: 1.30-1.58 (12H, m), 1.63-1.71 (2H, m), 2.44-3.00 (6H, m), 3.23-3.45 (2H, m), 3.74-3.78 (2H, m), 4.46 (2H, s), 6.98-7.32 (14H, m).
1H-NMR (CDCl3)δ: 1.32-1.41 (1H, m), 1.57-1.73 (3H, m), 2.54-2.75 (7H, m), 2.87-2.98 (2H, m), 3.69 (1H, d, J = 16.1 Hz), 3.76 (1H, d, J = 16.1 Hz), 3.82 (2H, s), 6.96-6.99 (1H, m), 7.04-7.06 (1H, m), 7.09-7.19 (5H, m), 7.22-7.31 (7H, m).
a) 3−クロロ−2−メチルベンジルアルコールの製造
1H-NMR (CDCl3)δ:2.39 (3H, s), 4.72 (2H, s), 7.13 (1H, dd, J = 7.6, 7.9 Hz), 7.27 (1H, d, J = 7.6 Hz), 7.32 (1H, d, J = 7.9 Hz).
1H-NMR (CDCl3)δ:2.47(3H, s), 4.61 (2H, s), 7.12 (1H, dd, J = 7.7, 7.9 Hz), 7.22 (1H, d, J = 7.7 Hz), 7.35 (1H, d, J = 7.9 Hz).
1H-NMR (CDCl3)δ:2.52 (3H, s), 4.89 (2H, s), 7.06 (1H, dd, J = 7.7, 7.8 Hz), 7.18 (1H, d, J = 7.7 Hz), 7.29 (1H, d, J = 7.8 Hz), 7.74 (2H, dd, J = 3.1, 5.5 Hz), 7.87 (2H, dd, J= 3.1, 5.5 Hz).
1H-NMR (CDCl3)δ:2.38 (3H, s), 3.88 (2H, s), 7.11 (1H, dd, J = 7.7, 8.1 Hz), 7.22 (1H, d, J = 7.7 Hz), 7.27 (1H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ:1.46 (9H, s), 2.37 (3H, s), 4.34 (2H, d, J = 5.6 Hz), 4.70 (1H, brs), 7.10 (1H, dd, J = 7.1, 7.8 Hz), 7.15 (1H, d, J = 7.1 Hz), 7.30 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ:1.44 (9H, s), 3.86 (2H, s), 4.01 (2H, s), 4.16 (2H, d, J = 5.4 Hz), 4.74 (1H, brs), 7.15-7.22 (2H, m), 7.23-7.37 (6H, m).
1H-NMR (CDCl3)δ:2.95-3.07 (2H, m), 3.10 (1H, dd, J = 10.7, 12.8 Hz), 3.57-3.67 (1H, m), 3.69 (1H, dd, J = 3.9, 12.8 Hz), 4.36 (1H, d, J = 16.1 Hz), 4.51 (1H, d, J = 16.1 Hz), 7.04 (1H, d, J = 7.7 Hz), 7.17 (1H, dd, J = 7.7, 7.7 Hz), 7.26-7.32 (4H, m), 7.33-7.39 (2H, m).
1H-NMR (DMSO-d6)δ:2.39 (1H, dd, J = 9.6, 13.1 Hz), 2.56 (1H, dd, J = 4.8, 12.3 Hz), 2.60-2.72 (3H, m), 2.73-2.86 (2H, m), 2.88 (1H, dd, J = 4.9, 13.1 Hz), 3.22-3.34 (1H, m), 3.75 (2H, s), 3.79 (2H, s), 7.06-7.14 (2H, m), 7.16-7.32 (11H, m).
a) 3−ベンジル−6−クロロ−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.62 (1H, dd, J = 10.2, 16.6 Hz), 2.73-2.77 (1H, m), 2.79 (1H, dd, J = 7.8, 13.4 Hz), 2.89 (1H, dd, J = 5.8, 13.4 Hz), 3.09-3.17 (1H, m), 3.95 (1H, d, J = 15.8 Hz), 4.00 (1H, d,J = 15.8 Hz), 6.94 (1H, d, J = 8.0 Hz), 7.06-7.09 (2H, m), 7.24-7.28 (3H, m), 7.32-7.36 (2H, m).
1H-NMR (CDCl3)δ:1.44-1.48 (9H, br), 2.35-2.86 (6H, m), 3.09-3.46 (3H, m), 3.69-3.84 (2H, m), 4.44-4.49 (2H, m), 6.92-7.33 (13H, m).
1H-NMR (CDCl3)δ:2.42 (1H, dd,J = 10.2, 13.2 Hz), 2.52 (1H, dd, J = 3.6, 16.6 Hz), 2.74-2.92 (6H, m), 3.17-3.23 (1H, m), 3.74 (2H, s), 3.79 (2H, s), 6.96 (1H, d, J = 8.3 Hz), 7.05 (1H, m), 7.09 (1H, d, J = 8.3 Hz), 7.09 (1H, s), 7.12 (1H, dd,J = 2.2, 8.3 Hz), 7.17-7.33 (8H, m).
a) 3−ベンジル−8−クロロ−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.64 (1H, dd,J = 10.4, 16.3 Hz), 2.74-2.79 (1H, m), 2.80 (1H, dd, J = 7.8, 13.4 Hz), 2.88 (1H, dd, J = 5.9, 13.4 Hz), 3.08-3.15 (1H, m), 3.87 (1H, d,J = 16.7 Hz), 4.19 (1H, d, J = 16.7 Hz), 6.97 (1H, d, J = 7.8 Hz), 7.06 (1H, dd, J = 7.8, 7.8 Hz), 7.16 (1H, d, J = 7.8 Hz), 7.24-7.27 (3H, m), 7.31-7.36 (2H, m).
1H-NMR (CDCl3)δ:1.44-1.49 (9H, br), 2.34-2.87 (6H, m), 3.08-3.47 (3H, m), 3.69-3.84 (2H, m), 4.44-4.49 (2H, m), 6.95 (1H, d, J = 7.8 Hz), 7.05-7.12 (3H, m), 7.18-7.33 (9H, m).
1H-NMR (CDCl3)δ:2.41 (1H, dd,J = 10.2, 13.2 Hz), 2.56 (1H, dd, J = 3.3, 16.4 Hz), 2.76-2.95 (6H, m), 3.19-3.25 (1H, m), 3.68 (1H, d, J = 17.1 Hz), 3.81 (2H, s), 3.89 (1H, d, J = 17.1 Hz), 6.97 (1H, d, J = 7.6 Hz), 7.05-7.12 (3H, m), 7.16-7.33 (9H, m).
a) 3−フルオロ−2−メチルベンジルアルコールの製造
1H-NMR (CDCl3)δ:2.26 (3H, d, J = 2.0 Hz), 4.71 (2H, s), 6.94-7.01 (1H, m), 7.06-7.20 (2H, m).
1H-NMR (CDCl3)δ:2.39 (3H, d, J = 2.2 Hz), 4.87 (2H, s), 6.91-6.98 (1H, m), 7.04 -7.12 (2H, m), 7.74 (2H, dd, J = 3.1, 5.4 Hz), 7.87 (2H, dd, J = 3.1, 5.4 Hz).
1H-NMR (CDCl3)δ:2.25 (3H, d, J = 2.4 Hz), 3.87 (2H, s), 6.93 (1H, dd, J = 8.5, 8.5 Hz), 7.08-7.18 (2H, m).
1H-NMR (CDCl3)δ:1.46 (9H, s), 2.23 (3H, d, J= 2.0 Hz), 4.32 (2H, d, J = 5.6 Hz), 4.70 (1H, brs), 6.96 (1H, dd, J= 8.3, 8.3 Hz), 7.03 (1H, d, J = 8.3 Hz), 7.09-7.16 (1H, m).
1H-NMR (CDCl3)δ:1.44 (9H, s), 3.83 (2H, s), 3.87 (2H, s), 4.15 (2H, d, J = 5.4 Hz), 4.79 (1H, brs), 6.98 (1H, dd, J= 8.6, 8.6 Hz), 7.09 (1H, d, J = 8.6, 8.6 Hz), 7.18-7.37 (6H, m).
1H-NMR (CDCl3)δ:2.18 (1H, brs), 2.48 (1H, dd, J= 10.8, 16.9 Hz), 2.81 (1H, dd, J = 8.1, 13.5 Hz), 2.88 (1H, dd, J= 3.8, 16.9 Hz), 2.95 (1H, dd, J = 5.5, 13.5 Hz), 3.08-3.16 (1H, m), 3.98 (1H, d, J = 15.8 Hz), 4.03 (1H, d, J = 15.8 Hz), 6.80 (1H, d, J = 7.8 Hz), 6.85 (1H, dd, J = 8.9, 8.9 Hz), 7.04-7.11 (1H, m), 7.23-7.29 (3H, m), 7.31-7.36 (2H, m).
1H-NMR (CDCl3)δ:2.47 (1H, dd, J = 9.7, 13.3 Hz), 2.64-2.68 (2H, m), 2.72-2.80 (3H, m), 2.84-2.96 (2H, m), 3.03-3.30 (1H, m), 3.79 (2H, s), 3.80 (2H, s), 6.83 (1H, d, J = 7.6 Hz), 6.87 (1H, dd, J= 8.7, 8.7 Hz), 7.08-7.15 (3H, m), 7.17-7.32 (8H, m).
a) 2−ベンジル−6−フルオロ−1,2,3,4−テトラヒドロイソキノリン−3−カルボン酸メチルの製造
1H-NMR (CDCl3)δ:3.09 (1H, dd, J = 3.7, 16.1 Hz ), 3.09 (1H, dd, J = 3.7, 16.1 Hz ),3.68 (3H, s), 3.75-3.82 (2H, m), 3.92-4.00 (3H, m), 6.79-6.87 (2H, m), 6.91-6.96 (1H, m), 7.25-7.40 (5H, m).
1H-NMR (CDCl3)δ:3.06-3.14 (1H, m), 3.15 (3H, s), 3.38-3.49 (1H, m), 3.61 (3H, s), 4.14-4.60 (5H, m), 6.84-6.94 (2H, m), 7.06-7.12 (1H, m), 7.34-7.41 (3H, m), 7.42-7.48 (2H, m).
1H-NMR (CDCl3)δ:3.05 (1H, dd, J = 6.1, 17.2 Hz), 3.29 (1H, dd,J = 6.8, 17.2 Hz ),3.47-3.51 (1H, m), 3.63 (1H, d, J = 13.2 Hz), 3.76-3.84 (3H, m), 3.88-3.96 (1H, m), 4.53 (1H, dd, J = 6.5, 6.5 Hz), 6.81-6.89 (2H, m), 6.91-6.96 (1H, m), 7.17-7.30 (5H, m), 7.44-7.52 (2H, m), 7.56-7.62 (1H, m), 8.06-8.13 (2H, m).
1H-NMR (CDCl3)δ:2.64 (1H, dd, J = 10.2, 16.6 Hz), 2.73-2.80 (1H, m), 2.81 (1H, dd, J = 7.8, 13.4 Hz), 2.89 (1H, dd, J = 5.8, 13.4 Hz), 3.10-3.20 (1H, m), 3.97 (1H, d, J = 15.4 Hz), 4.01 (1H, d,J = 15.4 Hz), 6.76 (1H, dd, J = 2.6, 9.5 Hz), 6.81 (1H, ddd, J= 2.6, 8.5, 8.5 Hz), 6.96 (1H, dd, J = 5.8, 8.5 Hz), 7.24-7.28 (3H, m), 7.32-7.37 (2H, m).
1H-NMR (CDCl3)δ:1.40-1.50 (9H, br), 2.34-3.50 (9H, m), 3.69-3.86 (2H, m), 4.40-4.50 (2H, m), 6.74 (1H, dd, J = 2.6, 9.5 Hz), 6.84 (1H, ddd,J = 2.6, 8.4, 8.4 Hz), 6.92-7.00 (1H, m), 7.04-7.14 (2H, m), 7.18-7.34 (8H, m).
1H-NMR (CDCl3)δ:2.44 (1H, dd, J = 10.2, 13.1 Hz), 2.53 (1H, dd,J = 3.7, 16.6 Hz), 2.74-2.90 (6H, m), 3.16-3.24 (1H, m), 3.74 (2H, s), 3.80 (2H, s), 6.76 (1H, dd, J = 2.7, 9.5 Hz), 6.85 (1H, ddd, J = 2.7, 8.3, 8.3 Hz), 6.98 (1H, dd, J = 5.8, 8.3 Hz), 7.06-7.12 (2H, m), 7.16-7.34 (8H, m).
a) N−メトキシ−N−メチル−(7−フルオロ−2−メトキシカルボニル−1,2,3,4−テトラヒドロイソキノリン)−3−カルボキシアミドの製造
1H-NMR (CDCl3)δ: 2.96 (0.7H, m), 3.13-3.20 (3.3H, m), 3.67-3.80 (4H, m), 3.85 (2H, s), 4.56-4.88 (3H, m), 5.05 (0.3H, dd, J = 5.9, 5.9 Hz), 5.20 (0.7H, dd, J = 5.9, 5.9 Hz), 6.85-7.11 (3H, m).
1H-NMR (CDCl3)δ: 3.05-3.26 (2H, m), 3.69 (1H, s), 3.79 (2H, s), 4.55 (0.7H, d, J = 16.6 Hz), 4.60 (0.3H, d, J= 16.4 Hz), 4.81 (0.7H, d, J = 16.6 Hz), 4.87 (0.3H, d, J = 16.4 Hz), 5.70 (0.3H, dd, J = 4.8, 6.5 Hz), 5.92 (0.7H, dd, J = 3.7, 6.3 Hz), 6.82-7.02 (3H, m), 7.45-7.62 (3H, m), 7.87-7.93 (2H, m).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 9.6, 13.4 Hz), 2.52 (1H, dd, J = 3.4, 15.8 Hz), 2.75-2.81 (4H, m), 2.86-2.92 (2H, m), 3.21-3.26 (1H, m), 3.74 (2H, s), 3.80 (2H, s), 6.73 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 7.00 (1H, dd, J = 5.6, 8.3 Hz), 7.10 (2H, d, J = 7.1 Hz), 7.17-7.32 (8H, m).
a) N−(2−フルオロ−6−ヨードベンジル)カルバミド酸 t-ブチルの製造
1H-NMR (CDCl3)δ: 1.45 (9H, s), 4.50 (2H, s), 6.95-7.00 (1H, m), 7.04-7.08 (1H, m), 7.63 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ: 1.51 (9H, s), 3.69 (2H, d, J = 3.9 Hz), 4.42 (2H, d, J = 5,1 Hz), 4.70 (1H, br), 6.33-6.36 (2H, m), 6.95 (1H, dd, J = 8.8, 8.8 Hz), 7.04 (1H, d, J = 7.6 Hz), 7.17-7.23 (2H, m), 7.25-7.34 (4H, m).
1H-NMR (CDCl3)δ: 2.73 (1H, d, J = 7.3 Hz), 2.75 (1H, d, J = 7.6 Hz), 3.27 (1H, d, J = 7.6 Hz), 3.29 (1H, d, J = 7.3 Hz), 3.68 (3H, s), 3.69 (2H, d, J = 6.8 Hz), 4.40 (2H, d, J = 4.4 Hz), 4.72 (1H, br), 6.28-6.36 (2H, m), 6.98 (1H, ddd, J = 0.9, 9.1, 9.1 Hz), 7.08 (1H, d, J = 7.6 Hz), 7.18-7.22 (2H, m), 7.25-7.34 (4H, m).
1H-NMR (CDCl3)δ: 2.58 (1H, d, J = 7.3 Hz), 2.60 (1H, d, J = 8.1 Hz), 2.99 (1H, d, J = 8.1 Hz), 3.01 (1H, d, J = 7.3 Hz), 3.64 (3H, s), 3.96 (2H, s), 4.70 (2H, s), 6.32 (1H, s), 6.90 (1H, d, J= 7.3 Hz), 6.98 (1H, dd, J = 8.5, 8.5 Hz), 7.20-7.34 (6H, m).
1H-NMR (CDCl3)δ: 2.44-2.61(2H, m), 2.71-2.78 (2H, m), 2.89 (1H, dd, J = 7.8, 13.2 Hz), 2.91-3.02 (2H, m), 3.10 (1H, dd, J = 5.8, 16.3 Hz), 3.64 (3H, s), 4.32 (1H, d, J = 17.4 Hz), 4.48-4.53 (1H, m), 4.85 (1H, d, J = 17.4 Hz), 6.93 (1H, d, J= 8.0 Hz), 6.95 (1H, d, J = 8.0 Hz), 7.18-7.25 (4H, m), 7.30-7.34 (2H, m).
反応終了後、反応液に濾液に水を加え、酢酸エチルで抽出した後、有機層を重曹水、飽和食塩水で洗浄し、無水硫酸ナトリウムで除水後、減圧濃縮した。得られた残渣をPLC(クロロホルム:メタノール=10:1)を用いて精製し、表題化合物4 mg(収率 77%)を黄色油状物として得た。
1H-NMR (CDCl3)δ: 2.64 (1H, dd, J = 10.5, 16.4 Hz), 2.76-2.91(3H, m), 3.11-3.18 (1H, m), 3.89 (1H, d, J = 16.2 Hz), 4.18 (1H, d, J = 16.2 Hz), 6.92-6.97 (2H, m), 6.80-6.85 (2H, m), 7.08 (1H, dd, J = 7.8, 13.8 Hz), 7.24-7.28 (3H, m), 7.32-7.36 (2H, m).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.4, 16.7 Hz), 2.77-2.95 (6H, m), 3.20-3.25 (1H, m), 3.72 (1H, d, J = 16.8 Hz), 3.81 (2H, s), 3.88 (1H, d, J= 16.8 Hz), 6.83-6.89 (2H, m), 7.08-7.20 (4H, m), 7.24-7.31 (7H, m).
a) 4−メトキシ−2−メチルベンジルアルコールの製造
1H-NMR (CDCl3)δ:1.38 (1H, t, J = 5.3 Hz), 2.37 (3H, s), 3.80 (3H, s), 4.64 (2H, d, J = 5.3 Hz), 6.72 (1H, dd, J= 2.6, 8.1 Hz), 6.75 (1H, d, J = 2.6 Hz), 7.24 (1H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ:2.41(3H, s), 3.79 (3H, s), 4.60 (2H, s), 6.71 (1H, d, J = 2.6, 8.3 Hz), 6.75 (1H, d, J = 2.6 Hz), 7.22 (1H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ:2.47 (3H, s), 3.76 (3H, s), 4.81 (2H, s), 6.68 (1H, dd, J = 2.6, 8.3 Hz), 6.71(1H, d, J = 2.6 Hz), 7.28 (1H, d, J = 8.3 Hz), 7.71 (2H, dd, J = 3.1, 5.4 Hz), 7.84 (2H, d, J = 3.1, 5.4 Hz).
1H-NMR (CDCl3)δ:2.33 (3H, s), 3.79 (3H, s), 3.80 (2H, s), 6.70-6.75 (2H, m), 7.20 (1H, d, J = 9.0 Hz).
1H-NMR (CDCl3)δ:1.46 (9H, s), 2.31 (3H, s), 3.78 (3H, s), 4.25 (2H, d, J = 5.1 Hz), 4.59 (1H, brs), 6.70 (1H, dd, J= 2.7, 8.3 Hz), 6.73 (1H, d, J = 2.7 Hz), 7.14 (1H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ:1.43-1.44 (9H, m), 3.75 (2H, s), 3.75 (2H, s), 3.79 (3H, s), 4.11 (1H, d, J = 5.4 Hz), 4.18 (1H, d, J= 5.4 Hz), 4.74 (1H, brs), 6.55 (1H, d, J = 2.4 Hz), 6.69 (1H, s), 6.71-6.78 (2H, m), 7.15-7.38 (4H, m).
1H-NMR (CDCl3)δ:2.64 (1H, dd, J = 10.3, 16.4 Hz), 2.74 (1H, dd, J = 3.9, 16.4 Hz), 2.80-2.92 (2H, m), 3.12-3.20 (1H, m), 3.76 (3H, s), 3.95 (1H, d, J = 16.2 Hz), 3.99 (1H, d, J= 16.2 Hz), 6.59 (1H, d, J = 2.6 Hz), 6.69 (1H, dd, J = 2.6, 8.4 Hz), 6.92 (1H, d, J = 8.4 Hz), 7.22-7.28(3H, m), 7.31-7.38 (2H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 10.0, 13.2 Hz), 2.53 (1H, dd, J = 3.4, 16.6 Hz), 2.77-2.80 (3H, m), 2.83-2.93 (3H, m), 3.19-3.24 (1H, m), 3.72 (2H, s), 3.78 (3H, s), 3.80 (2H, s), 6.59 (1H, d, J = 2.6 Hz), 6.73 (1H, dd, J= 2.6, 8.3 Hz), 6.94 (1H, d, J = 8.3 Hz), 6.94 (1H, d, J = 8.3 Hz), 7.11 (2H, d, J = 7.1 Hz), 7.16-7.33 (8H, m).
a) 2−(2−トルイル)−N−メトキシ−N−メチルアセトアミドの製造
反応終了後、氷冷下反応液に1N塩酸を加えて希釈し、クロロホルム抽出した。クロロホルム層を飽和重曹水、飽和食塩水の順に洗浄し、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル=2:1)で精製し、表題化合物3.20 g(収率96%)を無色油状物として得た。
1H-NMR (CDCl3)δ:2.31 (3H, s), 3.21 (3H, s), 3.61 (3H, s), 3.77 (2H, s), 7.12-7.21 (4H, m).
反応終了後、氷冷下反応液に1N塩酸をゆっくり加えて希釈し、酢酸エチルで抽出した。有機層を飽和重曹水、飽和食塩水の順に洗浄し、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル=5:1)及びPLC(ヘキサン:酢酸エチル=1:1)で精製し、表題化合物 49 mg (収率 2%)を微黄色油状物として得た。
1H-NMR (CDCl3)δ:0.89 (6H, d, J = 6.6 Hz), 2.09-2.20 (1H, m), 2.24 (3H, s), 2.30 (2H, d, J = 6.8 Hz), 3.68 (2H, s), 7.10-7.18 (4H, m).
反応終了後、クロロホルム抽出し、有機層を飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をPLC(クロロホルム:アンモニア飽和メタノール=20:1)で精製し、表題化合物42 mg(収率 85%)を淡黄色油状物として得た。
1H-NMR (CDCl3)δ:0.89 (3H, d, J = 6.6 Hz), 0.94 (3H, d, J= 6.6 Hz), 1.29-1.39 (2H, m), 1.67-1.87 (1H, m), 2.33 (3H, s), 2.43 (1H, dd, J= 9.2, 13.5 Hz), 2.81 (1H, dd, J = 4.3, 13.5 Hz), 3.01-3.13 (1H, m), 7.09-7.20 (4H, m).
反応終了後、反応液に水を加えて希釈し、2N塩酸で酸性にして酢酸エチルで抽出した。有機層を飽和重曹水、飽和食塩水の順に洗浄後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル=10:1〜8:1)で精製し、表題化合物53 mg(収率 97%)を無色油状物として得た。
1H-NMR (CDCl3)δ:0.84 (3H, d, J = 6.6 Hz), 0.89 (3H, d, J= 6.6 Hz), 1.23-1.34 (2H, m), 1.67 (1H, br), 2.35 (3H, s), 2.71 (1H, dd, J= 6.8, 13.5 Hz), 2.83 (1H, dd, J = 6.1, 13.5 Hz), 3.61 (3H, brs), 3.94 (1H, br), 4.40 (1H, br), 7.08-7.16 (4H, m).
反応終了後、氷冷下反応液に水を加えて希釈し、5N水酸化ナトリウムでアルカリ性にして酢酸エチルで抽出した。有機層を水と飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をPLC(ヘキサン:酢酸エチル=4:1)で精製し、表題化合物20 mg (収率 36%)を無色油状物として得た。
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.3 Hz), 0.93 (3H, d, J= 6.3 Hz), 1.10 (1H, br) 1.43-1.56 (2H, m), 2.23 (3H, s), 2.58 (1H, m), 2.85 (1H, dd, J= 6.1, 16.3 Hz), 3.74 (3H, s), 4.22 (1H, m), 4.55-5.10 (2H, br), 6.95 (1H, m), 7.02-7.11 (2H, m).
1H-NMR (CDCl3)δ:0.96 (6H, d, J = 6.6 Hz), 1.34-1.51 (2H, m), 1.89-1.99 (1H, m), 2.21 (3H, s), 2.39 (1H, d, J = 10.7 Hz), 2.69 (1H, dd, J = 4.1, 16.2 Hz), 2.90-2.99 (1H, m), 4.02 (1H, d, J = 16.1 Hz), 4.09 (1H, d, J = 16.1 Hz), 6.89 (1H, d, J = 7.1 Hz), 7.00-7.07 (2H, m).
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.6 Hz), 0.91 (3H, d, J= 6.6 Hz), 1.13-1.21 (1H, m), 1.41-1.48 (10H, br), 1.61 (1H, br), 2.20 (3H, s), 2.30-2.72 (4H, m), 2.90-3.45 (3H, m), 3.71-3.80 (2H, m), 4.46 (1H, m), 4.48 (1H, m), 6.85 (1H, br), 7.00 (1H, d, J = 6.6 Hz), 7.05-7.07 (1H, m) 7.20-7.33 (5H, m).
1H-NMR (CDCl3)δ:0.90 (6H, d, J = 6.6 Hz), 1.17-1.25 (1H, m), 1.40-1.48 (1H, m), 1.67-1.77 (1H, m), 2.21 (3H, s), 2.38 (1H, dd, J = 5.6, 16.8 Hz), 2.58-2.74 (5H, m), 3.04-3.11 (1H, m), 3.72 (1H, d, J = 16.3 Hz), 3.78 (1H, d, J = 16.3 Hz), 3.82 (2H, s), 6.84 (1H, d, J= 7.3 Hz), 7.00 (1H, d, J = 7.3 Hz), 7.04 (1H, dd, J = 7.3, 7.3 Hz), 7.24-7.35 (5H, m).
a) 4−メチル−1−(4−トルイル)−ペンタン−2−オンの製造
1H-NMR (CDCl3)δ:0.87 (6H, d, J = 6.6 Hz), 2.13 (1H, m), 2.30 (2H, d, J = 6.8 Hz), 2.33 (3H, s), 3.62 (2H, s), 7.08 (2H, d, J = 8.1 Hz), 7.13 (2H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.6 Hz), 0.94 (3H, d, J = 6.6 Hz), 1.29 (2H, t, J = 7.1 Hz), 1.76 (1H, m), 2.33 (3H, s), 2.38 (1H, d, J = 8.8 Hz), 2.41 (1H, d, J = 8.8 Hz), 3.04 (1H, m), 7.08 (2H, d, J = 8.1 Hz), 7.11 (2H, d, J = 8.1Hz).
1H-NMR (CDCl3)δ:0.86-0.95 (6H, m), 1.24-1.32 (2H, m), 1.66 (1H, m), 2.32 (3H, s), 2.70-2.83 (2H, m), 4.35(1H, m), 7.00-7.12 (4H, m).
1H-NMR (CDCl3)δ:0.95 (6H, d, J = 6.6 Hz), 1.39 (1H, m), 1.70 (1H, m), 1.97 (1H, m), 2.36 (3H, s), 2.47 (1H, dd, J = 12.4, 18.6 Hz), 2.74 (1H, dd, J = 5.9, 18.6 Hz), 3.62 (1H, m), 7.04 (1H, d, J = 7.6 Hz), 7.10 (1H, s), 7.17 (1H, d, J = 7.6 Hz), 8.30 (1H, d, J = 2.4 Hz).
1H-NMR (CDCl3)δ:0.94 (3H, d, J= 6.6 Hz), 0.95 (3H, d, J = 6.6 Hz), 1.30-1.46 (2H, m), 1.83 (1H, m), 2.29 (3H, s), 2.43 (1H, m), 2.75 (1H, m), 2.92 (1H, m), 4.00 (1H, d, J = 16.3 Hz), 4.06 (1H, d, J = 16.3 Hz), 6.84 (1H, s), 6.94 (1H, d, J = 8.1 Hz), 6.97 (1H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ:0.88 (6H, d, J = 6.6 Hz), 1.17 (1H, m), 1.38 (1H, m), 1.65 (1H, m), 2.29 (3H, s), 2.45 (1H, m), 2.62 (1H, m), 2.65-2.75 (3H, m), 2.85 (1H, m), 3.00 (1H, m), 3.70 (2H, s), 3.81 (2H, s), 6.81 (1H, s), 6.95 (2H, s), 7.30-7.40 (5H, m).
a) 4−メチル−1−(3−トルイル)−ペンタン−2−オンの製造
1H-NMR (CDCl3)δ:0.87 (6H , d, J = 6.6 Hz), 2.13 (1H, m), 2.32 (2H , d, J = 7.0 Hz), 2.34 (3H, s), 3.62 (2H, s), 6.99 (1H, d, J = 7.3Hz), 7.00 (1H, s), 7.07 (1H, d, J = 7.5 Hz), 2.21 (1H, dd, J = 7.5, 7.5 Hz).
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.6 Hz), 0.94 (3H, d, J = 6.6 Hz), 1.28 (2H, t, J = 7.3 Hz), 1.77 (1H, m), 2.34 (3H, s), 2.36 (1H, dd, J = 9.0, 14.4 Hz), 2.76 (1H, dd, J = 4.1, 14.4 Hz), 3.05 (1H, m), 6.98-7.04 (3H, m), 7.19 (1H, dd, J = 7.6, 7.6 Hz).
1H-NMR (CDCl3)δ:0.88-0.95 (6H, m), 1.31 (2H. t, J = 7.1 Hz), 1.64 (1H, m), 2.33 (3H, s), 2.70-2.84 (2H, m), 4.38 (1H, m), 6.92-7.05 (3H, m), 7.18 (1H, dd, J = 7.6, 7.6 Hz), 8.13 (1H, s).
1H-NMR (CDCl3)δ:0.96 (6H, d, J = 6.6Hz), 1.39 (1H, m), 1.70 (1H, m), 1.97 (1H, m), 2.36 (3H. s), 2.48 (1H, dd, J = 5.9, 16.2 Hz), 2.73 (1H, dd, J= 5.9, 16.2 Hz), 3.60 (1H, m), 6.96 (1H, s), 7.09 (1H, d, J = 7.8 Hz), 7.17 (1H, d, J = 7.8 Hz), 8.29 (1H, d, J = 2.7 Hz).
1H-NMR (CDCl3)δ:0.94 (3H, d, J = 6.6 Hz), 0.95 (3H, d, J = 6.6 Hz), 1.30-1.48 (2H, m), 1.83 (1H, m), 2.29 (3H, s), 2.44 (1H, m), 2.74 (1H, m), 2.91 (1H, m), 4.00 (1H, d, J = 15.6Hz), 4.04 (1H, d, J = 15.6 Hz), 6.89 (1H, s), 6.92-6.96 (2H, m).
1H-NMR (CDCl3)δ:0.88 (3H, d, J = 6.6 Hz), 0.89 (3H, d, J = 6.6 Hz), 1.17 (1H, m), 1.38 (1H, m), 1.68 (1H, m), 2.29 (3H, s), 2.48 (1H, dd, J = 5.1, 16.1 Hz), 2.67 (1H, m), 2.68-2.75 (3H, m), 2.87 (1H, dd, J = 5.4, 16.1 Hz), 3.00 (1H, m), 3.69 (2H, s), 3.82 (2H, s), 6.86-6.96 (3H, m), 7.22-7.32 (5H, m).
a) 3−イソブチル−8−メチル−3,4−ジヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:0.95 (3H, d, J = 6.6 Hz), 0.97 (3H, d, J = 6.6 Hz), 1.41 (1H, m), 1.71 (1H, m), 1.98 (1H, m), 2.47 (1H, dd, J = 11.7, 16.1 Hz), 2.48 (3H, s), 2.71 (1H, dd, J = 5.4, 16.1 Hz), 3.52 (1H, m), 6.97 (1H, d, J = 7.8 Hz), 7.07 (1H, d, J = 7.8 Hz), 7.22 (1H, dd, J = 7.8, 7.8 Hz), 8.63 (1H, d, J = 2.7 Hz).
1H-NMR (CDCl3)δ:0.94 (3H, d, J = 6.6 Hz), 0.95 (3H, d, J = 6.6 Hz), 1.30-1.46 (2H, m), 1.83 (1H, m), 2.18 (3H, s), 2.49 (1H, dd, J = 10.5, 16.1 Hz), 2.79 (1H, dd, J = 3.9, 16.1 Hz), 2.91 (1H, m), 3.92 (1H, d, J = 16.1 Hz), 4.04 (1H, d, J = 16.1 Hz), 6.89-6.98 (2H, m), 7.05 (1H, dd, J = 7.6, 7.6 Hz).
1H-NMR (CDCl3)δ:0.87 (3H, d, J = 6.6 Hz), 0.88 (3H, d, J = 6.6 Hz), 1.16 (1H, m), 1.34 (1H, m), 1.70 (1H, m), 2.14 (3H, s), 2.55 (1H, m), 2.66-2.78 (4H, m), 2.95-3.20 (2H, m), 3.54 (1H, d, J = 16.6 Hz), 3.63 (1H, d, J = 16.6 Hz), 3.81 (1H, s), 3.82 (1H, s), 6.88-6.98 (2H, m), 7.05 (1H, dd, J = 7.3, 7.3 Hz), 7.24-7.32 (5H, m).
a) tert−ブチル ベンジル[2−[3−イソブチル−5-ニトロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
得られた残渣をシリカゲルカラムクロマトグラフィー(クロロホルム:メタノール=30:1 )で精製し、さらにシリカゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル=5:1〜1:1 )で分画した。各フラクションをP-TLC(ヘキサン:酢酸エチル=1:1)で精製し、混合物油状物200 mgを得た。
得られた油状物を実施例32−f)と同様に反応・処理し、表題化合物を淡黄色油状物として得た。
1H-NMR (CDCl3)δ:0.88 (6H, d, J = 6.6 Hz), 1.04-1.14 (1H, m), 1.33 (1H, brs), 1.42-1.49 (9H, br), 1.62-1.73 (1H, m), 2.50-2.79 (3H, m), 2.80-3.10 (2H, m), 3.20-3.46 (2H, m), 3.79-3.89 (2H, m), 4.48 (2H, brs), 7.21-7.34 (7H, m), 7.96 (1H, d, J = 10.5 Hz).
1H-NMR (CDCl3)δ:0.88 (6H, d, J = 6.6 Hz), 1.09-1.17 (1H, m), 1.34-1.43 (1H, m), 1.61-1.73 (1H, m), 2.59-2.68 (1H, m), 2.71-2.82 (4H, m), 3.02-3.07 (1H, m), 3.10 (1H, dd, J = 5.1, 17.6 Hz), 3.76-3.87 (4H, m), 7.22-7.35 (7H, m), 7.78 (1H, dd, J = 2.2, 7.3 Hz).
MS (FAB) m/z 368 (M+H)+
IR (ATR cm-1): 2953, 1524, 1452, 1346, 733, 698.
a) tert−ブチル ベンジル[2−[3−イソブチル−6-ニトロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.89 (6H, d, J = 6.6 Hz), 1.03-1.19 (1H, m), 1.31 (1H, br), 1.40-1.50 (9H, br), 1.65-1.74 (1H, m), 2.39-2.80 (2H, m), 2.56 (1H, dd, J = 5.4, 16.6 Hz), 2.80-3.17 (2H, m), 3.17-3.44 (2H, m), 3.83 (2H, br), 4.47 (2H, brs), 7.13 (1H, brs), 7.20-7.33 (5H, m), 7.94-7.99 (2H, br).
1H-NMR (CDCl3)δ:0.89 (6H, d, J = 6.6 Hz), 1.08-1.16 (1H, m), 1.34-1.41 (1H, m), 1.61-1.73 (1H, m), 2.59-2.68 (2H, m), 2.72-2.78 (3H, m), 3.01 (1H, dd, J = 5.1, 16.3 Hz), 3.01-3.09 (1H, m), 3.78 (2H, s), 3.82 (2H, s), 7.13 (1H, d, J = 9.0 Hz), 7.23-7.35 (5H, m), 7.95-7.99 (2H, m).
MS (FAB) m/z 368 (M+H)+
a) 3−イソブチル−7―ニトロ−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:0.96 (6H, d, J = 6.8 Hz), 1.33-1.49 (2H, m), 1.77-1.91 (1H, m), 2.55 (1H, dd, J = 10.2, 16.6 Hz), 2.89 (1H, dd, J= 3.9, 17.1 Hz), 2.93-3.01 (1H, m), 4.14 (2H, s), 7.22 (1H, d, J = 8.3 Hz), 7.92 (1H, d, J = 2.2 Hz), 7.98 (1H, dd, J = 2.2, 8.3 Hz).
1H-NMR (CDCl3)δ:0.89 (6H, d, J = 6.6 Hz), 1.05-1.14 (1H, m), 1.34 (1H, br), 1.40-1.50 (9H, br), 1.68 (1H, br), 2.35-2.75 (3H, m), 2.80-3.25 (2H, m), 3.30-3.43 (2H, br), 3.82 (2H, br), 4.48 (2H, br), 7.17-7.31 (6H, m), 7.87 (1H, br), 7.97 (1H, br).
1H-NMR (CDCl3)δ:0.89 (6H, d, J = 6.6 Hz), 1.04-1.16 (1H, m), 1.35-1.43 (1H, m), 1.61-1.72 (1H, m), 2.58-2.67 (2H, m), 2.71-2.78 (3H, m), 2.99 (1H, dd, J = 5.4, 16.8 Hz), 3.03-3.10 (1H, m), 3.78 (2H, s), 3.83 (2H, s), 7.21 (1H, d, J = 8.3 Hz), 7.24-7.35 (5H, m), 7.88 (1H, d, J= 2.4 Hz), 7.98 (1H, dd, J = 2.4, 8.3 Hz).
MS (FAB) m/z 368 (M+H)+
IR (ATR cm-1): 2953, 1522, 1343, 739, 699.
a) 3−イソブチル−8―ニトロ−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:0.96 (6H, d, J = 6.6 Hz), 1.33-1.49 (2H, m), 1.78-1.90 (1H, m), 2.57 (1H, dd, J = 10.2, 16.3 Hz), 2.90 (1H, dd, J= 3.9, 16.3 Hz), 2.93-3.00 (1H, m), 4.32 (1H, d, J = 17.8 Hz), 4.38 (1H, d, J = 17.8 Hz), 7.29 (1H, dd, J = 7.8, 7.8 Hz), 7.36 (1H, d,J = 7.8 Hz), 7.87 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ:0.90 (6H, d, J= 6.6 Hz), 1.08-1.17 (1H, m), 1.40-1.50 (10H, m), 1.65-1.74 (1H, br), 2.25-2.75 (2H, m), 2.66 (1H, dd, J = 6.1, 16.8 Hz), 2.85-3.41 (4H, br), 3.98-4.01 (2H, br), 4.41-4.52 (2H, br), 7.18-7.34 (7H, m), 7.86 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ:0.90 (6H, d, J = 6.6 Hz), 1.13-1.21 (1H, m), 1.40-1.47 (1H, m), 1.65-1.74 (1H, m), 2.56-2.65 (2H, m), 2.69-2.78 (3H, m), 2.97-3.07 (2H, m), 3.81 (2H, s), 4.04 (2H, s), 7.20-7.37 (7H, m), 7.86 (1H, dd,J = 0.98, 8.0 Hz).
IR (ATR cm-1): 2953, 1525, 1345, 733, 698.
a) 3−イソブチル−2−トリフルオロアセチル−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:0.92-0.97 (6H, m), 1.18-1.62 (3H, m), 2.72 (1H, m), 3.15 (1H, m), 4.25 (0.5H, d, J = 17.6 Hz), 4.43 (0.5H, m), 4.49 (0.5H, d, J = 17.6 Hz), 4.83 (0.5H, d, J= 17.6 Hz), 5.04 (0.5H, m), 5.26 (0.5H, d, J = 17.6 Hz), 7.11-7.26 (4H, m).
1H-NMR (CDCl3)δ:0.87-0.95 (6H, m), 1.21-1.56 (3H, m), 2.60 (3H, s), 2.80 (1H, m), 3.18 (1H, m), 4.30 (0.5H, d, J = 17.1 Hz), 4.46 (0.5H, m), 4.54 (0.5H, d, J = 17.1 Hz), 4.90 (0.5H, d, J = 17.1 Hz), 5.08 (0.5H, m), 5.33 (0.5H, d, J = 17.1 Hz), 7.22-7.27 (1H, m), 7.73-7.83 (2H, m).
1H-NMR (CDCl3)δ:0.96 (6H, d, J= 6.6Hz), 1.34-1.50 (2H, m), 1.83 (1H, m), 2.55 (1H, m), 2.57 (3H, s), 2.85 (1H, m), 3.00 (1H, m), 4.13 (2H, s), 7.16 (1H, d, J = 7.8 Hz), 7.64 (1H, s), 7.71 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ:0.82 (6H, d, J= 6.6 Hz), 1.07 (1H, m), 1.33 (1H, m), 1.61 (1H, m), 2.50 (3H, s), 2,52-2.60 (2H, m), 2.67-2.69 (3H, m), 2.90 (1H, m), 2.97 (1H, m), 3.70 (2H, s), 3.75 (2H, s), 7.08 (1H, d, J = 7.8 Hz), 7.15-7.30 (5H,m), 7.53 (1H, s), 7.64 (1H, d, J = 7.8 Hz).
a) tert−ブチル ベンジル[2−[5−アミノ−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
反応終了後、1N 塩酸で弱酸性にして5分攪拌後、2N水酸化ナトリウムでアルカリ性とし、クロロホルムで抽出した。クロロホルム層を飽和食塩水で洗浄後、硫酸ナトリウムで乾燥し、減圧濃縮した。得られた油状物をP−TLC(クロロホルム:メタノール=20:1)精製し、表題化合物を淡黄色油状物として18 mg(収率 69%)を得た。
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.6 Hz), 0.91 (3H, d, J= 6.6 Hz), 1.14-1.23 (1H, m), 1.40-1.50 (9H, br), 1.72 (1H, br), 2.15 (1H, br), 2.38-2.71 (3H, m), 3.02-3.78 (6H, m), 4.35-4.50 (2H, br), 6.46 (1H, brs), 6.54 (1H, d, J = 7.8 Hz), 6.96 (1H, dd, J = 7.8, 7.8 Hz), 7.19-7.33 (5H, m).
1H-NMR (CDCl3)δ:0.90 (3H, d, J = 6.6 Hz), 0.91 (3H, d, J= 6.6 Hz), 1.19-1.27 (1H, m), 1.43-1.51 (1H, m), 1.65-1.80 (1H, m), 2.19 (1H, dd, J = 5.9, 16.1 Hz), 2.51 (1H, dd, J = 5.6, 16.1 Hz), 2.56-2.65 (1H, m), 2.65-2.76 (3H, m), 3.07-3.15 (1H, m), 3.56 (2H, s), 3.70 (1H, d, J= 16.3 Hz), 3.76 (1H, d, J = 16.3 Hz), 3.81 (2H,s), 6.47 (1H, d, J= 7.6 Hz), 6.54 (1H, d, J = 7.6 Hz), 6.96 (1H, dd, J = 7.6, 7.6 Hz), 7.21-7.32 (5H, m).
MS (FAB) m/z 338 (M+H)+
IR (ATR cm-1): 2951, 1619, 1591, 1467, 770, 737, 698.
a) tert−ブチル ベンジル[2−[6−アミノ−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.88 (6H, d, J = 6.6 Hz), 1.08-1.17 (1H, m), 1.32 (1H, br), 1.40-1.50 (9H, br), 1.67 (1H, br), 2.35-3.05 (4H, m), 3.15-3.75 (5H, m), 4.45-4.59 (2H, m), 6.40 (1H, d, J = 2.2 Hz), 6.49 (1H, dd, J= 2.2, 8.1 Hz), 6.77 (1H, brd, J = 8.1 Hz), 7.20-7.33 (5H, m).
MS (FAB) m/z 438 (M+H)+
1H-NMR (CDCl3)δ:0.87 (3H, d, J = 6.6 Hz), 0.88 (3H, d, J= 6.6 Hz), 1.13-1.21 (1H, m), 1.33-1.42 (1H, m), 1.61-1.73 (1H, m), 2.42 (1H, dd, J = 5.4, 16.3 Hz), 2.57-2.75 (4H, m), 2.81 (1H, dd, J = 5.1, 16.3 Hz), 2.94-3.01 (1H, m), 3.51 (2H, brs), 3.63 (2H, s), 3.81 (2H, s), 6.41 (1H, d, J = 2.4 Hz), 6.49 (1H, dd, J = 2.4, 8.1 Hz), 6.78 (1H, d, J = 8.1 Hz), 7.21-7.32 (5H, m).
MS (FAB) m/z 338 (M+H)+
IR (ATR cm-1): 2952, 2924, 1622, 1507, 1452, 809, 736, 698.
a) tert−ブチル ベンジル[2−[7−アミノ−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.88 (6H, d, J= 6.6 Hz), 1.09-1.18 (1H, m), 1.40-1.50 (9H, br), 1.60-1.75 (1H, br), 2.37 (1H, dd, J = 6.6, 16.3 Hz), 2.40-2.70 (3H, m), 2.85-3.00 (1H, br), 3.22-3.70 (5H, m), 4.40-4.55 (2H, br), 6.33 (1H, brs), 6.50 (1H, dd, J = 2.4, 8.0 Hz), 6.84 (1H, d, J = 8.0 Hz), 7.21-7.33 (5H, m).
1H-NMR (CDCl3)δ:0.87 (3H, d, J = 6.6 Hz), 0.88 (3H, d, J= 6.6 Hz), 1.13-1.22 (1H, m), 1.34-1.42 (1H, m), 1.63-1.74 (1H, m), 2.40 (1H, dd, J = 5.4, 16.1 Hz), 2.57-2.65 (1H, m), 2.67-2.81 (3H, m), 2.78 (1H, dd, J = 5.4, 16.1 Hz), 2.94-3.02 (1H, m), 3.50 (2H, brs), 3.65 (2H, s), 3.81 (2H, s), 6.43 (1H, d, J = 2.4 Hz), 6.50 (1H, dd, J = 2.4, 8.0 Hz), 6.85 (1H, d, J = 8.0 Hz), 7.20-7.33 (5H, m).
MS (FAB) m/z 338 (M+H)+
a) tert−ブチル ベンジル[2−[8−アミノ−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.87 (6H, d, J= 6.6 Hz), 1.09-1.14 (1H, m), 1.25-1.35 (1H, br), 1.40-1.65 (9H, m), 1.60-1.70 (1H, br), 2.49 (1H, dd, J = 5.6, 16.3 Hz), 2.50-3.00 (3H, m), 3.27-3.56 (5H, m), 4.50 (2H, brs), 6.51 (1H, dd, J = 7.8 Hz), 6.53 (1H, d, J= 7.6 Hz), 6.97 (1H, dd, J = 7.6, 7.8 Hz), 7.23-7.33 (5H, m).
1H-NMR (CDCl3)δ:0.87 (6H, d, J = 6.6 Hz), 1.12-1.20 (1H, m), 1.30-1.39 (1H, m), 1.59-1.70 (1H, m), 2.52 (1H, dd, J = 4.1, 16.1 Hz), 2.65-2.82 (4H, m), 2.93 (1H, dd, J = 5.1, 16.1 Hz), 2.95-3.02 (1H, m), 3.41 (2H, brs), 3.42 (1H, d, J = 15.4 Hz), 3.51 (1H, d, J = 15.6 Hz), 3.80 (1H, d, J = 13.4 Hz), 3.83 (1H, d, J = 13.4 Hz), 6.51 (1H, d, J = 7.8 Hz), 6.54 (1H, d, J = 7.6 Hz), 6.97 (1H, dd, J= 7.6, 7.8 Hz), 7.21-7.33 (5H, m).
MS (FAB) m/z 338 (M+H)+
IR (ATR cm-1): 2952, 2926, 1621, 1591, 1467, 1297, 768, 735, 696.
a) tert−ブチル ベンジル[2−[5−アセトアミド−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
反応液に水を加えてクロロホルムで抽出し、クロロホルム層を飽和食塩水で洗浄した。硫酸ナトリウムで乾燥後減圧濃縮し、PLC(クロロホルム:メタノール=20:1)精製して表題化合物を微黄色油状物として16 mg(収率 100%)を得た。
1H-NMR (CDCl3)δ:0.90 (6H, d, J= 6.3 Hz), 1.09-1.19 (1H, m), 1.40-1.50 (9H, br), 1.50-1.68 (2H, br), 2.21 (3H, s), 2.21-2.75 (4H, m), 2.96-3.49 (3H, m), 3.70-3.80 (2H, m), 4.46 (2H, brs), 6.85 (2H, brs), 7.15 (1H, dd, J = 7.8, 7.8 Hz), 7.19-7.33 (5H, m), 7.69 (1H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ:0.90 (6H, d, J= 6.6 Hz), 1.13-1.23 (1H, m), 1.40-1.46 (1H, m), 1.65-1.76 (1H, br), 2.20 (3H, s), 2.31 (1H, dd, J = 5.1, 16.1 Hz), 2.50-2.74 (5H, m), 3.05-3.15 (1H, br), 3.73 (1H, d, J = 16.6 Hz), 3.78 (1H, d, J = 16.6 Hz), 3.81 (2H, s), 6.84 (1H, d, J = 7.8 Hz), 6.86-6.92 (1H, br), 7.15 (1H, dd, J= 7.8, 7.8 Hz), 7.22-7.35 (5H, m), 7.67 (1H, d, J = 7.8 Hz).
MS (FAB) m/z 380 (M+H)+
IR (ATR cm-1): 2953, 1662, 1536, 1468, 1367, 1269, 749, 698.
a) tert−ブチル ベンジル[2−[6−アセトアミド−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.88 (6H, d, J= 6.6 Hz), 1.08-1.16 (1H, m), 1.25-1.37 (1H, br), 1.40-1.50 (9H, br), 1.62-1.71 (1H, br), 2.15 (3H, s), 2.35-2.50 (1H, m), 2.46 (1H, dd, J = 6.1, 16.6 Hz), 2.50-3.05 (3H, m), 3.24-3.50 (2H, br), 3.62-3.77 (2H, br), 4.37-4.60 (2H, br), 6.92 (1H, d, J = 8.0 Hz), 7.17 (2H, brs), 7.19-7.33 (5H, m).
1H-NMR (CDCl3)δ:0.87 (6H, d, J= 6.6 Hz), 1.11-1.19 (1H, m), 1.33-1.43 (1H, m), 1.61-1.72 (1H, m), 2.15 (3H, s), 2.50 (1H, dd, J = 4.9, 16.0 Hz), 2.57-2.67 (1H, m), 2.67-2.76 (3H, m), 2.89 (1H, dd, J = 5.1, 16.1 Hz), 2.96-3.03 (1H, m), 3.68 (2H, s), 3.81 (2H, s), 6.93 (1H, d, J = 8.0 Hz), 7.15-7.18 (2H, br), 7.21-7.34 (5H, m).
MS (FAB) m/z 380 (M+H)+
a) tert−ブチル ベンジル[2−[7−アセトアミド−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.88 (6H, d, J= 6.3 Hz), 1.08-1.16 (1H, br), 1.33 (1H, br), 1.40-1.50 (9H, br), 1.67 (1H, br), 2.15 (3H, s), 2.43 (1H, dd, J = 5.6, 16.1 Hz), 2.45-3.54 (6H, m), 3.60-3.80 (2H, br), 4.45-4.55 (2H, br), 6.99 (1H, d, J = 8.3 Hz), 7.05-7.20 (2H, br), 7.22-7.32 (5H, m).
1H-NMR (CDCl3)δ:0.88 (6H, d, J = 6.3 Hz), 1.11-1.19 (1H, m), 1.33-1.42 (1H, m), 1.63-1.73 (1H, m), 2.15 (3H, s), 2.47 (1H, dd, J = 4.9, 16.6 Hz), 2.57-2.65 (1H, m), 2.65-2.74 (3H, m), 2.85 (1H, dd, J = 4.9, 16.6 Hz), 2.97-3.04 (1H, m), 3.71 (2H, s), 3.81 (2H, s), 7.00 (1H, d, J= 8.3 Hz), 7.01 (1H, br), 7.12 (1H, d, J = 8.3 Hz), 7.23-7.32 (5H, m).
MS (FAB) m/z 380 (M+H)+
IR (ATR cm-1): 2958, 1665, 1602, 1546, 1504, 1367, 821, 739, 698.
a) tert−ブチル ベンジル[2−[8−アセトアミド−3−イソブチル−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメ−トの製造
1H-NMR (CDCl3)δ:0.88 (6H, d, J= 6.6 Hz), 1.09-1.24 (1H, br), 1.25-1.35 (1H, br), 1.40-1.50 (9H, br), 1.64-1.83 (1H, m), 2.20 (3H, brs), 2.49 (2H, br), 2.60-2.65 (1H, m), 2.79-2.89 (1H, br), 2.90-2.98 (1H, br), 3.25-3.45 (2H, br), 3.50-3.74 (2H, br), 4.40-4.51 (2H, br), 6.90-6.98 (1H, br), 7.15 (1H, dd, J = 7.6, 7.8 Hz), 7.22-7.48 (6H, m).
1H-NMR (CDCl3)δ:0.87 (6H, d, J = 6.6 Hz), 1.10-1.18 (1H, m), 1.30-1.38 (1H, m), 1.61-1.70 (1H, m), 2.16 (3H, s), 2.54 (1H, dd, J = 4.1, 16.1 Hz), 2.60-2.78 (4H, m), 2.90-3.03 (2H, m), 3.57 (2H, s), 3.81 (2H, s), 6.71 (1H, br), 6.93 (1H, d, J = 7.8 Hz), 7.15 (1H, dd, J = 7.8, 7.8 Hz), 7.22-7.34 (5H, m), 7.42 (1H, d, J = 7.8 Hz).
MS (FAB) m/z 380 (M+H)+
IR (ATR cm-1): 1662, 1535, 1468, 1453, 1368, 1295, 778, 739, 698.
a) 6−フルオロ−3−(4−フルオロベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.80 (1H, dd, J = 4.2, 16.8 Hz), 2.92 (1H, dd,J = 10.0, 16.8 Hz), 2.95 (1H, dd, J = 9.2, 13.2 Hz), 3.33 (1H, dd,J = 5.1, 13.2 Hz),3.34-3.44 (1H, m), 4.19 (1H, m), 4.31 (1H, m), 6.76 (1H, dd, J = 2.4, 9.3 Hz), 6.88 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.98-7.07 (3H, m), 7.18-7.24 (2H, m).
1H-NMR (CDCl3)δ:1.40-1.50 (9H, br), 2.34-2.90 (6H, m), 3.00-3.50 (3H, m), 3.60-3.90 (2H, m), 4.40-4.58 (2H, m), 6.73 (1H, dd, J = 2.7, 9.5 Hz), 6.85 (1H, ddd, J = 2.7, 8.4, 8.4 Hz), 6.90-7.10 (4H, m), 7.10-7.30 (6H, m).
1H-NMR (CDCl3)δ:2.40-2.52 (2H, m), 2.65-2.90 (6H, m), 3.12-3.22 (1H, m), 3.71 (2H, s), 3.82 (2H, s), 6.76 (1H, dd, J = 2.2, 9.2 Hz), 6.80-7.10 (6H, m), 7.16-7.34 (5H, m).
a) 6−フルオロ−3−(2−フルオロベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.68 (1H, dd, J = 10.0, 16.6 Hz), 2.76 (1H, dd, J = 4.2, 16.6 Hz), 2.94 (2H, d, J = 6.6 Hz), 3.24 (1H, dddd, J = 4.2, 6.6, 6.6, 10.0 Hz), 4.02 (1H, d, J = 15.5 Hz), 4.07 (1H, d, J = 15.5 Hz), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.82 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.97 (1H, dd, J = 5.9, 8.6 Hz), 7.04-7.10 (1H, m), 7.11 (1H, ddd, J = 1.2, 7.6, 7.6 Hz), 7.22-7.29 (3H, m).
1H-NMR (CDCl3)δ:2.48 (1H, dd, J = 9.8, 13.2 Hz), 2.52 (1H, dd,J = 3.4, 17.1 Hz), 2.77-2.99 (6H, m), 3.22-3.30 (1H, m), 3.72 (2H, s), 3.85 (2H, s), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.4, 8.4 Hz), 6.95 (1H, dd, J = 5.6, 8.4 Hz), 6.98-7.10 (3H, m), 7.16-7.20 (1H, m), 7.24-7.34 (5H, m).
a) 3−(4−クロロベンジル)−6−フルオロ−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.59 (1H, dd, J = 10.2, 16.3 Hz), 2.70-2.78 (2H, m), 2.83 (1H, dd, J = 5.8, 13.6 Hz), 3.05-3.13 (1H, m), 3.94 (1H, d, J = 15.5 Hz), 3.99 (1H, d, J = 15.5 Hz), 6.75 (1H, dd, J = 2.4, 9.8 Hz), 6.80 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.95 (1H, dd, J = 5.6, 8.5 Hz), 7.18 (2H, dd, J = 1.8, 6.5 Hz), 7.30 (2H, dd, J = 1.8, 6.5 Hz).
1H-NMR (CDCl3)δ:1.43 (9H, s), 2.45 (1H, dd, J = 9.5, 13.4 Hz), 2.48-2.54 (1H, m), 2.62-2.88 (4H, m), 3.14-3.34 (3H, m), 3.72-3.82 (2H, m), 4.92 (1H, brs), 6.75 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J= 2.4, 8.5, 8.5 Hz), 7.00 (1H, dd, J = 5.8, 8.5 Hz), 7.04 (2H, d, J= 8.3 Hz), 7.25 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 10.0, 13.2 Hz), 2.51 (1H, dd, J = 3.8, 16.7 Hz), 2.64-2.87 (5H, m), 2.90 (1H, dd, J = 4.5, 13.5 Hz), 3.17-3.23 (1H, m), 3.77 (1H, d, J = 15.7 Hz), ), 3.83 (1H, d,J = 15.7 Hz), 6.73-6.78 (1H, m), 6.83-6.88 (1H, m), 6.99-7.03 (1H, m), 7.05 (2H, dd, J = 1.3, 8.0 Hz), 7.25 (2H, dd, J = 1.3, 8.0 Hz).
1H-NMR (CDCl3)δ:2.42 (1H, dd, J = 10.0, 13.0 Hz), 2.49 (1H, dd,J = 3.7, 16.6 Hz), 2.72-2.92 (6H, m), 3.13-3.22 (1H, m), 3.73 (2H, s), 3.80 (2H, s), 6.75 (1H, dd, J = 2.5, 9.4 Hz), 6.86 (1H, ddd, J = 2.5, 8.5, 8.5 Hz), 6.98 (1H, dd, J = 5.8, 8.5 Hz), 7.02 (2H, d, J = 8.4 Hz), 7.22 (2H, d, J = 8.4 Hz), 7.23-7.36 (5H, m).
a) 1,3−ビス(4−フルオロフェニル)−2−プロパノンの製造
1H-NMR (CDCl3)δ:3.70 (4H, s), 6.96 - 7.04 (4H, m), 7.06 - 7.14 (4H, m),
1H-NMR (CDCl3)δ:2.52 (2H, dd, J = 13.5, 8,8 Hz), 2.80 (2H, dd, J = 13.5, 4.5Hz), 3.21 (1H, m), 6.96-7.02 (4H, m), 7.14-7.18 (4H,m).
1H-NMR (CDCl3)δ:2.55 (1H, m), 2.70-2.88 (3H, m), 3.09 (1H, m), 4.00 (2H, s), 6.73 (1H, m), 6.82 (1H, m), 6.97-7.04 (3H, m), 7.14-7.25 (2H, m).
1H-NMR (CDCl3)δ:1.42-1.50 (9H, br), 2.34-2.88 (6H, m), 3.02-3.48 (3H, m), 3.68-3.84 (2H, m), 4.42-4.50 (2H, m), 6.69-6.75 (1H, m), 6.84 (1H, ddd,J = 2.4, 8.6, 8.6 Hz), 6.92-7.08 (5H, m), 7.18-7.34 (5H, m).
1H-NMR (CDCl3)δ:2.43 (1H, dd, J = 9.8, 13.4 Hz), 2.48 (1H, dd,J = 3.9, 16.4 Hz), 2.68-2.92 (6H, m), 3.10-3.20 (1H, m), 3.74 (2H, s), 3.79 (2H, s), 6.73 (1H, dd, J = 2.5, 9.3 Hz), 6.85 (1H, ddd, J = 2.5, 8.6, 8.6 Hz), 6.90-7.05 (5H, m), 7.22-7.34 (5H, m).
a) 6−クロロ−3−(4−フルオロベンジル)−1,2,3,4−テトラヒドロイソキノリンの製造
1H-NMR (CDCl3)δ:2.59 (1H, dd, J = 10.7, 16.1 Hz), 2.70-2.79 (2H, m), 2.85 (1H, dd, J = 5.6, 13.4 Hz), 3.05-3.13 (1H, m), 3.95 (1H, d, J = 15.8 Hz), 4.01 (1H, d, J = 15.8 Hz), 6.94 (1H, d, J= 8.1 Hz), 7.02 (2H, dd, J = 8.6, 8.8 Hz), 7.05 (1H, d, J = 1.9 Hz), 7.08 (1H, dd, J = 1.9, 8.1 Hz), 7.21 (2H, dd, J = 5.4, 8.6 Hz).
1H-NMR (CDCl3)δ:1.44-1.48 (9H, br), 2.34-2.82 (6H, m), 3.05-3.48 (3H, m), 3.72-3.81 (2H, m), 4.43-4.48 (2H, m), 6.93-7.33 (13H, m).
1H-NMR (CDCl3)δ:2.41 (1H, dd, J = 9.8, 13.2 Hz), 2.49 (1H, dd,J = 3.8, 16.4 Hz), 2.73-2.88 (6H, m), 3.13-3.19 (1H, m), 3.74 (2H, s), 3.79 (2H, s), 6.92-6.97 (3H, m), 7.01-7.05 (3H, m), 7.13 (1H, dd, J = 2.2, 8.1 Hz), 7.23-7.33 (5H, m).
1H-NMR (CDCl3)δ:2.54 (1H, dd, J = 9.8, 16.1 Hz), 2.68-2.88 (3H, m), 3.05-3.13 (1H, m), 3.98 (2H, s), 6.96-7.32 (7H, m).
1H-NMR (CDCl3)δ:1.42-1.52 (9H, br), 2.34-2.88 (6H, m), 3.02-3.46 (3H, m), 3.66-3.82 (2H, m), 4.38-4.50 (2H, m), 6.92-7.04 (4H, m), 7.11 (1H, dd, J= 1.9, 8.0 Hz), 7.16-7.34 (7H, m).
c) N−ベンジル−2−[7−クロロ−3−(4−クロロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ:2.42 (1H, dd, J = 9.8, 13.4 Hz), 2.46 (1H, dd,J = 3.9, 16.6 Hz), 2.70-2.88 (6H, m), 3.13-3.22 (1H, m), 3.74 (2H, s), 3.78 (2H, s), 6.94-7.04 (4H, m) 7.11 (1H, dd, J = 1.7, 8.0 Hz), 7.19-7.34 (7H, m).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.8, 13.2 Hz), 2.57 (1H, dd, J = 3.8, 16.5 Hz), 2.72-2.79 (3H, m), 2.83-2.92 (3H, m), 3.20-3.26 (1H, m), 3.75 (2H, s), 3.79 (2H, s), 7.02-7.06 (2H, m), 7.10 (2H, d, J = 7.0 Hz), 7.11-7.22 (5H, m), 7.24-7.28 (4H, m).
1H-NMR (CDCl3)δ: 2.38 (1H, dd, J = 10.4, 12.8 Hz), 2.54 (1H, dd, J = 4.1, 16.4 Hz), 2.66-2.86 (6H, m), 3.09-3.15 (1H, m), 3.55 (2H, d, J = 13.9 Hz), 3.59 (2H, d, J = 13.9 Hz), 3.71 (1H, d, J = 13.9 Hz), 3.76 (1H, d, J = 13.9 Hz), 6.96-7.00 (3H, m), 7.02-7.04 (1H, m), 7.13-7.16 (2H, m), 7.19 (1H, d, J = 6.8 Hz), 7.23-7.30 (10H, m).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.8, 13.2 Hz), 2.57 (1H, dd, J = 3.8, 16.3 Hz), 2.71-2.80 (3H, m), 2.83-2.93 (3H, m), 3.21-3.27 (1H, m), 3.73 (1H, d, J = 13.8 Hz), 3.77 (1H, d, J= 13.8 Hz), 3.81 (2H, s), 7.04 (1H, d, J= 5.6 Hz), 7.06 (1H, d, J = 5.6 Hz), 7.10-7.18 (6H, m), 7.21-7.29 (5H, m).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 10.0, 13.1 Hz), 2.55 (1H, dd, J = 3.7, 16.4 Hz), 2.78-2.83 (3H, m), 2.86-2.93 (3H, m), 3.19-3.24 (1H, m), 3.79 (2H, s), 3.89 (2H, s), 7.01-7.06 (2H, m), 7.09 (2H, d, J = 7.1 Hz), 7.14-7.26 (7H, m), 7.32-7.37 (2H, m).
1H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 10.5, 12.9 Hz), 2.57 (1H, dd, J= 4.2, 16.6 Hz), 2.66-2.92 (6H, m), 3.17-3.23 (1H, m), 3.56 (2H, s), 3.78 (1H, d, J = 16.0 Hz), 3.83 (1H, d, J = 16.0 Hz), 7.00-7.06 (3H, m), 7.15-7.27 (5H, m), 7.35 (2H, d, J = 8.1 Hz), 7.44 (2H, d, J = 1.7 Hz).
1H-NMR (CDCl3)δ:2.53 (1H, dd, J = 9.8, 13.2 Hz), 2.58 (1H, dd,J = 3.9, 16.6 Hz), 2.70-2.90 (5H, m), 2.93 (1H, dd, J = 4.7, 13.3 Hz), 3.20-3.30 (1H, m), 3.49 (2H, s), 3.86 (2H, s), 7.04-7.32 (13H, m).
1H-NMR (CDCl3)δ:2.49 (1H, dd, J = 9.8, 13.2 Hz), 2.57 (1H, dd,J = 3.9, 16.4 Hz), 2.72-2.88 (5H, m), 2.91 (1H, dd, J = 4.9, 13.2 Hz), 3.20-3.28 (1H, m), 3.75 (1H, d, J = 13.8 Hz), 3.83 (1H, d, J= 13.8 Hz), 3.81 (2H, s), 6.90-7.30 (13H, m).
1H-NMR (CDCl3)δ:2.46 (1H, dd, J = 10.1, 13.0 Hz), 2.55 (1H, dd,J = 3.7, 16.4 Hz), 2.74-2.94 (6H, m), 3.17-3.24 (1H, m),3.79 (2H, s), 3.85 (2H, s), 6.98-7.32 (13H, m).
1H-NMR (CDCl3)δ:2.47-2.57 (2H, m), 2.77-2.96 (6H, m), 3.18-3.26 (1H, m), 3.54 (1H, d, J = 16.2 Hz), 3.70 (1H, d, J = 16.2 Hz), 3.79 (3H, s), 3.92 (2H, s), 6.83 (1H, d, J = 8.6 Hz), 6.95-6.98 (1H, m), 7.03-7.06 (1H, m), 7.09-7.30 (10H, m).
1H-NMR (CDCl3)δ:2.52 (1H, dd, J = 9.8, 14.0 Hz ), 2.55 (1H, dd,J = 3.4, 16.0 Hz ), 2.77-2.98 (6H, m), 3.22-3.29 (1H, m), 3.60-3.70 (2H, m), 3.73 (3H, s), 3.89 (2H, s), 6.80-6.88 (2H, m), 6.98-7.38 (11H, m).
1H-NMR (CDCl3)δ:2.47 (1H, dd, J = 9.8, 13.2 Hz ), 2.58 (1H, dd,J = 3.0, 16.8 Hz ), 2.78-2.88 (5H, m), 3.04-3.24 (3H, m), 3.29 (3H, s), 3.50 (1H, d, J = 15.6 Hz), 3.92 (1H, d, J = 13.4 Hz), 4.29 (1H, d, J = 13.4 Hz), 6.63 (1H, d, J = 8.3 Hz), 6.81 (1H, d, J= 6.4 Hz), 6.95-6.88 (2H, m), 6.98-7.39 (9H, m).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 10.0, 13.2 Hz), 2.57 (1H, dd, J= 3.6, 16.4 Hz), 2.75-2.85 (3H, m), 2.95-3.15 (4H, m), 3.53 (6H, s), 3.80 (2H, s), 4.22 (1H, d, J = 13.4 Hz), 4.33 (1H, d, J = 13.4 Hz), 6.42 (2H, d, J = 8.3 Hz), 6.75 (1H, d, J = 6.8 Hz), 7.06 (2H, d, J = 6.8 Hz), 7.15-7.30 (7H, m).
1H-NMR (CD3OD)δ: 2.37 (1H, dd, J = 10.2, 13.0 Hz), 2.51 (1H, dd, J = 3.6, 16.3 Hz), 2.74-2.82 (3H, m), 2.97-3.08 (3H, m), 3.29-3.31 (1H, m), 3.46 (1H, d, J = 16.1 Hz), 3.65 (1H, d, J= 16.1 Hz), 3.93 (2H, s), 6.78 (2H, d, J= 6.6 Hz), 6.89-7.04 (2H, m), 7.14-7.28 (9H, m).
1H-NMR (CDCl3)δ: 1.24 (3H, t, J = 7.6 Hz), 2.47 (1H, dd, J = 10.0, 12.9 Hz), 2.56 (1H, dd, J = 3.6, 16.6 Hz), 2.63 (2H, q, J = 7.6 Hz), 2.77-2.80 (3H, m), 2.84-2.94 (3H, m), 3.19-3.25 (1H, m), 3.77 (2H, s), 3.78 (2H, s), 7.01-7.06 (2H, m), 7.09-7.20 (8H, m), 7.24-7.31 (3H, m).
1H-NMR (CDCl3)δ: 1.22 (3H, t, J = 7.6 Hz), 2.48 (1H, dd, J = 10.0, 12.9 Hz), 2.56 (1H, dd, J = 3.6, 16.6 Hz), 2.62 (2H, q, J = 7.6 Hz), 2.77-2.82 (3H, m), 2.87-2.94 (3H, m), 3.21-3.28 (1H, m), 3.78 (2H, s), 3.80 (2H, s), 7.02-7.06 (2H, m), 7.08-7.21 (8H, m), 7.24-7.28 (3H, m).
1H-NMR (CDCl3)δ: 1.18 (3H, t, J = 7.6 Hz), 2.48 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.6, 16.5 Hz), 2.67 (2H, q, J = 7.6 Hz), 2.78-2.86 (4H, m), 2.90-2.96 (2H, m), 3.20-3.27 (1H, m), 3.79 (2H, s), 3.81 (2H, s), 7.01-7.06 (2H, m), 7.10 (2H, d, J = 7.1 Hz), 7.14-7.18 (7H, m), 7.24-7.30 (2H, m).
1H-NMR (CDCl3)δ:2.33(3H, s), 2.47 (1H, dd, J = 10.0, 13.2 Hz ), 2.55 (1H, dd, J = 3.7, 16.4 Hz ), 2.74-2.93 (6H, m), 3.18-3.24 (1H, m), 3.76 (2H, s), 3.79 (2H, s), 7.02-7.29 (13H, m).
1H-NMR (CDCl3)δ:2.32(3H, s), 2.47 (1H, dd, J = 10.0, 12.9 Hz ), 2.56 (1H, dd, J = 3.6, 16.3 Hz ), 2.74-2.95 (6H, m), 3.18-3.26 (1H, m), 3.76 (2H, s), 3.79 (2H, s), 7.00-7.29 (13H, m).
1H-NMR (CDCl3)δ:2.29(3H, s), 2.47 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.8, 16.5 Hz), 2.74-2.94 (6H, m), 3.18-3.26 (1H, m), 3.78 (2H, s), 3.79 (2H, s), 7.00-7.28 (13H, m).
1H-NMR (CDCl3)δ: 1.31 (9H, s), 2.48 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.5, 16.4 Hz), 2.77-2.82 (3H, m), 2.85-2.95 (3H, m), 3.20-3.25 (1H, m), 3.78 (4H, s), 7.02-7.08 (2H, m), 7.12-7.28 (9H, m), 7.33 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ: 2.50 (1H, dd, J = 9.9, 13.2 Hz ), 2.57 (1H, dd, J = 3.8, 16.5 Hz ), 2.72-2.94 (6H, m), 3.21-3.28 (1H, m), 3.81 (2H, s), 3.83 (2H, s), 7.02-7.34 (9H, m), 7.39 (2H, d, J = 8.0 Hz ), 7.56 (2H, d, J = 8.0 Hz ).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.6, 16.4 Hz), 2.77-2.92 (6H, m), 2.93 (6H, s), 3.22-3.27 (1H, m), 3.73-3.80 (4H, m), 6.68 (2H, d, J = 8.8 Hz), 6.98-7.18 (9H, m), 7.25-7.28 (2H, m).
1H-NMR (CDCl3)δ:2.45 (1H, dd,J = 10.4, 12.7 Hz), 2.56 (1H, dd, J = 3.6, 16.3 Hz), 2.62 (6H, s), 2.78-2.95 (6H, m), 3.19-3.26 (1H, m), 3.76 (2H, s), 3.86 (1H, d, J = 13.4 Hz), 3.91 (1H, d, J = 13.4 Hz), 7.00-7.30 (13H, m).
1H-NMR (CDCl3)δ:2.47 (1H, dd,J = 10.2, 13.0 Hz), 2.55 (1H, dd, J = 3.9, 16.6 Hz), 2.78-2.94 (6H, m), 2.91 (6H, s), 3.20-3.25 (1H, m), 3.77 (4H, s), 6.23 (2H, dd, J = 2.0, 8.0 Hz), 6.67 (1H, s), 7.00-7.05 (2H, m), 7.09-7.20 (6H, m), 7.24-7.28 (2H, m).
1H-NMR (CDCl3)δ: 2.51 (1H, dd, J = 9.6, 13.3 Hz), 2.58 (1H, dd, J = 3.8, 16.5 Hz), 2.71-2.81 (3H, m), 2.84-2.94 (3H, m), 3.22-3.28 (1H, m), 3.80 (1H, d, J = 16.4 Hz), 3.84 (1H, d, J= 16.4 Hz), 3.85 (1H, d, J = 14.6 Hz), 3.89 (1H, d, J = 14.6 Hz), 7.03-7.08 (2H, m), 7.11-7.20 (5H, m), 7.24-7.28 (2H, m), 7.44 (2H, d, J = 8.8 Hz), 8.16 (2H, d, J = 8.8 Hz).
1H-NMR (CDCl3)δ:2.51 (1H, dd,J = 9.5, 13.2 Hz), 2.58 (1H, dd, J = 3.9, 16.4 Hz), 2.72-2.94 (6H, m), 3.23-3.28 (1H, m), 3.81 (1H, d, J = 16.1 Hz), 3.84 (1H, d, J= 14.2 Hz), 3.86 (1H, d, J = 16.1 Hz), 3.89 (1H, d, J = 14.2 Hz), 7.04-7.28 (9H, m), 7.47 (1H, dd, J = 7.8, 7.8 Hz), 7.63 (1H, d, J= 7.8 Hz), 8.10 (1H, d, J = 7.8 Hz), 8.18 (1H, s).
1H-NMR (CDCl3)δ:2.49 (1H, dd, J = 9.8, 13.2 Hz), 2.57 (1H, dd,J = 4.2, 16.4 Hz), 2.76-2.94 (6H, m), 3.22-3.28 (1H, m), 3.83 (2H, s), 4.04 (2H, s), 7.03-7.26 (9H, m), 7.37-7.42 (1H, m), 7.56 (1H, dd, J = 7.6, 7.6 Hz), 7.61 (1H, d, J = 7.6 Hz), 7.94 (1H, d, J = 7.6 Hz).
1H-NMR (CDCl3)δ: 2.51 (1H, dd, J = 9.8, 13.2 Hz), 2.57 (1H, dd, J = 3.4, 16.2 Hz), 2.70-2.79 (3H, m), 2.83-2.92 (3H, m), 3.23-3.26 (1H, m), 3.82 (4H, s), 7.04-7.20 (7H, m), 7.25-7.30 (2H, m), 7.39 (2H, d, J = 7.8 Hz), 7.59 (2H, d, J = 7.8 Hz).
1H-NMR (CDCl3)δ: 2.53 (1H, dd, J = 9.8, 13.2 Hz), 2.58 (1H, dd, J = 3.4, 16.2 Hz), 2.71-2.79 (3H, m), 2.84-2.92 (3H, m), 3.23-3.27 (1H, m), 3.74 (1H, d, J = 16.4 Hz), 3.80 (1H, d, J= 16.4 Hz), 3.82 (2H, s), 7.00-7.02 (1H, m), 7.07-7.20 (6H, m), 7.26 (2H, dd, J = 7.3, 7.3 Hz), 7.40 (1H, dd, J = 7.8, 7.8 Hz), 7.52-7.56 (2H, m), 7.64 (1H, s).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.5, 13.5 Hz), 2.53 (1H, dd, J = 3.4, 16.2 Hz), 2.59 (3H, s), 2.73-2.84 (3H, m), 2.87-2.93 (3H, m), 3.20-3.26 (1H, m), 3.80 (2H, s), 3.84 (2H, s), 7.02-7.07 (2H, m), 7.10 (2H, d, J= 7.1 Hz), 7.15-7.20 (3H, m), 7.24-7.27 (2H, m), 7.37 (2H, d, J = 8.2 Hz), 7.90 (2H, d, J = 8.2 Hz).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.5, 13.5 Hz), 2.53-2.61 (4H, m), 2.74-2.84 (3H, m), 2.86-2.96 (3H, m), 3.20-3.29 (1H, m), 3.81 (2H, s), 3.84 (2H, s), 7.02-7.08 (2H, m), 7.10 (2H, d, J= 7.8 Hz), 7.14-7.19 (3H, m), 7.23-7.27 (2H, m), 7.41 (1H, dd, J = 7.8, 7.8 Hz), 7.51 (1H, d, J = 7.5 Hz), 7.84 (1H, d, J = 7.5 Hz), 7.88 (1H, s).
a) 1−(3−フルオロフェニル)−4−メチル−2−ペンタノールの製造
1H-NMR (CDCl3)δ: 0.91 (3H, d,J = 6.7 Hz ), 0.94 (3H, d, J = 6.7 Hz ), 1.30 (1H, dd, J = 4.2, 9.0 Hz ), 1.41-1.49 (1H, m), 1.71-1.86 (1H, m), 2.63 (1H, dd, J = 8.3, 13.4 Hz ), 2.76-2.87 (1H, m), 3.81-3.92 (1H, m), 6.90-6.95 (2H, m), 6.97-7.02 (1H, m), 7.23-7.30 (1H, m).
1H-NMR (CDCl3)δ: 0.89 (6H, d,J = 6.6 Hz ), 2.08-2.19 (1H, m), 2.33 (2H, d, J = 7.1 Hz ), 3.66 (2H, s), 6.88-7.00 (3H, m), 7.26-7.31 (1H, m).
1H-NMR (CDCl3)δ:0.89 (3H, d, J = 6.6 Hz),0.94 (3H, d, J = 6.6 Hz), 1.24-1.32 (4H, m), 1.70-1.82 (1H, m), 2.43 (1H, dd, J = 8.8, 13.4 Hz), 2.77 (1H, dd, J = 4.4, 13.4 Hz), 3.01-3.10 (1H, m), 6.86-6.94 (2H, m), 6.95-7.02 (1H, m), 7.22-7.30 (1H, m).
1H-NMR (CDCl3)δ:0.89 (3H, d, J= 6.4 Hz), 0.94 (3H, d, J = 6.4 Hz), 1.34-1.51 (2H, m), 1.88-1.89 (1H, m), 2.40-2.49 (1H, m), 2.74-2.80 (1H, m), 3.12-3.22 (1H, m), 4.03 (2H, s), 6.80-7.00 (3H, m).
1H-NMR (CDCl3)δ:0.89 (6H, d, J= 6.6 Hz), 1.12-1.20 (1H, m), 1.34-1.42 (1H, m), 1.60-1.72 (1H, m), 2.52 (1H, dd, J = 4.4, 16.1 Hz), 2.58-2.68 (1H, m), 2.72-2.78 (3H, m), 2.86-3.04 (2H, m), 2.98 (3H, s), 3.71 (2H, s), 3.82 (2H, s), 6.78 (1H, dd, J = 2.4, 9.0 Hz), 6.83 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.95 (1H, dd, J= 5.6, 8.3 Hz), 7.12-7.18 (2H, m), 7.26-7.32 (2H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 10.0, 13.1 Hz), 2.57 (1H, dd, J = 3.9, 16.4 Hz), 2.75-2.84 (3H, m), 2.87-2.94 (3H, m), 3.21-3.27 (1H, m), 3.79 (1H, d, J = 13.6 Hz), 3.84 (2H, s), 3.86 (1H, d, J = 13.6 Hz), 7.10-7.25 (9H, m), 7.34-7.36 (2H, m), 7.41-7.45 (3H, m), 7.54 (2H, d, J = 7.6 Hz), 7.58 (2H, d, J = 7.6 Hz).
1H-NMR (CDCl3)δ: 1.04 (3H, d, J = 6.3 Hz), 2.35 (6H, m), 2.54 (1H, dd, J =4.8, 16.2 Hz), 2.67 (1H, dd, J =6.4, 12.4 Hz), 2.76-2.86 (3H, m), 2.98 (1H, dd, J =4.8, 16.2 Hz), 3.01-3.09 (1H, m), 3.58 (1H, d, J = 15.6 Hz), 3.67 (1H, d, J = 15.6 Hz), 3.82 (2H, m), 6.94-6.99 (3H, m), 7.03-7.07 (2H, m), 7.10-7.13 (2H, m).
1H-NMR (CDCl3)δ:1.23 (3H, t, J = 7.7 Hz), 2.45 (1H, dd, J= 10.0, 13.2 Hz), 2.51 (1H, dd, J = 3.8, 16.6 Hz), 2.63 (2H, q, J= 7.7 Hz), 2.74-2.90 (6H, m), 3.12-3.22 (1H, m), 3.75 (2H, s), 3.78 (2H, s), 6.88-6.96 (2H, m), 7.00-7.06 (4H, m), 7.10-7.21 (6H, m).
1H-NMR (CDCl3)δ:2.32 (3H, s), 2.45 (1H, dd, J = 9.8, 13.4 Hz), 2.52 (1H, dd, J = 3.9, 16.1 Hz), 2.72-2.90 (6H, m), 3.14-3.22 (1H, m), 3.76 (2H, s), 3.79 (2H, s), 6.88-7.22 (12H, m).
1H-NMR (CDCl3)δ:1.18 (3H, t, J = 7.6 Hz), 2.45 (1H, dd, J= 9.8, 13.2 Hz), 2.52 (1H, dd, J = 3.8, 16.6 Hz), 2.66 (2H, q, J= 7.6 Hz), 2.75-2.91 (6H, m), 3.15-3.23 (1H, m), 3.79 (2H, s), 3.80 (2H, s), 6.90-6.95 (2H, m), 7.00-7.07 (4H, m), 7.10-7.21 (6H, m).
1H-NMR (CDCl3)δ:1.31 (9H, s), 2.45 (1H, dd, J = 9.8, 13.4 Hz), 2.52 (1H, dd, J = 3.9, 16.4 Hz), 2.74-2.91 (6H, m), 3.14-3.22 (1H, m), 3.76 (2H, s), 3.78 (2H, s), 6.90-6.96 (2H, m), 7.00-7.07 (4H, m), 7.14-7.18 (2H, m), 7.21 (2H, d, J = 8.3 Hz), 7.33 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ: 2.24 (3H, s), 2.29 (6H, s) 2.43 (1H, dd, J = 9.8, 13.3 Hz), 2.50 (1H, dd, J = 3.7, 16.4 Hz), 2.74-2.90 (6H, m), 3.13-3.19 (1H, m), 3.73 (2H, s), 3.77 (2H, s), 6.81 (2H, s), 6.88-6.92 (2H, m), 6.98-7.04 (4H, m), 7.14 (2H, dd, J = 3.4, 5.6 Hz).
a) tert−ブチル 3−エチルアミノベンジル[2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
粗生成物をPLCで精製して表題化合物21.6 mg(収率 58%)を微黄色油状物として得た。
1H-NMR (CDCl3)δ: 1.23 (3H, t, J = 7.1 Hz), 1.46 (9H, s), 2.40 (1H, dd, J = 10.0, 12.9 Hz), 2.48-2.52 (1H, m), 2.60-2.86 (4H, m), 3.12 (2H, q, J= 7.1 Hz), 3.15-3.44 (3H, m), 3.83 (2H, s), 4.38 (2H, s), 6.44-6.55 (3H, m), 6.95 (2H, dd, J = 8.7, 8.7 Hz), 7.01-7.14 (7H, m).
1H-NMR (CDCl3)δ: 1.22 (3H, t, J = 7.2 Hz), 2.44 (1H, dd, J = 9.9, 13.4 Hz), 2.52 (1H, dd, J = 4.0, 16.4 Hz), 2.74-2.90 (6H, m), 3.12 (2H, q, J = 7.2 Hz), 3.15-3.20 (1H, m), 3.72 (2H, s), 3.77 (1H, d, J= 16.4 Hz), 3.81 (1H, d, J = 16.4 Hz), 6.47-6.50 (1H, m), 6.54 (1H, s), 6.60 (1H, d, J = 7.6 Hz), 6.94 (2H, dd, J= 8.8, 8.8 Hz), 6.91-7.02 (4H, m), 7.11 (1H, dd, J = 7.6, 7.6 Hz), 7.13-7.16 (2H, m).
a) 2−(4−ニトロベンジルアミノ)エタノールの製造
1H-NMR (CDCl3)δ: 2.83 (2H, t, J = 5.1 Hz), 3.71 (2H, t, J = 5.1 Hz), 3.94 (2H, s), 7.52 (2H, d, J = 8.8 Hz), 8.20 (2H, d, J = 8.8 Hz).
1H-NMR (CDCl3)δ: 1.41-1.57 (9H, br), 3.47 (2H, brs), 3.76 (2H, brs), 4.59 (2H, brs), 7.40 (2H, d, J = 8.5 Hz), 8.21 (2H, d, J= 8.5 Hz).
1H-NMR (CDCl3)δ: 1.45-1.47 (9H, br), 3.91 (1H, s), 4.07 (1H, s), 4.58-4.63 (2H, m), 7.39-7.45 (2H, m), 8.19-8.21 (2H, m), 9.51-9.58 (1H, m).
1H-NMR (CDCl3)δ: 1.38-1.49 (9H, br), 2.46 (1H, dd, J = 9.8, 13.6 Hz), 2.49-2.55 (1H, m), 2.60-2.86 (4H, m), 3.12-3.49 (3H, m), 3.81 (2H, s), 4.49-4.55 (2H, m), 6.96 (2H, dd, J = 8.8, 8.8 Hz), 7.00-7.06 (4H, m), 7.13-7.16 (2H, m), 7.29-7.38 (2H, m), 8.15 (2H, d, J = 8.8 Hz).
1H-NMR (CDCl3)δ: 1.47 (9H, s), 2.41 (1H, dd, J = 9.8, 13.4 Hz), 2.46-2.52 (1H, m), 2.55-2.83 (4H, m), 3.07-3.62 (3H, m), 3.78-3.86 (2H, m), 4.32 (2H, s), 6.63 (2H, d, J = 8.5 Hz), 6.96 (2H, dd, J = 8.5, 8.5 Hz), 7.02-7.15 (8H, m).
1H-NMR (CDCl3)δ: 2.50 (1H, dd, J = 9.0, 13.0 Hz), 2.51 (1H, dd, J = 5.4, 16.1 Hz), 2.78-2.95 (6H, m), 3.20-3.24 (1H, m), 3.64 (1H, d, J = 16.1 Hz), 3.72 (1H, d, J = 16.1 Hz), 3.76 (1H, d, J = 13.4 Hz), 3.80 (1H, d, J = 13.4 Hz), 6.62 (2H, d, J = 7.8 Hz), 6.92-7.09 (8H, m), 7.13-7.16 (2H, m).
a) tert−ブチル 4−エチルアミノベンジル[2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.1 Hz), 1.47 (9H, s), 2.39 (1H, dd, J = 10.5, 13.2 Hz), 2.44-2.51 (1H, m), 2.54-2.83 (4H, m), 3.14 (2H, q, J= 7.1 Hz), 3.08-3.43 (3H, m), 3.74-3.87 (2H, m), 4.30-4.37 (2H, m), 6.54 (2H, d, J = 8.5 Hz), 6.95 (2H, dd, J = 8.8, 8.8 Hz), 7.00-7.14 (8H, m).
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.2 Hz), 2.44 (1H, dd, J = 9.8, 13.2 Hz), 2.51 (1H, dd, J = 3.9, 16.4 Hz), 2.74-2.88 (6H, m), 3.14 (2H, q, J = 7.2 Hz), 3.11-3.18 (1H, m), 3.69 (2H, s), 3.77 (2H, s), 6.55 (2H, d, J = 8.3 Hz), 6.93 (2H, dd, J= 8.6, 8.6 Hz), 7.01-7.05 (4H, m), 7.08 (2H, d, J = 8.3 Hz), 7.13-7.16 (2H, m).
1H-NMR (CDCl3)δ: 1.14 (6H, t, J = 7.1 Hz), 2.43 (1H, dd, J = 10.0, 13.4 Hz), 2.51 (1H, dd, J = 3.9, 16.4 Hz), 2.74-2.90 (6H, m), 3.13-3.19 (1H, m), 3.33 (4H, q, J = 7.1 Hz), 3.67 (1H, d, J = 13.4 Hz), 3.70 (1H, d, J = 13.4 Hz), 3.76 (1H, d, J = 16.1 Hz), 3.80 (1H, d, J = 16.1 Hz), 6.63 (2H, d, J = 8.8 Hz), 6.93 (2H, dd, J = 8.6, 8.6 Hz), 7.01-7.05 (4H, m), 7.11 (2H, d, J = 8.8 Hz), 7.13-7.15 (2H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 9.6, 13.3 Hz), 2.52 (1H, dd, J = 3.8, 16.5 Hz), 2.76-2.87 (6H, m), 3.12-3.19 (5H, m), 3.73 (2H, s), 3.78 (2H, s), 3.86 (4H, t, J = 4.9 Hz), 6.86 (2H, d, J = 8.8 Hz), 6.91-6.96 (2H, m), 7.02-7.05 (4H, m), 7.14-7.20 (4H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.5, 13.5 Hz), 2.54 (1H, dd, J = 3.6, 16.6 Hz), 2.75-2.79 (3H, m), 2.82-2.90 (3H, m), 3.19-3.24 (1H, m), 3.82 (2H, s), 4.04 (2H, s), 6.92 (2H, dd, J = 8.8, 8.8 Hz), 7.04-7.08 (4H, m), 7.14-7.16 (2H, m), 7.40 (1H, ddd, J = 1.8, 8.0, 8.0 Hz), 7.56-7.60 (2H, m), 7.94 (1H, d, J = 7.6 Hz).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.5, 13.4 Hz), 2.52 (1H, dd, J = 3.6, 16.6 Hz), 2.73-2.78 (3H, m), 2.84-2.90 (3H, m), 3.19-3.24 (1H, m), 3.82 (2H, s), 3.87 (2H, s), 6.93 (2H, dd, J = 8.8, 8.8 Hz), 7.05-7.07 (4H, m), 7.15-7.17 (2H, m), 7.47 (1H, dd, J = 7.8, 7.8 Hz), 7.62 (1H, d, J = 7.6 Hz), 8.10 (1H, d, J = 7.6 Hz), 8.18 (1H, s).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.5, 13.4 Hz), 2.52 (1H, dd,J = 4.2, 16.4 Hz), 2.68-2.80 (3H, m), 2.83-2.90 (3H, m), 3.18-3.24 (1H, m), 3.79-3.80 (2H, brs), 3.82 (2H, s), 6.92-6.96 (2H, m), 7.04-7.09 (4H, m), 7.14-7.18 (2H, m), 7.40 (1H, dd, J = 7.7, 7.7 Hz), 7.50-7.55 (2H, m), 7.61 (1H, s).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.3, 13.2 Hz), 2.54 (1H, dd,J = 3.4, 16.6 Hz), 2.58 (3H, s), 2.74-2.94 (6H, m), 3.17-3.25 (1H, m), 3.80 (2H, s), 3.86 (2H, s), 6.89-6.95 (2H, m), 6.98-7.08 (4H, m), 7.13-7.18 (2H, m), 7.42 (1H, dd, J = 7.6, 7.6 Hz), 7.51 (1H, d, J = 7.6 Hz), 7.85 (1H, d, J = 7.6 Hz), 7.89 (1H, s).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 9.5, 13.4 Hz), 2.53 (1H, dd, J = 3.9, 16.6 Hz), 2.72-2.79 (3H, m), 2.81-2.89 (3H, m), 3.16-3.22 (1H, m), 3.79 (2H, s), 3.83 (2H, s), 3.90 (3H, s), 6.92 (1H, d, J = 8.8 Hz), 6.94 (1H, d, J = 8.8 Hz), 7.02-7.06 (4H, m), 7.13-7.17 (2H, m), 7.38 (1H, dd, J=7.6, 7.6 Hz), 7.49 (1H, d, J = 7.6 Hz), 7.93 (1H, d, J = 7.6 Hz), 7.97 (1H, s).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 9.6, 13.3 Hz), 2.53 (1H, dd, J = 4.0, 16.5 Hz), 2.71-2.79 (3H, m), 2.81-2.90 (3H, m), 3.15-3.21 (1H, m), 3.80 (2H, s), 3.83 (2H, d, J = 2.6 Hz), 3.91 (3H, s), 6.92 (1H, d, J = 8.8 Hz), 6.94 (1H, d, J = 8.8 Hz), 7.03 (2H, d, J = 5.6), 7.05 (2H, d, J = 5.6), 7.14-7.17 (2H, m), 7.35 (2H, d, J = 8.3 Hz), 7.98 (2H, d, J= 8.3 Hz).
1H-NMR (CDCl3)δ: 2.44-2.51 (2H, m), 2.81-2.98 (5H, m), 3.09-3.12 (1H, m), 3.25-3.29 (1H, m), 3.81 (2H, s), 3.95 (2H, s), 6.85 (1H, d, J = 8.5 Hz), 6.87 (1H, d, J = 8.5 Hz), 6.98-7.04 (4H, m), 7.08-7.11 (2H, m), 7.26-7.35 (2H, m), 8.03 (1H, d, J = 7.6 Hz), 8.44-8.48 (1H, m).
1H-NMR (CDCl3)δ: 2.46-2.54 (2H, m), 2.84-2.98 (5H, m), 3.04-3.08 (1H, m), 3.28-3.34 (1H, m), 3.86 (2H, s), 3.98 (2H, s), 6.88 (1H, d, J = 8.5 Hz), 6.90 (1H, d, J = 8.5 Hz), 7.00-7.06 (4H, m), 7.11-7.14 (2H, m), 7.32 (2H, d, J= 7.6 Hz), 7.90 (2H, d, J = 7.6 Hz).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 9.6, 13.3 Hz), 2.53 (1H, dd, J = 3.6, 16.6 Hz), 2.77-2.83 (3H, m), 2.86-2.90 (3H, m), 3.19-3.23 (1H, m), 3.81 (2H, s), 3.84 (2H, s), 5.76 (1H, br), 6.21 (1H, br), 6.92 (1H, d, J = 8.5 Hz), 6.94 (1H, d, J = 8.5 Hz), 7.03-7.07 (4H, m), 7.14-7.17 (2H, m), 7.39 (1H, dd, J = 7.6, 7.6 Hz), 7.41-7.46 (1H, m), 7.71 (1H, d, J = 7.6 Hz), 7.81 (1H, s).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.6, 13.5 Hz), 2.54 (1H, dd, J = 4.4, 16.8 Hz), 2.73-2.80 (3H, m), 2.83-2.91 (3H, m), 3.18-3.24 (1H, m), 3.80 (2H, s), 3.84 (2H, s), 5.73 (1H, br), 6.09 (1H, br), 6.92 (1H, d, J = 8.8 Hz), 6.94 (1H, d, J = 8.8 Hz), 7.01-7.07 (4H, m), 7.14 (1H, d, J = 3.4 Hz), 7.16 (1H, d, J= 3.4 Hz), 7.36 (2H, d, J = 8.0 Hz), 7.70 (2H, d, J = 8.0 Hz).
a) tert−ブチル [(3−メトキシカルボニル)ベンジル](2−オキソエチル)カルバメート
1H-NMR (CDCl3)δ: 1.48-1.50 (9H, br), 3.90-3.93 (5H, m), 4.80 (2H, s), 7.39 (1H, dd, J = 7.8, 7.8 Hz), 7.47-7.51 (1H, m), 7.93-7.98 (2H, m), 9.29 (1H, br).
1H-NMR (CDCl3)δ: 1.24 (3H, t, J = 7.2 Hz), 2.47 (1H, dd, J = 9.6, 13.3 Hz), 2.53 (1H, dd, J = 4.1, 16.5 Hz), 2.76-2.80 (3H, m), 2.82-2.89 (3H, m), 3.16-3.21 (1H, m), 3.44-3.51 (2H, m), 3.80 (2H, s), 3.82 (2H, s), 6.21 (1H, br), 6.92 (1H, d, J= 8.8 Hz), 6.94 (1H, d, J = 8.8 Hz), 7.03-7.05 (4H, m), 7.14 (1H, d, J = 3.4 Hz), 7.16 (1H, d, J = 3.4 Hz), 7.35-7.42 (2H, m), 7.66 (1H, d, J = 7.2 Hz), 7.72 (1H, s).
a) tert−ブチル [(4−メトキシカルボニル)ベンジル](2−オキソエチル)カルバメート
1H-NMR (CDCl3)δ: 1.43-1.49 (9H, m), 3.87-3.95 (5H, m), 4.51-4.59 (2H, m), 7.27-7.34 (2H, m), 7.99-8.02 (2H, m), 9.46-9.54 (1H, m).
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.2 Hz), 2.47 (1H, dd, J = 9.5, 13.4 Hz), 2.53 (1H, dd, J = 3.9, 16.2 Hz), 2.72-2.77 (3H, m), 2.82-2.89 (3H, m), 3.16-3.22 (1H, m), 3.46-3.53 (2H, m), 3.79 (2H, s), 3.82 (2H, s), 6.10 (1H, br), 6.93 (1H, d, J= 8.8 Hz), 6.96 (1H, d, J = 8.8 Hz), 7.02-7.07 (4H, m), 7.14 (1H, d, J = 3.4 Hz), 7.16 (1H, d, J = 3.4 Hz), 7.32 (2H, d, J = 8.0 Hz), 7.70 (2H, d, J = 7.6 Hz).
1H-NMR (CDCl3)δ: 1.11 (3H, br), 1.26 (3H, br), 2.48 (1H, dd, J = 9.6, 13.6 Hz), 2.53 (1H, dd, J = 4.1, 16.6 Hz), 2.75-2.91 (6H, m), 3.19-3.24 (3H, m), 3.47-3.59 (2H, br), 3.80 (2H, s), 3.82 (2H, s), 6.95 (1H, dd, J = 8.8, 8.8 Hz), 7.04-7.09 (4H, m), 7.15 (1H, d, J= 3.6 Hz), 7.16 (1H, d, J = 3.6 Hz), 7.23-7.26 (1H, m), 7.32-7.33 (4H, m).
1H-NMR (CDCl3)δ: 1.04-1.16 (3H, br), 1.18-1.32 (3H, br), 2.58 (1H, dd, J = 9.5, 13.4 Hz), 2.64 (1H, dd, J = 3.9, 16.6 Hz), 2.74-2.90 (6H, m), 3.11-3.24 (3H, m), 3.46-3.55 (2H, br), 3.88-3.94 (2H, m), 4.03 (2H, s), 7.00-7.13 (6H, m), 7.20-7.32 (6H, m).
a) 2−(3−ニトロベンジルアミノ)エタノールの製造
1H-NMR (CDCl3)δ: 2.83 (2H, t, J = 5.2 Hz), 3.72 (2H, t, J = 5.2 Hz), 3.95 (2H, s), 7.49-7.64 (2H, m), 8.08-8.18 (2H, m).
1H-NMR (CDCl3)δ: 1.46 (9H, brs), 3.44 (2H, brs), 3.76 (2H, brs), 4.58 (2H, brs), 7.47-7.53 (1H, m), 7.59 (1H, d, J = 7.6 Hz), 8.09-8.16 (2H, m).
1H-NMR (CDCl3)δ: 1.48 (9H, s), 3.89-4.07 (2H, m), 4.53-4.64 (2H, m), 7.49-7.64 (2H, m), 8.08-8.18 (2H, m), 9.50-9.58 (1H, m).
1H-NMR (CDCl3)δ:1.38-1.54 (9H, br), 2.45 (1H, dd, J = 10.0, 13.2 Hz), 2.52 (1H, dd, J = 3.4, 16.6 Hz), 2.62-2.94 (4H, m), 3.06-3.52 (3H, m), 3.82 (2H, s), 4.46-4.58 (2H, m), 6.92-7.00 (2H, m), 7.00-7.10 (4H, m), 7.12-7.18 (2H, m), 7.40-7.60 (2H, m), 8.06-8.12 (2H, m).
1H-NMR (CDCl3)δ: 1.46 (9H, s), 2.42 (1H, dd, J = 10.0, 13.2 Hz), 2.48-2.53 (1H, m), 2.60-2.85 (4H, m), 3.10-3.87 (5H, m), 4.36-4.38 (2H, m), 6.51-6.64 (3H, m), 6.96 (2H, dd, J = 8.7, 8.7 Hz), 7.01-7.15 (7H, m).
1H-NMR (CDCl3)δ:2.48 (1H, dd, J = 9.5, 13.2 Hz), 2.54 (1H, dd,J = 3.9, 16.6 Hz), 2.75-2.94 (6H, m), 2.95 (3H, s), 3.19-3.30 (1H, m), 3.79 (2H, s), 3.81 (2H, s), 6.90-6.97 (2H, m), 7.02-7.11 (4H, m), 7.12-7.18 (4H, m), 7.27-7.32 (2H, m).
a) N−(4−メタンスルホニルアミノベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.3, 13.4 Hz), 2.54 (1H, dd, J = 3.9, 16.6 Hz), 2.74-2.91 (6H, m), 2.97 (3H, s), 3.18-3.24 (1H, m), 3.76 (2H, s), 3.80 (2H, s), 6.93 (2H, dd, J = 8.7, 8.7 Hz), 7.02-7.17 (8H, m), 7.26 (2H, d, J = 8.3 Hz).
得られた粗生成物46.6 mgを 10 mLナスフラスコに取り酢酸エチル 1 mLに溶解させ、氷冷下、4N 塩酸−酢酸エチル 1 mLを加えて攪拌した。室温で2時間攪拌した。反応終了後、反応液を氷冷下、飽和重曹水、酢酸エチルを加えて、有機層を分離し、水層に再度酢酸エチルを加え抽出し、有機層を合わせて、飽和食塩水で洗浄した。有機層を無水硫酸ナトリウムで乾燥後、減圧濃縮し溶媒を留去し、粗生成物を 37.8 mg得た。
粗生成物をPLCで精製して表題化合物 29.9 mg(収率 79%)を微黄色油状物として得た。
1H-NMR (CDCl3)δ: 2.17 (3H, s), 2.46 (1H, dd, J = 9.8, 13.4 Hz), 2.52 (1H, dd, J = 3.8, 16.7 Hz), 2.73-2.88 (6H, m), 3.14-3.21 (1H, m), 3.75 (2H, s), 3.79 (2H, s), 6.93 (2H, dd, J = 8.6, 8.6 Hz), 7.02-7.24 (4H, m), 7.13-7.16 (2H, m), 7.23 (2H, d, J = 8.1 Hz), 7.43 (2H, d, J = 8.1 Hz).
a) tert−ブチル 2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルカルバメートの製造
1H-NMR (CDCl3)δ:1.44 (9H, s), 2.46 (1H, dd, J = 9.3, 13.4 Hz), 2.52 (1H, dd, J = 2.6, 16.4 Hz), 2.64-2.73 (1H, m), 2.76-2.90 (3H, m), 3.14-3.36 (3H, m), 3.79 (2H, s), 4.90 (1H, brs), 6.77 (1H, dd, J = 2.2, 9.5 Hz), 6.87 (1H, ddd, J = 2.2, 8.6, 8.6 Hz), 6.94-7.04 (3H, m), 7.04-7.12 (2H, m).
1H-NMR (CDCl3)δ:2.40-2.62 (4H, m), 2.66-2.96 (6H, m), 3.16-3.28 (1H, m), 3.80 (2H, s), 6.76(1H, dd, J = 2.0, 9.5 Hz), 6.86(1H, ddd, J = 2.0, 8.3, 8.3 Hz), 6.94-7.04 (3H, m), 7.08 (2H, dd, J = 5.9, 8.0 Hz).
1H-NMR (CDCl3)δ:1.22 (3H, t, J = 7.6 Hz), 2.50 (1H, dd, J= 4.2, 11.7 Hz), 2.53 (1H, dd, J = 8.8, 13.2 Hz), 2.63 (2H, q, J= 7.6 Hz), 2.81 (1H, dd, J = 6.6, 13.9 Hz), 2.84-3.08 (5H, m), 3.25-3.32 (1H, m), 3.48 (1H, d, J = 16.0 Hz), 3.63 (1H, d, J = 16.0 Hz), 3.96 (1H, d, J = 13.6 Hz), 4.02 (1H, d, J = 13.6 Hz), 6.75 (1H, dd, J = 2.5, 9.3 Hz), 6.82-6.89 (2H, m), 6.91-6.97 (2H, m), 7.09-7.31 (2H, m), 7.17 (2H, d, J = 8.1 Hz), 7.23 (2H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ:1.31 (9H, s), 2.42 (1H, dd, J = 10.0, 13.4 Hz), 2.49 (1H, dd, J = 3.6, 16.6 Hz), 2.72-2.91 (6H, m), 3.12-3.20 (1H, m), 3.73 (2H, s), 3.77 (2H, s), 6.75 (1H, dd, J = 2.5, 9.5 Hz), 6.85 (1H, ddd, J = 2.5, 8.3, 8.3 Hz), 6.90-6.96 (3H, m), 7.00-7.07 (2H, m), 7.21 (2H, d, J = 8.1 Hz), 7.33 (2H, d, J = 8.1 Hz).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 9.5, 13.4 Hz), 2.50 (1H, dd,J = 3.9, 16.6 Hz), 2.59 (3H, s), 2.71-2.90 (6H, m), 3.14-3.22 (1H, m), 3.75 (2H, s), 3.84 (2H, s), 6.76 (1H, dd, J = 2.6, 9.5 Hz), 6.85 (1H, ddd,J = 2.6, 8.3, 8.3 Hz), 6.90-7.06 (5H, m), 7.41 (1H, dd, J = 7.7, 7.7 Hz), 7.50 (1H, d, J = 7.7 Hz), 7.84 (1H, d, J = 7.7 Hz), 7.89 (1H, s).
a) tert−ブチル 3−ニトロベンジル[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ:1.39-1.51 (9H, br), 2.42 (1H, dd, J = 9.8, 13.4 Hz), 2.49 (1H, dd, J = 4.2, 16.6 Hz), 2.62-2.90 (3H, m), 2.75 (1H, dd,J = 5.0, 16.7 Hz), 3.08-3.52 (3H, m), 3.77 (2H, s), 4.46-4.58 (2H, m), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.94-7.08 (5H, m), 7.42-7.58 (2H, m), 8.07-8.12 (2H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.3, 13.4 Hz), 2.53 (1H, dd,J = 3.9, 17.1 Hz), 2.72-2.79 (3H, m), 2.81-2.91 (3H, m), 3.18-3.24 (1H, m), 3.79 (2H, s), 3.88 (2H, s), 6.77 (1H, dd, J = 2.6, 9.6 Hz), 6.87 (1H, ddd, J = 2.6, 8.5, 8.5 Hz), 6.91-6.97 (2H, m), 7.00 (1H, dd, J = 5.6, 8.8 Hz), 7.04-7.09 (2H, m), 7.48 (1H, dd, J = 7.8, 7.8 Hz), 7.62-7.65 (1H, m), 8.11 (1H, dd, J = 1.5, 7.8 Hz), 8.18 (1H, s).
a) tert−ブチル 3−アミノベンジル[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.46 (9H, brs), 2.39 (1H, dd, J = 9.9, 13.3 Hz), 2.44-2.52 (1H, m), 2.54-3.84 (11H, m), 4.34-4.40 (2H, m), 6.50-6.65 (3H, m), 6.73 (1H, dd, J = 2.6, 9.4 Hz), 6.84 (1H, ddd, J = 2.6, 8.5, 8.5 Hz), 6.94-7.11 (6H, m).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 9.8, 13.4 Hz), 2.50 (1H, dd,J = 3.9, 16.8 Hz), 2.72-2.92 (6H, m),3.14-3.25 (1H, m), 3.52-3.68 (2H, m), 3.72-3.74 (4H, m), 6.56-6.60 (1H, m), 6.62-6.68 (2H, m), 6.75 (1H, dd, J= 2.5, 9.3 Hz), 6.85 (1H, ddd, J = 2.5, 8.3, 8.3 Hz), 6.92-7.01 (3H, m), 7.02-7.12 (3H, m).
a) tert−ブチル 3−(アセチルアミノ)ベンジル[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.44-1.47 (9H, br), 2.14 (3H, s), 2.39 (1H, dd, J= 9.9, 13.3 Hz), 2.47 (1H, dd, J = 4.0, 16.5 Hz), 2.55-2.88 (4H, m), 3.05-3.49 (3H, m), 3.71-3.81 (2H, m), 4.38-4.46 (2H, m), 6.73 (1H, dd, J= 2.6, 9.4 Hz), 6.84 (1H, ddd, J = 2.6, 8.7, 8.7 Hz), 6.93-7.48 (10H, m).
1H-NMR (CDCl3)δ: 2.15 (3H, s), 2.43 (1H, dd, J = 9.6, 13.3 Hz), 2.50 (1H, dd, J = 3.7, 16.6 Hz), 2.70-2.90 (6H, m), 3.13-3.22 (1H, m), 3.73 (2H, s), 3.77 (2H, s), 6.75 (1H, dd, J = 2.6, 9.4 Hz), 6.86 (1H, ddd, J = 2.6, 8.6, 8.6 Hz), 6.91-7.07 (7H, m), 7.13 (1H, s), 7.38-7.44 (2H, m).
1H-NMR (CDCl3)δ:2.44 (1H, dd, J = 9.8, 13.4 Hz), 2.50 (1H, dd,J = 3.9, 16.6 Hz), 2.72-2.90 (6H, m), 2.95 (3H, s), 3.14-3.22 (1H, m), 3.76 (2H, s), 3.77 (2H, s), 6.75 (1H, dd, J = 2.4, 9.5 Hz), 6.86 (1H, ddd,J = 2.4, 8.5, 8.5 Hz), 6.94 (2H, ddd, J = 2.0, 6.6, 8.6 Hz), 6.99 (1H, dd, J = 5.7, 8.5 Hz), 7.02-7.15 (4H, m), 7.26-7.31 (2H, m).
a) [(tert−ブトキシカルボニル) 4−メチル−3−ニトロベンジルアミノ]アセトアルデヒドの製造
1H-NMR (CDCl3)δ: 1.47 (9H, s), 2.59 (3H, s), 3.84-4.04 (2H, m), 4.46-4.58 (2H, m), 7.28-7.46 (2H, m), 7.81-7.88 (1H, m), 9.48-9.56 (1H, m).
1H-NMR (CDCl3)δ:1.38-1.50 (9H, br), 2.41 (1H, dd, J = 9.8, 13.4 Hz), 2.48 (1H, dd, J = 4.2, 16.6 Hz), 2.56 (3H, s), 2.68-2.90 (3H, m), 3.00-3.50 (4H, m), 3.74-3.78 (2H, m), 4.38-4.52 (2H, m), 6.74 (1H, dd, J= 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.93-7.00 (3H, m), 7.01-7.08 (2H, m), 7.22-7.26 (1H, m), 7.28-7.40 (1H, m), 7.83 (1H, s).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.3, 13.4 Hz), 2.53 (1H, dd,J = 3.9, 17.1 Hz), 2.58 (3H, s), 2.73-2.92 (6H, m), 3.19-3.26 (1H, m), 3.78 (2H, s), 3.83 (2H, s), 6.77 (1H, dd, J = 2.6, 9.5 Hz), 6.86 (1H, ddd,J = 2.6, 8.5, 8.5 Hz), 6.91-6.96 (2H, m), 6.99 (1H, dd, J = 5.9, 8.5 Hz), 7.07 (2H, dd, J = 5.5, 8.4 Hz), 7.28 (1H, d, J = 7.8 Hz), 7.46 (1H, d, J = 7.8 Hz), 7.90 (1H, s).
1H-NMR (CDCl3)δ: 2.14 (3H, s), 2.41 (1H, dd, J = 10.0, 13.2 Hz), 2.48 (1H, dd, J = 3.5, 16.5 Hz), 2.72-2.89 (6H, m),3.11-3.19 (1H, m), 3.45-3.60 (2H, m), 3.69 (2H, s), 3.74 (2H, s), 6.58-6.62 (2H, m), 6.75 (1H, dd, J = 2.6, 9.5 Hz), 6.85 (1H, ddd, J = 2.6, 8.5, 8.5 Hz), 6.92-7.06 (6H, m).
1H-NMR (CDCl3)δ: 2.18 (3H, s), 2.23 (3H, s), 2.41 (1H, dd, J = 9.9, 13.3 Hz), 2.49 (1H, dd, J = 3.5, 16.5 Hz), 2.70-2.90 (6H, m), 3.12-3.20 (1H, m), 3.73 (2H, s), 3.75 (2H, s), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.93 (2H, ddd, J = 2.2, 6.6, 8.8 Hz), 6.98 (1H, dd, J = 5.8, 8.5 Hz), 7.00-7.06 (4H, m), 7.12 (1H, d, J = 7.8 Hz), 7.69 (1H, s).
1H-NMR (CDCl3)δ:2.29 (3H, s), 2.43 (1H, dd, J = 9.8, 13.4 Hz), 2.50 (1H, dd, J = 3.9, 16.6 Hz), 2.72-2.90 (6H, m), 2.97 (3H, s), 3.12-3.22 (1H, m), 3.75-3.77 (4H, m), 6.75 (1H, dd, J = 2.5, 9.5 Hz), 6.85 (1H, ddd, J = 2.5, 8.6, 8.6 Hz), 6.94 (2H, ddd, J = 2.0, 6.7, 8.7 Hz), 6.99 (1H, dd, J = 5.6, 8.6 Hz), 7.01-7.08 (3H, m), 7.16 (1H, d, J = 7.6 Hz), 7.37 (1H, d, J = 1.0 Hz).
a) tert−ブチル 3−(2−プロピルスルホニルアミノ)ベンジル−[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.36 (6H, d, J = 6.8 Hz), 1.44-1.47 (9H, br), 2.41 (1H, dd, J = 10.0, 13.4 Hz), 2.48 (1H, dd, J = 3.9, 16.4 Hz), 2.61-2.83 (4H, m), 3.02-3.42 (4H, m), 3.72-3.82 (2H, m), 4.39-4.44 (2H, m), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.94-7.27 (9H, m).
1H-NMR (CDCl3)δ: 1.37 (6H, d, J = 6.8 Hz), 2.42-2.53 (2H, m), 2.74-2.90 (6H, m), 3.16-3.22 (1H, m), 3.25-3.32 (1H, m), 3.76 (2H, s), 3.77 (2H, s), 6.74-7.28 (11H, m).
a) tert−ブチル [3−(N−メチル−2−プロピルスルホニルアミノ)ベンジル]−[2−[6−フルオロ−3−(4−フルオロベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル)エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.34 (6H, d, J = 6.6 Hz), 1.42-1.49 (9H, br), 2.41 (1H, dd, J = 10.0, 13.4 Hz), 2.45-2.51 (1H, m), 2.59-2.95 (4H, m), 3.11-3.36 (4H, m), 3.34 (3H, s), 3.72-3.84 (2H, m), 4.39-4.49 (2H, m), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.96 (2H, dd, J = 8.5, 8.5 Hz), 7.00-7.31 (7H, m).
1H-NMR (CDCl3)δ: 1.35 (6H, d, J = 6.8 Hz), 2.44 (1H, dd, J = 9.8, 13.2 Hz), 2.51 (1H, dd, J = 3.6, 16.6 Hz), 2.74-2.90 (6H, m), 3.15-3.22 (1H, m), 3.24-3.31 (1H, m), 3.35 (3H, s), 3.77 (2H, s), 3.79 (2H, s), 6.76 (1H, d, J = 9.5 Hz), 6.86 (1H, dd, J = 8.8, 8.8 Hz), 6.94 (2H, dd, J = 8.5, 8.5 Hz), 6.98 (1H, dd, J = 5.8, 8.8 Hz), 7.05 (2H, dd, J = 5.4, 8.5 Hz), 7.18 (1H, d, J = 6.8 Hz), 7.21-7.33 (2H, m), 7.36 (1H, s).
a) N−[3,5−ビス(tert−ブチルオキシカルボニル)アミノベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 1.50 (18H, s), 2.41 (1H, dd, J = 10.0, 13.2 Hz), 2.45-2.51 (1H, m), 2.71-2.89 (6H, m), 2.13-3.19 (1H, m), 3.70 (1H, d, J = 7.1 Hz), 3.72 (2H, s), 3.74 (1H, d, J = 7.1 Hz), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.95 (2H, dd, J = 8.6, 8.6 Hz), 6.97-7.01 (3H, m), 7.04 (2H, dd, J = 5.6, 8.6 Hz), 7.36 (1H, s).
1H-NMR (CDCl3)δ: 1.50 (18H, s), 2.28-2.88 (6H, m), 2.98-3.20 (1H, m), 3.33-3.50 (2H, m), 3.73 (1H, d, J = 16.1 Hz), 3.78 (1H, d, J = 16.1 Hz), 4.41-4.46 (2H, m), 5.15 (1H, d, J = 14.9 Hz), 5.19 (1H, d, J = 14.9 Hz), 6.28 (1H, s), 6.44 (1H, s), 6.70-7.06 (7H, m), 7.30-7.46 (6H, m).
粗生成物をPLCで精製して 目的物を20.9 mg(収率 79%)得た。
1H-NMR (CDCl3)δ: 2.28-3.84 (11H, m), 4.32-4.35 (2H, m), 5.17 (2H, s), 5.87 (1H, s), 5.90-5.93 (1H, m), 6.00 (1H, s), 6.70-7.08 (6H, m), 7.30-7.37 (6H, m).
1H-NMR (CDCl3)δ: 2.32-2.51 (2H, m), 2.62-2.86 (3H, m), 2.92-3.01 (6H, m), 3.06-3.49 (4H, m), 3.67-3.84 (2H, m), 4.40-4.44 (2H, m), 5.16 (2H, s), 6.71-7.07 (9H, m), 7.28-7.36 (6H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 9.8, 13.2 Hz), 2.51 (1H, dd, J = 3.6, 16.6 Hz), 2.75-2.90 (6H, m), 2.98 (6H, s), 3.12-3.23 (1H, m), 3.73 (2H, s), 3.79 (2H, s), 6.76 (1H, dd, J = 2.7, 9.3 Hz), 6.87 (1H, ddd, J = 2.7, 8.6, 8.6 Hz), 6.90 (1H, s), 6.91 (1H, s), 6.95 (2H, dd, J = 8.6, 8.6 Hz), 6.96 (1H, s), 7.02 (1H, dd, J= 5.6, 8.6 Hz), 7.06 (2H, dd, J = 5.6, 8.6 Hz).
a) tert−ブチル 3−トリフルオロメタンスルホニルアミノベンジル[2−[6−フルオロ−3−(4−フルオロベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル)エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.46 (9H, s), 2.39 (1H, dd, J = 10.0, 13.4 Hz), 2.45-2.50 (1H, m), 2.58-2.84 (4H, m), 3.07-3.83 (5H, m), 4.35-4.39 (2H, m), 6.51-6.64 (3H, m), 6.73 (1H, dd, J = 2.4, 9.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.94-7.11 (6H, m).
1H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 9.8, 13.2 Hz), 2.50 (1H, dd, J = 3.7, 16.6 Hz), 2.73-2.89 (6H, m), 3.17 (1H, dt, J = 4.6, 9.8 Hz), 3.70 (2H, s), 3.72 (1H, d, J = 16.1 Hz), 3.77 (1H, d, J = 16.1 Hz), 6.57 (1H, dd, J = 1.7, 7.8 Hz), 6.62 (1H, s), 6.66 (1H, d, J = 7.8 Hz), 6.76 (1H, dd, J = 2.7, 9.5 Hz), 6.86 (1H, ddd, J = 2.7, 8.5, 8.5 Hz), 6.95 (2H, ddd, J = 2.2, 8.5, 8.5 Hz), 6.99 (1H, dd, J = 5.8, 8.5 Hz), 7.04 (2H, ddd, J = 2.2, 5.6, 8.5 Hz), 7.09 (1H, dd, J = 7.8, 7.8 Hz).
a) tert−ブチル 3−エタンスルホニルアミノベンジル[2−[6−フルオロ−3−(4−フルオロベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル)エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.34 (3H, t, J = 7.3 Hz), 1.43-1.51 (9H, br), 2.41 (1H, dd, J = 10.0, 13.4 Hz), 2.48 (1H, dd, J = 3.4, 16.8 Hz), 2.57-2.89 (4H, m), 3.10 (2H, q, J = 7.3 Hz), 3.15-3.49 (3H, m), 3.77 (1H, d, J = 15.6 Hz), 3.81 (1H, d, J = 15.6 Hz), 4.40-4.45 (2H, m), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.86 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 7.00 (2H, dd, J = 8.6, 8.6 Hz), 7.01-7.09 (3H, m), 7.09 (1H, s), 7.10-7.14 (2H, m), 7.27 (1H, dd, J = 7.3, 7.3 Hz).
1H-NMR (CDCl3)δ: 1.30 (3H, t, J = 7.3 Hz), 2.43-2.54 (2H, m), 2.82-3.04 (6H, m), 3.09 (2H, q, J = 7.3 Hz), 3.20-3.29 (1H, m), 3.74 (2H, s), 3.91 (2H, s), 6.73 (1H, d, J = 9.0 Hz), 6.84 (1H, dd, J = 8.0, 8.0 Hz), 6.90-6.97 (3H, m), 7.05-7.09 (3H, m), 7.23-7.27 (2H, m), 7.39 (1H, s).
a) tert−ブチル (3−プロパンスルホニルアミノベンジル)−[2−[6−フルオロ−3−(4−フルオロベンジル−3,4−ジヒドロイソキノリン−2(1H)−イル)エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.00 (3H, t, J = 7.6 Hz), 1.43-1.51 (9H, br), 1.83 (2H, tq, J = 7.6, 7.6 Hz), 2.41 (1H, dd, J = 10.0, 13.4 Hz), 2.46-2.53 (1H, m), 2.58-2.88 (4H, m), 3.02-3.06 (2H, m), 3.19-3.48 (3H, m), 3.70-3.83 (2H, m), 4.40-4.45 (2H, m), 6.74 (1H, dd, J= 2.4, 9.5 Hz), 6.86 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.97 (2H, dd, J = 8.5, 8.5 Hz), 7.00-7.10 (6H, m), 7.27 (1H, dd, J = 7.8, 7.8 Hz).
1H-NMR (CDCl3)δ: 1.00 (3H, t, J = 7.8 Hz), 1.83 (2H, tq, J= 5.4, 7.8 Hz), 2.44 (1H, dd, J = 9.8, 13.4 Hz), 2.51 (1H, dd, J = 3.9, 16.6 Hz), 2.73-2.89 (6H, m), 3.01-3.05 (2H, m), 3.15-3.21 (1H, m), 3.74 (1H, d, J = 16.6 Hz), 3.77 (2H, s), 3.78 (1H, d, J = 16.6 Hz), 6.76 (1H, dd, J = 2.7, 9.5 Hz), 6.86 (1H, ddd, J = 2.7, 8.6, 8.6 Hz), 6.95 (2H, ddd, J = 2.2, 8.8, 8.8 Hz), 7.00 (1H, dd, J = 5.6, 8.6 Hz), 7.05 (2H, ddd, J = 2.2, 5.6, 8.8 Hz), 7.06-7,10 (2H, m), 7.11 (1H, s), 7.27 (1H, dd, J = 7.6, 7.6 Hz).
a) N−[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]−3−ビニル−5−ニトロベンズアミドの製造
1H-NMR (CDCl3)δ:2.55 (1H, dd, J = 8.5, 13.7 Hz), 2.58 (1H, dd,J = 4.6, 16.8 Hz), 2.80-2.97 (4H, m), 3.27-3.34 (1H, m), 3.45-3.54 (1H, m), 3.66-3.73 (1H, m), 3.89 (2H, s), 5.50 (1H, d, J = 11.0 Hz), 5.94 (1H, d, J = 17.6 Hz), 6.77 (1H, dd, J = 11.0 , 17.6 Hz ), 6.78-6.92 (5H, m), 7.02-7.10 (3H, m), 8.05-8.07 (1H, m), 8.26-8.28 (1H, m), 8.33-8.35 (1H, m).
反応終了後、反応液をセライトろ過し、表題化合物103 mg(収率 98%)を黄色油状物として得た。
1H-NMR (CDCl3)δ:1.19 (3H, t, J = 7.6 Hz), 2.47-2.63 (3H, m), 2.57 (2H, q, J = 7.6 Hz), 2.80-3.04 (5H, m), 3.28-3.37 (1H, m), 3.46-3.56 (1H, m), 3.64-3.76 (1H, m), 3.93 (2H, brs), 6.64 (1H, brs), 6.77-6.96 (7H, m), 7.02-7.10 (3H, m).
1H-NMR (CDCl3)δ:1.20 (3H, t, J = 7.6 Hz), 2.47-2.63 (3H, m), 2.60 (2H, q, J = 7.6 Hz), 2.80-3.04 (5H, m), 2.99 (3H, s), 3.26-3.93 (3H, m), 6.65 (1H, brs), 6.75-7.12 (10H, m).
1H-NMR (CDCl3)δ:1.20 (3H, t, J = 7.6 Hz), 2.44 (1H, dd, J= 9.8, 13.2 Hz), 2.50 (1H, dd, J = 3.7, 16.8 Hz), 2.50-2.54 (1H, m), 2.60 (2H, q, J = 7.6 Hz), 2.74-2.90 (5H, m), 2.96 (3H, s), 3.12-3.22 (1H, m), 3.74 (2H, s), 3.76 (2H, s), 6.75 (1H, dd, J = 2.6, 9.3 Hz), 6.86 (1H, ddd, J = 2.6, 8.0, 8.0 Hz), 6.92-7.08 (8H, m).
a) tert−ブチル (4−アミノベンジル)−[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.46 (9H, s), 2.34-3.48 (8H, m), 3.62-3.82 (3H, m), 4.29-4.39 (2H, m), 6.62 (2H, d, J = 8.3 Hz), 6.70-7.06 (9H, m).
1H-NMR (CDCl3)δ: 1.20 (6H, d, J = 6.1 Hz), 1.47 (9H, s), 2.37 (1H, dd, J = 10.2, 13.2 Hz), 2.43-2.48 (1H, m), 2.52-2.89 (4H, m), 3.01-3.44 (3H, m), 3.55-3.65 (1H, m), 3.67-3.82 (2H, m), 4.28-4.38 (2H, m), 6.52 (2H, d, J = 8.6 Hz), 6.70-6.74 (1H, m), 6.85 (1H, dd, J= 8.5, 8.5 Hz), 6.93-7.08 (7H, m).
1H-NMR (CDCl3)δ: 1.20 (6H, d, J = 6.1 Hz), 2.40 (1H, dd, J = 10.0, 13.4 Hz), 2.48 (1H, dd, J = 3.7, 16.6 Hz), 2.73-2.88 (6H, m), 3.13 (1H, m), 3.56-3.68 (1H, m), 3.67 (2H, s), 3.73 (2H, s), 6.53 (2H, d, J = 8.3 Hz), 6.74 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.94 (2H, dd, J = 8.6, 8.6 Hz), 6.98 (1H, dd, J = 5.6, 8.5 Hz), 7.03 (2H, dd, J = 5.6, 8.6 Hz), 7.07 (2H, d, J = 8.3 Hz).
a) tert−ブチル (4−エチルアミノ)ベンジル −[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.25 (3H, d, J = 7.1 Hz), 1.47 (9H, s), 2.36 (1H, dd, J = 10.5, 12.7 Hz), 2.43-2.48 (1H, m), 2.52-2.89 (4H, m), 3.13 (2H, q, J= 7.1 Hz), 3.22-3.45 (3H, m), 3.68-3.84 (2H, m), 4.28-4.39 (2H, m), 6.54 (2H, d, J = 8.3 Hz), 6.72 (1H, dd, J = 2.2, 9.5 Hz), 6.84 (1H, ddd, J = 2.2, 8.5, 8.5 Hz), 6.93-7.09 (7H, m).
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.2 Hz), 2.41 (1H, dd, J = 9.9, 13.3 Hz), 2.48 (1H, dd, J = 3.6, 16.7 Hz), 2.76-2.87 (6H, m), 3.11-3.17 (3H, m), 3.70 (2H, s), 3.71 (2H, s), 6.55 (2H, d, J = 8.3 Hz), 6.75 (1H, dd, J = 2.2, 9.5 Hz), 6.85 (1H, ddd, J = 2.2, 8.5, 8.5 Hz), 6.92-6.99 (3H, m), 7.03 (2H, dd, J = 5.4, 8.6 Hz), 7.08 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 9.8, 13.4 Hz), 2.49 (1H, dd, J = 3.7, 16.6 Hz), 2.74-2.89 (6H, m), 3.12-3.19 (5H, m), 3.72 (2H, s), 3.74 (2H, s), 3.86 (2H, d, J = 4.9 Hz), 3.87 (2H, d, J= 4.6 Hz), 6.75 (1H, dd, J = 2.2, 9.2 Hz), 6.82-6.88 (3H, m), 6.94 (2H, dd, J= 8.6, 8.6 Hz), 6.97 (1H, dd, J = 5.6, 8.0 Hz), 7.03 (2H, dd, J = 5.6, 8.6 Hz), 7.19 (2H, d, J = 8.5 Hz).
1H-NMR (CDCl3)δ: 1.41-1.51 (2H, m), 2.02 (2H, d, J = 12.9 Hz), 2.43 (1H, dd, J = 9.8, 13.5 Hz), 2.48 (1H, dd, J = 3.9, 17.0 Hz), 2.76-2.92 (6H, m), 3.16-3.20 (1H, m), 3.47-3.54 (3H, m), 3.71 (2H, s), 3.73 (2H, s), 3.98-4.02 (2H, m), 6.55 (2H, d, J = 8.3 Hz), 6.75 (1H, dd, J = 2.4, 9.5 Hz), 6.84-6.87 (1H, m), 6.92-6.98 (3H, m), 7.04 (2H, dd, J = 5.5, 8.5 Hz), 7.10 (2H, d, J= 8.5 Hz).
1H-NMR (CDCl3)δ: 1.30 (3H, t, J = 7.1 Hz), 2.42 (1H, dd, J = 9.8, 13.4 Hz), 2.49 (1H, dd, J = 4.2, 16.8 Hz), 2.75-2.77 (3H, m), 2.83-2.87 (3H, m), 3.13-3.19 (1H, m), 3.70 (4H, s), 3.89 (2H, d, J = 5.4 Hz), 4.25 (2H, q, J = 7.1 Hz), 6.56 (2H, d, J = 8.5 Hz), 6.75 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.92-6.97 (3H, m), 6.99-7.06 (2H, m), 7.10 (2H, d, J= 8.5 Hz).
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.2 Hz), 1.94 (2H, q, J = 7.1 Hz), 2.39-2.44 (3H, m), 2.48 (1H, dd, J = 3.8, 16.5 Hz), 2.73-2.78 (3H, m), 2.81-2.88 (3H, m), 3.13-3.19 (3H, m), 3.69 (2H, s), 3.72 (2H, s), 4.14 (2H, q, J = 7.2 Hz), 6.55 (2H, d, J = 8.5 Hz), 6.75 (1H, dd, J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.92-6.99 (3H, m), 7.02-7.08 (4H, m).
1H-NMR (CDCl3)δ: 2.38 (1H, dd, J = 9.8, 13.0 Hz), 2.47 (1H, dd, J = 3.8, 16.8 Hz), 2.68-2.87 (6H, m), 3.04-3.08 (1H, m), 3.83-3.86 (4H, s), 4.33-4.38 (2H, m), 6.60 (2H, d, J = 8.8 Hz), 6.72 (1H, dd, J = 2.4, 8.6 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.94-6.98 (3H, m), 7.04-7.13 (4H, m).
1H-NMR (CDCl3)δ: 1.78 (2H, q, J = 3.4 Hz), 2.34-2.40 (2H, m), 2.71-2.79 (4H, m), 2.88 (2H, br), 2.96 (2H, br), 3.08-3.16 (1H, m), 3.58 (2H, s), 3.62 (2H, brs), 3.71 (2H, brs), 6.36 (2H, d, J = 8.2 Hz), 6.62-6.65 (1H, m), 6.74-6.79 (1H, m), 6.83-6.87 (3H, m), 6.86 (2H, d, J = 8.6 Hz), 6.96-7.00 (4H, m).
1H-NMR (CDCl3)δ: 2.43-2.53 (2H, m), 2.76-2.96 (6H, m), 3.19-3.21 (1H, m), 3.29 (2H, t, J = 5.1 Hz ), 3.64 (2H, s), 3.77 (2H, s), 3.84 (2H, t, J = 5.1 Hz ), 6.59 (2H, d, J = 8.5 Hz ), 6.76 (1H, d, J = 9.2 Hz ), 6.83-6.88 (1H, m), 6.93-7.00 (3H, m), 7.05-7.09 (4H, m).
1H-NMR (CDCl3)δ: 2.43-2.55 (2H, m), 2.78-2.95 (6H, m), 3.20-3.28 (1H, m), 3.57 (4H, t, J = 5.2 Hz ), 3.64 (2H, s), 3.78 (2H, s), 3.85 (4H, t, J = 5.2 Hz ), 6.65 (2H, d, J = 8.6 Hz ), 6.77 (1H, d, J = 9.2 Hz ), 6.83-6.89 (1H, m), 6.91-6.99 (3H, m), 7.05-7.14 (4H, m).
1H-NMR (CDCl3)δ: 1.21-1.25 (4H, m), 2.49 (1H, dd, J = 9.6, 13.5 Hz), 2.52 (1H, dd, J = 3.9, 16.8 Hz), 2.79-2.95 (6H, m), 3.17-3.24 (1H, m), 3.62-3.79 (5H, m), 6.36 (2H, d, J = 8.6 Hz), 6.77 (1H, dd, J= 2.4, 9.2 Hz), 6.83-6.89 (1H, m), 6.94 (1H, d, J = 8.5 Hz), 6.97 (2H, d, J= 8.6 Hz), 7.04-7.09 (4H, m).
a) tert−ブチル 4−[2−(4−モルホリノ)エチル]アミノベンジル[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.47 (9H, s), 2.37 (1H, dd, J = 10.0, 13.2 Hz), 2.43-2.52 (6H, m), 2.63 (2H, t, J = 5.6 Hz), 2.66-2.74 (2H, br), 2.77-2.90 (2H, br), 3.15 (2H, t, J = 5.6 Hz), 3.24-3.34 (2H, br), 3.66-3.83 (2H, m), 3.72 (4H, t, J = 4.4 Hz), 4.34 (2H, d, J = 13.9 Hz), 6.58 (2H, d, J = 8.3 Hz), 6.73 (1H, dd, J = 2.4, 10.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.5, 8.5 Hz ), 6.96 (2H, dd, J = 8.5, 8.5 Hz), 7.00-7.09 (5H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 10.0, 13.2 Hz ), 2.44-2.52 (5H, br), 2.63 (2H, t, J = 5.8 Hz), 2.72-2.80 (3H, m), 2.80-2.89 (2H, m), 3.12-3.18 (4H, br), 3.68 (2H, s), 3.70-3.78 (6H, m), 6.59 (2H, d, J = 8.5 Hz), 6.75 (1H, dd, J= 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.94 (2H, dd, J = 8.5, 8.5 Hz), 6.91-7.06 (1H, m), 7.02 (2H, dd, J = 5.6, 8.5 Hz), 7.95 (2H, d, J= 8.5 Hz).
a) tert−ブチル 4−メトキシアセトアミドベンジル[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.45 (9H, brs), 2.30-3.30 (9H, m), 3.51 (3H, s), 3.60-3.80 (2H, m), 4.02 (2H, s), 4.40-4.44 (2H, m), 6.73 (1H, m), 6.85 (1H, m), 6.95-7.30 (5H, m), 6.97 (2H, d, J = 8.5 Hz), 7.52 (2H, d, J = 8.5 Hz).
1H-NMR (CDCl3)δ: 2.40-2.51 (2H, m), 2.70-2.90 (6H, m), 3.15 (1H, m), 3.51 (3H, s), 3.74 (2H, s), 3.76 (2H, s), 4.02 (2H, s), 6.76 (1H, m), 6.80-7.10 (6H, m), 7.24-7.26 (2H, m), 7.52 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ: 2.3-2.51 (2H, m), 2.70-2.90 (6H, m), 3.15 (1H, m), 3.28 (2H, t, J = 5.1 Hz), 3.39 (3H, s), 3.61 (2H, t, J = 5.1 Hz), 3.69 (2H, s), 3.72 (2H, s), 6.58 (2H, d, J = 8.5 Hz), 6.75 (1H, m), 6.85 (1H, m), 6.93-7.05 (5H, m), 7.08 (2H, d, J = 8.5 Hz).
1H-NMR (CDCl3)δ: 1.04-1.14 (3H, br), 1.19-1.29 (3H, br), 2.48 (1H, dd, J= 9.6, 13.4 Hz), 2.54 (1H, dd, J = 3.6, 16.8 Hz), 2.74-2.94 (6H, m), 3.15-3.29 (3H, br), 3.50 (2H, br) 3.80 (2H, s), 3.82 (2H, s), 6.94 (1H, d, J = 8.8 Hz), 6.96 (1H, d, J = 8.8 Hz), 7.04-7.07 (3H, m), 7.14-7.16 (2H, m), 7.30-7.33 (4H, m).
a) 2−(3−ブロモフェニル)−2−イソプロピル−1,3−ジオキソランの製造
1H-NMR (CDCl3)δ: 1.17 (6H, d, J = 6.8 Hz), 3.44 (1H, sept, J = 6.8 Hz), 3.81-3.84 (2H, m), 4.25-4.28 (2H, m), 7.31 (1H, ddd, J = 0.8, 7.9, 7.9 Hz), 7.62-7.65 (1H, m), 7.81-7.84 (1H, m), 8.02-8.08 (1H, m).
1H-NMR (CDCl3)δ: 0.69 (3H, d, J = 6.8 Hz), 0.93 (3H, d, J = 6.8 Hz), 2.00 (1H, sept, J = 6.8 Hz), 2.44 (1H, dd, J = 9.5, 13.4 Hz), 2.50 (1H, dd, J = 3.5, 16.7 Hz), 2.77-2.90 (6H, m), 3.17-3.22 (1H, m), 3.72 (2H, s), 3.84 (2H, s), 6.72-6.78 (1H, m), 6.83-6.89 (1H, m), 6.93-6.97 (3H, m), 7.04-7.07 (2H, m), 7.14 (1H, d, J = 7.2 Hz), 7.23-7.27 (2H, m), 7.32 (1H, s).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 9.5, 13.6 Hz), 2.52 (1H, dd, J = 3.9, 16.8 Hz), 2.69-2.89 (6H, m), 3.19 (1H, dt, J = 5.1, 9.5 Hz), 3.77 (2H, s), 3.78 (1H, d, J = 13.9 Hz), 3.82 (1H, d, J = 13.9 Hz), 6.76 (1H, dd, J = 2.7, 9.5 Hz), 6.87 (1H, ddd, J = 2.7, 8.4 , 8.4 Hz), 6.95 (2H, ddd, J = 2.2, 8.8, 8.8 Hz), 7.00 (1H, dd, J = 5.6, 8.4 Hz), 7.06 (2H, dd, J = 5.6, 8.8 Hz), 7.40 (1H, dd, J = 7.7 Hz), 7.51-7.55 (2H, m), 7.61 (1H, s).
1H-NMR (CDCl3)δ: 1.57 (6H, s), 2.43 (1H, dd, J = 9.5, 13.6 Hz), 2.49 (1H, dd, J = 3.6, 16.8 Hz), 2.73-2.79 (3H, m), 2.83-2.90 (3H, m), 3.16-3.20 (1H, m), 3.73 (2H, s), 3.79 (2H, s), 6.75 (1H, dd, J = 2.4, 9.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.91-6.99 (3H, m), 7.04 (1H, d, J = 5.4 Hz), 7.06 (1H, d, J = 5.4 Hz), 7.25 (2H, d, J = 8.6 Hz), 7.43 (2H, d, J = 8.6 Hz).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 9.5, 13.4 Hz), 2.53 (1H, dd, J = 3.9, 16.2 Hz), 2.77-2.83 (3H, m), 2.86-2.90 (3H, m), 3.19-3.23 (1H, m), 3.81 (2H, s), 3.84 (2H, s), 5.76 (1H, brs), 6.21 (1H, brs), 6.75 (1H, d, J= 7.6 Hz), 6.85 (1H, dd, J = 8.5, 8.5 Hz), 6.86 (1H, dd, J = 8.5, 8.5 Hz), 7.03-7.07 (4H, m), 7.39 (1H, dd, J = 7.6, 7.6 Hz), 7.45 (1H, d, J = 7.6 Hz), 7.70 (1H, d, J = 7.6 Hz), 7.81 (1H, s).
1H-NMR (CDCl3)δ:1.31 (9H, s), 2.42 (1H, dd, J = 9.8, 13.2 Hz), 2.48 (1H, dd, J = 3.9, 16.6 Hz), 2.72-2.90 (6H, m), 3.12-3.20 (1H, m), 3.72 (2H, s), 3.77 (2H, s), 6.75 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.97 (1H, dd, J = 5.9, 8.3 Hz), 7.02 (2H, d, J = 8.3 Hz), 7.19-7.24 (4H, m), 7.33 (2H, d, J = 8.3 Hz).
a) tert−ブチル 3−メタンスルホニルアミノベンジル[2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ: 1.43-1.51 (9H, br), 2.41 (1H, dd, J = 9.8, 13.2 Hz), 2.48 (1H, dd, J = 3.9, 16.6 Hz), 2.62-2.85 (4H, m), 2.98 (3H, s), 3.10-3.43 (3H, m), 3.71-3.82 (2H, m), 4.39-4.45 (2H, m), 6.74 (1H, dd, J = 2.2, 9.3 Hz), 6.86 (1H, ddd, J = 2.2, 8.8, 8.8 Hz), 6.97-7.11 (6H, m), 7.25 (2H, d, J = 8.5 Hz), 7.29 (1H, dd, J= 7.8, 7.8 Hz).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 10.0, 13.4 Hz), 2.50 (1H, dd, J = 3.9, 16.8 Hz), 2.73-2.89 (6H, m), 2.96 (3H, s), 3.15-3.22 (1H, m), 3.74 (1H, d, J = 17.1 Hz), 3.77 (2H, s), 3.78 (1H, d, J = 17.1 Hz), 6.75 (1H, dd, J= 2.4, 9.3 Hz), 6.86 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.99 (1H, dd, J = 5.6, 8.5 Hz), 7.03 (2H, d, J = 8.3 Hz), 7.09-7.12 (2H, m), 7.13 (1H, s), 7.23 (2H, d, J = 8.3 Hz), 7.30 (1H, dd, J= 7.6, 8.8 Hz).
a) tert−ブチル 3−ニトロベンジル[2−[6−フルオロ−3−(2−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ:1.40-1.51 (9H, br), 2.44 (1H, dd, J = 9.8, 13.0 Hz), 2.52 (1H, dd, J = 4.0, 16.4 Hz), 2.62-2.96 (4H, m), 3.18-3.60 (3H, m), 3.78 (2H, s), 4.46-4.62 (2H, m), 6.72-6.79 (1H, m), 6.82-6.89 (1H, m), 6.95-7.11 (4H, m), 7.16-7.23 (1H, m), 7.46 (1H, dd, J = 8.2, 8.2 Hz), 7.50-7.60 (1H, m), 8.07-8.11 (2H, m).
1H-NMR (CDCl3)δ: 1.41-1.52 (9H, br), 2.38-2.98 (5H, m), 2.52 (1H, dd,J = 4.4, 16.0 Hz), 3.20-3.38 (2H, m), 3.44-3.86 (5H, m), 4.32-4.44 (2H, m), 6.50-6.66 (3H, m), 6.72-6.80 (1H, m), 6.82-6.88 (1H, m), 6.96-7.30 (6H, m).
1H-NMR (CDCl3)δ: 1.48 (9H, brs), 2.38-3.36 (6H, m), 3.60-3.92 (3H, m), 4.20-4.34 (2H, m), 4.46 (2H, brs), 6.80-6.84 (1H, m), 6.96-7.30 (10H, m).
1H-NMR (CDCl3)δ:2.48 (1H, dd, J = 9.8, 12.9 Hz), 2.54 (1H, dd,J = 2.9, 16.6 Hz), 2.74-2.99 (6H, m), 2.95 (3H, s), 3.18-3.32 (1H, m), 3.78 (2H, s), 3.79 (2H, s), 6.77 (1H, dd, J = 2.4, 9.2 Hz), 6.89 (1H, ddd,J = 2.4, 8.5, 8.5 Hz), 6.97-7.22 (7H, m), 7.25-7.30 (2H, m).
a) tert−ブチル 3−ニトロベンジル[2−[6−クロロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ:1.38-1.52 (9H, br), 2.41 (1H, dd, J = 9.9, 13.3 Hz), 2.48 (1H, dd, J = 4.0, 16.6 Hz), 2.58-2.94 (3H, m), 2.74 (1H, dd,J = 5.1, 16.6 Hz), 3.05-3.26 (1H, m), 3.30-3.50 (2H, m), 3.77 (2H, s), 4.44-4.58 (2H, m), 6.92-7.00 (3H, m), 7.00-7.09 (3H, m), 7.10-7.16 (1H, m), 7.47 (1H, dd, J = 8.0, 8.0 Hz), 7.50-7.60 (1H, m), 8.06-8.12 (2H, m).
1H-NMR (CDCl3)δ:2.43 (1H, dd, J = 9.5, 13.4 Hz), 2.50 (1H, dd,J = 3.8, 16.7 Hz), 2.72-2.92 (6H, m), 2.96 (3H, s), 3.15-3.24 (1H, m), 3.76 (2H, s), 3.78 (2H, s), 6.91-6.99 (3H, m), 7.02-7.16 (6H, m), 7.25-7.33 (2H, m).
a) tert−ブチル 3−ニトロベンジル[2−[7−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ:1.42-1.56 (9H, m), 2.40-2.50 (2H, m), 2.60-2.90 (4H, m), 3.20-3.80 (3H, m), 3.79 (2H, s), 4.48-4.55 (2H, m), 6.72-7.08 (7H, m), 7.45-7.58 (2H, m), 8.10 (2H, d, J = 7.3 Hz).
1H-NMR (CDCl3)δ:1.26 (9H, brs), 2.30-2.50 (2H, m), 2.50-2.80 (3H, m), 3.00-3.50 (3H, m), 3.62 (1H, m), 3.65-3.85 (2H, m), 4.32-4.42 (2H, m), 6.50-7.10 (11H, m).
1H-NMR (CDCl3)δ:1.44-1.48 (9H, m), 2.39-2.50 (2H, m), 2.54-2.80 (3H, m), 3.02 (3H, s), 3.16-3.50 (3H, m), 3.80 (1H, m), 3.92 (2H, s), 3.80-4.00 (2H, m), 6.72-7.10 (7H, m), 7.26-7.31 (4H, m).
1H-NMR (CDCl3)δ: 2.43-2.52 (2H, m), 2.72-2.90 (6H, m), 2.97 (3H, s), 3.19 (1H, m), 3.77 (2H, s), 3.78 (2H, s), 6.75 (1H, m), 6.84-7.16 (9H, m), 7.32 (1H, m).
a) tert−ブチル 4−ニトロベンジル[2−[7−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]カルバメートの製造
1H-NMR (CDCl3)δ:1.39-1.49 (9H, m), 2.40-2.50 (2H, m), 2.50-3.50 (7H, m), 3.80 (2H, brs), 4.45-4.55 (2H, m), 6.70-7.10 (5H, m), 6.98 (2H, d, J = 8.5 Hz), 7.30-7.40 (2H, m), 8.16 (2H, d, J = 8.5 Hz).
1H-NMR (CDCl3)δ:1.47 (9H, s), 2.30-2.50 (2H, m), 2.50-3.70 (9H, m), 4.26-4.38 (2H, m), 6.63 (2H, d, J = 8.3 Hz), 6.65-7.10 (9H, m).
1H-NMR (CDCl3)δ:1.20 (6H, d, J = 6.1 Hz), 1.47 (9H, s), 2.30-2.50 (2H, m), 2.50-3.60 (10H, m), 4.28-4.36 (2H, m), 6.52 (2H, d, J = 8.3 Hz), 6.70-7.08 (9H, m).
1H-NMR (CDCl3)δ:1.21 (6H, d, J = 6.3 Hz), 2.40-2.50 (2H, m), 2.70-2.88 (6H, m), 3.16 (1H, m), 3.62 (1H, m), 3.69 (2H, s), 3.72 (2H, s), 6.53 (2H, d, J = 8.3 Hz), 6.73 (1H, m), 6.85 (1H, m), 6.95 (2H, d, J = 8.3 Hz), 6.92-7.10 (5H, m).
a) N−(3−ニトロベンジル)−N−[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチル]グリシン エチルエステルの製造
1H-NMR (CDCl3)δ: 1.24 (3H, t, J = 7.2 Hz), 2.39 (1H, dd, J= 10.0, 13.2 Hz), 2.49 (1H, dd, J = 3.8, 16.5 Hz), 2.70-2.92 (6H, m), 3.10-3.19 (1H, m), 3.44 (2H, s), 3.72 (1H, d, J = 16.0 Hz ), 3.81 (1H, d, J = 16.0 Hz ), 3.95 (2H, s), 4.12 (2H, q, J = 7.2 Hz ), 6.74 (1H, dd, J = 2.5, 9.5 Hz), 6.85 (1H, ddd, J = 2.5, 8.6, 8.6 Hz), 6.91-7.02 (5H, m), 7.46 (1H, dd, J = 7.9, 7.9 Hz), 7.68-7.71 (1H, m), 8.08-8.12 (1H, m), 8.26 (1H, brs).
1H-NMR (CDCl3)δ: 1.25 (3H, t, J = 7.1 Hz ), 2.50-2.60 (1H, m), 2.71 (1H, dd, J = 6.8, 17.8 Hz), 2.92-3.04 (2H, m), 3.12-3.22 (1H, m), 3.28-3.38 (2H, m), 3.44-3.56 (4H, m), 3.56 (2H, s), 3.75 (2H, s), 4.13 (2H, q,J = 7.1 Hz ), 4.35 (1H, d, J = 16.3 Hz ), 4.56 (1H, d, J = 16.3 Hz ), 6.66 (1H, d, J = 7.8 Hz ), 6.79 (1H, dd, J = 2.4, 8.8 Hz), 6.90-7.09 (7H, m), 7.18-7.25 (2H, m).
1H-NMR (CDCl3)δ: 2.34-2.42 (1H, m), 2.46-2.56 (1H, m), 2.74-3.00 (6H, m), 2.97 (3H, s), 3.24-3.32 (1H, m), 3.36-3.42 (2H, m), 3.80-3.88 (2H, m), 4.06-4.18 (2H, m), 6.68-6.76 (1H, m), 6.82-6.90 (1H, m), 6.94-7.06 (5H, m), 7.10-7.22 (2H, m), 7.24-7.36 (3H, m).
a) N−(3−ニトロベンジル)−N−(3−エトキシカルボキシプロピル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン
1H-NMR (CDCl3)δ: 1.22 (3H, t, J = 7.2 Hz), 1.81 (2H, tt, J= 7.1, 7.1 Hz), 2.33 (2H, t, J = 7.1 Hz), 2.39 (1H, dd, J = 10.0, 13.2 Hz), 2.48-2.53 (1H, m), 2.53 (2H, t, J = 7.1 Hz), 2.62-2.90 (6H, m), 3.08-3.18 (1H, m), 3.71 (2H, s), 3.72 (1H, d, J = 15.6 Hz), 3.78 (1H, d, J = 15.6 Hz), 4.09 (2H, q, J = 7.2 Hz), 6.74 (1H, dd,J = 2.4, 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.98-7.05 (5H, m), 7.44 (1H, dd, J = 7.9, 7.9 Hz), 7.66 (1H, d, J = 7.9 Hz), 8.08 (1H, dd, J = 2.1, 7.9 Hz), 8.20-8.23 (1H, br).
1H-NMR (CDCl3)δ: 1.21 (3H, t,J = 7.1 Hz), 1.90-2.00 (2H, m), 2.24-2.30 (2H, m), 2.34 (2H, t, J = 8.2 Hz), 2.44 (1H, dd, J = 9.8, 13.4 Hz), 2.51 (1H, dd, J = 3.9, 16.6 Hz), 2.68-2.92 (5H, m), 3.20-3.29 (1H, m), 3.34-3.52 (5H, m), 3.82 (1H, d,J = 15.9 Hz), 3.88 (1H, d, J = 15.9 Hz), 4.03 (2H, q, J = 7.1 Hz), 6.48-6.54 (2H, m), 6.58 (1H, d, J = 7.3 Hz), 6.75 (1H, dd, J= 2.4, 9.3 Hz), 6.86 (1H, ddd, J = 2.5, 8.5, 8.5 Hz), 6.94-7.12 (6H, m).
1H-NMR (CDCl3)δ: 1.97 (2H, tt,J = 7.3, 7.3 Hz), 2.30-2.60 (7H, m), 2.80-3.00 (4H, m), 2.99 (3H, s), 3.34-3.56 (4H, m), 3.92 (2H, brs), 6.76 (1H, dd, J = 2.2, 9.5 Hz ), 6.88 (1H, ddd, J = 2.2, 8.6, 8.6 Hz), 6.96-7.35(10H, m).
1H-NMR (CDCl3)δ:2.47 (1H, dd, J= 10.0, 13.2 Hz), 2.55 (1H, dd, J = 3.7, 16.4 Hz), 2.74-2.88 (5H, m), 2.91 (1H, dd, J = 5.4, 13.2 Hz), 3.18-3.30 (1H, m), 3.81 (2H, s), 3.99 (2H, s), 6.89-6.92 (1H, m), 6.94 (1H, dd, J = 3.4, 5.1 Hz), 7.01-7.08 (2H, m), 7.09-7.32 (8H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 10.0, 13.2 Hz), 2.56 (1H, dd, J = 3.8, 16.6 Hz), 2.74-2.95 (6H, m), 3.19-3.27 (1H, m), 3.80 (2H, s), 3.81 (2H, s), 6.99-7.22 (9H, m), 7.23-7.30 (3H, m).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J= 10.0, 13.2 Hz), 2.56 (1H, dd, , J = 3.8, 16.5 Hz), 2.75-2.82 (3H, m), 2.85-2.94 (3H, m), 3.19-3.23 (1H, m), 3.78 (2H, s), 3.80 (2H, s), 6.16 (1H, d, J= 3.2 Hz ), 6.30 (1H, dd, J = 2.0, 3.2 Hz), 7.03-7.34 (10H, m).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J= 10.0, 13.2 Hz), 2.57 (1H, dd, J = 3.9, 16.6 Hz), 2.77-2.83 (3H, m), 2.86-2.94 (3H, m), 3.22-3.26 (1H, m), 3.64 (2H, s), 3.82 (2H, s), 6.35 (1H, brs), 7.05-7.37 (11H, m).
1H-NMR (CDCl3)δ:2.49 (1H, dd, J= 10.3, 10.3 Hz), 2.58 (1H, d, J = 16.4 Hz), 2.70 (1H, brs), 2.79-3.00 (6H, m), 3.22-3.33 (1H, m), 3.84 (2H, s), 3.96 (2H, s), 7.02-7.32 (11H, m), 7.63 (1H, dd, J = 7.7, 7.7 Hz), 8.50-8.56 (1H, m).
1H-NMR (CDCl3)δ:2.18 (1H, brs), 2.47-2.62 (2H, m), 2.71-2.96 (6H, m), 3.20-3.30 (1H, m), 3.79 (2H, s), 3.82 (2H, s), 7.02-7.30 (10H, m), 7.63 (1H, d, J = 7.1 Hz), 8.47-8.55 (2H, m).
1H-NMR (CDCl3)δ:2.11 (1H, brs), 2.52 (1H, dd, J = 9.8, 13.2 Hz), 2.59 (1H, dd, J = 3.8, 16.5 Hz), 2.68-2.96(6H, m), 3.23-3.31 (1H, m), 3.79 (2H, s), 3.82 (2H, s), 7.02-7.30 (11H, m), 8.50-8.54 (2H, m).
a) 2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 2.53 (1H, dd, J = 10.0, 13.2 Hz), 2.59 (1H, dd, J = 4.2, 15.8 Hz), 2.64-2.94 (6H, m), 3.17-3.26 (1H, m), 3.83 (2H, s), 4.42 (2H, brs), 6.96 (2H, dd, J = 8.6, 8.6 Hz), 7.02-7.16 (6H, m).
1H-NMR (CDCl3)δ: 2.50 (1H, dd, J = 9.5, 13.4 Hz), 2.56 (1H, dd, J = 3.9, 16.4 Hz), 2.70-2.80 (3H, m), 2.83-2.92 (3H, m), 3.18-3.26 (1H, m), 3.79 (2H, s), 3.82 (2H, s), 6.95 (2H, ddd, J = 2.2, 6.6, 8.8 Hz), 7.02-7.09 (4H, m), 7.15-7.18 (2H, m), 7.19-7.22 (2H, m), 8.53 (2H, dd, J = 1.6, 4.5 Hz).
1H-NMR (CDCl3)δ: 2.50 (1H, dd, J= 9.4, 13.3 Hz), 2.55 (1H, dd, J = 3.8, 16.2 Hz), 2.69-2.80 (3H, m), 2.83-2.90 (3H, m), 3.18-3.24 (1H, m), 3.76 (1H, d, J = 14.2 Hz), 3.81 (1H, d, J = 14.2 Hz), 3.83 (2H, s), 6.92-6.97 (2H, m), 7.05-7.09 (4H, m), 7.15-7.17 (2H, m), 8.68 (2H, s), 9.12 (1H, s).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J= 9.5, 13.4 Hz), 2.53 (1H, dd, J = 3.9, 16.4 Hz), 2.74-2.90 (6H, m), 3.15-3.21 (1H, m), 3.56 (3H, s), 3.74 (2H, s), 3.77 (2H, s), 6.01 (1H, d, J = 1.6 Hz), 6.03-6.05 (1H, m), 6.55 (1H, dd, J = 2.4, 2.4 Hz), 6.92-6.97 (2H, m), 7.02-7.07 (4H, m), 7.13-7.16 (2H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 9.8, 13.3 Hz), 2.52 (1H, dd, J = 3.9, 16.3 Hz), 2.73-2.90 (6H, m), 3.16-3.23 (1H, m), 3.63 (3H, s), 3.80 (2H, s), 3.86 (2H, s), 6.81 (1H, d, J = 1.2 Hz), 6.92-6.97 (3H, m), 7.03-7.08 (4H, m), 7.14-7.16 (2H, m).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J= 9.8, 13.3 Hz), 2.53 (1H, dd, J = 3.7, 16.2 Hz), 2.76-2.88 (6H, m), 3.14-3.22 (1H, m), 3.63 (3H, s), 3.79 (2H, s), 3.86 (2H, s), 6.81 (2H, s), 6.89-6.98 (3H, m), 7.00-7.05 (3H, m), 7.13-7.16 (2H, m).
a) tert−ブチル 3−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]プロピルカルバメートの製造
1H-NMR (CDCl3)δ:1.41 (9H, s), 1.75 (2H, tt, J = 6.5, 6.5 Hz), 2.44 (1, dd, J = 10.2, 13.2 Hz), 2.55 (1H, dd, J = 4.0, 16.4 Hz), 2.64-2.78 (2H, m), 2.84 (1H, dd, J = 5.1, 16.4 Hz), 2.90 (1H, dd, J = 4.1, 13.2 Hz), 3.15-3.27 (3H, m), 3.80 (1H, d, J = 16.1 Hz), 3.87 (1H, d, J = 16.1 Hz), 5.26 (1H, brs), 6.97 (2H, ddd, J= 2.2, 6.5, 8.7 Hz), 7.01-7.09 (4H, m), 7.12-7.17 (2H, m).
1H-NMR (CDCl3)δ:1.66-1.74 (2H, m), 2.45 (1H, dd, J = 10.2, 13.0 Hz), 2.59 (1H, dd, J = 4.0, 16.5 Hz), 2.68-2.97 (6H, m), 3.21-3.29 (1H, m), 3.84 (1H, d, J = 15.9 Hz), 3.89 (1H, d, J = 15.9 Hz), 7.00-7.09 (6H, m), 7.12-7.20 (2H, m).
1H-NMR (CDCl3)δ:1.82 (2H, tt, J = 6.7, 6.7 Hz), 2.44 (1H, dd, J= 10.0, 13.2 Hz), 2.55 (1H, dd, J = 4.2, 16.4 Hz), 2.72 (2H, t, J = 6.6 Hz), 2.72-2.84 (3H, m), 2.91 (1H, dd, J = 4.2, 13.2 Hz), 3.20-3.27 (1H, m), 3.77 (2H, s), 3.83 (1H, d, J = 16.0 Hz), 3.90 (1H, d, J = 16.0 Hz), 6.96 (2H, ddd, J = 2.2, 6.3, 8.5 Hz), 7.02-7.10 (4H, m), 7.14-7.18 (2H, m), 7.18-7.22 (2H, m), 8.49 (2H, dd, J= 1.5, 4.4 Hz).
1H-NMR (CDCl3)δ:1.70-1.86 (2H, m), 2.40 (1H, dd, J = 10.3, 13.2 Hz), 2.50 (2H, t, J = 7.2 Hz), 2.47-2.55 (1H, m), 2.59-2.70 (3H, m), 2.83-2.90 (1H, m), 3.08-3.17 (1H, m), 3.55 (2H, d, J = 14.6 Hz), 3.59 (2H, d, J = 14.6 Hz), 3.77 (1H, d, J = 16.7 Hz), 3.82 (1H, d, J = 16.7 Hz), 6.98 (2H, ddd, J = 2.2, 6.6, 8.8 Hz), 7.01-7.07 (4H, m), 7.14-7.18 (2H, m), 7.26-7.29 (4H, m), 8.52 (4H, dd, J= 1.5, 4.4 Hz).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 9.3, 13.4 Hz), 2.51 (1H, dd, J = 3.7, 16.2 Hz), 2.68-2.78 (3H, m), 2.81-2.91 (3H, m), 3.17-3.26 (1H, m), 3.76 (2H, s), 3.79 (2H, s), 6.77 (1H, dd, J = 2.6, 9.3 Hz), 6.87 (1H, ddd, J = 2.6, 8.5, 8.5 Hz), 7.00 (1H, dd, J = 5.9, 8.5 Hz), 7.04 (2H, d, J = 8.3 Hz), 7.21 (2H, d, J = 5.9 Hz), 7.23 (2H, d, J = 8.3 Hz), 8.53 (2H, dd, J = 1.4, 5.9 Hz).
a) tert−ブチル 2−[3−(4−フルオロベンジル)−7−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルカルバメートの製造
1H-NMR (CDCl3)δ:1.44 (9H, s), 2.46-2.54 (2H, m), 2.64-2.87 (4H, m), 3.16−3.32 (3H, m), 3.81 (2H, s), 4.90 (1H, brs), 6.76-7.10 (7H, m).
1H-NMR (CDCl3)δ:2.45-2.53 (2H, m), 2.66-2.92 (6H, m), 3.22 (1H, m), 3.82 (2H, s), 6.75-7.10 (7H, m).
1H-NMR (CDCl3)δ:2.45-2.54 (2H, m), 2.70-2.92 (6H, m), 3.21 (1H, m), 3.79 (4H, s), 6.75-7.08 (7H, m), 7,21 (1H, d, J = 5.9 Hz), 7.72 (1H, m), 8.52-8.54 (2H, m).
a) tert−ブチル 2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルカルバメートの製造
1H-NMR (CDCl3)δ:1.44 (9H, s), 2.46 (1H, dd, J = 9.3, 13.4 Hz), 2.52 (1H, dd, J = 2.6, 16.4 Hz), 2.64-2.73 (1H, m), 2.76-2.90 (3H, m), 3.14-3.36 (3H, m), 3.79 (2H, s), 4.90 (1H, brs), 6.77(1H, dd, J = 2.2, 9.5 Hz), 6.87 (1H, ddd, J = 2.2, 8.6, 8.6 Hz), 6.94-7.04 (3H, m), 7.04-7.12 (2H, m).
1H-NMR (CDCl3)δ:2.40-2.62 (4H, m), 2.66-2.96 (6H, m), 3.16-3.28 (1H, m), 3.80 (2H, s), 6.76 (1H, dd, J= 2.0, 9.5 Hz), 6.86 (1H, ddd, J = 2.0, 8.3, 8.3 Hz), 6.94-7.04 (3H, m), 7.08 (2H, dd, J = 5.9, 8.0 Hz).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J= 9.5, 13.4 Hz), 2.52 (1H, dd, J = 3.9, 16.6 Hz), 2.70-2.76 (3H, m), 2.81-2.91 (3H, m), 3.16-3.24 (1H, m), 3.77 (2H, s), 3.79 (2H, s), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.87 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.96 (2H, ddd, J = 1.9, 6.4, 8.3 Hz), 7.00 (1H, dd, J = 5.6, 8.3 Hz), 7.04-7.08 (2H, m), 7.21 (2H, d, J = 5.8 Hz), 8.53-8.56 (2H, m).
1H-NMR (CDCl3)δ: 2.38 (1H, dd, J = 9.9, 13.4 Hz), 2.49 (1H, dd, J = 4.2, 16.4 Hz), 2.63-2.86 (6H, m), 3.06-3.13 (1H, m), 3.64 (4H, brs), 3.69 (2H, brs), 6.75 (1H, dd, J = 2.6, 9.5 Hz), 6.86 (1H, ddd, J = 2.6, 8.5, 8.5 Hz), 6.92-6.96 (5H, m), 7.29-7.32 (4H, m), 8.53 (4H, dd, J = 1.5, 4.4 Hz).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J= 9.8, 13.4 Hz), 2.50 (1H, dd, J = 3.9, 16.6 Hz), 2.73-2.92 (6H, m), 3.14-3.23 (1H, m), 3.73 (2H, s), 3.84 (2H, s), 6.75 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.92-7.02 (5H, m), 7.05 (1H, dd, J = 5.6, 8.5 Hz), 7.11-7.14 (1H, br), 7.27 (1H, dd, J = 3.0, 4.9 Hz).
1H-NMR (CDCl3)δ: 2.34 (1H, dd, J= 10.2, 13.2 Hz), 2.48 (1H, dd, J = 4.2, 16.6 Hz), 2.64-2.86 (6H, m), 3.06-3.13 (1H, m), 3.66 (4H, s), 3.70 (1H, d, J = 15.1Hz), 3.76 (1H, d, J = 15.1Hz), 6.73 (1H, dd, J = 2.4, 9.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.92-6.95 (5H, m), 7.07 (2H, dd, J = 1.2, 4.9 Hz), 7.13 (2H, dd, J = 1.2, 2.9 Hz), 7.26 (2H, dd, J = 2.9, 4.9 Hz).
1H-NMR (CDCl3)δ: 1.29 (1.5H, d, J= 6.6 Hz), 1.30 (1.5H, d, J = 6.6 Hz), 2.45 (1H, dd, J = 9.5, 13.7 Hz), 2.49-2.84 (7H, m), 3.14-3.24 (1H, m), 3.68-3.74 (1H, m), 3.69 (2H, s), 6.77 (1H, dd, J = 2.3, 9.3 Hz), 6.86 (1H, ddd, J = 2.3, 8.6, 8.6 Hz), 6.96-7.00 (3H, m), 7.04-7.09 (2H, m), 7.21 (2H, dd, J= 1.6, 5.9 Hz), 8.50-8.54 (2H, m).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 9.8, 13.4 Hz), 2.56 (1H, dd, J = 3.7, 16.8 Hz), 2.72-2.92 (6H, m), 3.22-3.28 (1H, m), 3.79 (2H, s), 3.96 (2H, s), 6.79 (1H, dd, J = 2.4, 9.2 Hz), 6.86 (2H, brs), 6.88 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.96 (2H, ddd, J = 2.0, 8.8, 8.8 Hz), 7.01 (1H, dd, J = 5.6, 8.3 Hz), 7.08 (2H, dd, J = 5.6, 8.8 Hz).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J= 9.8, 13.2 Hz), 2.51 (1H, dd, J = 3.4, 16.6 Hz), 2.73-2.91 (6H, m), 3.17-3.23 (1H, m), 3.77 (1H, d, J = 16.8 Hz), 3.81 (1H, d, J = 16.8 Hz), 4.10 (1H, d, J = 15.4 Hz), 4.15 (1H, d, J = 15.4 Hz), 6.76 (1H, dd, J = 2.0, 9.2 Hz), 6.86 (1H, ddd, J = 2.0, 8.3, 8.3 Hz), 6.95 (2H, dd, J = 8.8, 8.8 Hz), 7.00 (1H, dd, J = 5.6, 8.3 Hz), 7.06 (2H, dd, J = 5.6, 8.8 Hz), 7.26 (1H, d, J = 2.9 Hz), 7.71 (1H, d, J = 2.9 Hz).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J= 9.8, 13.4 Hz), 2.51 (1H, dd, J = 3.6, 16.6 Hz), 2.72-2.91 (6H, m), 3.16-3.23 (1H, m), 3.78 (2H, s), 3.80 (2H, s), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.86 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.89 (1H, s), 6.95 (2H, dd, J = 8.8, 8.8 Hz), 7.00 (1H, dd, J = 5.6, 8.3 Hz), 7.06 (2H, dd, J = 5.6, 8.8 Hz), 7.52 (1H, s).
1H-NMR (CDCl3)δ: 2.49-2.60 (2H, m), 2.70-2.92 (3H, m), 3.12 (1H, dd, J = 5.0, 13.0 Hz), 3.18-3.36 (2H, m), 3.44-3.54 (1H, m), 3.81 (2H, s), 5.90-5.99 (1H, br), 6.60-6.82 (3H, m), 6.89 (1H, ddd, J = 2.4, 8.4, 8.4 Hz), 6.94-7.16 (6H, m), 8.02-8.10 (1H, br).
1H-NMR (CDCl3)δ: 2.42 (1H, dd, J= 9.8, 13.2 Hz), 2.50 (1H, dd, J = 3.9, 16.6 Hz), 2.71-2.89 (6H, m), 3.14-3.20 (1H, m), 3.56 (3H, s), 3.71 (2H, s), 3.75 (2H, s), 6.00-6.01 (1H, m), 6.03-6.05 (1H, m), 6.55-6.56 (1H, m), 6.75 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.95 (2H, ddd, J = 2.0, 8.8, 8.8 Hz), 6.98 (1H, dd, J = 5.6, 8.5 Hz), 7.05 (2H, ddd, J = 2.2, 5.6, 8.8 Hz).
1H-NMR (CDCl3)δ: 2.49 (1H, dd, J= 9.5, 13.4 Hz), 2.54 (1H, dd, J = 3.9, 16.8 Hz), 2.70-2.81 (3H, m), 2.81-2.94 (3H, m), 3.20-3.30 (1H, m), 3.79 (2H, s), 3.83 (2H, s), 6.75-6.80 (1H, m), 6.85-6.92 (2H, m), 6.94-7.04 (3H, m), 7.05-7.12 (3H, m), 8.12-8.16 (1H, m).
1H-NMR (CDCl3)δ: 2.40-2.53 (2H, m), 2.77-2.92 (6H, m), 3.19 (1H, m), 3.75 (1H, d, J = 15.9 Hz), 3.81 (1H, d, J = 15.9 Hz), 3.92 (2H, s), 6.75-7.30 (9H, m), 7.64 (1H, t, J = 7.6 Hz), 8.54 (1H, d, J = 4.1 Hz).
1H-NMR (CDCl3)δ: 2.42-2.54 (2H, m), 2.70-2.90 (6H, m), 3.18 (1H, m), 3.76 (2H, s), 3.79 (2H, s), 6.75-7.26 (8H, m), 7.61 (1H, d, J = 7.8 Hz), 8.50 (1H, d, J = 4.9 Hz), 8.54 (1H, s).
1H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 9.5, 13.4 Hz), 2.52 (1H, dd, J = 3.9, 16.2 Hz), 2.72-2.78 (3H, m), 2.83-2.90 (3H, m), 3.17-3.24 (1H, m), 3.77 (2H, s), 3.86 (2H, s), 6.74-6.78 (1H, m), 6.84-6.90 (1H, m), 6.93-7.01 (3H, m), 7.06 (2H, dd, J = 5.5, 8.3 Hz), 7.30 (1H, dd, J = 5.5, 5.5 Hz), 8.35 (1H, d, J = 4.6 Hz), 8.39 (1H, d, J = 1.6 Hz).
a) 2−エチル−4−[(メチルスルホニルオキシ)メチル]ピリジンの製造
1H-NMR (CDCl3)δ: 1.32 (3H, t, J = 7.6 Hz), 2.86 (2H, q, J = 7.6 Hz), 3.05 (3H, s), 5.21 (2H, s), 7.13 (1H, d, J = 5.1 Hz), 7.18 (1H, s), 8.57 (1H, d, J = 5.1 Hz).
1H-NMR (CDCl3)δ: 1.29 (3H, t, J = 7.6 Hz), 2.42-2.56 (2H, m), 2.70-2.90 (8H, m), 3.20 (1H, m), 3.77 (4H, brs), 6.74-7.10 (9H, m), 8.44 (1H, d, J = 5.0 Hz).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.5, 13.7 Hz), 2.53 (1H, dd, J = 3.9, 16.4 Hz), 2.67-2.78 (3H, m), 2.82-2.91 (3H, m), 3.18-3.24 (1H, m), 3.73 (1H, d, J = 15.4 Hz), 3.77 (1H, d, J= 15.4 Hz), 3.78 (2H, s), 6.77 (1H, dd, J= 2.7, 9.4 Hz), 6.88 (1H, ddd, J = 2.7, 8.4, 8.4 Hz), 6.97 (2H, ddd, J = 2.1, 6.7, 8.8 Hz), 7.01 (1H, dd, J = 5.6, 8.4 Hz), 7.08-7.10 (2H, m), 7.22 (2H, d, J= 7.1 Hz), 8.14 (2H, d, J = 7.1 Hz).
1H-NMR (CDCl3)δ: 2.42-2.56 (2H, m), 2.68-2.92 (6H, m), 3.19 (1H, m), 3.74 (2H, s), 3.77 (2H, s), 3.94 (3H, s), 6.68 (1H, s), 6.74-7.08 (8H, m), 8.08 (1H, d, J = 5.1 Hz).
a) 3−エチル−4−[(メチルスルホニルオキシ)メチル]ピリジンの製造
1H-NMR (CDCl3)δ: 1.24 (3H, t, J = 7.6 Hz), 2.64 (2H, q, J = 7.6 Hz), 4.78 (2H, s), 7.41 (1H, d, J = 4.9 Hz), 8.37 (1H, s), 8.44 (1H, d, J = 4.9 Hz).
1H-NMR (CDCl3)δ: 1.21 (3H, t, J= 7.6 Hz), 2.44-2.58 (2H, m), 2.64 (2H, q, J = 7.6 Hz), 2.70-2.92 (6H, m), 3.21 (1H, m), 3.77 (2H, s), 3.79 (2H, s), 6.74-7.12 (8H, m), 7.22 (1H, d, J = 5.1 Hz), 8.38 (1H, s).
1H-NMR (CDCl3)δ: 2.39 (1H, dd, J = 9.8, 13.4 Hz), 2.45 (1H, dd, J = 3.7, 16.6 Hz), 2.73-2.90 (6H, m), 3.07-3.12 (1H, m), 3.61 (1H, d, J = 16.6 Hz), 3.66 (1H, d, J = 16.6 Hz), 3.94 (2H, s), 6.51 (1H, s), 6.74 (1H, dd, J = 2.7, 9.5 Hz), 6.83 (1H, ddd, J = 2.7, 8.6, 8.6 Hz), 6.89 (1H, dd, J = 5.6, 8.6 Hz), 6.90 (2H, ddd, J = 2.2, 8.8, 8.8 Hz), 6.97 (2H, ddd, J = 2.2, 5.6, 8.8 Hz), 7.09 (1H, dd, J = 1.7, 8.3 Hz), 7.23 (1H, dd, J = 2.7, 2.7 Hz), 7.32 (1H, d, J = 8.3 Hz), 7.52 (1H, s).
1H-NMR (CDCl3)δ: 2.40-2.52 (2H, m), 2.76-2.94 (6H, m), 3.14-3.22 (1H, m), 3.75 (2H, s), 4.26 (2H, s), 6.73-6.78 (1H, m), 6.83-6.89 (1H, m), 6.90-7.00 (3H, m), 7.00-7.07 (2H, m), 7.36-7.40 (1H, m), 7.46-7.52 (1H, m), 7.65-7.72 (1H, m), 8.04 (1H, brd, J = 8.4 Hz), 8.11 (1H, brd, J = 8.4 Hz), 8.85 (1H, dd, J = 2.0, 4.2 Hz).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 9.8, 13.4 Hz), 2.51 (1H, dd, J = 3.9, 16.8 Hz), 2.74-2.92 (6H, m), 3.15-3.22 (1H, m), 3.77 (2H, s), 3.99 (2H, s), 6.76 (1H, dd, J = 2.4, 9.2 Hz), 6.85 (1H, ddd, J = 2.4, 8.4, 8.4 Hz), 6.88-6.97 (2H, m), 6.97 (1H, dd, J = 5.7, 8.4 Hz), 7.00-7.06 (2H, m), 7.54 (1H, ddd, J = 1.5, 8.3, 8.3 Hz), 7.69 (1H, ddd, J = 1.5, 8.3, 8.3 Hz), 7.77 (1H, brd, J = 8.3 Hz), 8.06 (1H, d, J = 2.0 Hz), 8.10 (1H, brd, J = 8.3 Hz), 8.87 (1H, d, J = 2.0 Hz).
1H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 9.6, 13.6 Hz), 2.51 (1H, dd, J = 3.9, 16.6 Hz), 2.73-2.77 (3H, m), 2.81-2.89 (3H, m), 3.15-3.21 (1H, m), 3.77 (2H, s), 3.81 (2H, s), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.86 (1H, ddd, J = 2.6, 8.3, 8.3 Hz), 6.93-7.07 (5H, m), 7.13-7.17 (1H, m), 7.73-7.76 (1H, m), 8.10 (1H, d, J = 4.6 Hz ).
1H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 9.6, 13.5 Hz), 2.52 (1H, dd, J = 3.9, 16.8 Hz), 2.80-2.77 (3H, m), 2.82-2.90 (3H, m), 3.15-3.23 (1H, m), 3.77 (2H, s), 3.82 (2H, s), 6.76 (1H, dd, J = 2.5, 9.4 Hz), 6.86 (1H, ddd, J = 2.7, 8.3, 8.3 Hz), 6.93-7.01 (3H, m), 7.04-7.08 (2H, m), 7.13-7.17 (1H, m), 7.73-7.78 (1H, m), 8.10 (1H, d, J = 4.8 Hz ).
a) N−[1−(tert−ブトキシカルボニル)−1H−ベンズイミダゾール−5−イル]メチル−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 1.70 (9H, s), 2.37-2.50 (2H, m), 2.77-2.88 (6H, m), 3.07-3.18 (1H, m), 3.73 (2H, s), 3.93 (2H, s), 6.75 (1H, d, J = 9.0 Hz), 6.83-7.03 (6H, m), 7.33 (1H, d, J = 8.3 Hz), 7.70 (1H, s), 7.91 (1H, d, J = 8.3 Hz), 8.42 (1H, s).
粗生成物をPLCで精製して 目的物を2.9 mg(収率 88%)得た。
1H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 9.8, 13.4 Hz), 2.49 (1H, dd, J = 3.7, 16.8 Hz), 2.75-2.90 (6H, m), 3.14-3.18 (1H, m), 3.73 (2H, s), 3.92 (2H, s), 6.75 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.92 (2H, ddd, J = 2.0, 8.8, 8.8 Hz), 6.95 (1H, dd, J = 5.6, 8.3 Hz), 7.01 (2H, ddd, J = 2.2, 5.6, 8.8 Hz), 7.21 (1H, dd, J = 1.5, 8.3 Hz), 7.52-7.64 (2H, m), 8.03 (1H, s).
(S)−1−メチル]エタンアミンの製造
a) tert−ブチル 2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]−[(S)−1−メチル]エチルカルバメート
1H-NMR (CDCl3)δ: 1.17 (3H, d, J= 8.6 Hz), 1.43 (9H, s), 2.40-2.65 (4H, m), 2.77-2.90 (2H, m), 3.17 (1H, m), 3.70-3.90 (2H, m), 4.68 (1H, m), 6.75-7.11 (7H,m).
1H-NMR (CDCl3)δ: 1.20-1.28 (3H,m), 2.42-2.55 (2H, m), 2.85-2.96 (2H, m), 3.15-3.25 (2H, m), 3.70 (1H, m), 3.89 (1H, m), 4.11 (1H, d, J = 14.4 Hz), 4.13 (1H, d, J= 14.4 Hz), 6.73-7.11 (7H, m).
1H-NMR (CDCl3)δ: 0.99 (1.5H, d, J = 6.1 Hz), 1.00 (1.5H, d, J = 6.1 Hz), 2.36-2.90 (2H,m), 3.13 (0.5H, m), 3.20 (0.5H, m), 3.50-3.89 (4H, m), 6.77-7.17 (9H, m), 8.47-8.52 (2H, m).
a) tert−ブチル 2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]−[(R)−1−メチル]エチルカルバメートの製造
1H-NMR (CDCl3)δ: 1.17 (3H, d, J = 6.3 Hz), 1.43 (9H, s), 2.39-2.46 (4H, m), 2.79-2.89 (2H, m), 3.21-3.23 (1H, m), 3.67-3.89 (3H, m), 6.76 (1H, dd, J = 2.4, 9.5 Hz), 6.87 (1H, ddd, J = 2.4, 8.5, 8.5 Hz ), 6.95-7.12 (3H, m), 7.04-7.12 (2H, m).
1H-NMR (CDCl3)δ: 1.04 (1.5H, d, J = 6.3 Hz ), 1.05 (1.5H, d, J = 6.3 Hz), 2.23-2.37 (1H, m), 2.40-2.68 (3H, m), 2.81-2.92 (2H, m), 3.14-3.24 (2H, m), 3.69-3.76 (1H, m), 3.89 (1H, d, J = 16.1 Hz), 6.77 (1H, dd, J = 2.4, 9.5 Hz), 6.87 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.94-7.04 (3H, m), 7.07 (2H, dd, J = 5.6, 8.5 Hz).
1H-NMR (CDCl3)δ: 1.00 (1.5H, d, J = 6.1 Hz), 1.01 (1.5H, d, J = 6.1 Hz), 2.34-2.69 (4H, m), 2.72-2.90 (3H, m), 3.10-3.24 (1H, m), 3.50-3.90 (4H, m), 6.78 (1H, dd, J = 2.4, 9.5 Hz), 6.83-6.99 (4H, m), 7.03-7.17 (4H, m), 8.46 (1H, dd, J = 1.5, 4.4Hz), 8.51 (1H, dd, J = 1.5, 4.4 Hz).
IR (ATR cm-1): 1601, 1560, 1221, 1139, 860, 811, 757.
MS (FAB) m/z408 (M)+
1H-NMR (CDCl3)δ: 2.40-2.53 (2H, m), 2.75-2.92 (6H, m), 3,17 (1H, m), 3.78 (2H, brs), 3.98 (2H, s), 6.75-7.07 (7H, m), 7.14 (1H, d, J = 2.0 Hz), 8.76 (1H, d, J = 2.0 Hz).
1H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 10.0, 13.2 Hz), 2.51 (1H, dd, J = 3.6, 16.5 Hz), 2.73-2.82 (3H, m), 2.86-2.94 (3H, m), 3.16-3.21 (1H, m), 3.77 (2H, s), 4.24 (1H, d, J = 14.4 Hz), 4.27 (1H, d, J = 14.4 Hz), 7.00-7.07 (5H, m), 7.13-7.25 (4H, m), 7.41-7.44 (4H, m), 7.76 (1H, d, J= 7.8 Hz), 7.82-7.85 (1H, m), 8.05-8.08 (1H, m).
1H-NMR (CDCl3)δ:2.55-2.65 (2H, m), 2.68-2.76 (1H, m), 2.80-2.90 (2H, m), 2.91 (1H, dd, J = 5.6, 11.9 Hz), 3.27-3.40 (3H, m), 3.88 (1H, d, J = 18.1 Hz), 3.94 (1H, d, J = 18.1 Hz), 5.15-5.30 (1H, br), 6.95-7.00 (1H, m), 7.05-7.10 (2H, m), 7.13-7.35 (11H, m).
1H-NMR (CDCl3)δ:2.50-2.61 (1H, m), 2.62 (1H, dd, J = 4.5, 17.0 Hz), 2.72-2.90 (3H, m), 2.93 (1H, dd, J = 5.4, 13.7 Hz), 3.31-3.40 (3H, m), 3.67 (6H, s), 3.75 (3H, s), 3.91 (1H, d, J= 18.4 Hz), 3.95 (1H, d, J = 18.4 Hz), 5.30-5.51 (1H, br), 6.54 (2H, s), 7.05-7.10 (2H, s), 7.12-7.25 (5H, m), 7.29-7.34 (2H, m).
a) 2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミンの製造
1H-NMR (CDCl3)δ: 2.53 (1H, dd, J = 10.0, 13.2 Hz), 2.59 (1H, dd, J = 4.2, 15.8 Hz), 2.64-2.94 (6H, m), 3.17-3.26 (1H, m), 3.83 (2H, s), 4.42 (2H, brs), 6.96 (2H, dd, J = 8.6, 8.6 Hz), 7.02-7.16 (6H, m).
1H-NMR (CDCl3)δ: 2.48 (1H, dd, J = 9.5, 13.6 Hz), 2.62 (1H, dd, J = 4.4, 15.6 Hz), 2.66-2.88 (4H, m), 3.16-3.23 (1H, m), 3.24-3.40 (2H, m), 3.78 (1H, d, J = 16.1 Hz), 3.82 (1H, d, J = 16.1 Hz), 4.29 (2H, d, J = 5.6 Hz), 4.80-4.90 (1H, br), 5.00-5.18 (1H, br), 6.95 (2H, dd, J = 8.7, 8.7 Hz), 7.02-7.09 (4H, m), 7.14-7.20 (2H, m), 7.20-7.28 (5H, m).
1H-NMR (CDCl3)δ: 2.50 (1H, dd, J = 9.2, 13.6 Hz), 2.55 (1H, dd, J = 4.2, 17.0 Hz), 2.64-2.89 (6H, m), 3.18-3.44 (5H, m), 3.89 (2H, brs), 4.32 (1H, brs), 4.68-4.86 (1H, br), 6.95 (2H, dd, J = 8.7, 8.7 Hz), 7.02-7.09 (4H, m), 7.12-7.30 (7H, m).
1H-NMR (CDCl3)δ: 2.55 (1H, dd, J = 9.3, 13.4 Hz), 2.58 (1H, dd, J = 4.9, 16.4 Hz), 2.72-2.94 (4H, m), 3.24-3.30 (1H, m), 3.34-3.42 (2H, m), 3.90 (2H, brs), 5.11-5.17 (1H, br), 6.99 (2H, ddd, J = 2.2, 6.4, 8.6 Hz), 6.99-7.02 (1H, m), 7.06-7.12 (4H, m), 7.18-7.29 (7H, m).
1H-NMR (CDCl3)δ: 2.61 (1H, dd, J = 8.8, 13.6 Hz), 2.65 (1H, dd, J = 5.1, 15.6 Hz), 2.75-2.83 (1H, m), 2.85-2.95 (3H, m), 3.30-3.40 (3H, m), 3.95 (2H, brs), 5.08-5.15 (1H, br), 7.00 (2H, ddd, J = 8.7, 8.7 Hz), 7.09-7.15 (2H, m), 7.19-7.26 (4H, m), 7.36-7.48 (3H, m), 7.52-7.60 (1H, m), 7.66-7.71 (1H, m).
a) tert−ブチル 3−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]プロピルカルバメートの製造
1H-NMR (CDCl3)δ:1.41 (9H, s), 1.75 (2H, tt, J = 6.5, 6.5 Hz), 2.44 (1, dd, J = 10.2, 13.2 Hz), 2.55 (1H, dd, J = 4.0, 16.4 Hz), 2.64-2.78 (2H, m), 2.84 (1H, dd, J = 5.1, 16.4 Hz), 2.90 (1H, dd, J = 4.1, 13.2 Hz), 3.15-3.27 (3H, m), 3.80 (1H, d, J = 16.1 Hz), 3.87 (1H, d, J = 16.1 Hz), 5.26 (1H, brs), 6.97 (2H, ddd, J= 2.2, 6.5, 8.7 Hz), 7.01-7.09 (4H, m), 7.12-7.17 (2H, m).
1H-NMR (CDCl3)δ:1.66-1.74 (2H, m), 2.45 (1H, dd, J = 10.2, 13.0 Hz), 2.59 (1H, dd, J = 4.0, 16.5 Hz), 2.68-2.97 (6H, m), 3.21-3.29 (1H, m), 3.84 (1H, d, J = 15.9 Hz), 3.89 (1H, d, J = 15.9 Hz), 7.00-7.09 (6H, m), 7.12-7.20 (2H, m).
1H-NMR (CDCl3)δ:1.75-1.84 (2H, m), 2.42 (1H, dd, J = 10.1, 13.2 Hz), 2.53 (1H, dd, J = 4.0, 16.6 Hz), 2.71 (1H, dd, J = 4.8, 16.6 Hz), 2.79 (2H, t, J = 6.1 Hz), 2.86 (1H, dd, J = 4.4, 13.2 Hz), 3.16-3.24 (1H, m), 3.30-3.48 (2H, m), 3.81 (2H, brs), 6.36-6.58 (1H, br), 6.97 (2H, dd, J = 8.7, 8.7 Hz), 6.99-7.09 (5H, m), 7.12-7.20 (7H, m).
1H-NMR (CDCl3)δ:1.70-1.80 (2H, m), 2.41 (1H, dd, J = 10.0, 13.2 Hz), 2.51 (1H, dd, J = 3.6, 16.6 Hz), 2.72-2.80 (3H, m), 2.88 (1H, dd, J = 4.2, 13.2 Hz), 3.17-3.24 (1H, m), 3.25-3.36 (2H, m), 3.77 (2H, brs), 4.12 (1H, dd, J = 5.6, 15.1 Hz), 4.28 (1H, dd, J = 6.1, 15.1 Hz), 4.98-5.22 (1H, br), 6.95 (2H, dd, J = 8.7, 8.7 Hz), 6.99-7.06 (4H, m), 7.12-7.18 (5H, m), 7.19-7.24 (3H, m).
1H-NMR (CDCl3)δ:1.68-1.79 (2H, m), 2.43 (1H, dd, J = 10.0, 13.4 Hz), 2.55 (1H, dd, J = 3.4, 16.6 Hz), 2.64 (2H, t, J = 6.8 Hz), 2.76 (1H, dd, J = 5.9, 16.6 Hz), 2.78 (2H, t, J = 6.1 Hz), 2.88 (1H, dd, J = 4.4, 13.4 Hz), 3.11-3.34 (6H, m), 3.80 (2H, brs), 4.58-4.80 (1H, br), 6.96 (2H, ddd, J = 2.2, 6.6, 8.8 Hz), 7.02-7.08 (6H, m), 7.16-7.20 (3H, m), 7.22-7.24 (2H, m).
MS (EI) m/z445 (M)+
MS (EI) m/z445 (M)+
MS (EI) m/z445 (M)+
MS (FAB) m/z448 (M+H)+
MS (FAB) m/z448 (M+H)+
MS (FAB) m/z448 (M+H)+
1H-NMR (CDCl3)δ:1.76 (2H, tt, J = 6.1, 6.1 Hz), 2.37 (1H, dd, J = 10.3, 12.9 Hz), 2.47 (1H, dd, J = 4.0, 16.7 Hz), 2.62-2.88 (4H, m), 2.86 (6H, s), 3.23-3.24 (1H, m), 3.25-3.29 (2H, m), 3.75 (1H, d, J = 16.1 Hz), 3.81 (1H, d, J = 16.1 Hz), 5.98 (1H, brs), 6.35-6.39 (1H, m), 6.45 (1H, d, J = 7.8 Hz), 6.49 (1H, brs), 6.66 (1H, brs), 6.80-7.04 (6H, m), 7.10-7.24 (3H, m).
MS (FAB) m/z452, 454 (M+H)+
MS (FAB) m/z 452, 454 (M+H)+
MS (FAB) m/z452, 454 (M+H)+
1H-NMR (CDCl3)δ:1.82 (2H, tt, J = 6.4, 6.4 Hz), 2.46 (1H, dd, J = 10.0, 13.2 Hz), 2.47 (1H, dd, J = 4.0, 17.1 Hz), 2.70-2.89 (4H, m), 3.23-3.34 (1H, m), 3.25-3.42 (2H, m), 3.75-3.79 (2H, br), 4.15-4.25 (1H, br), 6.25-6.45 (1H, br), 6.81 (1H, dd, J= 2.2, 6.4 Hz), 6.85-7.24 (10H, m), 7.40-7.46 (1H, m).
MS (FAB) m/z460 (M+H)+
MS (FAB) m/z460 (M+H)+
MS (FAB) m/z443 (M+H)+
MS (FAB) m/z443 (M+H)+
MS (FAB) m/z463 (M+H)+
MS (FAB) m/z463 (M+H)+
MS (FAB) m/z463 (M+H)+
MS (FAB) m/z461 (M+H)+
a) tert−ブチル 3−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]プロピルカルバメートの製造
1H-NMR (CDCl3)δ:1.41 (9H, s), 1.70-1.79 (2H, m), 2.40 (1H, dd, J = 10.3, 13.2 Hz), 2.51 (1H, dd, J= 3.5, 16.7 Hz), 2.64-2.78 (2H, m), 2.81 (1H, dd, J = 5.0, 16.7 Hz), 2.89 (1H, dd, J = 3.9, 13.2 Hz), 3.15-3.26 (3H, m), 3.74 (1H, d, J= 15.7 Hz), 3.83 (1H, d, J = 15.7 Hz), 5.10-5.23 (1H, br), 6.75 (1H, dd,J = 2.4, 9.3 Hz), 6.86 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 7.01 (1H, dd, J = 5.9, 8.3 Hz), 7.04 (2H, d, J = 8.0 Hz), 7.25 (2H, d, J= 8.0 Hz).
1H-NMR (CDCl3)δ: 1.60-1.72 (2H, m), 2.40 (1H, dd, J = 10.2, 13.1 Hz), 2.54 (1H, dd, J = 3.9, 16.7 Hz), 2.64-2.95 (6H, m), 3.18-3.29 (3H, m), 3.79 (1H, d, J = 15.9 Hz), 3.87 (1H, d, J = 15.9 Hz), 6.76 (1H, dd, J = 2.5, 9.3 Hz), 6.88 (1H, ddd, J = 2.5, 8.4, 8.4 Hz), 7.00 (1H, dd, J = 5.7, 8.4 Hz), 7.02 (2H, d, J = 8.0 Hz), 7.27 (2H, d,J = 8.0 Hz).
1H-NMR (CDCl3)δ: 1.74-1.82 (2H, m), 2.37 (1H, dd, J = 10.0, 13.2 Hz), 2.46 (1H, dd, J = 3.8, 17.1 Hz), 2.66 (1H, dd, J = 5.6, 17.1 Hz), 2.73-2.78 (2H, m), 2.83 (1H, dd, J = 4.1, 13.2 Hz), 3.13-3.20 (1H, m), 3.29-3.45 (2H, m), 3.71 (1H, d, J = 15.8 Hz), 3.78 (1H, d, J = 15.8 Hz), 6.42-6.45 (1H, br), 6.73 (1H, dd, J = 2.7, 9.2 Hz), 6.80-7.02 (1H, m), 6.87 (1H, ddd, J= 2.7, 8.6, 8.6 Hz), 6.98 (1H, dd, J = 5.6, 8.6 Hz), 6.99 (2H, d, J= 8.3 Hz), 7.13-7.19 (4H, m), 7.25 (2H, d, J = 8.3 Hz).
1H-NMR (CDCl3)δ:1.41 (9H, s), 1.70-1.77 (2H, m), 2.40 (1H, dd, J = 10.3, 13.2 Hz), 2.51 (1H, dd, J = 3.9, 1.8 Hz), 2.64-2.84 (3H, m), 2.89 (1H, dd, J = 3.9, 12.9 Hz), 3.17-3.24 (3H, m), 3.75 (1H, d, J = 15.9 Hz), 3.83 (1H, d, J = 15.9 Hz), 6.95-7.01 (3H, m), 7.04-7.08 (3H, m), 7.13 (1H, dd, J = 2.0, 8.0 Hz).
1H-NMR (CDCl3)δ:1.71-1.79 (2H, m), 2.37 (1H, dd, J = 10.2, 13.2 Hz), 2.49 (1H, dd, J = 3.6, 17.1 Hz), 2.63-2.82 (5H, m), 2.89 (1H, dd, J = 3.4, 12.7 Hz), 3.15-3.22 (1H, m), 3.73 (1H, d, J = 16.4 Hz), 3.83 (1H, d, J = 16.4 Hz), 6.94-7.11 (7H, m).
1H-NMR (CDCl3)δ:1.51-1.86 (2H, m), 2.36 (1H, dd, J = 10.2, 13.0 Hz), 2.46 (1H, dd, J = 3.1, 16.6 Hz), 2.64 (1H, dd, J = 5.2, 16.6 Hz), 2.73-2.81 (2H, m), 2.84 (1H, dd, J= 4.1, 13.5 Hz), 3.14-3.21 (1H, m), 3.29-3.46 (2H, m), 3.72 (1H, d, J = 16.6 Hz), 3.78 (1H, d, J = 16.6 Hz), 6.94-7.04 (7H, m), 7.13-7.19 (5H, m).
a) tert−ブチル 3−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]プロピルカルバメートの製造
1H-NMR (CDCl3)δ:1.41 (9H, s), 1.70-1.80 (2H, m), 2.42 (1H, dd, J = 10.3, 13.3 Hz), 2.53 (1H, dd, J= 3.9, 16.0 Hz), 2.66-2.80 (2H, m), 2.82 (1H, dd, J = 5.2, 16.0 Hz), 2.93 (1H, dd, J = 4.2, 13.2 Hz), 3.14-3.29 (3H, m), 3.77 (1H, d, J= 15.8 Hz), 3.86 (1H, d, J = 15.8 Hz), 5.18 (1H, brs), 6.76 (1H, dd,J = 2.4, 9.2 Hz), 6.87 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.98 (2H, ddd, J = 2.0, 6.6, 8.6 Hz), 7.00-7.10 (3H, m).
1H-NMR (CDCl3)δ: 1.68-1.78 (2H, m), 2.40 (1H, dd, J = 10.2, 13.2 Hz), 2.52 (1H, dd, J = 4.0, 16.3 Hz), 2.65-2.83 (5H, m), 2.92 (1H, dd, J = 4.9, 13.2 Hz), 3.16-3.24 (1H, m), 3.76 (1H, d, J = 15.7 Hz), 3.85 (1H, d, J = 15.7 Hz), 6.75 (1H, dd, J = 2.2, 9.5 Hz), 6.85 (1H, ddd, J = 2.2, 8.6, 8.6 Hz), 6.97 (2H, ddd, J = 2.0, 6.8, 8.8 Hz), 7.00-7.10 (3H, m).
1H-NMR (CDCl3)δ: 1.70-1.80 (2H, m), 2.35 (1H, dd, J = 10.3, 13.2 Hz), 2.46 (1H, dd, J = 3.9, 16.7 Hz), 2.65 (1H, dd, J = 5.0, 16.7 Hz), 2.68-2.76 (2H, m), 2.82 (1H, dd, J = 4.1, 13.2 Hz), 3.08-3.18 (1H, m), 3.24-3.40 (2H, m), 3.68 (1H, d, J = 15.2 Hz), 3.75 (1H, d, J = 15.2 Hz), 5.85 (1H, brs), 6.72 (1H, dd, J = 2.2, 9.3 Hz), 6.86 (1H, ddd, J = 2.4, 8.5, 8.5 Hz), 6.92-7.02 (6H, m), 7.12-7.18 (4H, m).
1H-NMR (CDCl3)δ: 1.14 (3H, t, J= 7.6 Hz), 1.70-1.80 (2H, m), 2.33 (1H, dd, J = 10.2, 13.2 Hz), 2.45 (1H, dd, J = 3.9, 15.6 Hz), 2.49 (2H, q, J = 7.6 Hz), 2.65 (1H, dd,J = 5.0, 15.6 Hz), 2.67-2.76 (2H, m), 2.81 (1H, dd, J = 4.2, 13.2 Hz), 3.09-3.18 (1H, m), 3.24-3.38 (2H, m), 3.68 (1H, d, J = 15.5 Hz), 3.75 (1H, d, J = 15.5 Hz), 5.86 (1H, brs), 6.71 (1H, dd, J = 2.6, 9.3 Hz), 6.85 (1H, ddd, J = 2.6, 8.3, 8.3 Hz), 6.91-7.08 (8H, m), 7.26 (1H, s).
1H-NMR (CDCl3)δ: 1.70-1.79 (2H, m), 2.35 (1H, dd, J = 10.0, 13.4 Hz), 2.45 (1H, dd, J = 4.0, 16.6 Hz), 2.62-2.72 (3H, m), 2.82 (1H, dd, J = 3.6, 13.4 Hz), 3.10-3.18 (1H, m), 3.25-3.40 (2H, m), 3.69 (1H, d, J = 15.4 Hz), 3.70 (3H, s), 3.75 (1H, d, J = 15.4 Hz), 5.94 (1H, brs), 6.51 (1H, dd, J = 2.4, 8.3 Hz), 6.67 (1H, d, J = 7.8 Hz), 6.71 (1H, d, J = 9.5 Hz), 6.85 (1H, ddd, J = 2.4, 8.3, 8.3 Hz), 6.91-7.06 (8H, m).
1H-NMR (CDCl3)δ: 1.33 (3H, t, J= 6.9 Hz), 1.68-1.79 (2H, m), 2.33 (1H, dd, J = 10.4, 13.2 Hz), 2.45 (1H, dd, J = 3.8, 16.6 Hz), 2.61-2.77 (3H, m), 2.81 (1H, dd, J = 4.0, 13.2 Hz), 3.08-3.19 (1H, m), 3.24-3.40 (2H, m), 3.68 (1H, d, J = 16.1 Hz), 3.75 (1H, d, J = 16.1 Hz), 3.90 (2H, q, J = 6.9 Hz), 5.99 (1H, brs), 6.50 (1H, dd, J = 2.4, 8.3 Hz), 6.65-6.74 (2H, m), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.88-7.07 (8H, m).
1H-NMR (CDCl3)δ: 1.70-1.81 (2H, m), 2.36 (1H, dd, J = 10.2, 13.4 Hz), 2.39 (3H, s), 2.47 (1H, dd,J = 3.6, 17.1 Hz), 2.64-2.78 (3H, m), 2.83 (1H, dd, J = 4.1, 13.4 Hz), 3.12-3.20 (1H, m), 3.24-3.40 (2H, m), 3.69 (1H, d, J = 15.9 Hz), 3.76 (1H, d, J = 15.9 Hz), 5.91 (1H, brs), 6.73 (1H, dd, J = 2.4, 9.2 Hz), 6.82 (1H, dd, J = 1.8, 7.1 Hz), 6.85-6.90 (2H, m), 6.74-7.06 (7H, m), 7.18 (1H, dd, J = 1.8, 1.8 Hz).
1H-NMR (CDCl3)δ: 1.69-1.78 (2H, m), 2.34 (1H, dd, J = 10.3, 13.2 Hz), 2.45 (1H, dd, J = 3.9, 16.6 Hz), 2.63-2.76 (3H, m), 2.82 (1H, dd, J = 4.2, 13.2 Hz), 3.08-3.18 (1H, m), 3.23-3.38 (2H, m), 3.66 (6H, s), 3.67 (1H, d, J = 15.9 Hz), 3.75 (1H, d, J = 15.9 Hz), 6.04 (1H, brs), 6.08 (1H, dd, J = 2.2, 2.2 Hz), 6.45 (2H, d, J = 2.2 Hz), 6.70 (1H, dd, J = 2.4, 9.5 Hz), 6.84 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.92-7.03 (5H, m), 7.12 (1H, brs).
1H-NMR (CDCl3)δ: 1.74-1.84 (2H, m), 2.39 (1H, dd, J = 10.1, 13.3 Hz), 2.50 (1H, dd, J = 3.4, 15.6 Hz), 2.52 (3H, s), 2.72 (1H, dd, J = 4.9, 15.6 Hz), 2.73-2.83 (2H, m), 2.86 (1H, dd, J = 4.5, 13.3 Hz), 3.18-3.26 (1H, m), 3.29-3.43 (2H, m), 3.72 (1H, d, J = 15.9 Hz), 3.78 (1H, d, J = 15.9 Hz), 5.88 (1H, brs), 6.73 (1H, dd, J = 2.4, 9.3 Hz), 6.85 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.92-7.00 (3H, m), 7.01-7.06 (2H, m), 7.24 (1H, d, J= 8.0 Hz), 7.51 (1H, dd, J = 1.7, 7.8 Hz), 7.48-7.55 (1H, m), 7.75 (1H, dd, J = 1.7, 1.7 Hz).
1H-NMR (CDCl3)δ: 1.72-1.88 (2H, m), 2.43 (1H, dd, J = 10.0, 13.4 Hz), 2.57 (1H, dd, J = 2.9, 16.8 Hz), 2.76-2.85 (3H, m), 2.89 (1H, dd, J = 4.6, 13.4 Hz), 3.24-3.32 (1H, m), 3.32-3.42 (2H, m), 3.78 (2H, s), 5.73 (1H, brs), 6.79 (1H, dd, J= 2.7, 9.3 Hz), 6.89 (1H, ddd, J = 2.7, 8.6, 8.6 Hz), 6.96-7.02 (3H, m), 7.03-7.09 (2H, m), 7.17-7.21 (2H, m), 7.30-7.37 (1H, m), 7.53 (1H, brs).
1H-NMR (CDCl3)δ: 1.68-1.80 (2H, m), 2.41 (1H, dd, J = 10.3, 13.2 Hz), 2.52 (1H, dd, J = 3.7, 16.6 Hz), 2.66-2.84 (5H, m), 2.92 (1H, dd, J = 4.0, 13.2 Hz), 3.17-3.26 (1H, m), 3.76 (1H, d, J = 15.9 Hz), 3.85 (1H, d, J = 15.9 Hz), 4.11 (1H, brs), 6.52 (2H, dd, J = 1.5, 4.6 Hz), 6.75 (1H, dd, J = 2.4, 9.2 Hz), 6.86 (1H, ddd, J = 2.4, 8.6, 8.6 Hz), 6.98 (2H, ddd, J= 2.0, 6.8, 8.8 Hz), 7.02 (1H, dd, J = 5.8, 8.6 Hz), 7.04-7.09 (2H, m), 7.11 (1H, brs), 8.22 (2H, dd, J = 1.5, 4.6 Hz).
モルモット好酸球の調整は、文献(Pinkus, Blood. 52 (1978) 127-134)の方法を参考にして行った。即ち、6週齡のHartley系雄性モルモット(日本エスエルシー)腹腔内に、PBS(−)で希釈したポリミキシンB(SIGMA)を動物あたり2 mgとなるように週1回注入した。同様の操作を4回行った24時間後、ジエチルエーテル麻酔下にて腹腔内に個体あたり6U/mLのヘパリンおよび1mM EDTAを含むPBS(−)50mLを注入し、同液を回収した。1mM EDTAを含むPBS(−)にて洗浄後、比重1.070のPercoll液に懸濁した細胞を、不連続Percollグラジエント液を用いた遠心分離を行って好酸球粗画分を得た。PBS(−)にて洗浄後、1%FCSを含むRPMI−1640培地(SIGMA)にて懸濁し、CO2インキュベータ中で終夜培養した。翌日細胞を回収し、0.1%BSA(Bovine Serum Albumin、ウシ血清アルブミン、SIGMA)を含むRPMI−1640培地にて懸濁した好酸球に被験化合物を加え、37℃、30分間静置して前処置した。96ウェルケモタキシスチャンバー(Neuroprobe)の下室に終濃度100ng/mLとなるように調製したモルモットエオタキシン(Chmeical Synthesis Services)と被験化合物の混合液を加え、ポリビニルピロリドン(PVP)処理済みのポアサイズ5μmのポリカーボネートフィルター(Neuroprobe)、上室にウェルあたり12.0x105個の好酸球と被験化合物の混合液の順で重ねてセットし、CO2インキュベータ中で1時間反応させた。反応終了後、フィルターを取り出し、Diff−Quik染色キット(国際試薬)にて細胞染色を行い、顕微鏡下で遊走した好酸球を計数した。ウェルあたり5視野のカウントを行い、その平均値をもって遊走好酸球数とし、エオタキシンのみの反応を100%とした場合の阻害率を算出し、濃度―阻害率曲線から50%阻害を示す濃度(IC50値)を算出した。結果を表1に示す。
雄性Std/Hartleyモルモット(n=8)に10μg卵白アルブミン(OVA、Sigma)と100 mg水酸化アルミニウム(和光純薬)との懸濁液を腹腔内投与することにより感作(初回感作)を行い、さらにその2日後に同様の条件で再度感作を行なった。
初回感作から16日後に、0.5%OVAを30分間吸入させ、その30分前と4時間後に0.5%メチルセルロース水溶液に懸濁させた本発明化合物(実施例126)を10 mg/kgの用量で投与した。なお、control群には溶媒(0.5%メチルセルロース水溶液)のみを投与し、normal群には無処置動物を用いた。
初回感作から17日後、肺胞内を0.1%BSAを含むPBSで洗浄(10 mL×5往復×2回)して肺胞洗浄液を回収した。
回収した肺胞洗浄液は、多項目自動血球分析装置XT-2000i(Sysmex)により好酸球数を測定した。結果を図1に示す。
雄性Std/Hartleyモルモットに10μg卵白アルブミン(OVA、Sigma)と100 mg水酸化アルミニウム(和光純薬)との懸濁液を腹腔内投与することにより感作(初回感作)し、さらにその2日後に同様の条件で再度感作をした。
初回感作から16日後、生理食塩水に溶解させた被験物質(実施例180)を3 mg/kgの用量で静脈内投与し、その5分後に100ngエオタキシン(PeproTech)を気管内投与した。
なお、control群には溶媒(生理食塩水)のみを投与し、normal群には無処置動物を用いた。
エオタキシン気管内投与の2時間後、肺胞内を0.1%BSAを含むPBSで洗浄(10 mL×5往復×2回)し、肺胞洗浄液を回収した。
回収した肺胞洗浄液は総白血球数をカウントし、作成した塗沫標本のDiff-Quick染色により好酸球比率を測定し、好酸球数を算出した。結果を図2に示す。
雄性Std/Hartleyモルモット(n=10)に10μg卵白アルブミン(OVA、Sigma)と100 mg水酸化アルミニウム(和光純薬)との懸濁液を腹腔内投与することにより感作を行なった。
感作から7、14、21日後に、0.5%OVAを5分間、感作から28日後に5%OVAを30分間吸入させ、それぞれ、OVA吸入30分前と4時間後に0.5%メチルセルロース水溶液に懸濁させた本発明化合物(実施例161)を10 mg/kgの用量で投与した。また、感作から8〜13、15〜20、22〜27日後は、1日1回、30 mg/kgの用量でそれぞれ本発明化合物を同様に投与した。なお、control群には溶媒(0.5%メチルセルロース水溶液)のみを投与し、normal群には無処置動物を用いた。
感作から29日後、ペントバルビタール麻酔・人工呼吸下で1.25〜80μg/kgアセチルコリン(Ach)の静脈内投与による気道収縮を測定し、気道過敏性の指標として20%気道収縮を誘発するAch濃度(PC20)を算出した。結果を図3に示す。
本出願は、2007年4月4日出願の米国仮特許出願第60/909,997号(U.S. Provisional patent application No. 60/909,997)および2007年5月22日出願の米国仮特許出願第60/939,415号(U.S. Provisional patent application No. 60/939,415)、に基づくものであり、その内容は全てここに参照として取り込まれる。
Claims (13)
- 下記式(1):
R1、R2、R3、R4は、同一または異なって、−H、−ハロゲン、置換されていてもよいC1−6アルキル、−OH、−O−C1−6アルキル、−SH、−S−C1−6アルキル、−COOH、−CO−C1−6アルキル、−CO−O−C1−6アルキル、−CO−NH−C1−6アルキル、−NO2、−NH2、−NH−C1−6アルキル、−N(C1−6アルキル)2、または−NH−CO−C1−6アルキル、を示し、
R5は、置換されていてもよいC1−6アルキル(但し、アミノメチルを除く)、置換されていてもよいC3−10シクロアルキル、置換されていてもよいC6−14アリール、−C1−6アルキレン−置換されていてもよいC3−10シクロアルキル、または−C1−6アルキレン−置換されていてもよいC6−14アリールを示し、
R6は、−H、置換されていてもよい−C1−6アルキル、または−Y’−A’を示し、 XはC1−6アルキレンを示し、
Y及びY’は、同一または異なって、単結合又はC1−6アルキレンを示し、
A及びA’は、同一または異なって、置換されていてもよいC6−14アリールまたは置換されていてもよい3〜15員のヘテロ環基を示し、
nは0または1を示す。)
で示されるテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。 - nが0で、Aが以下の式で示される基である請求項1記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物
- Xがエチレン、Yがメチレン、R6が−Hである請求項2記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- R1、R4が−Hで、R2、R3が、同一又は異なって、−Hまたは−ハロゲンである請求項3記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- R5が、置換されていてもよいベンジルである請求項4記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- R5が、ハロゲノベンジルである請求項5記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- nが0で、R5が、−C1−6アルキレン−置換されていてもよいC6−14アリールで、A及びA’が、同一または異なって、置換されていてもよい3〜15員のヘテロ環基、またはナフチルである請求項1記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- A及びA’が、同一または異なって、ピリジル、ピリジル N−オキシド、ピリミジニル、イミダゾリル、ピロリル、チエニル、フリル、チアゾリル、キノリル、インドリル、及びベンゾイミダゾリルから選ばれる置換されていてもよいヘテロ環基、またはナフチルである請求項7記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- R1、R2、R3、及びR4が、同一または異なって、−Hまたは−ハロゲン、Xがエチレン、Yがメチレン、R6が−Hである請求項8記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。
- N−(4−tert−ブチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−アセチルベンジル)−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
3−[[2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド、
N−(4−tert−ブチル ベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−アセチルベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−[3−(メタンスルホニルアミノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3,5−ジメタンスルホニルアミノベンジル)−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−エチルアニリン、
N−[4−(4−モルホリノ)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−(2−メトキシエチル)アニリン、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N,N−ジエチルベンズアミド、
N−[4−(1−ヒドロキシ−1−メチルエチル)ベンジル]−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
3−[[2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]ベンズアミド、
N−(4−tert−ブチルベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
N−(3−メタンスルホニルアミノベンジル)−2−[3−(4−クロロベンジル)−6−フルオロ−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、
4−[[2−[7−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エチルアミノ]メチル]−N−イソプロピルアニリン、
N−(ピリジン−4−イル)メチル−2−[3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン、及び
N−(ピリジン−4−イル)メチル−2−[6−フルオロ−3−(4−フルオロベンジル)−3,4−ジヒドロイソキノリン−2(1H)−イル]エタンアミン
から選択されるテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物。 - 請求項1〜10のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物と、製薬学的に許容される担体とからなる医薬組成物。
- 請求項1〜10のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物を有効成分とするケモカインレセプタータイプ3(CCR3)拮抗剤。
- 請求項1〜10のいずれか1項に記載のテトラヒドロイソキノリン化合物、その製薬学的に許容される塩、またはそれらの溶媒和物を有効成分とする喘息、アレルギー性鼻炎、副鼻腔炎、アレルギー性結膜炎、アトピー性皮膚炎、潰瘍性大腸炎、クローン病、関節リウマチ、自己免疫疾患、HIV感染、またはHIV感染に伴う疾患の予防及び/または治療剤。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90999707P | 2007-04-04 | 2007-04-04 | |
US60/909,997 | 2007-04-04 | ||
US93941507P | 2007-05-22 | 2007-05-22 | |
US60/939,415 | 2007-05-22 | ||
PCT/JP2008/056677 WO2008123582A1 (ja) | 2007-04-04 | 2008-04-03 | テトラヒドロイソキノリン化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2008123582A1 JPWO2008123582A1 (ja) | 2010-07-15 |
JP5313881B2 true JP5313881B2 (ja) | 2013-10-09 |
Family
ID=39831046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009509297A Expired - Fee Related JP5313881B2 (ja) | 2007-04-04 | 2008-04-03 | テトラヒドロイソキノリン化合物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8273766B2 (ja) |
EP (1) | EP2143714B1 (ja) |
JP (1) | JP5313881B2 (ja) |
WO (1) | WO2008123582A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8707268B2 (en) | 2011-05-23 | 2014-04-22 | Interntional Business Machines Corporation | Testing operations of software |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR068509A1 (es) * | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
US8653299B2 (en) | 2011-03-17 | 2014-02-18 | Allergan, Inc. | Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
US8993555B2 (en) * | 2012-12-21 | 2015-03-31 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
WO2019058393A1 (en) | 2017-09-22 | 2019-03-28 | Jubilant Biosys Limited | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD |
SG11202003463XA (en) | 2017-10-18 | 2020-05-28 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
CN111386265A (zh) | 2017-11-06 | 2020-07-07 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1活化的抑制剂的嘧啶衍生物 |
MX2020005363A (es) | 2017-11-24 | 2020-10-01 | Jubilant Episcribe Llc | Compuestos heterociclicos como inhibidores de prmt5. |
EP3765453A1 (en) | 2018-03-13 | 2021-01-20 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
JP7212144B2 (ja) * | 2019-03-28 | 2023-01-24 | 興和株式会社 | 非細胞性根管充填材および非細胞性歯組織再生促進キット |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000066551A1 (fr) * | 1999-04-28 | 2000-11-09 | Takeda Chemical Industries, Ltd. | Composes d'amides cycliques, leurs procedes de preparation et d'utilisation |
WO2002012166A2 (en) * | 2000-08-04 | 2002-02-14 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
WO2002026708A1 (fr) * | 2000-09-27 | 2002-04-04 | Toray Industries, Inc. | Composes conenant de l'azote et inhibiteurs de ccr3 contenant ces composes en tant que principe actif |
JP2003093231A (ja) * | 2001-09-25 | 2003-04-02 | Df Shoei:Kk | 真空調理機 |
JP2004529132A (ja) * | 2001-03-27 | 2004-09-24 | アクテリオン ファマシューティカルズ リミテッド | 1,2,3,4−テトラヒドロイソキノリン誘導体 |
WO2006008133A2 (en) * | 2004-07-20 | 2006-01-26 | Siena Biotech S.P.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
JP2006514618A (ja) * | 2002-10-30 | 2006-05-11 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性のピペリジニル−アルファ−アミノアミドモジュレーター |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294621A (en) | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
WO2000051607A1 (en) | 1999-03-02 | 2000-09-08 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
WO2000053600A1 (fr) | 1999-03-11 | 2000-09-14 | Banyu Pharmaceutical Co., Ltd. | Derives piperidiniques |
NZ525055A (en) | 2000-09-29 | 2004-09-24 | Glaxo Group Ltd | Compounds useful in the treatment of inflammatory diseases |
AU2002222853A1 (en) | 2000-12-07 | 2002-06-18 | Astrazeneca Ab | Therapeutic compounds |
WO2002059081A2 (en) | 2001-01-26 | 2002-08-01 | Kirin Beer Kabushiki Kaisha | Urea derivatives as inhibitors of ccr-3 receptor |
WO2003041641A2 (en) * | 2001-11-09 | 2003-05-22 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity |
GB0203299D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel compounds |
GB0212355D0 (en) | 2002-05-29 | 2002-07-10 | Glaxo Group Ltd | Novel compounds |
AU2003301226A1 (en) | 2002-12-20 | 2004-07-22 | Pharmacia Corp | Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
DE10333650A1 (de) | 2003-07-24 | 2005-02-24 | Bayerische Motoren Werke Ag | Steuersystem für ein zumindest zeitweise vierradgetriebenes Kraftfahrzeug |
ES2286664T3 (es) | 2003-09-15 | 2007-12-01 | Novartis Ag | Derivados de azetidina 1,3-disustituida para ser utilizados como antagonistas del receptor ccr en el tratamiento de enfermedades inflamatorias y alergicas. |
US7723360B2 (en) | 2004-08-06 | 2010-05-25 | Boehringer Ingelheim International Gmbh | Alkyl-and piperidine-substituted benzimidazole derivatives |
GB0417804D0 (en) | 2004-08-10 | 2004-09-15 | Novartis Ag | Organic compounds |
PT1801108E (pt) | 2004-09-08 | 2012-12-03 | Mitsubishi Tanabe Pharma Corp | Composto de morfolina para o tratamento de inflamações |
-
2008
- 2008-04-03 WO PCT/JP2008/056677 patent/WO2008123582A1/ja active Application Filing
- 2008-04-03 EP EP08739784.0A patent/EP2143714B1/en not_active Not-in-force
- 2008-04-03 US US12/531,318 patent/US8273766B2/en not_active Expired - Fee Related
- 2008-04-03 JP JP2009509297A patent/JP5313881B2/ja not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000066551A1 (fr) * | 1999-04-28 | 2000-11-09 | Takeda Chemical Industries, Ltd. | Composes d'amides cycliques, leurs procedes de preparation et d'utilisation |
WO2002012166A2 (en) * | 2000-08-04 | 2002-02-14 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
WO2002026708A1 (fr) * | 2000-09-27 | 2002-04-04 | Toray Industries, Inc. | Composes conenant de l'azote et inhibiteurs de ccr3 contenant ces composes en tant que principe actif |
JP2004529132A (ja) * | 2001-03-27 | 2004-09-24 | アクテリオン ファマシューティカルズ リミテッド | 1,2,3,4−テトラヒドロイソキノリン誘導体 |
JP2003093231A (ja) * | 2001-09-25 | 2003-04-02 | Df Shoei:Kk | 真空調理機 |
JP2006514618A (ja) * | 2002-10-30 | 2006-05-11 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性のピペリジニル−アルファ−アミノアミドモジュレーター |
WO2006008133A2 (en) * | 2004-07-20 | 2006-01-26 | Siena Biotech S.P.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8707268B2 (en) | 2011-05-23 | 2014-04-22 | Interntional Business Machines Corporation | Testing operations of software |
US8745588B2 (en) | 2011-05-23 | 2014-06-03 | International Business Machines Corporation | Method for testing operation of software |
Also Published As
Publication number | Publication date |
---|---|
EP2143714A4 (en) | 2011-09-07 |
WO2008123582A1 (ja) | 2008-10-16 |
JPWO2008123582A1 (ja) | 2010-07-15 |
EP2143714B1 (en) | 2013-06-05 |
US20100120844A1 (en) | 2010-05-13 |
EP2143714A1 (en) | 2010-01-13 |
US8273766B2 (en) | 2012-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5313881B2 (ja) | テトラヒドロイソキノリン化合物 | |
EP3164395B1 (en) | Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators | |
JP4732354B2 (ja) | グリシン輸送阻害薬としての二環式[3.1.0]誘導体 | |
EA006300B1 (ru) | Производные фталазинона | |
JP3397320B2 (ja) | 縮合イミダゾリウム誘導体 | |
JP2020515583A (ja) | アリールシクロプロピル−アミノ−イソキノリニルアミド化合物 | |
KR20170018913A (ko) | 리신 특이적 데메틸라제-1의 억제제 | |
JPWO2006057270A1 (ja) | 含窒素3環化合物 | |
JP2019529359A (ja) | ベータ−アミノ−イソキノリニルアミド化合物 | |
AU707574B2 (en) | Tri-aryl ethane derivatives as PDE IV inhibitors | |
JP2005232175A (ja) | 5−置換イソキノリン医薬 | |
MXPA04009374A (es) | Derivados de tiazolidincarboxamida como moduladores del receptor de prostaglandina. | |
ES2645847T3 (es) | Derivado de glicinamida alfa-sustituido | |
WO2012075232A1 (en) | Opioid receptor ligands and methods of using and making the same | |
US20100179118A1 (en) | Cyclic aminoalkylcarboxamide derivative | |
JP2018519247A (ja) | リガンド結合ドメインを標的とする新規なepha4阻害剤 | |
TWI659022B (zh) | 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物 | |
JP4903355B2 (ja) | フタラジノン誘導体 | |
CA3178647A1 (en) | Substituted tricyclic amides, analogues thereof, and methods using same | |
CN108997328B (zh) | 亚氨基噻二嗪二氧化物衍生物及其用途 | |
CN114685472B (zh) | 多取代的尿嘧啶衍生物及其用途 | |
JP2016094407A (ja) | 新規なtrpm8阻害薬 | |
JP2004083511A (ja) | アクリルアミド誘導体 | |
TW202214585A (zh) | 經取代之異喹啉基甲基醯胺類、其類似物及使用其之方法 | |
TW202214574A (zh) | 經取代之(呔-1-基甲基)脲類、經取代之n-(呔-1-基甲基)醯胺類及其類似物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130412 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130611 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130704 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |